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ABSTRACT 
Background 
Restrictive bariatric procedures have been increasingly used to manage obesity in 
Western countries (1). Despite the substantial weight loss and improvement in 
several health outcomes seen following bariatric surgery (2, 3), there is evidence to 
suggest little or no change in objective measures of physical activity (PA) and 
sedentary behaviour (SB) (4-9). However, the studies that investigated pre- to post-
surgery changes in objective measures of PA and SB had important limitations in 
regards to the assessment methods used, including low adherence to the motion 
sensor used (4), and suboptimal placement of the motion sensor around the waist or 
hip, which might decrease accuracy due to motion sensor tilt as a result of 
abdominal adipose tissue (5, 8). Additionally, the samples in these studies contained 
mostly people who underwent gastric bypass, which may limit the generalisability of 
their findings to people who undergo restrictive bariatric surgery. Therefore, there is 
a need for studies that use state-of-the-art devices to investigate changes in 
objective measures of PA and SB following restrictive bariatric surgery. If, following 
surgery, people do not change their PA and SB, they remain at risk of the 
detrimental effects of participation in little PA and increased SB, regardless of the 
amount of weight loss achieved post-surgery. Little is known about outcomes 
relevant to participation in PA among people who undergo restrictive bariatric 
surgery, such as self-efficacy to exercise, cardiovascular fitness, sleep quality, 
daytime sleepiness, body composition and bone mineral density (BMD). Further, 
there are scarce data on the reasons why people scheduled to undergo restrictive 
bariatric surgery engage in low levels of PA or why this behaviour appears to persist 
despite significant post-surgery weight loss. A better understanding of the effect of 
surgery on outcomes relevant to PA, and of factors that influence participation in PA, 
such as beliefs about PA, perceived barriers and facilitators to PA among people 
who undergo restrictive bariatric surgery, and how they change post-surgery, is 
needed to shape behavioural interventions aimed at increasing PA in this population 
(10, 11). Although the favourable effects of bariatric surgery on measures of weight, 
health-related quality of life (HRQoL) and symptoms of mental health disorders are 
well-documented following surgery, little is known regarding the pattern of change in 
these outcomes over the first 12 months following bariatric surgery, when the 
majority of weight loss is expected to happen. The investigation of the pattern of 
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change in different outcomes post-surgery could provide useful data to inform 
patients’ expectations and post-surgery management (12-15). 
This programme of research comprised two studies. Study 1 was a quantitative, 
longitudinal study that investigated changes in the primary outcome measures of PA 
and SB, and in secondary outcome measures. First, changes were investigated in 
secondary outcomes that have not been widely investigated in previous literature 
and are relevant to PA. Second, changes were investigated in secondary outcomes 
that have been widely investigate, in order to confirm the previously established 
efficacy of restrictive bariatric surgery procedures and ensure that the investigation 
of measures of PA and SB occurred in the context of the expected response to 
surgery. Further, for the primary outcomes, and when feasible, for secondary 
outcomes, measures were collected pre-surgery and every 3 months for the first 12 
months post-surgery, in order to investigate the magnitude and pattern of change 
following restrictive bariatric surgery. Study 2 was a qualitative, longitudinal study in 
a separate sample to Study 1 that explored participants’ perceptions of factors 
related to their participation in PA pre-surgery and 12 months post-surgery, and how 
these differed from their pre-surgery perceptions. Study 2 was divided in two parts: 
Study 2(A) was conducted prior to restrictive bariatric surgery and Study 2(B) at 12 
months following restrictive bariatric surgery. Both Study 2(A) and (B) were 
conducted in the same sample of participants.  
Study 1 – Physical activity, sedentary behaviour and other health 
outcomes following restrictive bariatric surgery 
The following research questions were addressed in Study 1:  
(i) Compared with measures collected pre-surgery, what is the magnitude of change 
in measures of PA and SB collected over the first 12 months following restrictive 
bariatric surgery? 
(ii) Compared with measures collected pre-surgery, what is the magnitude of change 
in measures of cardiovascular fitness, self-efficacy to exercise, sleep quality, 
daytime sleepiness, body composition and BMD, collected over the first 12 months 
following restrictive bariatric surgery? 
(iii) Compared with measures collected pre-surgery, what is the magnitude of 
change in measures of weight, obesity-related comorbid conditions, HRQoL, 
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obesity-related quality of life and weight-related symptoms, and symptoms of 
depression, anxiety and stress; and (iv) does the magnitude of change in measures 
of weight differ between laparoscopic sleeve gastrectomy (LSG) in comparison to 
laparoscopic adjustable gastric banding (LAGB) over the first 12 months following 
restrictive bariatric surgery ? 
Methods: Obese adults who were scheduled to undergo restrictive bariatric surgery 
were assessed pre-surgery and every 3 months for the first 12 months post-surgery. 
Pre-surgery and at 12 months post-surgery, measurements were collected of PA 
and SB, using the SenseWear Armband (SAB) and the StepWatch 3 Activity Monitor 
(SAM). Energy expenditure, expressed as METs, derived from the SAB, were used 
to group time spent in SB and PA at different intensities. Specifically, each minute of 
waking hours was grouped into the following categories; SB (i.e. < 1.5 METs), light 
intensity PA (i.e. 1.5 to < 3 METs), and moderate to vigorous intensity PA (≥ 3 
METs). Data from the SAM provided measures of daily step count. Measures were 
also collected of cardiovascular fitness (Physical Working Capacity 170 test), self-
efficacy to exercise (Exercise Self-Efficacy Scale), sleep quality (Pittsburgh Sleep 
Quality Index), daytime sleepiness (Epworth Sleepiness Scale), body composition 
and BMD (whole-body dual energy x-ray absorptiometry), weight (scale), obesity-
related comorbid conditions (blood samples and ApneaLink), HRQoL (Medical 
Outcomes Study Short Form 12 General Health Survey v2), obesity-related quality 
of life and weight-related symptoms (Impact of Weight on Quality of Life 
Questionnaire, Obesity and Weight-loss Quality-of-life Instrument, and Weight-
related Symptoms Measure), and symptoms of depression, anxiety and stress (Beck 
Depression Inventory and Depression Anxiety Stress Scales). Additionally, at 3, 6 
and 9 months post-surgery, measures were collected of all outcomes except 
cardiovascular fitness, body composition and BMD, and obesity-related comorbid 
conditions.  
Results: Thirty obese adults (20 females) participated in this study, with a mean 
age of 44.1 years (standard deviation [SD], 11.2), weight of 114.6 kg (SD, 17.2), and 
body mass index (BMI) of 39.6 kg/m2 (SD, 5.5). Twenty two (73%) participants 
underwent LSG and eight (27%) underwent LAGB. Compared to pre-surgery 
measures, 12 months post-surgery there were no changes in measures of SB 
(mean change, -2% waking hours; 95% confidence interval [CI], -6 to 3), light 
intensity PA (mean change, 1% waking hours; 95% CI, -3 to 5), or moderate to 
vigorous intensity PA (MVPA; mean change, 1% waking hours; 95% CI, -1 to 3). At 
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all time points, participants spent more than 70% of their waking hours in SB, which 
was mostly accumulated in prolonged uninterrupted bouts ≥ 30 minutes (i.e. ≥ 51% 
of total time in SB), and only 5% of their waking hours in MVPA, which was mostly 
accumulated in very short bouts < 10 minutes (i.e. ≥ 82% of total time in MVPA). 
Additionally, the little time participants spent in PA was mostly performed in light 
intensity (i.e. around 20% of waking hours). There was also no change in 
participants’ daily step count or cardiovascular fitness. The lack of change in 
measures of PA, SB and cardiovascular fitness occurred despite a significant 
improvement in participants’ self-efficacy to exercise (mean change, 18.9 points; 
95% CI, 11.3 to 26.5) and large and significant reductions in weight-related 
measures (mean change, 72% of excess weight loss; 95% CI, 61 to 83). Similarly, 
there were large and significant improvements in measures of sleep quality, daytime 
sleepiness, HRQoL, obesity-related quality of life and weight-related symptoms and 
symptoms of depression, anxiety and stress. The substantial weight loss achieved 
post-surgery was accompanied by reductions in fat mass (mean change, -21.9 kg; 
95% CI, -26.9 to -17.0) and fat-free mass (mean change, -5.1 kg; 95% CI, -6.5 to -
3.7), with no change in total body BMD. The majority of change in significantly 
improved outcomes was observed in the first 3 months, with less or no change 
between 6 and 12 months post-surgery. 
Study 2 – Qualitative exploration of factors related to participation in 
physical activity among people prior to and 12 months following 
restrictive bariatric surgery 
The following research questions were addressed in Study 2:  
(i) Prior to restrictive bariatric surgery, what are participants’ beliefs about PA, and 
perceived barriers and facilitators to PA? 
(ii) Twelve months following restrictive bariatric surgery, (a) what are the perceptions 
of participants regarding their ability to participate in PA as well as barriers and 
facilitators to PA? (b) How do these perceptions differ from participants’ perceptions 
pre-surgery? and (c) What are the perceived motivators to PA at 12 months 
following restrictive bariatric surgery? 
Methods: Study 2(A): obese adults participated in a semi-structured one-on-one 
interview within the month immediately prior to restrictive bariatric surgery. Study 
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2(B): participants from Study 2(A) were invited to participate in semi-structured one-
on-one interviews 12 months following restrictive bariatric surgery. The interviews 
comprised open-ended questions focused on participants’ beliefs about PA, 
perceived barriers and facilitators to PA, perceived ability to engage in PA and 
perceived motivators to PA. All interviews were audio-recorded and transcribed 
verbatim. Data were analysed using thematic analysis and emergent themes were 
reported with supporting quotes. 
Results: Study 2(A): 19 obese adults (15 females) were interviewed pre-surgery, 
with a mean age of 41.6 years (range, 19 - 66), weight of 119.2 kg (range, 92.8 - 
182.2), and BMI of 41.6 kg/m2 (range, 30.0 - 54.2). Although most participants 
believed that engaging in regular PA was important for health benefits, they reported 
participating in insufficient PA levels to obtain those benefits. The perceived barriers 
to PA were both obesity-related (e.g. bodily pain, physical limitation, and self-
presentational concerns) and non-obesity related (e.g. lack of motivation, lack of 
time and social support issues). All participants reported weight loss as the main 
perceived facilitator to PA, together with social factors, better time management, and 
access to financial resources. Study 2(B): 14 (12 females) of the 19 participants 
from Study 2(A) were interviewed at 12 months post-surgery. Eight (57%) 
participants underwent LSG and six (43%) underwent LAGB. At this post-surgery 
interview, their mean weight was 90.3 kg (range, 60.0 - 152.0), BMI was 31.7 kg/m2 
(range, 22.3 - 48.2), and average percentage of excess weight loss was 66% 
(range, 2 - 127). Most participants indicated not engaging in PA during the first 3 to 
6 months post-surgery, and many reported no change or decreased participation in 
PA over the first 12 months post-surgery. Participants reported an increase in their 
ability to engage in PA, which was mostly described as a result of the reduction in 
obesity-related physical barriers to PA achieved with weight loss, such as bodily 
pain and extra physical work. Despite the reports of improvements in some obesity-
related barriers to PA (e.g. physical barriers and self-presentational concerns), many 
participants indicated that there were residual obesity-related perceived barriers to 
PA (e.g. joint pain) and for some there was a shift in focus regarding self-
presentational concerns from pre-surgery to 12 months post-surgery (i.e. from 
excess weight to excess skin). Most participants reported that the non-obesity 
related perceived barriers to PA identified pre-surgery, such as lack of motivation, 
lack of time and social support issues, were still present at 12 months post-surgery. 
Participants reported low motivation to engage in PA, and believed PA to be 
unnecessary post-surgery given the substantial weight loss achieved. Perceived 
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facilitators to PA were consistent between pre- and post-surgery interviews. 
Regarding motivators to PA, at 12 months post-surgery, extrinsic, esteem-based 
motivators, such as additional weight loss and improving physical appearance were 
the most commonly reported. 
Discussion and conclusions  
Study 1 demonstrated that, when compared with pre-surgery measures, there were 
no changes in total time spent in PA, at any intensity, in total time spent in SB, or in 
the way PA and SB were accumulated over the first 12 months following restrictive 
bariatric surgery. There was also no change in cardiovascular fitness. The lack of 
change in measures of PA, SB and cardiovascular fitness occurred despite large 
and significant weight loss and improvement in self-efficacy to exercise. These 
findings also strongly suggest that large and significant improvements in sleep 
quality, daytime sleepiness, HRQoL, obesity-related quality of life and weight-related 
symptoms and symptoms of mental health disorders do not result in enhanced 
participation in PA and SB. The lack of change in PA despite improvements in self-
efficacy to exercise and other health outcomes (e.g. weight-related symptoms) was 
supported by findings from Study 2, which demonstrated most participants did not 
change their participation in PA over the first 12 months post-surgery despite reports 
of an increase in their ability to engage in PA and of reductions in obesity-related 
barriers to PA. Findings from Study 2 also indicated the presence of several residual 
perceived barriers to PA, particularly non-obesity related barriers, such as lack of 
motivation, lack of time and social support issues at 12 months post-surgery. 
Particularly, at 12 months post-surgery, participants presented mainly extrinsic or 
controlled types of motivation, such as additional weight loss and improvement in 
physical appearance, rather than intrinsic or self-determined types of motivation, 
such as enjoyment of PA. This is important given extrinsic types of motivation have 
little association with maintenance of PA (16, 17).  
The findings from this programme of research provide novel insight into factors 
relevant to participation in PA in people following restrictive bariatric surgery, and 
highlights that a behavioural intervention with a multidisciplinary approach is likely to 
be required in order to change PA in this population. Further, these findings 
demonstrated that the little time people spent in PA was mostly performed in light 
intensity PA rather than MVPA. Therefore, a behavioural intervention should include 
goal setting strategies that target feasible goals for increasing PA, such as an initial 
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increase in light intensity PA, which would likely further improve people’s self-
efficacy to engage in PA and serve as a gateway to both reduce time spent in SB 
and increase participation in more challenging activities (i.e. MVPA). Such an 
intervention could also be enhanced by including a combination of problem solving 
and planning strategies to manage the several barriers to PA identified both pre- 
and post-surgery. Further, the use of strategies aimed at reducing extrinsic types of 
motivation and promoting intrinsic types of motivation in such an intervention is likely 
to enhance the efficacy of such interventions. Future research is needed in people 
following restrictive bariatric surgery to investigate the effect of a multidisciplinary 
behavioural intervention aimed at optimising PA on significant and sustained 
changes in PA, as well as other relevant outcomes, such as reduced 
cardiometabolic risk and weight maintenance. Such an intervention should target 
goal setting, problem solving and planning strategies, as well as self-efficacy and 
motivation to engage in PA.  
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CHAPTER 1 INTRODUCTION 
Overview 
Obesity has become a major health problem, and is currently considered one of the 
most important causes of preventable death worldwide (18). The prevalence of 
obesity has increased rapidly, with the most recent population-based data from 
Australia indicating that 63% of adults were overweight or obese in 2011-2012, 
which represented a 7% increase from 1995 (19). Surgical treatment, also referred 
to as bariatric surgery, has been increasingly used to manage obesity in Western 
countries (1). This increase is because when compared to non-surgical treatment 
options (e.g. diet, exercise, lifestyle interventions), surgical treatment results in 
greater and sustained weight loss, as well as improvement and/or resolution of 
obesity-related comorbid conditions (2, 3). 
Despite the effectiveness of bariatric surgery for the treatment of obesity, there is 
evidence to show that, both pre- and post-surgery, people participate in little 
physical activity (PA) and spend most of their waking hours in sedentary behaviour 
(SB) (20-29). The few studies that have collected objective measures of PA and SB 
data in people pre- and post-surgery often report little or no change in these 
measures (4-9). However, these studies presented important limitations regarding 
methods used to assess PA and SB. Specifically, these limitations included low 
adherence to the motion sensor used (4), and suboptimal placement of the motion 
sensor around the waist or hip, which might decrease accuracy due to motion 
sensor tilt as a result of abdominal adipose tissue (5, 8). If, following bariatric 
surgery, people do not increase their participation in PA and reduce time spent in 
SB, they are still at risk of the detrimental health effects associated with a pattern of 
little participation in PA and increased SB, regardless of the significant weight loss 
and improvement and/or resolution of obesity-related comorbid conditions achieved 
post-surgery (30-33). Given the increased use of bariatric surgery for the treatment 
of obesity, particularly of restrictive procedures, there is a need for studies which 
use state-of-the-art devices to investigate pre- to post-surgery changes in objective 
measures of PA and SB. 
There is a growing interest in the possible beneficial effects of adding behavioural 
interventions that target an increase in PA, pre- or post-surgery, on bariatric surgery 
outcomes (34-38). However, little is known about outcomes relevant to participation 
in PA among people who undergo restrictive bariatric surgery, such as self-efficacy 
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to exercise, cardiovascular fitness, sleep quality, daytime sleepiness, body 
composition and bone mineral density (BMD). Additionally, there are scarce data on 
people’s perceptions of barriers, facilitators and motivators to PA in this population. 
A comprehensive understanding of factors that influence participation in PA among 
people who undergo restrictive bariatric surgery, and how they change post-surgery, 
is needed to shape behavioural interventions aimed at increasing PA in this 
population (10, 11). 
Furthermore, although beneficial changes in a number of outcomes, including 
measures of weight, health-related quality of life (HRQoL) and symptoms of mental 
health disorders are well-documented following bariatric surgery, little is known 
regarding the pattern of change in these outcomes over the first 12 months post-
surgery, when the majority of weight loss is expected to happen. The assessment of 
the pattern of change, that is, the investigation of the time over which most of the 
change in different outcomes occurs for the average patient during the first 12 
months post-surgery is relevant to inform both patients’ expectations and post-
surgical management (12-15). 
This programme of research investigated changes in measures of PA, SB, and other 
health outcomes relevant to participation in PA over the first 12 months following 
restrictive bariatric surgery. Additionally, in a separate sample, it explored 
participants’ perceptions of factors related to their participation in PA pre-surgery 
and how these changed post-surgery. This chapter provides an overview of the 
literature related to the development of the research questions addressed by the two 
studies that comprised this programme of research. The significance of the 
programme of research is also discussed.  
1.1 Study 1 
The first study in this programme of research investigated changes in measures of 
PA, SB, and other health outcomes following restrictive bariatric surgery. The 
primary outcome measures of PA and SB were collected pre-surgery and every 3 
months for the first 12 months post-surgery. Secondary outcome measures were 
divided in two groups. First, measures were collected of outcomes that have not 
been widely investigated in previous literature and are relevant to participation in 
PA. These measures comprised cardiovascular fitness, self-efficacy to exercise, 
sleep quality, daytime sleepiness, body composition and BMD. Second, measures 
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were collected to confirm the previously established efficacy of restrictive bariatric 
surgery procedures, to ensure that the investigation of measures of PA and SB 
occurred in the context of the expected response to surgery. These measures 
comprised weight, obesity-related comorbid conditions, HRQoL, obesity-related 
quality of life and weight-related symptoms, and symptoms of depression, anxiety 
and stress. When feasible, secondary outcome measures were also collected at 
multiple time points over the first 12 months post-surgery, in order to investigate the 
magnitude and pattern of change post-surgery.  
1.1.1 Primary research question 
Compared with measures collected pre-surgery, what is the magnitude of change in 
measures of PA and SB collected over the first 12 months following restrictive 
bariatric surgery? 
1.1.1.1 Background 
People who are obese and those scheduled to undergo bariatric surgery participate 
in little PA and spend most of their time in SB (20-24, 27, 39, 40). There are also 
data to suggest that people scheduled to undergo bariatric surgery have lower 
participation in PA and spend more time in SB than the general population (21, 41). 
This is of concern since regular participation in PA, particularly moderate to vigorous 
intensity PA (MVPA), has been associated with several physical and mental health 
benefits, such as lower risk of obesity-related comorbid conditions (e.g. diabetes 
mellitus type 2 [DM2] and cardiovascular diseases), symptoms of mental health 
disorders, and all-cause and disease-specific mortality (42). Further, research has 
shown that increased time spent in SB results in deleterious health effects, 
regardless of participation in MVPA (43-45). More recently, there is evidence to 
show beneficial effects on cardiometabolic health when time spent in SB is replaced 
by light intensity PA (46-49). In addition to the total amount of time spent in PA and 
SB, the way in which PA and SB are accumulated is also relevant to health effects 
(43, 50). International guidelines for the development and maintenance of health 
recommend that, in order to optimise the health benefits related to PA, adults should 
participate in a minimum of 150 minutes of MVPA per week, and that MVPA should 
be accumulated in bouts of at least 10 minutes (50). In order to prevent weight gain, 
recent guidelines recommend that adults should accumulate between 150 and 250 
minutes of MVPA per week, with greater amounts (>250 minutes of MVPA per 
week) needed for weight loss (51). Additionally, data from recent research 
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recommend people to interrupt prolonged continuous periods of SB (i.e. > 30 
minutes) as often as possible, which can be done with light intensity PA (e.g. 
standing, slow walking) (52-54). 
It might be reasonable to expect that following bariatric surgery, the dramatic weight 
loss would facilitate greater participation in PA and decreased time in SB. 
Nevertheless, the few studies that have investigated pre- to post-surgery changes in 
objective measures of PA and SB suggest little or no change in such measures (4-
9). However, the results of these studies may be limited by factors related to the 
assessment of PA and SB, including low adherence to the motion sensor used (i.e. 
only 37% of participants with valid motion sensor data) (4), and suboptimal 
placement of the motion sensor around the waist or hip, which might decrease 
accuracy due to motion sensor tilt as a result of abdominal adipose tissue (5, 8). 
Further, these studies focused on measures of MVPA and daily step count, with only 
two studies reporting time spent in SB (7, 8) and no study reporting time spent in 
light intensity PA. Additionally, the samples in these studies were comprised mostly 
of people who underwent gastric bypass, which may limit the generalisability of their 
findings to people who undergo restrictive bariatric surgery. This is because 
malabsorptive and mixed bariatric procedures have been found to result in longer 
hospital stay, higher rates of post-surgery complications and of nutritional 
deficiencies that may affect post-surgery recovery, energy levels, and participation 
in PA (3, 55, 56). 
Understanding the effect of bariatric surgery on PA and SB is important. This is 
because the health benefits of participation in PA and the detrimental health effects 
of SB are independent of obesity (43-45, 57-65). That is, despite large weight loss 
post-surgery, if people do not change their PA and SB, they remain at risk of the 
detrimental effects of participation in little PA and increased time spent in SB. 
Furthermore, specific to this population, participation in the recommended amounts 
of MVPA and decreased time spent in SB have been associated with better post-
surgery outcomes, such as greater weight loss, favourable changes in body 
composition and risk factors of cardiovascular disease, and better HRQoL (66-69). 
This study will extend the current understanding of the effect of restrictive bariatric 
surgery on PA and SB by reporting changes at multiple time points over the first 12 
months post-surgery, and how time in PA and SB is accumulated. This is important 
since not just total time spent in PA and SB, but also the way in which they are 
accumulated is important to health effects (43, 50, 54, 70). Finally, this study will 
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report on changes across the activity spectrum, including light intensity PA. This is 
of relevance given the increasing recognition of the cardiometabolic health benefits 
associated with participation in light intensity PA (46-49).Therefore, in this 
population, detailed analyses that characterise PA, at any intensity, and SB pre-
surgery and over the first 12 months post-surgery will provide useful information on 
which to shape future behavioural interventions that aim to optimise total time in PA 
and SB and/or the way in which time in PA and SB are accumulated. Such 
interventions may enhance other post-surgery outcomes. 
1.1.2 Secondary research question (outcomes relevant to physical activity)  
Compared with measures collected pre-surgery, what is the magnitude of change in 
measures of cardiovascular fitness, self-efficacy to exercise, sleep quality, daytime 
sleepiness, body composition and BMD, collected over the first 12 months following 
restrictive bariatric surgery? 
1.1.2.1 Background 
In people who undergo bariatric surgery, little attention has been given to factors 
that may influence, or be influenced by, participation in PA. Specifically, people who 
are overweight and obese often report that starting and adhering to planned and 
structured PA poses a daunting challenge. This population also often reports 
negative experiences regarding participation in PA (71, 72). They are therefore likely 
to have low self-efficacy to engage in PA, which is defined as the belief that one has 
the ability to successfully engage in PA (73). To date, no study has investigated the 
effect of restrictive bariatric surgery on self-efficacy, which is surprising given that 
self-efficacy to exercise has been recognised as an important determinant of change 
in PA (74). Following bariatric surgery, the dramatic weight loss may serve to 
improve people’s self-efficacy to exercise. As self-efficacy can be changed and 
developed through behavioural interventions (75), understanding whether or not 
bariatric surgery improves self-efficacy to exercise may inform clinicians of whether 
self-efficacy to exercise should be targeted in this population. Further, information 
regarding timing of any such change during the first 12 months post-surgery may be 
useful when determining the optimal time for an intervention that aims to increase 
participation in PA among people following bariatric surgery.  
One important factor that may limit participation in MVPA among people scheduled 
for bariatric surgery is impaired cardiovascular fitness. That is, people who are 
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obese and have low cardiovascular fitness may lack the capacity to engage in 
MVPA (76-80). Reductions in aerobic reserve may explain earlier reports of people 
who are overweight or obese perceiving MVPA as more laborious and less pleasant 
than their normal-weight counterparts (71, 72, 81). This, in turn, is likely to 
compromise their participation in MVPA. There are scarce data on pre- to post-
surgery changes in measures of cardiovascular fitness following restrictive bariatric 
surgery. Measures have been made using either a maximal or submaximal exercise 
test, and changes in cardiovascular fitness reported between 7 to 36 months post-
surgery have been inconsistent (82-85). Although two studies have found a 
significant increase in measures of cardiovascular fitness (i.e. six-minute walk 
distance and resting heart rate) at 12 months following LAGB (82) and 3 years 
following RYGB and LAGB (85), the other two studies have found no change in 
measures of cardiovascular fitness (i.e. six-minute walk distance and peak oxygen 
uptake) at 7 months following LSG (84) and 28 months following RYGB and LSG 
(83).The inconsistent results might be explained by the different sample sizes (e.g. 
range of 15 to 1,205 participants per study), heterogeneous samples included in the 
studies, different assessment methods used and diverse follow-up periods. In 
addition, the aforementioned studies used either a maximal exercise test that may 
be influenced by people’s ability and/or willingness to exercise until exhaustion, or a 
submaximal test that required walking, in which performance may be limited by gait 
limitations often found in the obese population (86). There are no studies that have 
investigated pre- to post-surgery changes in cardiovascular fitness using an 
exercise test that does not require maximal effort and is minimally affected by gait 
limitations, such as a submaximal exercise cycle test. Understanding the effect of 
restrictive bariatric surgery on cardiovascular fitness will inform clinicians about 
whether or not people’s capacity to engage in MVPA improves post-surgery and 
whether an increase in cardiovascular fitness should be targeted as part of post-
surgery management. 
In addition to low cardiovascular fitness, it is possible that participation in PA is 
compromised by problems related to sleep, such as sleep disordered breathing (i.e. 
obstructive sleep apnoea), poor sleep quality and excessive daytime sleepiness. A 
high prevalence of such problems has been well established in people who are 
obese (87-89). The low energy levels and high levels of fatigue reported by people 
who experience problems with sleep are likely to have a negative influence on 
participation in PA (90). This is supported by findings from recent research showing 
that poor sleep predicts lower levels of PA (91, 92). Additionally, there is evidence to 
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show that regular participation in PA results in better sleep (90). Little is known 
about the effect of restrictive bariatric surgery on measures of sleep quality and 
daytime sleepiness (93-98). The two studies that have investigated pre- to post-
surgery changes in measures of sleep quality have reported significant 
improvements following restrictive bariatric surgery, however, only one of the two 
studies used a validated outcome measure (93, 96). The few studies that 
investigated pre- to post-surgery changes in measures of daytime sleepiness 
reported significant improvements following restrictive bariatric surgery (93-95, 97, 
98). However, these studies focused exclusively on people who had severe 
obstructive sleep apnoea, which limits the generalisability of their findings to the 
wider population of people who undergo bariatric surgery. 
Regarding factors that may be influenced by participation in PA, this programme of 
research also explored the effect of restrictive bariatric surgery on measures of body 
composition and BMD, using whole-body dual energy x-ray absorptiometry (DXA). 
Previous investigations of changes in measures of body composition following 
restrictive bariatric surgery have typically used bioelectrical impedance analysis 
(BIA) due to low cost and ease of application. However, measures of BIA are known 
to have considerable error in obese populations, and those studies which have used 
DXA have focused exclusively on people who underwent laparoscopic adjustable 
gastric banding and were limited to female samples (99-104). Previous research 
using DXA has consistently reported large and significant reductions in fat mass up 
to 2.5 years following restrictive bariatric surgery (100, 102-112). Of note, however, 
is that significant reductions in fat free mass up to 2 years have also been reported 
following restrictive bariatric surgery (100, 102-104, 106-108, 110-113). This is an 
undesirable outcome of surgery since decreased muscle mass, which is a 
component of fat-free mass, has been associated with limited mobility and increased 
risk of falls, particularly among older adults (114, 115). There are also data to 
suggest that the substantial weight loss achieved following restrictive bariatric 
surgery may reduce BMD, particularly regional measures of BMD (e.g. hip and 
spine) (99, 101, 104, 105, 112, 116-118). This information is relevant to assist 
clinicians with providing appropriate advice on the type of PA or exercise that should 
be adopted by people who undergo bariatric surgery. For example, participation in 
weight-bearing activities and resistance training is likely to prevent the loss of 
muscle and bone mass that may occur during the period of rapid weight loss post-
surgery (119).  
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1.1.3 Secondary research questions (outcomes used to confirm the 
previously established efficacy of restrictive bariatric procedures) 
Compared with measures collected pre-surgery, what is the magnitude of change in 
measures of weight, obesity-related comorbid conditions, HRQoL, obesity-related 
quality of life and weight-related symptoms, and symptoms of depression, anxiety 
and stress; and (iv) does the magnitude of change in measures of weight differ 
between laparoscopic sleeve gastrectomy (LSG) in comparison to laparoscopic 
adjustable gastric banding (LAGB) over the first 12 months following restrictive 
bariatric surgery? 
1.1.3.1 Background 
The main goal of obesity treatment is to achieve a substantial reduction in body 
weight that is maintained in the long term (2, 3). When compared to non-surgical 
interventions (e.g. diet, exercise, lifestyle interventions), bariatric surgery, regardless 
of the type of surgical procedure used, has been considered the most effective 
approach for the treatment of obesity as it provides greater and sustained weight 
loss (2, 3). The most recent worldwide survey of bariatric surgery has shown that in 
the Asia/Pacific region, which includes Australia, restrictive bariatric procedures (e.g. 
LAGB, LSG) have been favoured over mixed or malabsorptive procedures (e.g. 
Roux-en-Y gastric bypass, biliopancreatic diversion) (120). This preference appears 
to be explained by the lower post-surgery complication rates and risk of long-term 
nutritional deficiencies following restrictive bariatric procedures (3, 55). Successful 
weight loss has been reported at 12 months following restrictive bariatric surgery, 
with percentage of excess weight loss (%EWL) values ranging from 63% to 87% 
following LSG (121-124) and 30% to 46% following LAGB (125-130). Although little 
is known about how LSG compares with LAGB in different post-surgery outcomes, 
there are data to show greater weight loss following LSG (131-135). The most 
recent study comparing two large cohorts reported that, at 12 months post-surgery, 
those people who underwent LSG had a 26% greater %EWL than those who 
underwent LAGB (60% versus 34%; p < 0.001) (135). The mechanisms that explain 
the greater weight loss found following LSG than LAGB might be explained by a 
greater reduction in stomach capacity and in hormones involved in hunger 
regulation (134, 136, 137). Together with weight loss, a primary aim of bariatric 
surgery is the improvement and/or resolution of obesity-related comorbid conditions 
(3). It is well established that significant improvement and/or resolution of DM2, 
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dyslipidaemia, hypertension, and obstructive sleep apnoea occurs at 12 months, 
and is sustained up to 5 years following restrictive bariatric surgery (121, 122, 124, 
129, 130, 138-149).  
Since impaired HRQoL has been reported as an important factor related to people’s 
motivation to seek bariatric surgery, the effect of restrictive bariatric surgery on 
HRQoL has been extensively investigated, mostly measured using generic HRQoL 
questionnaires, and also with obesity-related quality of life questionnaires (150-153). 
Significant improvements in measures of generic and obesity-related quality of life, 
particularly those related to physical health, have been consistently reported at 12 
months and up to 5 years following restrictive bariatric surgery (66, 129, 134, 141, 
154-175).  
In addition, obesity has been consistently associated with increased symptoms of 
depression and anxiety (176-178), and there is some evidence to show an 
association between obesity and increased symptoms of stress (179, 180). It is 
likely that the association between obesity and poorer mental health is bi-directional. 
Obesity could lead to psychological distress (e.g. increased symptoms of 
depression, anxiety and stress) through the development of obesity-related 
comorbid conditions, weight-related stigma and discrimination, and biological factors 
(e.g. dysregulation of the hypothalamic-pituitary-adrenocortical system) (176, 178). 
Alternatively, psychological distress could lead to obesity by stress-induced changes 
in eating (e.g. binge eating) and PA patterns (e.g. decreased participation in PA due 
to depression) (176, 178). Significant improvements in symptoms of depression and 
anxiety, measured using validated self-reported questionnaires, have been reported 
at 12 months and sustained up to 5 years following restrictive bariatric surgery (154, 
156, 162, 167, 168, 181-191). The only study that investigated the effect of 
restrictive bariatric surgery on self-reported stress has indicated significant 
improvements at 12 months post-surgery; however, it failed to report the magnitude 
of change (186).  
This programme of research has investigated changes in measures of weight, 
obesity-related comorbid conditions, HRQoL, obesity-related quality of life and 
weight-related symptoms, and symptoms of depression and anxiety in order to 
confirm that the investigation of PA and SB occurred in the context of responses to 
restrictive bariatric surgery that were as expected. But also, this programme of 
research provides novel data on the pattern of change in these outcomes, and 
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additionally on the change in stress, over the first 12 months post-surgery. Although 
the effects of bariatric surgery on these outcomes are well-established, the pattern 
of change over the first 12 months post-surgery is unknown. This information is 
relevant to inform both patients and clinicians on the expected time course of 
change for these outcomes following surgery (153). 
1.2 Study 2 
The second study in this programme of research explored participants’ perceptions 
of factors related to their participation in PA pre-surgery and 12 months following 
restrictive bariatric surgery.  
1.2.1 Research questions 
(i) Prior to restrictive bariatric surgery, what are participants’ beliefs about PA, and 
perceived barriers and facilitators to PA? 
(ii) Twelve months following restrictive bariatric surgery: (a) What are the 
perceptions of participants regarding their ability to participate in PA as well as 
barriers and facilitators to PA? (b) How do these perceptions differ from participants’ 
perceptions pre-surgery? and (c) What are the perceived motivators to PA at 12 
months following restrictive bariatric surgery? 
1.2.1.1 Background 
Promoting change in PA has been a challenge, with little or no change in PA levels 
found as a result of population-based initiatives which informed people about PA 
guidelines and suggested strategies to increase their participation in PA (192). 
Systematic reviews of randomised controlled trials (RCTs) investigating the 
effectiveness of interventions aimed at promoting PA among adults in the general 
population have reported at best, a modest effect on PA levels (i.e. effect sizes 
around 0.50) (193, 194). The modest effects found for interventions promoting PA in 
adults may be explained by the generic nature of these interventions, such as the 
use of generic advice and counselling regarding participation in PA. Although fewer 
RCTs have investigated the effectiveness of interventions aimed at increasing PA 
among people who are obese or those scheduled to undergo bariatric surgery, their 
findings suggest that those interventions that used a tailored approach addressing 
factors relevant to people’s participation in PA appear to be more effective than 
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interventions which used generic approaches to increase PA (34, 195, 196). For 
example, an RCT of candidates for bariatric surgery that compared a control group 
(i.e. standard pre-surgery care) to a comprehensive theory-based behavioural 
intervention, which consisted of individual counselling sessions addressing problem-
solving for barriers to PA, goal setting regarding purposeful walking and used 
behavioural and cognitive strategies aimed at increasing self-efficacy and motivation 
to PA, reported a significant increase of 21.0 min/day (SD, 26.9) in total time spent 
in MVPA in the intervention group, while no change was seen in the control group 
(34). In contrast, an RCT of obese adults with DM2 that compared a control group 
(i.e., general education) to a more generic intervention, which consisted of individual 
educational sessions about benefits of PA and prescription of a PA program, 
reported a significant but modest increase of 5.5 min/day (SD, 2.9) in total time 
spent in MVPA in the intervention group, while no change was seen in the control 
group (195). Although these data indicate that a more tailored intervention can 
produce substantial and significant short-term increases in participation in PA pre-
surgery, when targeting ways to counteract people’s barriers to PA (i.e. factors that 
would make it difficult or prevent people from engaging in PA), and providing 
strategies to optimise facilitators to PA (i.e. factors that would make it easier for 
people to engage in PA), further research about barriers and facilitators to PA 
among people who undergo bariatric surgery is needed. Of note, in the study by 
Bond et al (34), only one in four people screened were randomised to participate in 
the study, which may have decreased the representativeness of the sample to those 
motivated to increase their PA. Further, since the intervention was performed pre-
surgery, the long-term and post-surgery sustainability of any increase in PA 
following the completion of a behavioural intervention has not yet been investigated.  
In the general population, there is a reasonable amount of information pertaining to 
barriers and facilitators to PA. Specifically, the most frequently reported barriers to 
PA in the general adult population include lack of time, lack of motivation, work and 
family commitments, lack of support or lack of company to engage in PA, and 
presence of pain or poor health (197-207). The most frequently reported facilitators 
to PA in the general population include being physically active with family members, 
being a role model for children, prioritising PA, and receiving social support (208-
210). There is some evidence to show that population sub-groups may present 
particular factors that influence their participation in PA (211-213). Specifically, in 
addition to those barriers commonly found in the general population, people who are 
obese have consistently reported the presence of obesity-related barriers to PA, 
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such as feeling overweight or obese, self-consciousness regarding their body 
image, and perceived lack of self-discipline or laziness (214-218). Barriers to PA 
may differ between people in different classes of obesity, due to differences in the 
prevalence of obesity-related comorbid conditions and the influence of the excess 
weight on participation in PA (214, 215, 217). People who are obese frequently 
reported weight loss as the most important facilitator to PA (219, 220). 
Although there are some data on the barriers and facilitators to PA in the general 
population and people who are obese, these data may not be applicable to people 
who undergo bariatric surgery. This is because surgical treatment for obesity is 
usually considered after repeated unsuccessful attempts to lose weight using non-
surgical treatment options, and people who are scheduled to undergo bariatric 
surgery may have a different perception of factors that influence their participation in 
PA, when compared to the general obese population (221). Thus, there remains a 
need for research on barriers and facilitators to PA specific to this population. 
Study 2 uses a qualitative design to explore factors relevant to participation in PA, 
such as barriers, facilitators and motivators to PA, in people prior to and following 
restrictive bariatric surgery. In contrast, the majority of studies investigating barriers 
and facilitators to PA have used surveys and structured questionnaires or scales 
(206, 214, 215, 217, 222). Qualitative methods, such as interviews or focus groups, 
do not limit people’s responses to pre-specified items and provide a rich, detailed 
exploration of why people participate or not in PA. Further, qualitative data provide 
an in-depth insight into people’s experiences and perceptions of factors related to 
participation in PA within the social context of a particular population (202, 210, 223-
225). Rich, in-depth and detailed information regarding pre- to post-surgery changes 
in factors related to participation in PA might give insight into the reasons why 
people participate in little PA pre-surgery and do not seem to increase their 
participation in PA following restrictive bariatric surgery. This information is relevant 
to inform clinicians and shape interventions that have the best chance of success at 
increasing participation in PA pre- and post-surgery and optimising post-surgery 
outcomes (74, 75, 226, 227). 
1.3 Significance and novelty of the programme of research 
Restrictive bariatric procedures have been increasingly used to manage obesity in 
Western countries (1). There is strong evidence that restrictive bariatric procedures 
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result in substantial and sustained weight loss, as well as improvements in obesity-
related comorbid conditions, HRQoL and symptoms of mental health disorders (3, 
152, 167). There are data to suggest that, when compared to the general 
population, people scheduled to undergo bariatric surgery have lower participation in 
PA and spend more time in SB (21, 41). Further, despite the effectiveness of 
restrictive bariatric surgery for the treatment of obesity, the few studies that 
investigated pre- to post-surgery changes in objective measures of PA and SB 
suggest little or no change in these measures (4-8). However, these studies 
presented important limitations regarding the methods used to assess PA and SB, 
including low adherence to the motion sensor used (4) and suboptimal placement of 
the motion sensor around the waist or hip, which might decrease accuracy due to 
motion sensor tilt as a result of abdominal adipose tissue (5, 8). Further these 
studies focused on measures of MVPA and daily step count, and little attention has 
been given to the way in which people spend most of their waking hours, that is, 
time spent in SB and light intensity PA. In this respect, this programme of research 
was the first to collect objective measures of PA, at any intensity, and SB using two 
state-of-the-art devices, pre-surgery and every 3 months for the first 12 months 
post-surgery. Also, this programme of research was the first to investigate the 
pattern of change, over the first 12 months post-surgery, in measures of PA, SB, 
and other health outcomes relevant to participation in PA. This adds to the literature 
by providing robust data on the magnitude and pattern of change in objective 
measures of PA and SB following restrictive bariatric surgery. Information regarding 
the effect of surgery on time spent in PA and SB, as well as on the way PA and SB 
are accumulated is relevant to inform clinicians about whether or not additional 
interventions are needed to optimise post-surgery participation in PA, at any 
intensity, and provides data to guide behavioural interventions in this population. 
This is important because the detrimental effects of participation in little PA and 
increased time in SB are independent of obesity (43-45, 57-65). Thus, despite large 
weight loss post-surgery, if people do not change their PA and SB, they remain at 
risk of the detrimental health effects of this lifestyle. Additionally, participation in the 
recommended amounts of MVPA and decreased time spent in SB has been 
associated with better post-surgery outcomes (66-69). The data on the pattern of 
change in PA, SB, and other health outcomes post-surgery could be useful for 
clinical practice, in order to inform patients’ expectations of realistic post-surgery 
results and guide content and timing for interventions aimed at optimising 
participation in PA in this population. 
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This programme of research has also investigated outcome measures that are novel 
and relevant to PA. Information about the effect of surgery on outcomes that may 
influence, or be influenced by, participation in PA, such as cardiovascular fitness, 
self-efficacy to exercise, sleep quality, daytime sleepiness, body composition and 
BMD, could provide clinicians with additional factors to consider with regards to 
optimising participation in PA among people who undergo restrictive bariatric 
surgery. The investigation of change in weight, obesity-related comorbid conditions, 
HRQoL, obesity-related quality of life and weight-related symptoms, and symptoms 
of mental health disorders was performed to ensure that the estimation of PA 
changes was made in the context of the expected responses to restrictive bariatric 
surgery with regard to these outcomes.  
It is likely that people who undergo restrictive bariatric surgery will need additional 
interventions to improve their participation in PA, as post-surgery weight loss alone 
may not result in changes in PA. This programme of research is the first to provide a 
longitudinal in-depth exploration of people’s perceptions of factors related to their 
participation in PA pre- and post-surgery and how these perceptions changed 
following restrictive bariatric surgery. This in-depth information contributes to the 
understanding of why there may be a lack of favourable changes in people’s PA and 
SB following restrictive bariatric surgery and may help to shape behavioural 
interventions aimed at optimising participation in PA in this population. 
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CHAPTER 2 LITERATURE REVIEW 
Overview 
This chapter reviews the literature pertaining to the development of the research 
questions and methods used in the studies that comprise this programme of 
research. Section 2.1 defines obesity and presents information concerning its 
prevalence, health implications and healthcare burden. Section 2.2 outlines the 
available management approaches to obesity. Section 2.3 discusses the influence 
of restrictive bariatric surgery on health outcomes. Section 2.4 provides an overview 
on physical activity (PA) and sedentary behaviour (SB) and comprises definitions, 
recommendations, assessment methods, and health implications. Section 2.5 
discusses PA and SB measures prior to and following bariatric surgery. Section 2.6 
outlines the available evidence on perceived barriers and facilitators to PA prior to 
and following bariatric surgery.  
2.1 Obesity 
This section provides information on the definition and prevalence of obesity, as well 
as its health implications and associated healthcare burden. Particular attention is 
given to the health implications of obesity, with an outline of the evidence pertaining 
to the association between obesity and several comorbid conditions.  
2.1.1 Definition and prevalence 
Obesity is defined as an abnormal or excessive accumulation of fat that may impair 
health (18). It is most commonly caused by an imbalance between energy 
consumption (i.e. dietary intake) and energy expenditure (i.e. energy loss due to 
metabolic and physical activities) (228). The prevalence of obesity among adults has 
increased rapidly. In 2014, the World Health Organisation estimated that more than 
1.9 billion adults worldwide were overweight, and of these, over 600 million were 
obese (18). The most recent data from the Australian Health Survey showed that in 
2011-2012, 63% of Australian adults were overweight or obese, which represented 
a 7% increase from 1995 (19).  
There are several factors that influence the development of obesity, including 
genetic, metabolic, behavioural, and environmental factors (228, 229). The speed 
with which the prevalence of obesity has increased suggests that behavioural and 
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environmental factors, such as changes in eating habits (e.g. high availability of 
processed foods), and a decrease in PA levels (e.g. increased use of motor vehicle 
transportation and shift from active to sedentary occupations) have been greater 
contributing factors to the obesity epidemic, compared to genetic and metabolic 
factors (e.g. genetic abnormalities or endocrine disruptors resulting in weight gain) 
(228, 229). The most widely used measurement of body fat is the body mass index 
(BMI; weight in kilograms divided by height in metres squared). Thresholds have 
been established using BMI to classify adults as normal-weight (18.5 to 24.9 kg/m2), 
overweight (≥ 25 kg/m2), and obese (≥ 30 kg/m2). The category of obese has been 
further classified into classes I (30 to 34.9 kg/m2), II (35 to 39.9 kg/m2), and III (> 40 
kg/m2) (230). Most recently, measurement of waist circumference, an important 
predictor of abdominal obesity, has also been used as a measure of obesity and has 
been suggested as a better predictor of cardiovascular disease (CVD) and diabetes 
mellitus type 2 (DM2) than the traditional BMI (231). The measurement of waist 
circumference may be a better predictor of CVD and DM2 since abdominal obesity 
is a known risk factor of CVD and DM2 (232). According to the World Health 
Organisation, the risk of metabolic complications associated with abdominal obesity 
is substantially increased with waist circumference > 88 cm for women, and > 102 
cm for men (230). 
2.1.2 Health implications 
Obesity has been associated with the risk of developing various comorbid 
conditions, such as DM2, CVD and associated risk factors, musculoskeletal 
disorders (e.g. osteoarthritis), increased symptoms of mental health disorders (e.g. 
depression and anxiety), sleep problems (e.g. obstructive sleep apnoea), some 
types of cancer, and increased risk of both all-cause and cause-specific mortality. 
The following paragraphs summarise the evidence pertaining to the association 
between obesity and different comorbid conditions, and provide an overview of the 
possible mechanisms by which obesity is associated to the development and 
maintenance of such conditions. 
The association between obesity and DM2, a common chronic disease that affects 
glucose metabolism, has been established in several large observational studies 
(233-236) and subsequent meta-analyses (231, 237). Specifically, a strong dose-
response association between DM2 and various measures of obesity (e.g. BMI, 
waist circumference, waist-hip ratio) has been consistently demonstrated. The most 
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recent meta-analysis indicates that obese men and women (i.e. BMI > 30 kg/m2) 
have a statistically significant higher risk for DM2 compared to those in the normal-
weight range, with relative risks ranging from 6.7 to 12.4 (231). Similar associations 
were observed when obesity was assessed by other measures, such as waist 
circumference. The suggested mechanisms that may explain the development and 
persistence of DM2 in people who are obese include a reduction in insulin receptors 
and insulin resistance, both of which accompany excess fat accumulation and 
ultimately alter glucose metabolism (238). 
Obesity has also been associated with several risk factors (e.g. dyslipidaemia, 
hypertension) that contribute to the development of different types of CVD, such as 
coronary heart disease, congestive heart failure, and stroke. Associations between 
obesity and dyslipidaemia (i.e. elevated triglycerides and cholesterol levels) have 
been consistently demonstrated (239-242). Longitudinal investigations have 
reported that, when compared to people in the normal-weight range, obese men and 
women presented with 60 to 100 mg/dL higher triglycerides levels (241), and with 17 
to 23 mg/dL higher total and low-density lipoprotein cholesterol levels (239, 240). A 
meta-analysis of cohort studies has also reported statistically significant 
associations between another CVD risk factor, hypertension, and obesity in adults, 
with relative risks ranging from 1.8 to 2.4, when compared with people within the 
normal-weight range (231). Similar findings have been demonstrated for risk of 
coronary heart disease, congestive heart failure, and stroke (231, 243, 244). 
Complex mechanisms have been proposed to explain the association between 
obesity and CVD, including obesity-related metabolic issues (e.g. hypertension, 
elevated triglycerides and cholesterol, impaired glucose tolerance), as well as 
increased systemic inflammation and oxidative stress that lead to endothelial 
dysfunction and atherosclerosis (245, 246). The effects of increased cardiac output, 
and of epicardial and myocardial fat accumulation on cardiovascular function have 
also been related to increased risk of cardiac failure (245, 246). 
Obesity has been implicated in the development and persistence of diverse 
musculoskeletal conditions, such as osteoarthritis of the lower limbs and hands, soft 
tissue conditions (e.g. plantar fasciitis) (247-250), and low back pain (251). Obesity 
is known to be a risk factor for both incidence and progression of osteoarthritis (248, 
252). For instance, a large cohort study (n = 1,854) with a 10-year follow-up period 
has reported associations between obesity and incident osteoarthritis with odds 
ratios of 2.8 (95% confidence interval [CI], 1.3 to 5.9) for osteoarthritis of the knee 
Chapter 2: Literature review 
18 
 
and 2.6 (95% CI, 1.1 to 6.2) for osteoarthritis of the hand (248). The suggested 
mechanisms by which obesity affects the musculoskeletal system are related to the 
functional and structural limitations imposed by the excessive weight on 
musculoskeletal structures, as well as metabolic factors, such as an increase in 
systemic inflammatory mediators (250, 253). 
Disturbances in mental health, reported as increased symptoms of depression and 
anxiety, have been associated with obesity (176-178, 254). The most recent large 
observational study (n = 6,514), with a 12-year follow-up period, reported moderate 
significant associations (i.e. hazard ratio of 1.1) between the onset of clinically 
relevant symptoms of depression and obesity, when compared to people in the 
normal-weight range (254). Results from the World Mental Health Surveys initiative, 
a compilation of general population surveys from 13 countries in North and South 
America, Europe, Middle East and Asia/Pacific regions, demonstrated moderate 
significant associations, with odds ratios ranging from 1.1 to 1.5, between obesity 
and depressive and anxiety disorders, assessed by a structured diagnostic interview 
(177). Although studies that investigated the association of obesity and perceived 
stress are scarce, data suggest that stress is positively associated with higher body 
weight (180, 255, 256). Observational studies have also reported moderate 
significant associations, with odds ratios ranging from 1.1 to 3.4, between obesity, 
assessed by BMI and waist circumference, and perceived general or work-related 
stress among men and women (179, 256). Although different factors have been 
suggested to explain the association of obesity and poorer mental health, the 
underlying mechanisms remain uncertain. The suggested mechanisms by which 
obesity is associated with poorer mental health include psychological stress caused 
by health issues related to obesity, negative effects of weight-related stigma and 
discrimination, biological factors (e.g. dysregulation of the hypothalamic-pituitary-
adrenocortical system), and stress-induced changes in eating and PA patterns (176, 
178). 
Sleep problems are prevalent among people who are obese and can include sleep 
disordered breathing, particularly obstructive sleep apnoea (OSA), as well as poor 
sleep quality and excessive daytime sleepiness. Obesity has been shown to be a 
strong correlate of OSA, and the prevalence of OSA among people who are obese 
is around 40% to 50% (87). A large cohort study (n = 690) has demonstrated that 
over a 4-year period, a 10% to 20% increase in body weight, when compared to no 
weight gain, was significantly associated with a 32% to 70% increase in the apnoea-
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hypopnoea index (AHI), an index of OSA severity measured using and overnight 
sleep study (257). Poor sleep quality and excessive daytime sleepiness are 
common complaints among people who are obese, when compared to those in the 
normal-weight range, even in the absence of sleep-disordered breathing (88, 258). 
Anatomical factors (e.g. fat deposits in the upper airway, changes in airway shape, 
increased neck circumference), neuromuscular factors (e.g. decreased upper airway 
musculature tone), and hormonal factors (e.g. alterations in the hormone leptin that 
can affect respiratory control) have all been suggested as contributors to the 
development of sleep problems, particularly OSA, among people who are obese 
(259, 260). The presence of poor sleep quality and excessive daytime sleepiness in 
the absence of OSA suggests that obesity itself is related to such disorders; 
however, the mechanisms of these association are still unknown (88, 258). 
Considering the range of factors involved in the development and persistence of 
obesity-related comorbid conditions, the mechanisms that explain the associations 
between obesity and its related comorbid conditions appear to be influenced by 
complex interactions between biological (e.g. metabolic and hormonal dysregulation, 
increased systemic inflammation and oxidative stress), mechanical (e.g. functional 
and structural limitations caused by excess weight) and psychosocial factors (e.g. 
weight-related stigma, increased symptoms of depression and anxiety). Additional 
issues, such as low levels of PA, may compound the complex interactions between 
various biological, mechanical and psychosocial factors and the increased risk of 
comorbid conditions, resulting in further impairments. For instance, one such 
interaction may involve mechanical and psychosocial factors (e.g. presence of 
osteoarthritis or gait limitations and lethargy related to depressive symptoms) that 
may have a role in the cardiovascular fitness impairment found among people who 
are obese (76-79). The resulting impairment in cardiovascular fitness, in turn, may 
be associated with decreased ability to engage in PA among people who are obese. 
Decreased cardiovascular fitness and little participation in PA are likely to play a role 
in the persistence of CVD risk factors observed in obese populations (261-263).  
The combination of mechanisms by which obesity influences the development and 
persistence of comorbid conditions and the complex interplay between these 
conditions and confounding factors (e.g. participation in PA) are likely to contribute 
to people’s impaired health-related quality of life (HRQoL) (264, 265). Additionally, 
when compared to their normal-weight counterparts, the obesity-related comorbid 
conditions and impairments of cardiovascular fitness and HRQoL result in increased 
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risk of both all-cause and cause-specific mortality among people who are obese 
(266-268). 
2.1.3 Healthcare burden 
When combined, obesity-related comorbid conditions impose considerable burden 
on the healthcare system. A systematic review that included 32 studies, published 
from 1990 to 2009, investigated the costs associated with obesity in both Western 
and Eastern countries (269). The results showed that the medical costs of people 
who were obese were around 30% greater when compared to those within the 
normal-weight range. The direct costs associated with obesity were estimated to be 
between 1% and 3% of a country’s overall healthcare expenses (269). According to 
data from the Australian Diabetes, Obesity and Lifestyle study, a national 
population-based study conducted in 1999-2000 with a follow-up survey in 2004-
2005, the total direct health cost (i.e. ambulatory services, hospitalisation, 
prescription medication, and some medically-related consumables) for being 
overweight or obese to Australia was AUD$21 billion per year, of which AUD$14.5 
billion was associated with obesity alone (270). Colagiuri et al (270) also compared 
direct health costs by weight change from 1999-2000 to 2004-2005. The annual 
direct health costs were highest for people who were obese (AUD$2,853 per 
person) in both surveys, and decreased by about 30% for those people who were 
overweight or obese and lost weight between the first and second surveys 
(AUD$1,982 per person) (270). 
2.2 Management approaches to obesity 
The main objective of obesity treatment is to achieve a substantial reduction of body 
weight and to maintain the weight loss in the long term. Weight loss, even as little as 
5% to 10% of initial body weight, is known to have beneficial effects on CVD risk 
factors, such as hypertension, dyslipidaemia, and DM2 (271-273). Successful 
weight loss maintenance has been defined as intentional loss of at least 10% of 
initial body weight that is maintained for at least 1 year (274). Different approaches 
have been used for the management of overweight and obesity, and for the purpose 
of this literature review, the management approaches will be divided into and 
described according to non-surgical and surgical treatments. Literature pertaining to 
the effect of non-surgical treatment on weight loss and obesity-related comorbid 
conditions (i.e. DM2 and CVD) will also be discussed. However, as the focus of this 
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programme of research was on surgical treatment for obesity, the evidence on the 
influence of bariatric surgery on different health outcomes, as well as PA and SB 
pre- and post- bariatric surgery will be discussed in more detail in sections 2.3 
(Influence of restrictive bariatric surgery on health outcomes) and 2.5 (Physical 
activity and sedentary behaviour prior to and following bariatric surgery), 
respectively. 
2.2.1 Non-surgical treatment for obesity 
Different non-surgical approaches have been used for the treatment of obesity, all of 
which aim to create a negative energy balance (i.e. when calorie intake is lower than 
calorie expenditure). These approaches include dietary interventions, exercise 
interventions, lifestyle interventions (i.e. combination of dietary and exercise 
interventions, with or without behavioural therapy), as well as pharmacotherapy 
(275-278). Caloric restriction is the key feature of diet-induced weight loss, with 
recommended energy intakes between <800 and 1,000-1,500 kilocalories per day 
for very low calorie and low calorie diets, respectively (279, 280). Several 
randomised controlled trials (RCTs) and systematic reviews of RCTs have sought to 
determine the effectiveness of any one diet over another, as well as over no 
treatment (281-285). These RCTs have demonstrated significant but modest weight 
lost for diets of at least 12 months of duration, with scarce data on the effectiveness 
of different diets on improvement and/or resolution of obesity-related comorbid 
conditions. The largest systematic review of RCTs comparing diet alone to no 
treatment reported modest results, with a mean difference in weight loss over a 12-
month follow-up period, when compared to no treatment, of -5.3 kg (95% CI, -5.8 to 
-4.7) with low fat diet, -6.2 kg (95% CI, -9.0 to -3.4) with low calorie diet, and -13.4 
kg (95% CI, -18.3 to -8.3) with very low calorie diet (281). Although diets with 
different daily energy intake and different proportions of macronutrients (i.e. fat, 
protein, carbohydrate) have been used, there is minimal evidence to support one 
over another (283, 284). Atallah et al (283) performed a systematic review of 12 
RCTs that investigated the effects of four popular diets on weight loss, with follow-
ups ≥ 12 months, including Atkins (i.e. very low carbohydrate with unlimited protein 
and fat), South Beach (i.e. low carbohydrate and high protein), Weight Watchers 
(i.e. caloric restriction in addition to a behaviour modification plan), and Zone (i.e. 
low carbohydrates and recommendation for intake of low fat proteins, low glycaemic 
load carbohydrates, and small amounts of good fat). At 12 months, findings from 
studies that compared more than one diet to usual care suggested modest and 
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similar weight loss between all groups, ranging from 1.6 to 4.7 kg. Their results also 
reported no long-term improvements in CVD risk factors, such as lipid levels, blood 
pressure and glycaemic control. An RCT that compared the effects of low 
carbohydrate (n = 60) to low fat (n = 59) diets, of 12 months duration, on weight and 
CVD risk factors found that both resulted in small but significant weight loss, 3.5 kg 
greater for the low carbohydrate diet group (5.3 kg; 95% CI, 3.8 to 6.8) than the low 
fat diet group (1.8 kg; 95% CI, 0.3 to 3.3) (284). Also at 12 months, the low 
carbohydrate diet group had significant reductions in the ratio of total and high-
density lipoprotein cholesterol and triglycerides, as well as increase in high-density 
lipoprotein cholesterol, while no significant change was found in the low fat diet 
group. 
Energy balance is also affected by energy expenditure as a result of PA (i.e. any 
bodily movement that results in energy expenditure) and/or exercise, which is 
defined as planned, structured, and repetitive PA which is intentionally undertaken 
with the goal of improving health and fitness (42). A high degree of heterogeneity 
has been found in studies that have investigated the effect of PA or exercise 
interventions, regarding the modality of PA or exercise used (e.g. aerobic versus 
resistance exercise), intensity and frequency of activities, duration of intervention, 
and supervised or unsupervised nature of the intervention (286, 287). Several 
studies have demonstrated that exercise interventions, when compared to no 
intervention, are ineffective in producing meaningful changes in body weight (278). 
Specifically, systematic reviews and meta-analyses of studies investigating the 
effects of exercise-only interventions reported small average weight loss ranging 
from 1.3 to 3.0 kg (286-288). Despite the modest magnitude of weight loss, there is 
evidence to support that engagement in PA and/or exercise produces a reduction in 
CVD risk factors (e.g. blood glucose, blood lipids, blood pressure) (287, 289-293). 
For example, a Cochrane systematic review reported that exercise as a sole 
intervention resulted in significant reductions in CVD risk factors, such as diastolic 
blood pressure (-2 mmHg; 95% CI, -4 to -1), triglycerides (-0.2 mmol/L; 95% CI, -0.3 
to -0.1), and fasting glucose (-0.2 mmol/L; 95% CI, -0.3 to -0.1) (287).  
The modest weight loss achieved with diet or exercise alone has led to the 
investigation of lifestyle interventions, which combine diet and exercise, with or 
without behavioural therapy (294-298). A recent systematic review and meta-
analysis included RCTs that compared behavioural weight management 
interventions combined with diet and exercise (i.e. lifestyle intervention), with diet-
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only or exercise-only, with a minimum follow-up period of 12 months (298). Results 
from the six RCTs that compared lifestyle versus diet-only interventions showed 
similar weight loss achieved at 3 to 6 months, but greater weight loss in the lifestyle 
intervention groups at 12 months (mean difference, -1.7 kg; 95% CI, -2.8 to -0.6). 
When comparing lifestyle versus exercise-only interventions, the lifestyle 
intervention groups had greater weight loss both at 3 to 6 months (mean difference, 
-5.3 kg; 95% CI, -7.6 to -3.0) and 12 to 18 months (mean difference, -6.3 kg; 95% 
CI, -7.3 to -5.2) (298). Regarding the effect on obesity-related comorbid conditions, 
an earlier systematic review and meta-analysis of RCTs that investigated the effect 
of lifestyle interventions in people who were overweight and obese, that ranged 
between 1 and 6 years in duration, reported a significant reduction in CVD risk 
factors in the mid to long-term (i.e. an average follow-up period of 3 years) (299). 
That is, when compared to control groups (described as receiving standard care), 
lifestyle interventions resulted in reduced systolic blood pressure (-3 mmHg; 95% CI, 
-4 to -1), diastolic blood pressure (-1 mmHg; 95% CI, -2 to -1), total cholesterol (-0.1 
mmol/L; 95% CI, -0.2 to -0.03), triglycerides (-0.1 mmol/L; 95% CI, -0.3 to -0.04), 
and 2-hour plasma glucose (-0.5 mmol/L; 95% CI, -0.8 to -0.2).  
A large amount of medications have been used as an adjunct to non-surgical 
interventions to promote weight loss, and several have been removed from the 
market due to safety issues (300). In Australia, Orlistat, a gastrointestinal fat blocker, 
is the only medication registered and approved for long-term use, while 
Phentermine, an appetite suppressant, is registered for short-term use only (277). 
Systematic reviews of placebo-controlled RCTs and individual RCTs have reported 
significantly greater weight loss in the medication groups (i.e. Orlistat or 
Phentermine), ranging from 2.9 to 3.6 kg, when compared to placebo groups (301-
303). Most trials also showed significant improvements in CVD risk factors, such as 
cholesterol, blood pressure, and glycaemic control (301-303). Of note, several 
adverse effects have been reported with Orlistat and Phentermine use, and the 
long-term effects of these drugs on weight loss and management of obesity-related 
comorbid conditions are unknown (300, 301 , 303).  
Several studies have reported modest (i.e. < 10% of initial weight) but significant 
weight loss and improvements in CVD risk factors following different non-surgical 
treatments (281, 287, 298). The combination of different strategies aimed at weight 
loss (i.e. diets, exercise, behavioural interventions, pharmacological) has been 
shown to result in greater weight loss than any one strategy alone (298, 304). 
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Although non-surgical treatments may produce short-term weight loss, studies that 
have investigated long-term weight loss maintenance (i.e.1 to 4 years) following 
non-surgical interventions have reported that only a small amount of weight loss, 
mostly lower than 5% of initial weight, is maintained in the long-term (304-306). 
Further, the long-term effectiveness of these treatments on improvement and/or 
resolution of obesity-related comorbid conditions is yet unknown (304, 307). 
2.2.2 Surgical treatment for obesity 
Surgical treatment for obesity, known as bariatric surgery, has been increasingly 
performed, particularly in Western countries, to counteract obesity and obesity-
related comorbid conditions (1, 120). This is because, in contrast to non-surgical 
approaches, bariatric surgery has been shown to confer substantial (i.e. ≥ 10% of 
initial weight) and sustained weight loss, accompanied by significant improvement 
and/or resolution of obesity-related comorbid conditions (2, 3). According to the 
latest report from the Australian Institute of Health and Welfare, the number of 
bariatric surgeries performed in Australia has increased from approximately 500 
procedures performed in 1998-1999 to 17,000 in 2007-2008 (308). The most recent 
worldwide survey of bariatric surgery has shown that, from 2003 to 2013, 10,467 
bariatric procedures were performed in Australia and New Zealand and of these, 
3,163 (30%) were adjustable gastric banding, 6,660 (64%) were sleeve 
gastrectomy, and the remaining 644 (6%) were Roux-en-Y gastric bypass (RYGB) 
(120). Surgical approaches are classified according to the anatomical change they 
produce as either restrictive, malabsorptive, or mixed procedures (3, 309). The 
restrictive procedures aim to reduce stomach capacity in order to accelerate satiety 
with reduced food intake, and include laparoscopic adjustable gastric banding 
(LAGB) and laparoscopic sleeve gastrectomy (LSG) (309). Laparoscopic adjustable 
gastric banding is a minimally invasive procedure in which an adjustable silicone 
band is placed around the entrance of the stomach, resulting in limitation of food 
intake through reducing the volume of the stomach (309). Adjustments are 
performed non-surgically, by the addition or removal of saline through a 
subcutaneous port to create a gastric pouch of 15 to 30 mL (309). Laparoscopic 
sleeve gastrectomy removes a major portion of the stomach along a vertical line, 
forming a small tubular shape to the stomach with a volume of 60 to 80 mL (about 
25% of its original size) (309). Sleeve gastrectomy was introduced as a first step of 
a two-step procedure in people with class III obesity, which was followed by a 
conversion to either gastric bypass or a duodenal switch at a later date. However, 
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due to the successful weight loss achieved, it has been increasingly performed as a 
stand-alone procedure (3). The malabsorptive procedures, such as biliopancreatic 
diversion with or without duodenal switch, bypass the foregut preventing the 
complete absorption of food eaten (309). Mixed procedures combine restrictive and 
malabsorptive techniques, such as RYGB (309). Restrictive procedures have been 
preferred over the malabsorptive or mixed procedures, due to lower risk of both 
surgical complications, and nutritional deficiencies (3, 55).  
2.2.3 Summary 
Obesity is a highly prevalent condition that has been consistently associated with 
increased risk for the development and maintenance of important health conditions 
(e.g. DM2, CVD, cancer, impaired HRQoL and mental health) (266, 310). Obesity 
has also been associated with increased all-cause and cause-specific mortality 
(266, 310). The management of obesity is complex, and despite successful weight 
loss and improvement in some obesity-related comorbid conditions achieved with 
non-surgical treatment options, the majority of people regain most of the weight over 
the first few years following the intervention (304, 311, 312). In addition, the long-
term effects of non-surgical treatment options on obesity-related comorbid 
conditions are yet unclear (306). In Australia, bariatric surgery, particularly restrictive 
procedures, has been increasingly used for the management of obesity (1, 120, 
308). 
2.3 Influence of restrictive bariatric surgery on health outcomes 
As the programme of research described in this thesis focuses on restrictive 
bariatric procedures, this section reviews the evidence for the effects of LAGB and 
LSG, rather than the malabsorptive or mixed procedures, on outcomes such as 
measures related to weight (e.g. weight, BMI, waist circumference), obesity-related 
comorbid conditions (i.e. DM2, CVD and associated risk factors), body composition 
and bone mineral density (BMD), cardiovascular fitness, sleep problems (i.e. OSA, 
sleep quality and daytime sleepiness), HRQoL, and symptoms mental health 
disorders. The most commonly used measurement methods or instruments to 
measure changes in the aforementioned outcomes are also discussed. These 
outcomes are related to those investigated in the first study undertaken in this 
programme of research. For this section, the studies first described are those in 
which the changes in a group that underwent surgery were compared with changes 
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in a control group that participated in a non-surgical weight loss treatment. 
Thereafter, studies are described in which the effect of surgery was reported in a 
single group without any comparison with a control group (i.e. case series). Given 
the main focus of the two studies that comprised this programme of research was to 
examine the influence of restrictive bariatric surgery on PA and SB, data on changes 
in PA and SB following restrictive bariatric surgery will be reviewed in section 2.5 
(Physical activity and sedentary behaviour prior to and following bariatric surgery). 
2.3.1 Weight-related measures 
Several studies have investigated weight loss following bariatric surgery alone or in 
comparison to non-surgical weight loss treatment. However, these studies are 
heterogeneous in regards to type of surgical procedure, type and duration of non-
surgical treatment, participant selection procedures, sample characteristics and 
outcome measures used (3, 313). Different measures of weight change have been 
reported including absolute weight (expressed in kg), BMI, and percentage of 
excess weight loss (%EWL), with excess weight defined as the difference between 
people’s weight and their ideal weight (i.e. weight for a BMI of 25 kg/m2) (3). The 
measurement of waist circumference has also been used to investigate abdominal 
obesity (2). The use of different weight parameters as outcome measures for weight 
change post-surgery often creates difficulties when comparing studies’ findings (3, 
314). 
Several RCTs and non-randomised controlled trials that compared the effects of 
restrictive bariatric surgery to non-surgical weight loss treatments have reported 
greater weight loss among people who underwent LAGB (144, 161, 315-319) and 
LSG (320-322). The most recent RCT investigated 45 obese adults with diagnosed 
DM2, and found LAGB to be superior to a 12-month non-surgical intervention that 
included diet, exercise, and advice on medication for DM2 (319). At 12 months, the 
mean weight loss in the surgical group was 5 kg greater when compared to the non-
surgical group (13.5 kg versus 8.5 kg; p = 0.03). Friedrich et al (321) performed the 
largest non-randomised controlled trial to compare the effects of LSG (n = 27) to a 
12-month non-surgical weight loss treatment (n = 27) that included diet, exercise, 
and behavioural interventions. At 12 months, the mean weight loss in the surgical 
group, expressed as the %EWL was 27% greater when compared to the non-
surgical group (65% versus 38%; p < 0.001). The same pattern of greater reduction 
in waist circumference has been reported following restrictive bariatric surgery, 
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when compared to non-surgical treatment, and sustained reductions in waist 
circumference, ranging from 9.2 to 20.7 cm, have been reported up to 5 years post-
surgery (130, 143, 316, 319, 322). 
Several case series have reported significant and sustained weight loss, ranging 
from 38 to 60 %EWL, up to 15 years following LAGB (125-130, 142), and from 49 to 
84 %EWL up to 6 years following LSG (121-124, 148, 162, 323). Although 
successful weight loss has been found following both types of restrictive bariatric 
surgery, studies that compared LAGB and LSG have consistently reported greater 
weight loss following LSG (131-135). The most recent study compared two matched 
cohorts and reported greater %EWL following LSG (n = 2,949), when compared to 
LAGB (n = 2,949), with a difference of 26% at 12 months (60% versus 34%; p < 
0.001), 20% at 2 years (60% versus 40%; p < 0.001), and 12% at 3 years post-
surgery (56% versus 44%; p < 0.001) (135).  
Despite the heterogeneity in the sample characteristics, surgery technique, and 
measures of reporting weight change (e.g. absolute weight, %EWL, waist 
circumference), there is evidence to show a pattern of significant and sustained 
weight loss following restrictive bariatric surgery (2, 3, 313). Although the 
mechanisms that explain differences in weight loss following LAGB and LSG are not 
yet clear, factors such as a greater reduction in stomach capacity and hormones 
involved in hunger regulation may explain the greater weight loss found after LSG 
(134, 136, 137). Several studies that have demonstrated sustained weight loss 
following restrictive bariatric surgery found that most of the weight loss was 
achieved during the first 12 months following the procedure, and mostly maintained 
up to 15 years post-surgery (122-126, 128, 144, 324, 325). However, the pattern of 
change in weight-related measures over the first 12 months following restrictive 
bariatric surgery is yet unknown. This information is important to inform both patients 
and clinicians on the expected time course of change in weight following surgery.  
2.3.2 Diabetes mellitus type 2, cardiovascular disease and associated risk 
factors 
Together with weight loss, a primary aim of bariatric surgery is to produce significant 
improvement and/or resolution of obesity-related comorbid conditions, such as DM2, 
CVD, and associated risk factors (e.g. metabolic syndrome) (3). The improvement 
and/or resolution in these conditions has been ascertained by either self-report or 
the magnitude of change in objective measures (e.g. blood tests). However, the 
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magnitude of change used to categorise improvement and/or resolution of a 
comorbid condition often differs between studies (3, 326). 
Systematic reviews of RCTs that compared the effects of bariatric surgery and non-
surgical weight loss treatments have reported greater improvement and/or resolution 
of obesity-related comorbid conditions for those people who underwent surgical 
treatment, regardless of the procedure used (2, 3). Regarding specific types of 
surgery, RCTs of LAGB and non-randomised controlled trials of LSG that have 
compared restrictive bariatric surgery to non-surgical weight loss treatments have 
mostly reported greater improvement and/or resolution of obesity-related comorbid 
conditions post-surgery (315-322). The most recent non-randomised controlled trial 
found a higher resolution of DM2 (36% versus 0%; p = 0.007) and hypertension 
(29% versus 0%; p = 0.018) for those who received LSG when compared to non-
surgical treatment at 12 months post-surgery (322). In contrast, a recent RCT was 
the only study to report that those who received LAGB or a 12-month intensive non-
surgical weight loss treatment had comparable benefits on diabetes control and 
cardiometabolic risk (319). The non-surgical intervention used in this study provided 
a greater emphasis on diet composition, duration and type of exercise, and 
adjustments in DM2 medication when compared to usual lifestyle interventions. The 
more intensive nature of the non-surgical weight loss treatment used might explain 
the comparable benefits observed for diabetes control and cardiometabolic risk 
despite the greater weight loss achieved by the LAGB group.  
Several case series have reported significant and sustained improvement and/or 
resolution of obesity-related comorbid conditions up to 5 years following LAGB (129, 
130, 138-144) and LSG (121, 122, 124, 145-149). The most recent case series of 
people undergoing LAGB found significant reductions in cardiometabolic risk factors 
and the prevalence of metabolic syndrome at 5 years after surgery (130). Compared 
with the percentage of participants who had metabolic syndrome pre-surgery, there 
was a significant reduction in the number with metabolic syndrome at 12 months 
(from 43% to 15%) and 5 years (from 43% to 13%). There was also a significant 
reduction in triglycerides levels of 69 mg/dL (from 155 mg/dL to 86 mg/dL) and a 
significant increase in high-density lipoprotein cholesterol levels of 10 mg/dL (from 
57 mg/dL to 67 mg/dL) at 12 months, which were maintained up to 5 years (130). 
The case series with the longest follow-up period after LSG found that more than 
70% of participants who had evidence of DM2, hypertension or dyslipidaemia pre-
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surgery demonstrated improvement and/or resolution of these conditions 5 years 
post-surgery (148).  
The use of different measures (e.g. self-report versus objective measures) to assess 
and report changes in obesity-related comorbid conditions may limit the comparison 
of findings from different studies that investigated the effects of restrictive bariatric 
surgery on these outcomes (314). Despite the use of different outcome measures, 
studies show a consistent pattern of significant and sustained improvement and/or 
resolution of obesity-related comorbid conditions that accompanies the large and 
sustained weight loss following restrictive bariatric surgery (3, 132, 135, 146, 326). 
2.3.3 Body composition and bone mineral density 
Although weight loss has been extensively investigated following restrictive bariatric 
surgery, the effect of surgery on body composition and BMD has received less 
attention. Changes in body composition and BMD as a consequence of bariatric 
surgery are important considerations, as reductions in muscle and bone mass have 
been associated with poor health outcomes, including osteoporosis, increased risk 
of fractures, increased risk of falls, and functional impairment (i.e. limitations in 
mobility performance, such as walking and climbing stairs), particularly in older 
adults (114, 327, 328). Changes in muscle and bone mass can be measured by 
changes in body composition, particularly fat-free mass (FFM) or lean body mass 
(LBM), and BMD. The term LBM is often used interchangeably with FFM, and refers 
to the combination of FFM and small amounts of essential fat (329, 330).  
Different methods can be used to assess body composition and BMD, including 
magnetic resonance imaging, computed tomography, whole-body dual energy x-ray 
absorptiometry (DXA), bioelectrical impedance analysis (BIA), and anthropometric 
measurements (e.g. BMI, waist and hip circumferences) (331). Studies of restrictive 
bariatric surgery have mostly used BIA to assess change in body composition, 
although some have used DXA (110, 113, 321, 332). Bioelectrical impedance 
analysis appears to be the most widely used method due to its low cost and ease of 
access and application. However, it is restricted to whole body composition 
measures and has limited accuracy, particularly in obese populations (331, 333). 
For instance, a study that compared measures of FM obtained via DXA and BIA 
reported that BIA produced values for FM which were, on average, 2% to 6% lower 
than those measured with DXA (334). Whole-body dual energy x-ray absorptiometry 
provides more accurate measurements of body composition than BIA, and also 
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provides regional measures in addition to whole body measures (331). Additionally, 
DXA can be used to assess BMD, while exposing people to a low dose of radiation, 
with lower cost and more accessibility than more advanced technologies such as 
magnetic resonance imaging and computed tomography (331). However, the 
investigation of changes in BMD following bariatric surgery may be limited due to 
difficulties in obtaining valid and reliable BMD measures using DXA in people who 
are obese. These difficulties include logistic issues regarding limits in body weight 
and size of scan tables, as well as technical issues regarding to the unpredictable 
impact of soft tissue (e.g. fat tissue) artefact on BMD imaging when using DXA 
(335). 
As restrictive bariatric surgery confers substantial weight loss, it is expected that FM 
loss will also be substantial following surgery. Two RCTs and a non-randomised 
controlled trial compared the effects of restrictive bariatric surgery and non-surgical 
weight loss treatments on FM measures (319, 321, 332). When compared to the 
loss of FM following non-surgical weight loss treatment, studies reported a greater 
loss of FM at 12 to 24 months following restrictive bariatric surgery, with between-
group differences ranging from 1.3 to 21.5 kg (319, 321, 332). These measures 
were made using either DXA (332) or BIA (319, 321). Several case series of LAGB 
have consistently reported significant post-surgery reductions in FM, measured 
using either BIA or DXA, ranging from 10.4 to 32.7 kg, at follow-up periods between 
6 months to 2.5 years (99, 100, 102, 103, 105, 106, 110, 113, 336-338). Similarly, 
several case series of LSG have consistently reported significant post-surgery 
reductions in FM, mostly measured using BIA, ranging from 21.0 to 38.9 kg, at 
follow-up periods between 6 to 12 months (104, 107-113). 
Given the substantial weight loss that occurs following restrictive bariatric surgery, it 
seems reasonable to expect that this surgery may also result in loss of FFM or LBM. 
Two RCTs and a non-randomised controlled trial compared the effects of restrictive 
bariatric surgery and non-surgical weight loss treatments on FFM or LBM measures 
(319, 321, 332). Two of the three studies found a similar reduction in FFM or LBM 
following restrictive bariatric surgery when compared to non-surgical treatment at 12 
months, measured using BIA (319, 321). The RCT by Dixon et al (332) was the only 
one to report a statistically significant 1.6 kg difference in FFM loss between the 
group who received LAGB (2.9 kg) and the non-surgical group (1.3 kg; p = 0.002). In 
contrast with the other two studies using BIA, the DXA measures of the latter study 
might have been more sensitive to assess changes in FFM. Several case series of 
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LAGB have reported significant post-surgery reductions in FFM or LBM, measured 
using either BIA or DXA, ranging from 2.1 to 9.0 kg, at follow-up periods between 1 
to 2 years (100, 102, 103, 106, 110, 113, 337, 338). Similarly, several case series of 
LSG have reported significant post-surgery reductions in FFM or LBM, mostly 
measured using BIA, ranging from 6.1 to 15.4 kg, at follow-up periods between 6 to 
12 months (104, 107, 108, 110-113). 
The substantial weight loss that occurs following restrictive bariatric surgery may 
also involve reductions in BMD. Of note, no study to date has compared the effects 
of restrictive bariatric surgery to non-surgical weight loss treatments on measures of 
BMD. The majority of the case series found no significant changes in total body 
BMD, assessed using DXA, at follow-up periods between 6 months to 2.5 years 
following surgery (99, 101, 104, 105, 112, 117). Regarding regional changes in 
BMD, some case series have reported significant reductions in measures of femoral 
neck and total hip BMD collected at 12 months, ranging from 0.06 to 0.08 g/cm2, as 
well as in lumbar spine BMD, ranging from 0.02 to 0.05 g/cm2 (101, 104, 116, 118), 
while others reported no change (99, 104, 117, 118). The conflicting data on 
changes in measures of BMD following restrictive bariatric surgery might be 
explained by different factors related to the different samples studied, including 
amount and rapidity of weight loss, nutritional deficiencies and use of nutritional 
supplements, levels of PA, as well as the effects of different hormones on bone 
metabolism and type of bone (i.e. cortical or trabecular), and inaccuracy related to 
DXA measures on people who are morbidly obese during weight loss (335, 339).  
Although several studies have investigated the effect of restrictive bariatric surgery 
on weight, there is less attention on its effects on body composition and BMD. 
Specifically, studies that have assessed body composition changes following 
restrictive bariatric surgery have typically used BIA, and those that have used DXA 
have focused exclusively on people who underwent LAGB and were limited to 
female samples. Additionally, conflicting data have been reported, particularly on the 
post-surgery changes in regional measures of BMD. 
2.3.4 Cardiovascular fitness  
Little attention has been given to the effect of restrictive bariatric surgery on 
cardiovascular fitness, also referred to as cardiorespiratory fitness or aerobic fitness. 
The investigation of the influence of LAGB and LSG on cardiovascular fitness is 
relevant since impairments in this outcome seem to be common among people who 
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are obese (76-79, 85). Poor cardiovascular fitness is an important predictor of 
mortality and was found to be associated with increased short-term complications 
following bariatric surgery (340-342). Additionally, people who are obese and have 
low cardiovascular fitness may lack the capacity to engage in PA, particularly of 
moderate to vigorous intensity (76-80). The optimal method for the assessment of 
cardiovascular fitness in people who undergo bariatric surgery has not yet been 
established, and both maximal and submaximal exercise tests have been used in 
studies of bariatric surgery (82, 84, 85, 343-346). The presence of biomechanical 
limitations caused by obesity (e.g. gait limitations), as well as obesity-related 
comorbid conditions (e.g. hypertension) may affect people’s ability and/or 
willingness to perform exercise tests (86, 347). Assessment using maximal exercise 
tests may be influenced by people’s inability or unwillingness to exercise until 
exhaustion, and submaximal tests that require walking, such as the six-minute 
walking test, may be limited by slow walking speed and gait limitations that are often 
found in the obese population (86, 348). Submaximal exercise tests using cycle 
ergometers have been used to assess cardiovascular fitness of people who are 
obese, and seem to be the most appropriate tests for use in the bariatric surgery 
population, since the use of a cycle ergometer provides a weight-supported activity 
that can reduce the strain on joints, as well as the influence of gait limitations on the 
participant’s performance (347, 349).  
To date, no studies have compared the effects of restrictive bariatric surgery with 
non-surgical weight loss treatments on measures of cardiovascular fitness. Maximal 
and submaximal exercise tests have been used to investigate changes in 
cardiovascular fitness following malabsorptive or mixed bariatric procedures (343-
346). The four case series that assessed the effect of restrictive bariatric surgery on 
cardiovascular fitness have reported inconsistent findings, with two studies reporting 
significant improvement (82, 85) and two reporting no changes (83, 84) in measures 
of cardiovascular fitness. Maniscalco et al. (82) followed 15 people and found a 
significant increase of 150 m (from 476 m to 626 m) in the six-minute walk distance 
at 12 months following LAGB. A recent study followed 1,205 people and found 
significant improvements in the time to complete a 400 metre walking test (382 to 
340 seconds) and in resting heart rate (79 to 71 beats/min) at 3 years following 
different surgical procedures (70% RYGB and 25% LAGB) (85). In contrast, a study 
of 18 people who underwent either RYGB (n = 16) or LSG (n = 2) reported no 
change in peak oxygen uptake measured during a maximal exercise test, performed 
on a cycle ergometer, at 28 months post-surgery (83). Similarly, a study of 30 
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people who underwent LSG found no changes in cardiovascular fitness measured 
by the six-minute walk distance at 7 months post-surgery (84). The inconsistent 
results might be explained by the varied sample sizes and heterogeneous samples 
included in the studies, different assessment methods used and diverse follow-up 
periods. 
Despite the importance of investigating the effects of bariatric surgery on 
cardiovascular fitness, only a small number of studies have measured change in this 
outcome following LAGB and LSG. Furthermore, no studies have used an outcome 
measure that is minimally affected by slow walking speed and gait limitations, such 
as a submaximal exercise cycle test, in order to assess changes in cardiovascular 
fitness following restrictive bariatric surgery.  
2.3.5 Sleep problems  
There are limited data on the effect restrictive bariatric surgery has on sleep 
disordered breathing (i.e. OSA), sleep quality, and daytime sleepiness. Obstructive 
sleep apnoea has been associated with impaired cardiovascular function, poorer 
HRQoL, increased risk of post-surgery complications, and found to be an 
independent prognostic marker of all-cause mortality in the general obese 
population and people scheduled to undergo bariatric surgery (i.e. candidates for 
bariatric surgery) (93, 350-352). The assessment of sleep quality and daytime 
sleepiness also seems relevant to people who undergo bariatric surgery, since 
complaints of poor sleep quality and excessive daytime sleepiness are common 
among people who are obese, with or without OSA (96, 353), and shorter sleep 
duration (i.e. < 7 hours) has been associated with increased weight and less weight 
loss (354, 355).  
The gold standard diagnostic method for OSA is an overnight polysomnography, 
which involves the objective monitoring of a person’s sleep overnight in a medical 
facility (356, 357). During an overnight polysomnography, several physiologic 
measures are recorded, including airflow, finger pulse oximetry, respiratory effort, 
electrocardiogram, electroencephalogram, electrooculogram, chin and leg 
electromyograms, and body position (357). The main measurement made is the 
AHI, which represents the frequency of apnoea and hypopnoea events per hour of 
sleep. A diagnosis of OSA is made when someone has an AHI ≥ 5 in conjunction 
with symptoms of sleep disturbance (356, 357). However, the use of 
polysomnography to measure AHI is expensive, as it requires trained personnel and 
Chapter 2: Literature review 
34 
 
the use of a medical facility overnight (355, 357). As an alternative to a full overnight 
polysomnography, home monitoring with portable devices, such as the ApneaLink 
(ResMed Ltd, Bella Vista, NSW, Australia), is also considered an acceptable 
objective measurement. The ApneaLink is a portable single-channel recording 
device that has been considered valid and reliable to detect apnoea and hypopnoea 
events, when compared to an overnight polysomnography (358-361). In the general 
population and people who undergo bariatric surgery, the impact of sleep problems 
has also been evaluated using validated scales and/or questionnaires to assess 
sleep quality and daytime sleepiness. These include the Pittsburgh Sleep Quality 
Index (PSQI) (89, 96, 362-364), and the Epworth Sleepiness Scale (ESS) (357, 
365).  
The only RCT that used polysomnography to compare the effect of restrictive 
bariatric surgery and a non-surgical weight loss treatment (i.e. dietary, exercise, and 
behavioural interventions) on OSA found significant reductions in the mean AHI in 
both the LAGB group (-26 events/hour; 95% CI, -37 to -14) and the non-surgical 
group (-14 events/hour; 95% CI, -25 to -3), with a between-group difference of −12 
events/hour (95% CI, −28 to 5) (317). Several case series of restrictive bariatric 
surgery have reported sustained improvement and/or resolution of OSA, in as many 
as 86% of participants (94, 97, 124, 132, 140, 149, 156, 366-374). However, most 
studies in this area rely on self-report of improvements in this condition with very few 
studies collecting objective measures of AHI (374). Nevertheless, the few studies 
that have collected objective data corroborate these findings. Specifically, a recently 
published case series of 36 participants which investigated the effects of LSG on 
OSA, measured using polysomnography, reported a reduction in AHI of 27 
events/hour (from 33 events/hour to 6 events/hour; p < 0.001) 5 years post-surgery 
(98).  
Few case series have investigated sleep quality (93, 96) and daytime sleepiness 
(93-95, 97, 98) following restrictive bariatric surgery. The only two case series that 
investigated sleep quality following restrictive bariatric surgery reported 
improvements in sleep quality and duration in this population (93, 96). Only one of 
the two case series used a validated measure of sleep quality and found a 
significant reduction of 4.2 points in the PSQI score (from 8.8 points to 4.6 points) 
and an increase in self-reported sleep duration (from 6.0 hours to 6.8 hours) at 3 to 
12 months following LSG (96). All case series that have investigated changes in 
daytime sleepiness have reported significant improvements in this outcome post-
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surgery among samples with diagnosed severe OSA (93-95, 97, 98). The most 
recent case series of people undergoing LSG found that 92% of participants had a 
significant reduction in daytime sleepiness of 9.7 points in the ESS score (from 16.8 
points to 7.1 points) at 5 years following surgery (98).  
Overnight polysomnography and portable monitors to measure apnoea and 
hypopnoea events are considered to be valid objective measures for the 
assessment of OSA. Significant post-surgery improvement and/or resolution of OSA 
have been consistently reported. Although a small number of studies have reported 
improvements in sleep quality and daytime sleepiness following restrictive bariatric 
surgery, the use of validated outcome measures was inconsistent and samples were 
limited to people with severe OSA. Therefore, there is a need for further studies to 
assess the effect of surgery on these outcomes using validated measures, such as 
the ESS and PSQI, among representative samples of people undergoing LAGB and 
LSG. Furthermore, despite evidence to show that improvements in sleep problems 
accompany weight loss, there are no studies investigating the pattern of change in 
these outcomes during the first 12 months following restrictive bariatric surgery, 
which is the period were the majority of weight loss and improvement in obesity-
related comorbid conditions are expected. This information is relevant to inform both 
patients and clinicians on the expected time course of change in these outcomes 
following surgery. 
2.3.6 Health-related quality of life 
The investigation of the effects of restrictive bariatric surgery on HRQoL is of 
importance, since impaired HRQoL is commonly found among candidates for 
bariatric surgery and is a motivating factor for seeking treatment with bariatric 
surgery (152, 153). Several instruments are available to assess both generic 
HRQoL and obesity-related quality of life. The Medical Outcomes Study Short Form 
36 General Health Survey (SF-36) appears to be the most commonly used generic 
instrument in studies of bariatric surgery (150, 151). When compared to generic 
HRQoL measures, fewer studies have investigated changes in obesity-related 
quality of life. The short version of the Impact of Weight on Quality of Life (IWQOL-
Lite) and the Moorehead-Ardelt Quality of Life Instrument appear to be the obesity-
related instruments most frequently used (150). The choice of either generic or 
condition-specific instruments to assess quality of life depends on the purpose of the 
study. For instance, the use of generic HRQoL instruments in bariatric surgery 
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studies allows for comparison between HRQoL of people who undergo bariatric 
surgery with other populations, while the use of obesity-related instruments may 
provide greater content validity, measure only the impact of obesity on various 
aspects of quality of life, and have greater sensitivity to detect post-surgery changes 
among people who undergo bariatric surgery (150, 151, 314).  
Several RCTs and non-randomised controlled trials have compared the effects of 
restrictive bariatric surgery with non-surgical weight loss treatments (315, 317-319, 
322). When compared to non-surgical weight loss treatments, most studies have 
reported a greater improvement in HRQoL measures following restrictive bariatric 
surgery. A recent non-randomised controlled trial found significantly greater 
improvements in HRQoL, assessed using the SF-36, in the LSG group, when 
compared to the non-surgical group (i.e. low calorie diet and DM2 medication) (322). 
Compared with baseline measures, 6 months following LSG, the physical 
component summary (PCS) score had improved by 9.8 points (from 46.4 to 56.2). 
The magnitude of this change was 5.6 points greater than the 4.2 points change 
found in the non-surgical group (from 50.7 to 54.9). The LSG group also presented a 
significant increase of 6.7 points in the mental component summary (MCS) score 
(from 48.3 to 55.0). The magnitude of this change was 6.1 points greater than the 
0.6 points change found in the non-surgical treatment group (from 50.9 to 51.5). 
Additionally, although the between-group differences were not reported, the LSG 
group had significant increases in the domains of physical functioning, role-physical, 
general health, vitality, social functioning, and mental health, while on the non-
surgical group, significant increase was only found on the physical functioning 
domain score (322).  
Case series of restrictive surgery have consistently reported improvements on 
HRQoL and obesity-related quality of life, particularly in measures related to 
physical health, with post-surgery scores reaching similar values of those from the 
general population normative values, at follow-up periods up to 5 years post-surgery 
(66, 129, 134, 141, 154-175). A recent case series of 230 people undergoing LAGB 
reported significant increases in all domains and summary scores of the SF-36 at 12 
months, with post-surgery scores similar to the general population normative values, 
which were maintained up to 3 years following surgery (174). At 12 months, there 
was a significant increase of 27.3 points in the PCS score and 22.9 points in the 
MCS score, as well as significant increases ranging from 5.3 to 57.4 points in all 
individual domains of the SF-36. Similarly, a recently published case series of 
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people undergoing LSG reported significant improvements in HRQoL and obesity-
related quality of life, assessed using the SF-36 and the Moorehead-Ardelt Quality 
of Life Instrument, respectively (170). At 12 months post-surgery, there were 
increases in all domains of the SF-36, ranging from 10.6 to 22.2 points, with values 
reaching those of the general population normative values. When assessed by the 
Moorehead-Ardelt Quality of Life Instrument, all participants presented 
improvements and were classified as having good or very good obesity-related 
quality of life at 12 months following LSG (170).  
Improvements in generic and obesity-related quality of life have been consistently 
reported following bariatric surgery (152, 153, 375, 376). Few studies have 
investigated changes in HRQoL following restrictive bariatric surgery using both 
generic and obesity-related quality of life instruments. The use of both generic and 
obesity-related instruments may provide more robust data on post-surgery changes 
in HRQoL (153, 314). This is because the use of generic instruments would allow 
comparisons of post-surgery values with normative population values, while the use 
of obesity-related instruments may be sensitive to change in aspects particularly 
relevant for people who are obese who have chosen to undergo restrictive bariatric 
surgery. Additionally, although there are some data to suggest that improvements in 
HRQoL occur mostly over the first 12 months following restrictive bariatric surgery 
(158, 160, 174, 377), little is known regarding the pattern of change in generic and 
obesity-related quality of life over this period. This information is of importance to 
inform both patients and clinicians on the expected time course of change in these 
outcomes following surgery. 
2.3.7 Mental health 
There are limited data on the effect of restrictive bariatric surgery on symptoms of 
different mental health disorders. The investigation of the effect of surgery on 
symptoms of mental health disorders, such as depression and anxiety is relevant 
since they have been shown to be prevalent among candidates for bariatric surgery 
and associated with worse post-surgical outcomes (190, 378, 379). Further, there is 
evidence to show an association between obesity and increased symptoms of stress 
(179, 180). Changes in mental health outcomes have been assessed via self-reports 
of a mental health disorder diagnosis, structured diagnostic clinical interviews, and 
commonly used validated self-reported questionnaires, such as the Beck 
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Depression Inventory (BDI) and the Hospital Anxiety and Depression Scale (168, 
187, 380).  
To date, no studies have compared the specific effects of restrictive bariatric surgery 
with non-surgical weight loss treatments on symptoms of mental health disorders. 
Several case series of LAGB and LSG have reported significant reductions in 
symptoms of depression at follow-up periods up to 5 years (154, 156, 162, 167, 168, 
181-191). The case series of people undergoing LAGB with the largest sample size 
(n = 487) reported a significant reduction in symptoms of depression of 9.9 points in 
the BDI score (from 17.2 points to 7.8 points) at 12 months, which was maintained 
up to 4 years (181). The most recent study that investigated the effect of restrictive 
bariatric surgery (i.e. LAGB and LSG) on symptoms of mental health, using the 
Hospital Anxiety and Depression Scale, found that when compared to the pre-
surgery depression subscale score, there was a significant reduction of 3.0 points at 
12 months (from 7.3 points to 4.3 points), which was maintained up to 4.5 years 
post-surgery (167).  
Fewer case series have investigated changes in symptoms of anxiety following 
restrictive bariatric surgery. Findings from these case series showed significant 
reductions in symptoms of anxiety up to 12 months post-surgery, but inconsistent 
findings have been reported regarding the long-term maintenance of such 
reductions (154, 167, 182-184, 188). The case series of people undergoing LAGB 
with the longest follow-up period found a significant reduction of 2.1 points (from 9.5 
points to 7.4 points) in the Hospital Anxiety and Depression Scale anxiety subscale 
score at 3 years, which was maintained up to 6 years following surgery (183). In 
contrast, the most recent study that investigated changes in symptoms of anxiety 
following restrictive bariatric surgery (i.e. LAGB and LSG), reported that the 
significant reduction of 1.2 points (from 6.7 points to 5.5 points) in the Hospital 
Anxiety and Depression Scale anxiety subscale score found at 12 months was not 
maintained up to 4.5 years post-surgery (167). A suggested reason for the 
inconsistent findings regarding maintenance of reductions in symptoms of anxiety 
found post-surgery is that symptoms of anxiety seem to be less related to weight 
loss when compared to those of depression, and therefore influenced by other 
factors not related to surgery (167, 184). 
The only study that investigated the effects of restrictive bariatric surgery on 
symptoms of stress reported a significant reduction in the stress module score of the 
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Patient Health Questionnaire at 12 months following LSG; however, the magnitude 
of change was not reported (186).  
There is evidence to suggest that the majority of improvement in symptoms of 
mental health disorders occurs in the first 12 months following restrictive bariatric 
surgery, when the majority of weight lost occurs, and that there is either 
maintenance of (182, 183) or a reduction in the improvement after the first post-
surgery year (167, 168, 191, 381). Despite findings that indicate the majority of 
improvement in symptoms of mental health disorders occurs in the first 12 months 
following restrictive bariatric surgery, the pattern of change during this period, and 
consequently, the expected time course of change in these outcomes are still 
unknown. Additionally, when compared to symptoms of depression, changes in 
symptoms of anxiety have been investigated by fewer studies, particularly of LSG 
(167, 183). Finally, despite evidence that suggests a relationship between obesity 
and stress, and a favourable effect of surgery on perceived stress, there is a lack of 
studies that have investigated the effect of restrictive bariatric surgery on symptoms 
of stress (180, 186). 
2.3.8 Summary 
There is data to show that restrictive bariatric surgery results in significant and 
sustained weight loss, improvement and/or resolution of obesity-related comorbid 
conditions, as well as significant improvements in generic and obesity-related quality 
of life and symptoms of mental health disorders. However, little attention has been 
given to the influence of LAGB and LSG on other health outcomes relevant to 
people’s participation in PA, including cardiovascular fitness, sleep quality, daytime 
sleepiness, body composition and BMD. Additionally, most studies have not 
assessed temporal changes in different health outcomes following restrictive 
bariatric surgery, particularly during the first 12 months following the procedure, 
when the majority of weight loss is expected to happen. The assessment of the 
pattern of change in different health outcomes post-surgery is relevant to inform 
both patients’ expectations of change and clinicians’ decision making regarding 
optimal post-surgical management (12-15, 153). 
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2.4 Physical activity and sedentary behaviour 
This section provides an overview of definitions and recommendations regarding PA 
and SB, as well as a summary of the different available methods to measure PA and 
SB. A discussion of the health implications of PA and SB is also provided. 
2.4.1 Definitions and recommendations 
Physical activity is defined as any bodily movement produced by skeletal muscles 
that results in energy expenditure above resting levels (50). It comprises exercise, 
sports, and PA done as part of daily living, occupation, leisure, and transportation 
(50). Physical activity can be classified as light, moderate or vigorous in intensity 
based on differences in energy expenditure (382). Energy expenditure is often 
expressed as metabolic equivalent units (METs). One MET represents the energy 
expenditure required at rest, which is equivalent to 3.5 mL/kg/min of oxygen intake 
(42). Of note, studies have reported higher energy expenditure among obese people 
when compared to people in the normal weight range, which appears to be 
explained by a higher cost of activities due to the higher body weight, and suggests 
that in obese people, the value for one MET could be lower than 3.5 mL/kg/min of 
oxygen intake (383-385). Light intensity PA involves activities with an energy 
expenditure of 1.5 to < 3 METs (e.g. slow walking, showering or ironing while 
standing). Moderate intensity PA involves activities with an energy expenditure of 3 
to < 6 METs (e.g. brisk walking, jogging). Vigorous intensity PA refers to activities 
with an energy expenditure ≥ 6 METs (e.g. running, cycling) (382, 386, 387). 
Sedentary behaviour is defined as activities performed during waking hours (i.e. 
excluding sleep) that involve low energy expenditure (i.e. < 1.5 METs), and are 
performed while in a sitting or reclining posture (45, 387). Television viewing, 
computer use, sitting, and lying down are common examples of SB, and occur 
across different domains, such as work, leisure, domestic, and transportation (45, 
387).  
Current international guidelines for the development and maintenance of health 
recommend that adults should engage, every week, in a minimum of 150 minutes of 
moderate to vigorous intensity PA (MVPA) or 75 minutes or more of vigorous PA, or 
an equivalent combination of both (50). The recommended amount of PA should be 
performed in bouts of at least 10 minutes, and it is preferable to accumulate the time 
spent in MVPA over five or more days each week (50). Since walking is considered 
a common way of accumulating PA, these recommendations have been translated 
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to a daily step count (388). An average of 7,000 steps per day spent at a moderate 
to vigorous intensity, every day of the week, is considered to approach 150 minutes 
of MVPA per week (388). The most recent international guidelines recommend that 
for adults, between 150 and 250 minutes of MVPA per week should be accumulated 
to prevent weight gain and greater amounts (>250 minutes of MVPA per week) are 
needed for weight loss (51).  
Since for most people, the majority of waking hours in a day is characterised by 
participation in SB and light intensity PA, regardless of meeting the guidelines for 
participation in MVPA, there has been increased interest in the health benefits of 
decreased time in SB and participation in light intensity PA (50, 389-391). Recently, 
guidelines on the recommended amounts of PA to maintain and improve health 
have included recommendations on the maximum amount of time adults should 
spend in SB to minimise the risk of deleterious health effects. Not only does total 
time spent in SB have a negative effect on health, but the way in which SB is 
accumulated also seems to be of importance (43, 54, 70). Current recommendations 
state that people should avoid prolonged periods of SB (i.e. sitting for more than 30 
minutes), which can be achieved through breaking prolonged uninterrupted periods 
of SB as often as possible with light intensity PA (52-54). There is recent evidence 
to suggest that uninterrupted periods of ≥ 10 minutes spent in SB may be 
associated with deleterious health effects (392, 393). Previous studies have also 
found a strong relationship between SB and light intensity PA, which indicates that 
SB is likely to be replaced by light intensity PA (44, 394). Since SB appears to be 
mostly replaced by light intensity PA, studies have investigated possible health 
benefits of participation in light intensity PA and found reductions in CVD risk factors 
when SB is replaced by light intensity PA (46-49). 
2.4.2 Measurement of physical activity and sedentary behaviour 
The measurement of PA and SB can be achieved via subjective methods (e.g. 
surveys, questionnaires) or objective methods (e.g. pedometers, accelerometers). 
The choice of method to measure PA and SB is influenced by different factors, 
including characteristics of the population being studied, study design and aims, 
cost, need for technical expertise, as well as validity, reliability and responsiveness 
of the various methods (395, 396). 
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2.4.2.1 Subjective methods 
Subjective methods involve asking people (or a proxy) to report PA and/or SB over a 
specified time period. Physical activity and SB surveys, diaries, logs, and 
questionnaires are extensively used due to the low cost, as well as speed and ease 
of application, particularly when data are collected for large epidemiological studies 
(396). In addition, subjective measures have the advantage of providing detailed 
information regarding the domain (e.g. occupational, leisure), type (e.g. watching 
television, reading), and reasons for participation in SB and PA (397). However, the 
use of subjective measures has some important limitations. For example, these 
methods rely on people’s recall of activities which may introduce measurement 
error, particularly when asking children and elderly participants to recall how they 
spent their time. Measurement error is also likely to be greater when people are 
required to recall PA and SB over a longer period (e.g. a week versus the previous 
day) (398).  
A systematic review of 173 studies that compared subjective (i.e. questionnaires, 
diary) and objective (i.e. pedometer, accelerometer) measurements of PA in adults 
found low to moderate correlations between these measurements, with a mean r 
value of 0.37 (399). Disparity between subjective and objective measures of PA has 
also been reported in people who are obese and those who undergo bariatric 
surgery. That is, studies that have compared subjective and objective measures of 
PA in obese populations report that obese adults often overstate the amount of PA 
they perform in daily life, particularly PA of vigorous intensity (5, 9, 400, 401). For 
example, a study that assessed changes in MVPA 6 months following bariatric 
surgery using self-reported (i.e. questionnaire) and objective (i.e. accelerometer) 
measures demonstrated a fivefold increase in self-reported amount of MVPA but no 
change in objective measures of MVPA (5). Overestimation of PA levels is common 
across many populations and may reflect problems with recall, however; there are 
two more potential reasons for the overestimation of PA levels among people who 
are obese. One reason is that the overestimation is likely to reflect social desirability 
bias, in that people who are obese are more likely to report engaging in healthy 
behaviours. Further, the overestimation of PA levels may also reflect a different 
perception of effort related to PA intensity, as people who are obese perceive 
activities to be of vigorous intensity more easily than normal-weight counterparts 
(71, 400, 401).  
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2.4.2.2 Objective methods 
Given the error associated with subjective methods, objective methods are 
increasingly being used to assess PA and SB. Objective measures use motion 
sensors to detect body movement (e.g. pedometers and accelerometers) and/or 
physiological sensors to estimate energy expenditure (e.g. metabolic monitors) 
(402). When compared to subjective methods, these devices are more accurate in 
providing detailed measures of body movement and intensity of activities performed 
(399, 403). Different measures have been considered to be gold standards for 
assessment of PA and SB, according to the measurement purpose (397, 404, 405). 
For the measure of body motion, the gold standard is direct observation, which can 
be done by observers watching in person or by video recordings to quantify people’s 
PA. For the measure of energy expenditure, the gold standard is doubly labelled 
water, an isotope-based technique to estimate carbon dioxide production in body 
fluid samples over a period of time (397, 404, 405). To date, the gold standard for 
measurement of SB has been direct observation or a combination of data from 
objective (e.g. accelerometer) and subjective measures (e.g. diary) (406). However, 
gold standard measures are usually intrusive on the person’s privacy and time 
consuming (e.g. direct observation), or limited by the high cost, participant burden, 
and need of laboratory setting and technical expertise (e.g. doubly labelled water) 
(407). When compared to the gold standard methods, motion sensors (e.g. 
pedometers and accelerometers) and metabolic monitors provide an accurate and 
more accessible way to objectively measure PA and SB and energy expenditure, 
respectively (397, 404). Disadvantages common to most motion sensors and 
metabolic monitors are that they need to be removed during bathing and water 
activities and do not provide assessment of arm movement. Although motion 
sensors and metabolic monitors provide more accurate measures of PA and SB, 
when compared to subjective methods, the comparison of objective measures of PA 
and SB between studies that use different devices might be problematic. This is 
because the way in which these measures are estimated often differ according to 
the device used. That is, time spent in MVPA might be derived from energy 
expenditure when using a metabolic monitor (e.g. time spent in PA with an energy 
expenditure ≥ 3 METs), while the same measure of time spent in MVPA might be 
derived from the number of steps taken per time epoch (e.g. time spent in walking-
based PA with a step cadence > 80 steps/minute) (7, 25). Additionally, the 
relationship between the ways in which a measure of PA is estimated (e.g. step 
count and energy expenditure) may differ between individuals and according to 
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environmental factors. That is, in some circumstances, the same step cadence will 
require different levels of energy expenditure (e.g. a person with normal weight 
walking at 60 steps/minute on flat ground will expend less energy than an obese 
person walking at 60 steps/minute up a steep hill, into a head wind). Further, even 
when studies use identical devices to measure PA and SB, the estimates may be 
influenced by differences in data handling procedures, such as different wear time 
criteria used to consider the data valid (i.e. minimum number of days and of hours 
per day the device needs to be used) (23, 408-411). The following paragraphs 
provide a summary of the most common motion sensors and metabolic monitor 
used to objectively measure PA and SB. 
Pedometers 
Pedometers, also referred to as step counters, are simple, inexpensive devices (i.e. 
cost range from AUD$15 to AUD$300) that are commonly used to obtain objective 
measures of PA. They are most often worn on the hip via a waistband, and are 
designed to detect vertical movement during ambulation, through a horizontal, 
spring-suspended lever arm that deflects with vertical movement (408, 412). In 
addition to the disadvantages common to motion sensors in general, the use of 
pedometers has specific limitations, such as counting any vertical movement as a 
step (e.g. vibrations when driving a car or standing up from a sitting position); lack of 
information regarding the intensity at which activities are performed; and 
underestimation of step counts in populations who walk at low speeds (e.g. elderly 
and obese) (412-414). Since pedometers are usually worn around the waist or hips, 
an additional limitation among people who are obese is decreased accuracy due to 
pedometer tilt (415). Abdominal adipose tissue can cause a waistband-mounted 
pedometer to tilt and place it in a non-optimal position to detect vertical movement, 
which might affect its capacity to provide an accurate measurement of steps (397, 
415). A new generation of pedometer has overcome some of these problems. The 
StepWatch 3 Activity Monitor (SAM) (Cyma Corporation; Seattle, WA, USA) is a 
micro-processor driven pedometer that responds to time, acceleration and position. 
It is worn on the right ankle, and has been shown to provide a valid and reliable 
count of steps in lean and obese adults, when compared to direct observation (416). 
The SAM records numbers of steps in one minute epochs, and cadence thresholds 
have been used to assess time spent in different intensities of walking-based PA (6, 
7, 20). It has been used to quantify changes in PA in a large observational study (n 
= 310) involving people who underwent bariatric surgery (6, 7, 20). 
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Accelerometers and portable metabolic monitors 
Accelerometers are generally small, lightweight devices that record body motion in 
one or more planes, and provide information regarding the amount and intensity of 
activities (395, 405). Portable metabolic monitors combine accelerometry data with 
non-invasive physiological sensors (e.g. body temperature and galvanic skin 
response) to provide an estimation of energy expenditure during different activities 
(417). Disadvantages common to most accelerometers and portable metabolic 
monitors are relatively high cost (i.e. AUD$700 to AUD$3,400) and the requirement 
of technical expertise to collect, manage and interpret the data collected (395, 396).  
Some accelerometers and portable metabolic monitors classify time into SB, light, 
moderate and vigorous-intensity PA based on intensity of movement and, when 
available, measures of physiological responses (e.g. heart rate and skin 
temperature) (417). In studies of people who undergo bariatric surgery, the most 
commonly used accelerometer appears to be the RT3 (Stayhealthy; Monrovia, CA, 
USA), a tri-axial accelerometer, worn around the waist, that provides PA data as 
activity counts (21, 418). The most commonly used portable metabolic sensor in 
studies of bariatric surgery appears to be the SenseWear Armband (SAB) 
(Bodymedia Inc.; Pittsburgh, PA, USA). The SAB is a small, lightweight monitor that 
is worn over the triceps brachii muscle bulk of the left arm. Placement of this device 
on the arm eliminates issues related to non-optimal position to detect movement 
caused by abdominal fat when devices are worn around the waist (e.g. RT3 
accelerometer) (23, 419). It combines a tri-axial accelerometer and non-invasive 
physiological sensors that detect heat flux, skin temperature and galvanic skin 
response to provide integrated measures of body motion and energy expenditure 
(23, 419). The SAB estimates energy expenditure and PA intensity using a 
proprietary algorithm and has been shown to provide valid measures and reliable 
measures in normal- and overweight adults, when compared to indirect calorimetry 
and doubly labelled water (420-422). It has also been used in studies that included 
people who are obese and those who underwent bariatric surgery (34, 40, 423). 
Although a pattern of low levels of PA has been found among candidates for 
bariatric surgery, when compared to people in the normal-weight range (21-23), few 
studies have used objective methods to assess the influence of restrictive bariatric 
surgery on PA and SB levels. Furthermore, a combination of different devices (e.g. 
pedometers and accelerometers) might provide more robust data on patterns of 
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accumulation of PA and SB (25). The combination of data from different devices in 
the same sample offers the combination of useful and easily interpreted measures, 
such as number of steps that can be translated into simple clinical messages, with 
more complex measures, such as energy expenditure that offer important details 
regarding the pattern of accumulation (i.e. bout-related PA and SB) and intensity of 
activities performed. 
Objective measurement of bout-related physical activity and sedentary behaviour  
When compared to subjective methods, the use of objective methods to assess PA 
and SB allows for more accurate, reliable and detailed measures of not only total 
time spent in SB and PA performed at different intensities, but also the accumulation 
of PA and SB in uninterrupted bouts of time (399, 403). The capacity to investigate 
patterns of accumulation of both SB and PA is important as this appears to influence 
health outcomes, independent of the total time spent in SB and PA, as described in 
sections 2.4.1 (Definitions and recommendations) and 2.4.3 (Health implications). 
The objective measurement of bout-related PA, particularly MVPA, in bouts ≥ 10 
minutes has been well established in studies of normal-weight and obese adults (6, 
7, 21, 424, 425). This is because the investigation of objectively-measured MVPA 
accumulated in uninterrupted bouts ≥ 10 minutes reflects current international 
guidelines, which recommend people to participate in a minimum of 150 
minutes/week of MVPA in bouts ≥ 10 minutes in order to obtain health benefits (42, 
50, 51).  
In contrast with the bout duration for MVPA, less is known about the maximum bout 
duration in which SB can be accumulated without increasing the risk of deleterious 
health outcomes. Evidence from observational and experimental studies indicates 
that people should avoid prolonged uninterrupted periods of SB (i.e. sitting for more 
than 30 minutes), which can be achieved by breaking these prolonged periods as 
often as possible (43, 44, 53, 54, 70, 391). However, a recent cross-sectional study 
of adults in the general population that investigated the association between 
objectively-measured SB bouts of different durations (i.e. 1, 2 to 4, 5 to 9, 10 to 14, 
15 to 19, 20 to 24, 25 to 29, and ≥30 minutes) and cardiometabolic risks has found 
that SB accumulated in bouts ≥ 10 minutes was associated with higher risk (i.e. 
increased waist circumference, triglycerides and high-density lipoprotein cholesterol) 
(392). Similarly, a cross-sectional study of adults with severe obesity that 
investigated the association between objectively-measured SB bouts of different 
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durations (i.e. 1, ≥ 10 and ≥ 30 minutes) and cardiometabolic risk factors (i.e. 
diabetes, metabolic syndrome, elevated blood pressure and waist circumference) 
reported that measures of SB in uninterrupted bouts ≥ 10 minutes appear to be a 
more conservative estimate in order to identify prolonged periods of SB, when 
compared to bouts ≥ 30 minutes, and should be considered when using objective 
measures of SB (393). 
2.4.3 Health implications  
Several international societies advocate the importance of regular participation in PA 
due to its numerous physical and mental health benefits in adults (42, 50). In 
addition to the benefits associated with regular participation in PA, there are recent 
data to suggest that similar benefits, independent of participation in PA, can be 
achieved by decreasing time spent in SB (44, 426). The following sub-sections 
summarise the role that participating in low levels of PA and accumulating increased 
time in SB may have in the development of obesity and different comorbid 
conditions. Possible mechanisms are discussed. The implications of PA and SB 
within the context of bariatric surgery are also discussed. 
2.4.3.1 Physical activity, sedentary behaviour and obesity  
Several cross-sectional and longitudinal studies have shown that participation in low 
levels of PA is associated with increased body weight (427-433). A recent large 
cohort study (n = 17,394) investigated the association between low levels of PA (i.e. 
not meeting the guidelines of 150 min/week of walking, moderate and vigorous 
activity) and incident obesity in South Australian adults (433). When compared to 
people who met the guidelines for PA, those who did not had a relative risk for 
developing obesity of 1.5 (95% CI, 1.1 to 1.9). A large cross-sectional population-
based study (n = 3,867) investigated the association between objective measures of 
PA and risk of being overweight (i.e. BMI ≥ 25 kg/m2) or obese (i.e. BMI ≥ 30 kg/m2) 
in adults (432). When compared to those in the most active quintile for PA, those in 
the least active quintile for PA had an odds ratio of 2.0 (95% CI, 1.7 to 2.5) for being 
overweight, and of 3.3 (95% CI, 2.5 to 5.0) for being obese.  
Increased time in SB, independent of participation in PA, has also been associated 
with higher risk of obesity (434-439). Chau et al (439) reported associations 
between occupational and leisure-time sitting, PA, and obesity in 10,785 working 
adults. When compared with workers who had jobs characterised by long standing 
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periods, and therefore considered to engage in less SB, those who had jobs 
characterised by long sitting periods had a relative risk for overweight or obesity of 
1.1 (95% CI, 1.1 to 1.3). The increased risk for overweight or obesity in those who 
reported more occupational sitting was found to be independent of PA and leisure-
time sitting. The same study showed that when compared to those who reported < 4 
h/day, those who reported ≥ 4 h/day of leisure-time sitting had a relative risk of 
overweight or obesity of 1.3 (95% CI, 1.1 to 1.4). The increased risk of overweight or 
obesity for those who reported greater time spent in leisure-time sitting was found to 
be independent of PA and occupational sitting. The association between the 
development of obesity and participation in low levels of PA and increased time in 
SB can be explained by reductions in total energy expenditure and consequent 
positive energy balance. A positive energy balance, when energy intake is higher 
than energy expenditure, results in increased energy storage and, consequently, in 
increased body weight (432, 439, 440).  
Physical activity and/or exercise also seem to play an important role in weight 
management and maintenance, as well as in body composition, especially in 
preserving FFM and reducing abdominal fat (51, 441-448). A large cohort study 
followed 3,554 people for 20 years and investigated the association between self-
reported habitual PA and changes in weight and waist circumference (444). When 
compared to people who reported low levels of PA (i.e. those in the lowest tertile of 
PA), those who maintained high levels of PA (i.e. those in the highest tertile) over 
time gained less weight and fewer centimetres in waist circumference. A high quality 
RCT that investigated the effects of a 16-month supervised exercise intervention 
(i.e. walking on a treadmill for 45 minutes, 5 days/week), without diet modification, 
on body weight and composition of overweight adults found that the exercise group 
reduced or maintained weight, FM, and FFM (441). Specifically, their findings 
showed that in comparison to the control group (i.e. who received instructions to 
maintain usual PA and dietary intake throughout the study), men in the exercise 
group had significantly greater reductions in weight (5.2 kg; SD, 4.7), BMI (1.6 
kg/m2; SD, 1.4), and FM (4.9 kg; SD, 4.4). Women in the exercise group maintained 
weight, BMI and FM, while those in the control group had significant increases in 
weight (2.9 kg; SD, 5.5), BMI (1.1 kg/m2; SD, 2.0), and FM (2.1 kg; SD, 4.8). Of 
note, men and women in the exercise group maintained their FFM and had 
significant reductions in abdominal fat (441).  
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2.4.3.2 Physical activity, sedentary behaviour and obesity-related comorbid 
conditions 
2.4.3.2.1 Physical activity 
Regular participation in PA, particularly MVPA, has been associated with reduced 
risk of developing different cardiometabolic conditions, such as DM2, CVD and 
associated risk factors (42). For example, a systematic review of 10 cohort studies 
indicated that both regular participation in MVPA and walking were associated with 
decreased risk of DM2 in adults (61). The relative risk of DM2 for those who 
reported participation in regular MVPA, when compared to low levels of PA, was 0.7 
(95% CI, 0.6 to 0.8). Similarly, the relative risk of DM2 for those who reported 
regular walking, when compared to almost no walking, was 0.7 (95% CI, 0.6 to 0.8). 
A large cohort study followed 27,055 women for an average of 11 years and found 
that those who reported expending ≥ 1500 kilocalories per week on PA, when 
compared to < 200 kilocalories per week, had a hazard ratio of 0.6 (95% CI, 0.5 to 
0.7) for CVD, and of 0.6 (95% CI, 0.5 to 0.7) for total, low-density lipoprotein, and 
high-density lipoprotein cholesterols (59). The associations between PA and risk of 
DM2, CVD and associated risk factors, such as blood lipids (i.e. triglycerides and 
cholesterol), blood pressure, and metabolic syndrome have been consistently 
shown to be independent of body weight and other relevant confounding factors, 
such as age, sex, smoking, alcohol use, medication use, family history of DM2, and 
risk factors for CVD (57-65, 294, 449-459). Participating in PA most likely reduces 
the risk of DM2 by decreasing insulin resistance and improving glycaemic control 
(57). Although the mechanisms by which participation in PA reduces the risk of CVD 
are not fully understood, improvements in endothelial function, as well as in CVD 
risk factors, such as blood pressure, lipid levels and glycaemic control seem to be 
the main contributors to the decreased risk of CVD (59, 460). 
There is evidence to suggest that participation in PA has a beneficial influence on 
the prevalence, incidence and slowing of progression of musculoskeletal conditions 
such as osteoarthritis of the lower limbs and osteoporosis (461, 462). Evidence from 
cohort studies suggests that participation in PA, in the absence of previous injury, is 
associated with decreased risk of lower limb osteoarthritis and, when adopted as 
part of the management of osteoarthritis, results in beneficial effects on pain and 
function (461, 463-465). A large cohort study of Australian women (n = 3,613) found 
that when compared to women who reported no leisure-time PA, those who reported 
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moderate levels of leisure-time PA (i.e. 75 to < 150 min/week of moderate intensity 
PA) had an odds ratio for osteoarthritis of 0.8 (95% CI, 0.7 to 0.9) (463). This 
association was found to be independent of body weight and other confounding 
factors (e.g. DM2, CVD, depression, and alcohol use) The suggested mechanisms 
by which participation in PA is associated with the management of osteoarthritis 
include the maintenance of muscle strength, joint range of motion, balance and 
fitness, which in turn result in reduction in joint pain and improvement in physical 
function (461, 465). Meta-analyses of RCTs and cohort studies have demonstrated 
beneficial effects of participation in PA on measures of skeletal health (i.e. BMD) 
and reduced risk of osteoporosis and fractures (466-472). The beneficial effects of 
weight-bearing and muscle-strengthening activities on BMD have been suggested 
as the mechanisms by which PA positively impact bone health (462, 473). Since 
BMD is a strong predictor of fracture risk, the reduction in fracture risk associated 
with PA is likely due to the capacity of PA to increase, or minimise the decrease in, 
BMD (42). 
Several cross-sectional and cohort studies, as well as RCTs have reported on the 
association between participation in low levels of PA and increased symptoms of 
mental health disorders, such as depression and anxiety (474-483). Vallance et al 
(482) investigated the association between objective measures of PA, collected 
using the ActiGraph accelerometer, and symptoms of depression in 2,862 adults. 
When compared to people who spent > 36.0 min/day in MVPA, those who spent < 
8.5 min/day in MVPA had an odds ratio for depression of 2.5 (95% CI, 1.4 to 5.0). 
This association was independent of body weight and other confounding factors 
(e.g. sex, age, smoking, education). A large population-based study (n = 41,914) 
reported that when compared to adults who reported at least 30 minutes of MVPA 
on at least 5 days/week, those who reported no participation in MVPA had an odds 
ratio for symptoms of depression of 1.2 (95% CI, 1.1 to 1.4) and for symptoms of 
anxiety of 1.3 (95% CI, 1.2 to 1.5) (476). The mechanisms by which PA is 
associated with lower risk of symptoms of mental health disorders are not fully 
known, and this association is likely to be explained by a complex interaction of 
psychological (e.g. increased self-efficacy, sense of mastery, and distraction) and 
neurobiological mechanisms (e.g. an increase in endorphins and norepinephrine, 
dopamine, and serotonin neurotransmitters, and changes in the hypothalamic 
adrenocortical system) (484). 
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In summary, there is strong evidence to show that regular participation in PA, 
independent of body weight, is associated with decreased risk of cardiometabolic, 
musculoskeletal and mental health conditions that are often comorbid with obesity. 
The association between participation in PA and decreased risk of comorbid 
conditions appears to be influenced by a complex interaction between biological 
(e.g. reduction in insulin resistance, improvement in endothelial function, and 
increase in different neurotransmitters), mechanical (e.g. increased weight-bearing 
and muscle-strengthening activities) and psychosocial factors (e.g. increased self-
efficacy, and distraction). 
2.4.3.2.2 Sedentary behaviour 
Several cross-sectional and cohort studies have reported that increased time in SB, 
particularly when accumulated in prolonged uninterrupted periods, is associated with 
increased risk of DM2, CVD and cardiometabolic risk factors (32, 43, 64, 392, 393, 
435, 458, 485-499). For instance, a meta-analysis of cohort studies reported an 
association between television viewing and risk of DM2, with a relative risk of 1.2 
(95% CI, 1.1 to 1.3) per 2 h/day of television viewing (494). Findings from a 
systematic review of cohort studies showed that for a 2-hour increase in screen time 
activities, the hazard ratio for cardiovascular events was 1.2 (95% CI, 1.1 to 1.2), 
and for a 2-hour increase in sitting time the hazard ratio for cardiovascular events 
was 1.1 (95% CI, 1.0 to 1.1) (496). A large cross-sectional study of adults in the 
general population (n = 5,917) has suggested that SB was associated with 
increased cardiometabolic risk factors (392). Findings consistently showed that SB 
accumulated in bouts ≥ 10 minutes were significantly associated with increased 
waist circumference, triglycerides and high-density lipoprotein cholesterol. A recent 
cross-sectional study (n = 927) investigated the relationship between objectively-
measured SB and cardiometabolic risk factors in people with severe obesity before 
bariatric surgery (393). The results showed that one hour per day of SB 
accumulated in uninterrupted bouts ≥ 10 minutes was significantly associated with 
higher odds of diabetes (odds ratio, 1.2; 95% CI, 1.1 to 1.3), metabolic syndrome 
(odds ratio, 1.1; 95% CI, 1.0 to 1.2) and elevated blood pressure (odds ratio, 1.1; 
95% CI, 1.0 to 1.3). The associations reported in these studies were found to be 
independent of body weight, participation in MVPA, and other confounding factors 
such as age, sex, smoking, alcohol use, family history of DM2, risk factors for CVD, 
and dietary factors. In contrast, other studies have found no association between SB 
and cardiometabolic risk factors after controlling for time spent in MVPA (489, 492, 
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498). A cross-sectional study of 370 adults characterised by high levels of objective 
measured total and bout-related MVPA reported that the association found between 
SB and cardiometabolic risk factors was no longer statistically significant after 
controlling for time spent in MVPA (498). A possible explanation for the contradictory 
findings in the study by Scheers et al. (498) regarding the independent association 
between time in SB and cardiometabolic risk may be that the effects of SB on 
cardiometabolic health are reduced by high levels of MVPA (500). This explanation 
is supported by data from a recent meta-analysis of 13 prospective cohort studies (n 
= 1,005,791) that investigated the association between measures of PA and SB and 
mortality (i.e. all-cause, cardiovascular disease and cancer-related mortality) (501). 
The findings showed no association between daily sitting time and mortality for 
participants in the most active quartile of PA. Specifically, for those who were 
grouped into the highest quartile for PA (3.5. MET-h/week) there was no difference 
in mortality risk between those who also sat for more than eight hours per day and 
those who sat for less than hour days per day. However, for those who were 
grouped into the lowest quartile of PA (i.e. < 2.5 MET-h/week) who also sat for less 
than four hours per day, there was an increased risk of dying (hazard ratio, 1.3; 95% 
CI, 1.2 to 1.3) (501). The association between increased time in SB and higher risk 
of DM2 and CVD, independent of PA levels, appears to be mediated by the effects 
of SB in reducing the levels of skeletal muscle lipoprotein lipase (502, 503). The 
skeletal muscle lipoprotein lipase is an enzyme that facilitates the uptake of free 
fatty acids into skeletal muscle and adipose tissue, and low levels of skeletal muscle 
lipoprotein lipase have been associated with decreased insulin sensitivity, plasma 
glucose intake, and high-density lipoprotein cholesterol, as well as with increased 
triglycerides levels and risk of CVD. 
There is a scarcity of studies that investigated the associations between SB and 
musculoskeletal conditions. However, there is some evidence to suggest that 
prolonged periods spent in SB, independent of MVPA, are associated with reduced 
BMD (504, 505). The association between SB and BMD appear to be explained by 
changes in bone metabolism due to decreased muscle activation and unloading of 
bone structure. Sedentary behaviour, particularly sitting, may result in increased 
bone reabsorption and decreased stimulation of bone formation, which consequently 
leads to reduced BMD and increased risk of osteoporosis (503).  
Various cross-sectional and cohort studies, as well as RCTs and non-randomised 
controlled trials have shown that increased time in SB, independent of participation 
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in MVPA, is associated with increased symptoms of mental health disorders, such 
as depression and anxiety (482, 506-511). A recent study investigated the 
association between objective measures of SB, collected using the ActiGraph 
accelerometer, and symptoms of depression and anxiety in a representative sample 
of the general population (509). When compared to people in the lowest tertile of 
sedentary time, those in the highest tertile had a higher risk of having symptoms of 
depression and anxiety (odds ratio, 1.7; 95% CI, 1.1 to 2.8). This association was 
found to be independent of participation in MVPA and socio-demographic factors. 
Although the mechanisms involved in the association between increased time in SB 
and increased symptoms of mental health disorders are still unknown, possible 
explanations include the displacement of light intensity PA caused by increased SB, 
the effects of SB (e.g. television viewing) on central nervous system arousal, sleep 
disturbances, poor metabolic health, as well as social withdrawal related to activities 
such as television viewing and computer use (507, 511).  
In summary, several studies have established the association between increased 
time in SB and increased risk of comorbid conditions. In several studies, these 
associations have been shown to be independent of body weight and participation in 
MVPA. Of particular note is that the effects of SB appear to be independent of 
participation in MVPA. That is, the deleterious effects of increased time in SB may 
not be offset by participation in MVPA, particularly for those people who participate 
in low levels of MVPA. The association between increased time in SB and increased 
risk of comorbid conditions is complex and likely to be explained by 
interrelationships between biological (e.g. reduction in skeletal muscle lipoprotein 
lipase levels and central nervous system arousal), mechanical (e.g. decreased 
muscle activation) and psychosocial factors (e.g. social withdrawal).  
Together, a pattern of both low levels of PA and increased time spent in SB involve 
interactions between different biological, mechanical and psychosocial factors in 
complex interactions that may result in further impairments in cardiovascular fitness 
(512-515) and HRQoL (516-518). People who participate in low levels of PA and 
increased time in SB, independent of body weight, have an increased risk of both 
all-cause and cause-specific mortality that might be explained by the presence of 
different comorbid conditions and impairments of cardiovascular fitness and HRQoL 
(31-33, 494, 519-522). Although obesity is an important risk factor for the 
development of the different comorbid conditions discussed in this section (i.e. DM2, 
CVD, musculoskeletal conditions, and symptoms of mental health disorders), it is 
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unlikely that weight loss would mitigate the detrimental effects of participation in low 
levels of PA and increased time in SB, since the associations between little PA and 
increased SB with different comorbid conditions are independent of body weight. 
Therefore, regardless of body weight, in order to improve health, it is important to 
promote both an increase in participation in PA and a reduction in time spent in SB. 
2.4.3.3 Physical activity, sedentary behaviour, weight loss and obesity-
related conditions within the context of bariatric surgery 
Different cross-sectional studies and case series of people undergoing bariatric 
surgery, mostly malabsorptive or mixed procedures, have reported that participation 
in PA results in better post-surgery outcomes, such as greater weight loss (66-68, 
419, 523-526), favorable changes in body composition (527), greater reduction in 
risk factors for CVD (e.g. blood lipids) (528), and better HRQoL (66). Regarding 
weight loss, Bond et al (66) assessed the association between changes in 
subjectively-measured PA, using the International Physical Activity Questionnaire, 
and weight loss following RYGB. At 12 months post-surgery, when compared to 
people who reported participation in low levels of PA (i.e. < 200 min/week of PA), 
those who reported participation in higher levels of PA (i.e. ≥ 200 min/week of PA) 
had significantly greater weight loss, expressed in absolute weight (52.5 kg versus 
46.4 kg) and BMI (18.9 kg/m2 versus 16.9 kg/m2). A cross-sectional study found that 
objective measures of MVPA, collected using the SAB, were associated with greater 
%EWL between 2 to 5 years following RYGB (419). When compared to those who 
participated in < 150 min/week of MVPA, those who participated in ≥ 150 min/week 
of MVPA had a greater %EWL (68% versus 52%; p = 0.01). In contrast to reports of 
people who underwent RYGB (66, 419, 523, 525), a study that investigated people 
who underwent LAGB found no associations between subjective measures of PA, 
collected using the International Physical Activity Questionnaire, and measures of 
weight loss (i.e. absolute weight, BMI, and %EWL) at 3, 6, and 12 months post-
surgery (526). The inconsistent results may be explained by a slower weight loss 
found following LAGB when compared to RYGB, as well as by inaccurate 
measurement of PA by subjective methods.  
The only study that investigated the association between subjective measures of 
PA, collected using the Modifiable Activity Questionnaire, and measures of body 
composition, using DXA, found that increased leisure-time PA was associated with 
favorable changes in body composition following RYGB (527). At 12 months, 
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leisure-time PA was positively associated with LBM (r = 0.20) and negatively 
associated with FM (r = -0.20). Regarding risk factors for CVD, a case series that 
investigated subjectively-measured PA, using the Modifiable Physical Activity 
Questionnaire, found that when compared to people who reported participation in 
low levels of PA (i.e. energy expenditure <1,250 METs/14 days), those who 
participated in higher levels of PA (i.e. energy expenditure ≥ 1,250 METs/14 days) 
had favourable changes in blood lipids following LSG (528). At 12 months, despite 
similar weight loss, those who reported participation in higher levels of PA had lower 
levels of total cholesterol (182.8 mg/dL versus 220 mg/dL) and low-density 
lipoprotein cholesterol (103.2 mg/dL versus 133 mg/dL). Bond et al (66) also 
assessed the relationship between changes in subjectively-measured PA, using the 
International Physical Activity Questionnaire, and HRQoL, using the SF-36, following 
RYGB. At 12 months, when compared to people who reported participation in low 
levels of PA (i.e. < 200 min/week of PA), those who reported participation in higher 
levels of PA (i.e. ≥ 200 min/week of PA) had significantly greater weight loss and 
improvements in the scores of the MCS, as well as general health, vitality, and 
mental health domains of the SF-36.  
Recently, a RCT of people who underwent RYGB, has reported positive effects of a 
post-surgery exercise training protocol on different outcomes (37, 529, 530). Coen 
et al (37) performed a RCT of people within one to three months following RYGB 
and found that when compared to a health education control group (n = 62), those 
who were randomly allocated to a 6-month semi-supervised moderate exercise 
intervention (n = 66) had significantly greater improvements in measures of insulin 
sensitivity and glucose effectiveness (i.e. the ability of glucose per se to stimulate 
glucose uptake). Additionally, when compared to the control group, the exercise 
group had a significantly greater improvement in peak oxygen uptake measured 
during a maximal exercise test, performed on a cycle ergometer. Data collected in a 
sub-sample of participants from the RCT by Coen et al (37), who completed the 
study and underwent muscle biopsy  showed that the exercise group (n = 50) had 
favourable changes in measures of skeletal muscle mitochondria and 
intramyocellular lipids, when compared to no changes in the control group (n = 51) 
(529). Further, Woodlief et al. (530) reported findings from a post hoc analysis of 
participants from the same study, who were grouped according to the amount of 
recorded exercise. Participants in the exercise group (n = 56) were grouped 
according to the mean amount of weekly exercise performed, as either low (54 
minutes/week; SD 8), middle (129 minutes/week; SD 4), or high exercise (286 
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minutes/week; SD 40), and compared to the control group (n = 42). This analysis 
showed that, when compared to the control group, both middle and high exercise 
sub-groups had significantly greater improvements in insulin sensitivity. However, 
only the high exercise sub-group had significantly greater weight loss, decrease in 
fat mass and abdominal fat, and improvements in cardiovascular fitness and skeletal 
muscle mitochondrial capacity (530). The findings of this RCT suggest that when 
compared with a health education control, an intervention involving semi-supervised 
moderate exercise results in greater improvements in post-surgery outcomes, such 
as cardiometabolic risk factors and cardiovascular fitness. Further, when the amount 
of weekly exercise performed was considered, a modest amount of exercise 
appears to provide additional improvements in insulin sensitivity following RYGB, 
however, higher volumes of exercise are needed to induce additional weight loss, 
changes in body composition, and improvements in cardiovascular fitness and 
skeletal muscle mitochondrial capacity. 
Regarding SB, one case series and one cross-sectional study have reported inverse 
associations between subjectively-measured SB and measures of weight loss (525, 
527) and body composition (527) following RYGB. A cross-sectional study that 
investigated the association between subjectively-measured SB, using self-reported 
occupational and leisure sitting time, and weight loss at 2 to 6 years post-surgery 
reported that when compared to people in the lowest tertile of sitting time, those in 
the highest tertile of sitting time had an odds ratio of 2.9 (95% CI, 0.1 to 5.7) for 
weight loss, and of 4.9 (95% CI, 0.6 to 9.3) for %EWL (525). These associations 
were independent of participation in PA. Vatier et al (527) investigated the 
association between subjectively-measured SB, using the Modifiable Activity 
Questionnaire, and measures of body composition, using DXA. At 12 months post-
surgery, television watching time was significantly negatively associated with LBM (r 
= -0.21) and positively associated with FM (r = 0.23). The relationship between 
decreased time in SB and body composition measures was independent of leisure-
time PA. 
2.4.4 Summary 
International guidelines provide clear recommendations regarding the minimum 
amount of MVPA that is required to improve and maintain health (50). More recently, 
there are data to suggest that participation in prolonged periods of SB is associated 
with deleterious effects on general health (43, 70, 531). Breaks in SB are likely to 
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represent an increase in time spent in light intensity PA, which has also been found 
to be associated with better health outcomes (46, 502). There are several subjective 
and objective methods for the measurement of PA and SB (397). The objective 
methods for assessment of PA and SB (e.g. accelerometers and portable metabolic 
monitors) have been shown to be more accurate and reliable than subjective 
methods (e.g. questionnaires and diaries) (397, 402). Earlier research has 
established the associations between poorer health outcomes and a lifestyle of 
participation in low levels of PA and increased time in SB (44, 532-534). Of note, 
studies show that the detrimental effects of increased time in SB are not fully offset 
by participation in MVPA (43, 496). Low levels of PA, as well as high levels of SB 
were found to be independently associated with higher risk of obesity and different 
comorbid conditions, which suggests that promoting reductions in time spent in SB 
may be as important as increasing PA levels as a strategy to prevent obesity and 
improve health in adults (47, 437, 439). Additionally, there is early evidence to 
suggest that PA and SB may be important considerations in the bariatric surgery 
population, since increased participation in PA and decreased time in SB have been 
associated with better post-surgery outcomes (37, 66, 68, 419, 523, 525-530, 535). 
2.5 Physical activity and sedentary behaviour prior to and 
following bariatric surgery 
As the programme of research described in this thesis focuses on surgical treatment 
of obesity, the evidence for the effects of bariatric surgery, particularly LAGB and 
LSG, on different health outcomes (e.g. weight-related measures, obesity-related 
comorbid conditions, body composition and BMD, cardiovascular fitness, sleep 
problems, HRQoL, and symptoms of mental health disorders) was previously 
summarised in section 2.3 (Influence of restrictive bariatric surgery on health 
outcomes). This section provides information on PA and SB in people pre- and post-
surgery. Given the bias associated with measuring PA and SB using subjective 
methods, only studies that have measured these variables using objective methods 
will be discussed. The studies first described are those which assessed PA and SB 
in candidates for bariatric surgery. Thereafter, studies are described in which PA 
and SB levels were assessed following bariatric surgery. Finally, studies that 
investigated the pre- to post-surgery changes on PA and SB measures are 
reviewed.  
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Several studies have demonstrated that candidates for bariatric surgery engage in 
little PA and spend most of their waking hours in SB (20-24, 27). The first study to 
investigate objective measures of PA in a large sample (n = 757) pre-surgery used 
the SAM, a micro-processor driven pedometer (20). Their findings showed that 
participants performed an average of 7,569 steps/day, with 54% of participants 
classified as sedentary (i.e. < 5,000 steps/day) or low active (i.e. 5,000 to 7499 
steps/day) and only 20% classified as active (i.e. ≥ 10,000 steps/day). Similarly, a 
recent study that used the SAB, a portable metabolic monitor, found that candidates 
for bariatric surgery (n = 71) averaged 7,140 steps/day, and 59% of participants 
were classified as sedentary or low active and 18% were classified as active (27). 
There are also data to suggest that the participation in PA among people scheduled 
to undergo bariatric surgery is lower that the participation in PA in the general 
population. The only study that compared the levels of PA of 38 candidates for 
bariatric surgery to 20 normal-weight controls, using the RT3 accelerometer, found 
candidates for bariatric surgery to be less active than controls (21). When compared 
to controls, candidates for bariatric surgery had significantly fewer activity counts per 
hour (13,799 counts/hr versus 19,462 counts/hr) and spent less time engaged in 
MVPA (26.4 min/day versus 52.4 min/day) and vigorous-intensity PA (1.2 min/day 
versus 11.8 min/day). Additionally, when assessing participants adherence to 
international recommendations (i.e. accumulation of 150 min/week of MVPA in bouts 
of ≥ 10 minutes), 5% of candidates for bariatric surgery met the recommendations 
when compared to 40% of controls, and more candidates for bariatric surgery failed 
to accumulate MVPA in bouts of ≥ 10 minutes when compared to controls (68% 
versus 13%). Compared with studies that have measured PA in candidates for 
bariatric surgery, fewer studies have investigated time spent in SB (22, 23, 536). 
The four studies that have investigated daily time spent in SB among candidates for 
bariatric surgery used the SAB and reported that they spent around 80% of their 
waking hours in SB (22, 23, 536). Although no studies have directly compared SB 
measured using objective methods between candidates for bariatric surgery and 
normal-weight controls, when comparing data from previous studies of candidates 
for bariatric surgery (22, 23, 536) to data from a population-based study (41), 
candidates for bariatric surgery appear to spend more of their waking hours in SB 
than the general population (80% versus 56%).  
Regarding PA and SB levels following bariatric surgery, studies demonstrate a 
similar pattern of low level of PA and prolonged time spent in SB. This is despite the 
significant weight loss achieved with bariatric surgery (25, 26, 28, 29). Chapman et 
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al (25) performed the first study to investigate patterns of PA and SB, using the SAM 
and the SAB, in people ≤ 18 months following restrictive bariatric surgery. 
Participants averaged 9,611 steps/day, and spent little of their waking hours in 
MVPA (5%) and most of their waking hours in SB (71%). Furthermore, their findings 
showed that MVPA was mostly accumulated in short bouts of ≤ 10 minutes, and SB 
was mostly accumulated in prolonged uninterrupted bouts of ≥ 30 minutes (25). A 
recent study investigated PA and SB levels, using the ActivPAL accelerometer, on 
average 9 years following RYGB (29). Their findings showed participants performed 
an average of 6,375 steps/day, with 37% of participants classified as sedentary (i.e. 
< 5,000 steps/day) and only 11% classified as active (i.e. ≥ 10,000 steps/day). Also, 
participants spent 88% of their waking hours in SB. Earlier research has reported 
that people over 2 years following RYGB were less active than non-obese controls 
(26, 28). When data from studies of bariatric surgery are compared to data from 
population-based studies, people who have undergone bariatric surgery appear to 
spend more time in SB than the general population (39, 537). 
Few studies have investigated pre- to post-surgery changes in objective measures 
of PA, and fewer have measured changes in SB (4-9). The first study to investigate 
post-surgery changes in PA used the RT3 accelerometer and found no changes in 
total time spent in MVPA and MVPA accumulated in bouts of ≥ 10 minutes at 6 
months post-surgery in a mixed sample of 20 participants (i.e. 13 LAGB and 7 
RYGB) (5). Similarly, two studies that investigated changes in PA and SB levels 
using the Actigraph accelerometer found no significant changes in time spent in 
MVPA, MVPA accumulated in bouts of ≥ 10 minutes, or in time spent in SB in a 
sample of 56 women at 9 months following RYGB (8) and no changes in time spent 
in MVPA in a sample of 43 women at 9 months following RYGB (9). In contrast, King 
et al (6) investigated changes in measures of PA, using the SAM, in a sample of 310 
participants (i.e. 214 RYGB, 67 LAGB, 29 others) and found, at 12 months following 
surgery, significant increases in median daily step count (7,563 vs 8,788 steps/day), 
minutes during which walking was measured (309 vs 340 min/day), and minutes 
during which high-cadence walking (step count > 80 steps/minute) was measured 
(72 vs 112 min/week). Similarly, King et al (7) investigated changes in both PA and 
SB, using the SAM, in a large sample of 473 participants who underwent different 
types of bariatric surgery (i.e. 329 RYGB, 108 LAGB, 26 LSG, 10 others) and found 
that were small reductions in SB and increases in PA during the first 12 months 
post-surgery that were maintained up to 3 years. At 12 months, there was a 
significant decrease of 28 min/day in the sedentary time (from 573 min/day to 545 
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min/day), and a significant increase of 29 min/week in MVPA (from 77 min/week to 
106 min/week) or 17 min/week in MVPA bouts of at least 10 minutes (from 7 
min/week to 24 min/week). The only study that investigated changes in objective 
measures of PA in people who underwent exclusively restrictive bariatric surgery, 
using a pedometer, also found improvements in PA measures following LAGB (4). 
At 12 months, valid pedometer data were only available for 37% of participants (n = 
48) and a significant increase of 2,655 steps/day was found (from 6061 steps/day to 
8716 steps/day). The contrasting findings regarding improvements in PA measures 
reported by different studies could be explained by the difference in the motion 
sensors used and varied follow-up times. The aforementioned studies may also 
have been underpowered due to small sample sizes, and have important limitations 
regarding the assessment methods used that might explain different findings, 
including low adherence to the motion sensor used (4), suboptimal placement of the 
motion sensor (e.g. waist or hip) (5, 8), and possible misclassification of SB and 
MVPA due to the use of indirect measures (i.e. estimated from step counts) (6, 7). 
Furthermore, the majority of participants from these studies underwent RYGB, which 
is a mixed bariatric procedure and results in much greater weight loss when 
compared to LAGB (3). Also, although the weight loss following RYGB appears to 
be similar to that achieved with LSG, when compared to restrictive bariatric 
procedures, RYGB typically results in longer hospital stay, higher rates of post-
surgery complications and nutritional deficiencies that may influence people’s 
participation in PA (3, 55, 56). Therefore, findings from these studies may have 
limited generalisability to people who undergo restrictive bariatric surgery. Table 2.1 
summarises the main characteristics and findings of studies that investigated pre- to 
post-bariatric surgery changes in objective measures of PA and SB.
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Table 2.1 Studies that investigated pre- to post-bariatric surgery changes in 
objective measures of physical activity and sedentary behaviour  
Study Device Measures of PA and/or SB 
Colles et al.(4) 
n = 48 (LAGB) 
Sportline 330 
pedometer 
Steps per day - Mean (SD) 
Pre-surgery: 6,061 (2,740)  
12m Post-surgery: 8,716 (5,348)* 
Bond et al. (5) 
n = 20 
LAGB = 13  
RYGB = 7 
RT3 
accelerometer 
MVPA min/week  in bouts ≥1min - Mean (SD) 
Pre-surgery: 186 (169) 
6m Post-surgery: 151 (118) 
 
MVPA min/week  in bouts ≥10min - Mean (SD) 
Pre-surgery: 41 (109) 
6m Post-surgery: 40 (71) 
King et al. (6) 
n = 310 
RYGB = 214 
LAGB = 67  
Others =  29 
StepWatch 3 
activity 
monitor 
Steps per day - Median [IQR] 
Pre-surgery: 7,563 [5,570-9,575] 
12m Post-surgery: 8,788 [6,655-11,149]*  
 
Active min/day (>0 steps/min) - Median [IQR] 
Pre-surgery: 309 [245-380] 
12m Post-surgery: 340 [276-413]* 
 
 High-cadence min/week (>80 steps/min) - Median [IQR] 
Pre-surgery: 72 [34-130] 
12m Post-surgery: 112 [50-185]* 
 
High-cadence min/week in bouts ≥10min - Median [IQR] 
Pre-surgery: 0 [0-26]  
12m Post-surgery: 23 [0-680]* 
King et al. (7) 
n = 473 
RYGB = 329 
LAGB = 108 LSG 
= 26 
Others =  10 
StepWatch 3 
activity 
monitor 
Steps per day - Mean (95% CI) 
Pre-surgery: 7,688 (7,401-7,974) 
12m Post-surgery: 8,959 (8,623-9,294)* 
24m Post-surgery: 9,214 (8,848-9,581)* 
36m Post-surgery: 8,935 (8,565-9,306)* 
 
MVPA min/week - Mean (95% CI) 
Pre-surgery: 77 (71-84) 
12m Post-surgery: 106 (98-116)* 
24m Post-surgery: 113 (100-123)* 
36m Post-surgery: 99 (88-110)* 
 
MVPA min/week in bouts ≥10min - Mean (95% CI) 
Pre-surgery: 7 (5-10) 
12m Post-surgery: 24 (18-29)* 
24m Post-surgery: 25 (19-33)* 
36m Post-surgery: 17 (13-24)* 
 
  
continues next page 
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Study Device Measures of PA and/or SB 
  
SB min/day - Mean (95% CI) 
Pre-surgery: 573 (564-582) 
12m Post-surgery: 545 (534-555)* 
24m Post-surgery: 548 (538-559)* 
36m Post-surgery: 547 (536-559)* 
 
SB min/day in bouts ≥10min - Mean (95% CI) 
Pre-surgery: 407 (396-418) 
12m Post-surgery: 381 (369-392)* 
24m Post-surgery: 388 (376-400)* 
36m Post-surgery: 386 (373-400)* 
 
SB min/day in bouts ≥30min - Mean (95% CI) 
Pre-surgery: 218 (208-227) 
12m Post-surgery: 193 (184-202)* 
24m Post-surgery: 201 (191-211)* 
36m Post-surgery: 199 (187-210)* 
Berglind et al. (8) 
n = 56 (RYGB) 
Actigraph 
accelerometer 
MVPA min/day - Mean (SD) 
Pre-surgery: 31 (18)  
9m Post-surgery: 32 (24) 
 
MVPA min/week bouts ≥10min - Mean (SD) 
Pre-surgery: 26 (26)  
9m Post-surgery: 30 (31) 
 
LIPA min/day - Mean (SD) 
Pre-surgery: 441 (92)  
9m Post-surgery: 441 (93) 
 
SB min/day - Mean (SD) 
Pre-surgery: 430 (142)  
9m Post-surgery: 421 (129) 
Berglind et al. (9) 
n = 43 (RYGB) 
Actigraph 
accelerometer 
MVPA min/day - Mean (SD) 
Pre-surgery: 31 (18)  
9m Post-surgery: 31 (21) 
 
MVPA min/week bouts ≥10min - Mean (SD) 
Pre-surgery: 28 (26)  
9m Post-surgery: 28 (29) 
 
LIPA min/day - Mean (SD) 
Pre-surgery: 438 (91)  
9m Post-surgery: 437 (92) 
 
SB min/day - Mean (SD) 
Pre-surgery: 442 (142)  
9m Post-surgery: 434 (124) 
Abbreviations: CI: confidence interval; IQR: interquartile range; LAGB: laparoscopic 
adjustable gastric banding; LSG: laparoscopic sleeve gastrectomy; MVPA: moderate to 
vigorous intensity physical activity; LIPA: light intensity physical activity; PA: physical activity; 
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RYGB: Roux-en-Y gastric bypass; SB: sedentary behaviour; SD: standard deviation. *p<0.05 
for pre- to post-surgery change. 
 
The few studies that have investigated changes in PA and SB from pre- to post-
surgery have suggested little or no change in total time and bout-related time spent 
MVPA and SB. Additionally, findings indicated that a large portion of people failed to 
achieve the international PA recommendations post-surgery and, when compared to 
the general population, spent more of their waking hours in SB. To date, there has 
been no investigation of pre- to post-surgery changes in PA and SB following LAGB 
and LSG, measured using accelerometers or portable metabolic monitors. Further, 
most studies in this population have focused on measures of MVPA and daily step 
count, with little attention given to the way in which people spend most of waking 
hours (i.e. SB and light intensity PA). Thus, studies using accelerometers and 
portable metabolic monitors, which provide detailed information regarding the 
pattern in which PA, at any intensity, and SB are accumulated are needed (538). 
More detailed information on the influence of restrictive bariatric surgery on PA and 
SB is relevant since these procedures have been increasingly performed in Australia 
(308), and people who undergo bariatric surgery are still at risk of health conditions 
related to participation in low levels of PA and increased time in SB (e.g. increased 
risk of DM2, CVD and mortality), irrespective of the substantial weight loss achieved 
post-surgery. 
2.5.1 Summary 
Despite the significant and sustained weight loss and improvement and/or resolution 
of comorbid conditions achieved following bariatric surgery, there is data to suggest 
that the pattern of participation in little PA and increased time spent in SB found 
among candidates for bariatric surgery remains mostly unchanged post-surgery (5, 
7, 8). Following surgery, if people do not change their PA and SB, they remain at 
risk of the detrimental effects of participation in little PA and increased time spent in 
SB, regardless of the large and significant weight loss achieved. Of note, data from 
studies that investigated pre- to post-surgery changes in PA and SB suggest that 
people who undergo bariatric surgery might need additional interventions to improve 
their participation in PA and decrease time spent in SB, given that the post-surgery 
weight loss and improvement and/or resolution of obesity-related comorbid 
conditions alone seem to be insufficient to promote changes in PA and SB. For this 
reason, there has been an increased interest in the possible additional effects of 
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behavioural interventions that include a PA component on post-surgery outcomes 
among people who undergo bariatric surgery (35). Findings from a recent RCT 
indicated that, when compared to standard pre-surgery care, a comprehensive 
behavioural intervention, which addressed factors relevant to PA (e.g. barriers and 
facilitators to PA), resulted in significant short-term increases in time spent in PA 
prior to surgery (34). Although there are some data to suggest that a behavioural 
intervention can be effective at increasing people’s participation in PA in the short-
term, the long-term and post-surgery sustainability of any increase in PA following 
the completion of such an intervention has not yet been investigated. Further, there 
has been no investigation of the effects of a behavioural intervention aimed at 
optimising participation in PA in people following bariatric surgery on changes in PA 
and other relevant health outcomes, such as reduced cardiometabolic risk factors 
and weight maintenance.  
2.6 Perceived barriers and facilitators to physical activity prior 
to and following bariatric surgery 
This section provides a summary of the evidence for barriers and facilitators to PA in 
adults, with focus on the bariatric surgery population. These considerations are 
relevant to the research questions addressed in the second study undertaken in this 
programme of research. Despite the vast knowledge of the health benefits 
associated with regular participation in PA, population-based data from 122 
countries have shown that a third of adults do not meet the recommended amount of 
PA to improve and/or maintain health (389, 390). The most recent survey that 
investigated levels of PA in Western Australia reported that in 2009, 40% of the 
adult population was considered either not active (i.e. reported no participation in 
PA) or insufficiently active (i.e. reported participation in PA that did not meet the 
national recommendations) (192). Public health initiatives (e.g. 
http://www.findthirtyeveryday.com.au) that aimed to inform Australian adults about 
PA guidelines, and suggest strategies to increase participation in PA have resulted 
in little or no change in reported PA levels (192, 226). A number of theories have 
helped clinicians to understand the complex mechanisms of PA behaviour change 
(e.g. Self-determination Theory, Theory of Planned Behaviour, Social Cognitive 
Theory), and there is evidence to show that theory-based interventions are an 
effective way of changing PA behaviour (11, 539, 540). The understanding of the 
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mechanisms of PA behaviour change requires an understanding of the different 
factors related to people’s participation in PA (10, 11).  
Among the multiple factors related to participation in PA, studies of the general 
population have mostly investigated people’s perceptions of barriers to PA, which 
are factors that would make it difficult or prevent them from engaging in PA, and 
facilitators to PA, which are factors that would make it easier for people to engage in 
PA. Earlier research has reported several barriers to PA in the general adult 
population, typically assessed using surveys or questionnaires (197-208, 210). 
Whether these barriers are real (i.e. a factor that truly influences participation in PA) 
or perceived (i.e. a factor that people believe to influence participation in PA), they 
may limit or prevent regular participation in PA (199). The most frequently reported 
barriers to PA among adults in the general population include lack of time, lack of 
motivation, work and family commitments, social issues (e.g. lack of support or lack 
of company to engage in PA), pain, and poor health (197-207). When compared to 
studies investigating barriers to PA, fewer studies have investigated facilitators to 
PA among adults in the general population (208-210). The most recent study used 
qualitative focus groups to explore the facilitators to PA among working parents and 
showed that being physically active with children, being a role model for children, 
prioritising PA, and social support were considered as facilitators to PA (210). There 
is evidence to show that factors related to participation in PA may be specific to 
population sub-groups (211-213). For example, people with chronic health 
conditions present with disease-related beliefs and barriers such as fatigue and 
decreased mobility, pain, presence of comorbid conditions, and fear of injury that 
influence their participation in PA (211-213).  
Different studies have compared the barriers to PA, mostly using questionnaires, 
between adults within the normal-weight range and those considered obese (217, 
224, 541-544).Their findings showed that when compared to those within the 
normal-weight range, adults who were obese reported a greater number of barriers 
to PA (217, 224, 541-544). Leone et al (224) used an online survey to compare 
participants’ agreement to different barriers to exercise between obese and non-
obese women. When compared to non-obese women, those who were obese 
reported greater agreement to 5 out of 6 barriers, including ‘my current weight 
makes it difficult for me to exercise’ (47% versus 7%), ‘I do not have anyone to 
exercise with’ (49% versus 41%), ‘I usually only exercise if I am trying to lose weight’ 
(42% versus 18%), ‘I do not have the energy to exercise’ (58% versus 42%), and ‘I 
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am uncomfortable with how I look while exercising or while wearing exercise 
clothing’ (44% versus 26%). Napolitano et al (217) investigated barriers to PA 
among 280 women, using the Expected Outcomes and Barriers for Habitual 
Physical Activity Scale, and found that those who were obese reported significantly 
greater barriers to PA when compared to those within normal-weight and 
overweight. Specifically, the barriers to PA that were more likely to be elevated for 
women who were obese were feeling too overweight, feeling self-conscious when 
exercising, minor aches and pains, and lack of self-discipline or willpower. There are 
no studies comparing facilitators to PA between people who were normal-weight 
and obese in the general population.  
Several studies that investigated barriers to PA exclusively among obese 
populations have consistently reported that in addition to the barriers commonly 
found in the general population (e.g. lack of time and lack of motivation), people who 
are obese often report obesity-related barriers to PA, such as feeling overweight or 
obese, self-consciousness about their body size, decreased fitness, and perceived 
laziness or lack of self-discipline, (214-216, 218, 219, 545, 546). For instance, a 
study of women who were overweight and obese involved in a weight loss program 
found that the main barriers to PA, assessed using a questionnaire, among inactive 
participants were lack of time, perceived laziness, health concerns, family 
commitments, illness or injury, environmental issues (i.e. weather, location, costs), 
lack of company, lack of confidence, and tiredness (219). Cannioto et al (546) used 
an online survey to assess the barriers to PA in a group of 30 overweight and obese 
working women and reported similar findings. Participants reported motivational 
factors (e.g. laziness, lack of energy) and lack of time to be the main barriers to PA, 
followed by home and family obligations, psychological limitations (e.g. poor body 
image, embarrassment about weight gain, insecurity), factors related to convenience 
and access to facilities, and lack of social support. Large cross-sectional studies 
have shown that the perception of being overweight also acts as a barrier to PA 
among Australian adults who are obese, and it is associated with lower odds of 
achieving the recommended levels of PA (214, 215). The few studies that 
investigated facilitators to PA in people who are obese highlighted that weight loss 
was the most frequently reported facilitator in this population (219, 220). One of 
these studies used a questionnaire to assess self-reported facilitators to PA of 
inactive women who were overweight and obese and participated in a weight loss 
program, and found that weight loss and better fitness were the factors most 
frequently described (219). Igelstrom et al (220) assessed facilitators to PA of 
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people who were obese with OSA, using qualitative semi-structured interviews, and 
found that participants perceived that PA would be facilitated if they lost weight, 
made PA a priority, and received social support. 
Despite some data on barriers and facilitators to PA in the general population and 
people who are obese, these might not be applicable to those who undergo bariatric 
surgery. This is because bariatric surgery is usually considered after a history of 
repeated unsuccessful attempts to lose weight using conservative methods (e.g. diet 
combined with increased PA), which could result in a different perception of factors 
related to participation in PA among people who undergo bariatric surgery, when 
compared to the general obese population (221, 547). Previous studies have shown 
that the experience of repeated unsuccessful attempts to lose weight among people 
who underwent bariatric surgery resulted in feelings of hopelessness and 
desperation regarding their body weight, perceived lack of control over PA and 
eating behaviours, as well as low confidence and self-esteem (221, 547). Since 
previous studies have shown that, when compared to the general population and 
people within the normal-weight range, people who undergo bariatric surgery spend 
less time engaging in PA and more time in SB (21, 25), it is reasonable to believe 
that this population experiences specific and salient obesity-related factors that 
influence their participation in PA.  
An RCT that compared standard pre-surgery care to a pre-surgery comprehensive 
theory-based behavioural intervention produced significant short-term improvements 
in objective measures of MVPA prior to bariatric surgery (34). Specifically, the 
intervention consisted of counselling sessions that included problem solving for 
barriers to PA, goal setting regarding purposeful walking and the use of behavioural 
and cognitive strategies aimed at increasing self-efficacy and motivation to PA (34). 
Despite some data to support that an intervention that targets factors related to 
participation in PA, such as barriers to PA, can produce significant increases in PA 
pre-surgery, more data are needed on the perceived barriers and facilitators to PA in 
order to guide interventions to increase participation in PA in people who undergo 
bariatric surgery. Few cross-sectional studies have reported on barriers to PA pre- 
or post-surgery (222, 223, 225, 548).Two studies have investigated barriers to PA 
among candidates for bariatric surgery (223, 548). One of these studies 
retrospectively assessed pre-surgery barriers to PA among 30 people who 
underwent bariatric surgery, using a questionnaire that included environmental, 
social, behavioural, and physical barriers (548). The majority (> 93%) of participants 
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reported behavioural and physical barriers to PA, with the most commonly reported 
barriers being ‘concern about appearance’, ‘concern about clothes during PA’, 
‘physical tiredness’, and ‘physical limitations’. Social barriers, mainly ‘extensive work 
hours’ and ‘lack of company’ were reported by a large portion (> 80%) of 
participants, and ‘lack of equipment’ was the most frequent of the environmental 
barriers reported by 57% of participants (548). Wiklund et al (223) used qualitative 
semi-structured interviews to explore how 18 obese adults scheduled to undergo 
RYGB experienced PA, including factors that prevented their participation in PA. 
Participants reported being embarrassed to be seen wearing exercise clothing, joint 
pain as a result of being obese, difficulties to manage a large body, difficulties to find 
an appropriate intensity of PA that could be tolerated and to adjust PA to the level of 
others.  
The few cross-sectional studies that have investigated barriers to PA post-surgery 
have mostly used questionnaires or surveys (222, 225, 548). The study with the 
largest sample (n = 366) investigated post-surgery barriers to PA using an online 
survey and divided barriers into internal (i.e. motivational and physical barriers) and 
external barriers (i.e. time, weather, resources, support, holidays) (222). The most 
frequently reported internal motivational barriers were ‘difficulty maintaining 
consistency of exercise behaviours’, ‘difficulty making exercise a priority’, ‘general 
motivational difficulties’, and ‘lack of enjoyment’. The most frequently reported 
internal physical barriers were ‘general physical limitations’ (e.g. pain and chronic 
illness) and ‘post-surgery issues’ (e.g. lack of stamina and diet-related problems), 
while the most frequently reported external barriers were ‘lack of time’ and ‘weather’. 
The only study using qualitative semi-structured interviews aimed to explore the 
experiences of PA of 24 people at 12 months following RYGB (225). Participants 
reported experiencing physical limitations of being overweight and post-surgery 
issues (e.g. excess skin and diarrhoea), lack of motivation and boredom related to 
exercising on their own, as well as embarrassment related to exposing themselves 
in front of other while engaging in PA.  
Although no studies have specifically investigated facilitators to PA in people who 
underwent bariatric surgery, a cross-sectional qualitative study that aimed to explore 
the PA experiences of people scheduled to undergo RYGB indicated that 
participants believed losing weight would facilitate their participation in PA (223). A 
qualitative study that also explored the PA experiences of people at 12 months 
following RYGB, reported that participants believed the weight loss achieved post-
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surgery facilitated engagement in PA due to improvements in physical limitations 
related to obesity (225).  
Studies of people who underwent bariatric surgery have investigated factors that 
may be related to, or have been reported as, barriers to PA, mostly among those 
who underwent RYGB. Their findings suggest that, prior to surgery, this population 
presents with persistent musculoskeletal pain and impaired walking capacity and 
physical function (85, 423, 549-552). Further, their findings report significant 
improvements in objective measures (e.g. scales, walking and functional tests) of 
musculoskeletal pain, walking capacity and physical function following surgery. A 
recent study has investigated changes in self-reported pain and physical function, 
measured by scales on the SF-36, and physical function measured by the 400-
metre walk time, in a sample of 2,221 people who underwent bariatric surgery (70% 
RYGB, 25% LAGB, 5% other) (85). When compared to pre-surgery measures, 
clinically meaningful improvements were reported at 1 year post-surgery in 58% 
(95% CI, 55 to 60%) of participants for bodily pain, 77% (95% CI, 75 to 79%) for 
physical function, and 60% (95% CI, 56 to 63%) for walk time. Furthermore, more 
than 75% of participants with severe pre-surgery knee/hip pain or disability reported 
joint-specific improvements in knee pain (77%; 95% CI, 74 to 81%) and in hip 
function (79%; 95% CI, 75 to 83%). The findings have also shown that between 1 
and 3 years post-surgery, while improvement rates for walk time, knee/hip pain and 
function did not change, the improvement rates for bodily pain and physical function 
measured by the SF-36 significantly decreased (85). Although significant 
improvement in such measures have been shown, studies indicate that people 
continue to report the presence of musculoskeletal pain and present with impaired 
physical function following bariatric surgery (549, 552). Furthermore, it is not clear if 
these improvements in pain and physical function are related to change in people’s 
participation in PA (85, 419, 423, 552). 
Most studies that have investigated factors related to participation in PA in different 
populations have relied on quantitative methods, such as structured questionnaires 
or scales, which despite being useful and easy to apply, are likely to restrict the 
choice of participants’ response (206, 214, 215, 217, 222). In contrast to quantitative 
methods, the use of qualitative methods, such as interviews or focus groups does 
not limit people’s responses to pre-specified items and allows for a rich, detailed 
exploration of reasons why people participate in PA (e.g. barriers, facilitators, 
motivators to PA) (210, 223-225). Additionally, the use of a qualitative exploration 
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provides an in-depth insight into people’s perceptions and experiences within the 
social context of a particular population (202, 210, 223-225). Rich, in-depth and 
detailed information regarding pre- and post-surgery beliefs about PA, and 
perceptions of factors that influence PA, such as barriers, facilitators and motivators 
to PA, as well as the way in which these change could offer insight into the reasons 
for the little participation in PA among people who undergo bariatric surgery. This 
information is important to inform clinicians and develop interventions aimed at 
optimising participation in PA both pre and post-surgery (74, 75, 226, 227). 
2.6.1 Summary 
There is some evidence to show the presence of obesity-related barriers to PA, in 
addition to those commonly found in the general population, both prior to and 
following bariatric surgery. Findings from previous studies have reported weight loss 
as the main perceived facilitator to PA identified both pre- and post-surgery. 
However, there is a lack of studies that provide in-depth information regarding 
factors the bariatric surgery population believe to be related to participation in PA, 
particularly among people who undergo restrictive bariatric surgery. This paucity of 
in-depth knowledge is because previous studies relied mostly on questionnaire or 
survey data obtained cross-sectionally, where the types of barriers and facilitators to 
PA were pre-determined by the researchers. The use of qualitative methods allows 
for a rich in-depth exploration of people’s perceptions and experiences without 
restricting findings to pre-specified responses. Furthermore, no studies have 
investigated changes in the perceptions of factors related to participation in PA 
among those who underwent bariatric surgery. A longitudinal qualitative exploration 
aimed at understanding people’s perceptions of how factors related to PA change 
post-surgery could inform the development of interventions that provide the best 
chance for success at optimising participation in PA and health benefits both pre- 
and post-bariatric surgery (34, 38, 75, 222, 227, 553). The few studies of bariatric 
surgery that used qualitative methods were of people who underwent RYGB, who 
may have different experiences of factors related to participation in PA when 
compared to those who undergo restrictive procedures due to different post-surgery 
recovery and outcomes. Longitudinal qualitative explorations of factors related to 
participation in PA, such as perceived barriers, facilitators and motivators to PA, as 
well as the way in which surgery influences such factors are warranted. Such 
explorations are needed to guide behavioural interventions aimed at optimising PA 
in this population, given the substantial increase in the amount of restrictive bariatric 
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surgery being performed (1), particularly in Western countries, and the beneficial 
effects of increasing participation in PA in this population, independent of weight 
loss. 
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CHAPTER 3 METHODS 
Overview 
This chapter presents the methods used in the two studies undertaken as part of 
this programme of research. Section 3.1 describes the methods used for Study 1. 
Section 3.2 describes the methods used for Study 2. For both studies, the study 
design, inclusion and exclusion criteria, recruitment process, assessment protocol, 
and data analyses are described. For Study 1, Section 3.1 also describes the 
outcome measures used. 
3.1 Study 1 
3.1.1 Study design 
3.1.1.1 Overview 
The study was longitudinal and observational in design. Data collection was 
undertaken between June 2013 and July 2015. Adults scheduled to undergo 
restrictive bariatric surgery were recruited from two private bariatric clinics in Perth, 
Western Australia. Prior to and over the first 12 months following surgery measures 
were collected of physical activity (PA) and sedentary behaviour (SB), 
cardiovascular fitness, self-efficacy to exercise, sleep quality, daytime sleepiness, 
body composition and bone mineral density (BMD), weight-related measures, 
obesity-related comorbid conditions, health-related quality of life (HRQoL), obesity-
related quality of life and weight-related symptoms, and symptoms of depression, 
anxiety and stress. The results from this study are presented and discussed in 
Chapter 4 (Study 1 - Results and discussion). 
3.1.1.2 Approval from human research ethics committee 
The study was approved by the Human Research Ethics Committee at Curtin 
University (approval number HR 08/2013). 
3.1.1.3 Participants 
3.1.1.3.1 Inclusion criteria 
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Individuals were eligible to participate in the study if they were aged over 18 years, 
with body mass index (BMI) > 30 kg/m2 and scheduled to undergo primary 
laparoscopic adjustable gastric banding (LAGB) or laparoscopic sleeve gastrectomy 
(LSG). 
3.1.1.3.2 Exclusion criteria 
Exclusion criteria comprised; (i) pregnancy or planning pregnancy within 12 months, 
(ii) presence of a permanent health condition such as a neurological, cardiovascular 
or orthopaedic disease that could compromise the performance of daily PA, (iii) 
body weight over 160 kg (due to weight limit of equipment used for assessments), 
and (iv) cognitive impairments or language barriers which could interfere with 
participation in the assessments. 
3.1.2 Recruitment 
Participants were recruited between April 2013 and June 2014. When attending the 
bariatric surgery clinic for an initial appointment with the surgeon, potential 
participants were handed a form that asked if they agreed to be contacted by a 
researcher. They were also provided with a participant information sheet which 
described the study. Only those who granted permission to be contacted were 
approached to participate in the study. All participants signed a written informed 
consent form prior to data collection.  
3.1.3 Assessment protocol 
Data collection comprised one assessment time point within the month prior to 
surgery and four assessment time points following surgery. The post-surgery 
assessment time points took place 3, 6, 9 and 12 months following the date of 
surgery. Figure 3.1 summarises the assessment protocol. At the pre-surgery and 12 
months post-surgery assessment time points, measurements were obtained of 
weight, height, waist circumference, systolic and diastolic blood pressure, 
cardiovascular fitness, self-efficacy to exercise, sleep quality, daytime sleepiness, 
body composition and BMD, HRQoL, obesity-related quality of life and weight-
related symptoms, and symptoms of depression, anxiety and stress. Participants 
were also fitted with two activity monitors to collect measures of PA and SB. The 
presence of any medically diagnosed obesity-related comorbid condition (i.e. 
diabetes mellitus type 2 [DM2], dyslipidaemia, hypertension, and obstructive sleep 
apnoea), medication use and the use of continuous positive airway pressure 
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treatment was documented. Participants also had a venous blood sample collected 
to measure fasting glucose, total fasting cholesterol, high-density and low-density 
lipoprotein cholesterol, and fasting triglycerides to confirm any medical diagnosis of 
obesity-related metabolic comorbid conditions. Participants with DM2 had 
glycosylated haemoglobin measured.  
At the 3, 6 and 9 months post-surgery assessment time points, measures were 
collected of weight, PA and SB, self-efficacy to exercise, sleep quality, daytime 
sleepiness, HRQoL, obesity-related quality of life and weight-related symptoms, and 
symptoms of depression, anxiety and stress. The pre-surgery and 12 months post-
surgery assessment time points lasted 8 days (7 days of PA monitoring and 1 day to 
collect all the other measures), and the 3, 6 and 9 months post-surgery assessment 
time points lasted for 7 days and were done remotely (via post and telephone 
contact). 
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Figure 3.1. Assessment protocol. 
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3.1.4 Measures 
3.1.4.1 Descriptive measures 
Pre-surgery, descriptive measures were collected, including type of bariatric surgery 
to be performed, gender and height (measured to the nearest 1 cm on a 
stadiometer, with the participants dressed in light clothing without shoes). During the 
hospitalisation period immediately following surgery, details were documented 
regarding the hospital length of stay and development of any peri-operative or early 
post-operative complications.  
3.1.4.2 Primary outcome measures 
3.1.4.2.1 Physical activity and sedentary behaviour 
Participants were instructed to wear two activity monitors for 7 consecutive days, 24 
hours per day, in order to minimise missing data due to non-wear periods (e.g. 
participants forgetting to put monitors back on as soon as they wake up) (20, 40, 
554). They were asked to remove the activity monitors only when performing water 
activities (e.g. bathing, swimming). 
SenseWear Armband™  
The SenseWear Armband™ (SAB; Bodymedia Inc., Pittsburgh, PA, United States of 
America [USA]) is a small, light-weight portable metabolic monitor worn on the upper 
posterior region of the left arm (over the triceps brachii muscle). The device 
estimates energy expenditure using proprietary software (SenseWear Professional 
7.0, Bodymedia Inc., Pittsburgh, PA, USA) which integrates non-invasive 
physiological measures such as skin temperature and galvanic response together 
with movement measures obtained from a tri-axial accelerometer. Data are 
expressed as metabolic equivalents (METs). Based on previous research, time 
spent in SB and PA at different intensities was estimated according to different 
thresholds of energy expenditure, reported as METs. Each minute of waking hours 
was grouped into the following categories; SB (i.e. < 1.5 METs), light intensity PA 
(i.e. 1.5 to < 3 METs), and moderate to vigorous intensity PA (≥ 3 METs) (382, 386, 
387). The device has been shown to produce valid and reliable measures of energy 
expenditure in healthy normal- and overweight adults (420-422). The SAB has also 
been used in studies of people who are obese and those who underwent bariatric 
surgery (34, 40, 423). 
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StepWatch 3 Activity Monitor™  
The StepWatch 3 Activity Monitor™ (SAM; Cyma Corp., Seattle, WA, USA) is a 
small microprocessor-driven pedometer that is worn just above the lateral malleolus 
on the right leg and attached with a strap. The SAM detects and counts steps every 
minute, for different gait styles. The output is expressed as the number of steps per 
day taken by the right leg and therefore the step count is multiplied by two in order 
to obtain the total number of steps taken. This device has been shown to provide a 
valid and reliable measure of number of steps in lean and obese healthy adults 
(416). The device has been used in research involving people who underwent 
bariatric surgery (6, 7, 554). 
3.1.4.3 Secondary outcome measures (outcomes relevant to physical 
activity)  
3.1.4.3.1 Cardiovascular fitness  
Cardiovascular fitness was assessed with the Physical Working Capacity 170 
(PWC-170) test, a submaximal exercise test designed to estimate the work capacity 
of a participant at a heart rate of 170 beats per minute (555, 556). Participants were 
required to rest (sitting on a chair) for at least 10 minutes prior to the test. Prior to 
and following the test, measurements were made of heart rate and blood pressure 
using a manual sphygmomanometer (Spirit Medical Co., Ltd, Taipei, Taiwan, 
China). Heart rate and arterial oxygen saturation (SpO2) were continuously 
monitored during the test using a polar monitor (Polar FT1, Polar Electro Oy, 
Kempele, Oulu, Finland), and a pulse oximeter and finger sensor (GE Ohmeda 
TuffSat, GE, Helsinki, Finland), respectively.  
The test was conducted on an electronically braked cycle ergometer (Lode Corival, 
Groningen, Netherlands) and comprised three stages. Each stage had a maximum 
duration of 6 minutes and was performed at increasing work rates (Watts [W]) with 
the aim of reaching target heart rates of 120, 135, and 150 beats per minute. 
Participants cycled at 60 revolutions per minute during the entire test. The 
participants performed a warm up period, cycling against a 10 W workload for 1 
minute followed by the initial workload, set at 25 W for all participants. To arrive at 
the target heart rates, work rates were modified each minute for each participant. 
The amount by which work rates were modified to reach the target heart rates was 
individualised. On completion of the final stage, participants completed a 1 minute 
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cool down. Using linear regression, the relationship between heart rates and the 
three different work rates was used to extrapolate the work rate required to result in 
a heart rate of 170 beats per minute (557). 
Rather than a maximal exercise test, which would have allowed the measurement of 
the peak rate of oxygen uptake, a submaximal cycle exercise test was chosen for 
this study. There were two reasons for this decision. First, undertaking a maximal 
exercise test would require the participant to exercise to exhaustion, and this may 
not have been possible in this population due to the mechanical difficulties resulting 
from a large body size, together with joint pain and exacerbation of obesity-related 
comorbid conditions (e.g. hypertension) (347). Second, given the risk associated 
with undertaking a maximal exercise test in this population, the test would 
necessitate the use of a 12-lead electrocardiogram and supervision by a medical 
practitioner, which was not possible with the funding available to conduct this study. 
Submaximal exercise tests have been widely used to assess cardiovascular fitness, 
including in obese populations (347, 349, 555, 556). 
3.1.4.3.2 Self-efficacy to exercise 
Self-efficacy to exercise was assessed using the Exercise Self-Efficacy Scale 
(ESES) described by Bandura (558). The ESES presents 18 different scenarios and 
asks the respondent to rate the degree of confidence in their ability to exercise in 
each scenario. The degree of confidence is measured with a scale that ranges from 
0 (cannot do this activity at all) to 100 (highly certain can do this activity) (558). The 
ESES has been used in studies of people who are overweight and obese with 
chronic health conditions, such as obstructive sleep apnoea (220), and 
cardiovascular disease (559). 
3.1.4.3.3 Sleep quality  
The Pittsburgh Sleep Quality Index (PSQI) is a self-reported questionnaire that 
assesses both sleep quality and disturbance that might affect sleep quality. It 
comprises 19 items and covers the components of sleep quality, sleep latency, 
sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping 
medications, and daytime dysfunction (362). A total sleep quality score is calculated, 
that ranges from zero to 21, with scores > 5 associated with poor sleep quality. 
Good psychometric properties of the PSQI have been confirmed in the general 
population and people with chronic health conditions (e.g. breast cancer, renal 
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transplants) (560), and it has been used in studies of people who are obese and 
those who underwent bariatric surgery (96, 364).  
3.1.4.3.4 Daytime sleepiness 
The Epworth Sleepiness Scale (ESS) is a simple measure of daytime sleepiness 
that uses a 4-point Likert type scale to measure the chance of dozing in eight day-
to-day situations (561, 562). The Likert type scale ranges from zero (would never 
doze) to three (high chance of dozing). A global score is calculated by the sum of all 
item scores, ranging from zero to 24, with a score ≥ 10 indicating excessive daytime 
sleepiness. The reliability and internal consistency of the ESS was shown in adults 
(365), and it has been used in studies investigating people who are obese (87) and 
those who underwent bariatric surgery (93, 258). 
3.1.4.3.5 Body composition and bone mineral density 
Body composition and BMD were assessed using whole-body dual energy x-ray 
absorptiometry (DXA) scanning (Lunar Prodigy, GE Healthcare, Diegem, Belgium). 
Measures were collected of fat mass (FM), percentage of FM, fat-free mass (FFM), 
percentage of FFM, and total, spine and pelvis BMD, as well as total body BMD T-
scores using proprietary software (encore v15 SP1, GE Healthcare, Shanghai, 
China). For those participants who did not fit the scanning area of the DXA scanner, 
two half body measures were performed and results were derived from the sum of 
left and right body measures. The way in which DXA measures were made for each 
participant was the same at both the pre-surgery and 12-month post-surgery 
assessments. Changes in measures of body composition and BMD using DXA have 
been investigated following different types of bariatric surgery (105, 113, 117, 563). 
3.1.4.4 Secondary outcome measures (outcomes used to confirm the 
previously established efficacy of restrictive bariatric procedures) 
3.1.4.4.1 Weight-related measures  
At the pre-surgery and 12 months post-surgery assessments, weight was measured 
to the nearest 0.1 kg on a calibrated scale, with the participants dressed in light 
clothing without shoes. At the 3, 6, and 9 months post-surgery assessment, 
participants were instructed to weigh themselves on a calibrated scale, dressed in 
light clothing without shoes, and report the weight measured. The participant’s 
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weight and height were used to calculate the BMI (i.e. weight in kilograms divided by 
the height in metres squared [kg/m2]). Waist circumference was measured using a 
non-elastic tape measure, at the midpoint between the lower margin of the last 
palpable rib and the top of the iliac crest (230).  
3.1.4.4.2 Measures associated with obesity-related comorbid conditions 
Venous blood samples were used to obtain measures of fasting glucose, 
glycosylated haemoglobin, total fasting cholesterol, high-density and low-density 
lipoprotein cholesterol, and fasting triglycerides, in order to confirm the medical 
diagnosis of any obesity-related metabolic comorbid conditions. Systolic and 
diastolic blood pressure was measured at rest using a calibrated manual 
sphygmomanometer (Spirit Medical Co., Ltd, Taipei, Taiwan, China). Improvement 
of a comorbid condition was confirmed by improvement in objective measures (e.g. 
blood samples) and by decrease in dosage and/or number of medications used. 
Resolution of a comorbid condition was confirmed by objective measures (e.g. blood 
samples) and cessation of medication use. Resolution of metabolic comorbid 
conditions was defined according to venous blood sample measures within the 
normal values without use of medication. The cut-offs used to define normal values 
for measures obtained by venous blood samples were: fasting glucose < 6.1 
mmol/L, glycosylated haemoglobin < 7.8 mmol/L, total fasting cholesterol < 5.5 
mmol/L, high-density lipoprotein cholesterol < 3.5 mmol/L, low-density lipoprotein 
cholesterol > 1.0 mmol/L for men and > 1.3 mmol/L for women, and fasting 
triglycerides < 2.0 mmol/L (319, 564). Resolution of hypertension was defined as 
measured systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 
mmHg without use of medication (564). 
Given sleep disordered breathing, the most common type being obstructive sleep 
apnoea, is a prevalent obesity-related comorbid condition, it was objectively 
assessed at all assessment time points with a portable single-channel recording 
device, the ApneaLink™ (ResMed Ltd, Bella Vista, NSW, Australia), and 
participants were asked to use the device for a whole night of sleep. Participants 
that used a continuous positive airway pressure device during sleep were asked to 
not use the device during the assessment night with the ApneaLink™. The 
ApneaLink™ uses a pressure-transduced oronasal airflow sensor and pulse 
oximetry to detect events suggestive of apnoea during sleep, and appears to 
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accurately detect apnoea and/or hypopnoea events in morbidly obese (361) and 
people with sleep-related complaints and comorbid conditions (565). The apnoea-
hypopnoea index, which is the frequency of apnoea and hypopnoea events per hour 
of sleep, was measured. Apnoea-hypopnoea index values ≥ 15 events per hour, or 
≥ 5 events per hour in addition to self-reported symptoms of sleep disturbance (e.g. 
daytime sleepiness, unrefreshing sleep, fatigue, waking up breath holding, gasping , 
or choking, snoring) are indicative of sleep disordered breathing (357). This device 
has been used in studies of obese populations (359, 360). 
3.1.4.4.3 Health-related quality of life, obesity-related quality of life and weight-
related symptoms 
Health-related quality of life 
The Medical Outcomes Study Short Form 12 General Health Survey version 2 (SF-
12v2) is a multidimensional, 12-item instrument that assesses generic HRQoL (566, 
567). The survey, adapted for use in Australia, comprises eight health domains and 
two component summary measures; the physical component summary (PCS) and 
the mental component summary (MCS). The PCS comprises four health domains: 
physical functioning, role-physical, bodily pain, and general health. Similarly, the 
MCS comprises four health domains: vitality, social functioning, role-emotional, and 
mental health. The answers for each domain and component summary are scored 
on a scale from zero to 100, with higher scores representing better HRQoL. Each 
component summary of the SF-12v2 is standardised to a population mean of 50.0 
(standard deviation, 10.0) arbitrary units (566). A change of 3 to 5 points in the 
summary scores of the SF-12v2 has been reported as clinically meaningful (568, 
569). For both people who are obese and those with normal weight, the SF-12v2 
has been shown to be highly correlated with the SF-36 (i.e. r values between 0.73 
and 0.89) (570, 571), which is a longer version of the survey that has been widely 
used in studies of bariatric surgery (138, 154, 163, 572).  
Obesity-related quality of life and weight-related symptoms  
The short version of the Impact of Weight on Quality of Life Questionnaire (IWQOL-
Lite), adapted for use in Australia, was used to assess obesity-related quality of life. 
It consists of 31 items within five scales: physical function, self-esteem, sexual life, 
public distress and work (573). Each item has five answer options, from one (never 
true) to five (always true), and the total score for the instrument is obtained by 
Chapter 3: Methods 
82 
 
converting the raw scores of each scale into scores that range from zero to 100, with 
higher scores indicating lower impact of weight, and therefore, higher quality of life. 
A total score of the IWQOL-Lite ≥ 87.1 indicates no impairment in quality of life, 79.5 
to 87.0 indicates mild, 71.9 to 79.4 indicates moderate, and < 71.9 indicates severe 
impairment in quality of life (574). A change of 12 points in the total score of the 
IWQOL-Lite has been reported as clinically meaningful (574). The IWQOL-Lite has 
been shown to be valid, reliable and sensitive to change in obese populations 
seeking treatment or not (573, 575). 
The Obesity and Weight-loss Quality-of-life Instrument (OWLQOL) and Weight-
related Symptoms Measure (WRSM), adapted for use in Australia, were used to 
measure obesity-related quality of life and weight-related symptoms. The OWLQOL 
measures people’s perception of life status related to weight, weight loss and 
treatment for weight loss, while the WRSM is focused on symptoms usually 
associated with obesity and obesity treatment (493). All 17 items on OWLQOL are 
answered with a 7-point Likert type scale ranging from zero (not at all) to six (a very 
great deal) and are used with equal weight to create a single score. The score 
ranges from zero to 100, where zero indicates the lowest and 100 the best quality of 
life. The 20 items on WRSM are answered with either yes or no response followed 
by a bothersomeness scale, identical to the OWLQOL scale. The total score ranges 
from zero to 120, with higher scores representing worse burden of symptoms. Both 
instruments yield valid and reliable measures amongst people who are overweight 
and obese (576). 
3.1.4.4.4 Mental health 
The version 1 of the Beck Depression Inventory (BDI) was used to assess the 
presence of symptoms of depression. It comprises 21 items, each with four possible 
responses (from zero to three) (577). The sum of the item scores is used, with 
higher scores indicating higher severity of symptoms. Cut-off points have been 
describe to classified the severity of symptoms, with scores < 10 indicating none to 
minimal, 10 to 18 indicating mild to moderate, 19 to 29 indicating moderate to 
severe, and 30 to 63 indicating severe symptoms of depression. The BDI has been 
considered to be valid (578), and has been commonly used to assess depressive 
symptoms amongst candidates for bariatric surgery (181, 185, 188, 190). 
The Depression Anxiety Stress Scales (DASS-21) were used to assess symptoms 
of depression, anxiety and stress. It comprises 21 items, rated on a 4-point Likert 
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type scale that ranges from zero (did not apply to me at all) to three (applied to me 
very much, or most of the time) (579). Items from each subscale (i.e. depression, 
anxiety and stress) are summed and a higher score indicates higher severity of 
symptoms in that domain. Table 3.1 presents the cut-offs, relative to the general 
population, for the severity of symptoms of depression, anxiety and stress according 
to the subscales scores of the DASS-21. This instrument has been shown to be 
valid and reliable in clinical populations of diagnosed mental health disorders and in 
the general population (580, 581), and has been used in studies of people who are 
obese (582, 583).  
Table 3.1 Severity of symptoms of anxiety, depression and stress according to the 
subscales of the DASS-21 
Severity of 
symptoms 
Depression 
subscale score 
Anxiety 
subscale score 
Stress 
subscale score 
None 0 - 4 0 - 3 0 - 7 
Mild 5 - 6 4 - 5 8 - 9 
Moderate 7 - 10 6 - 7 10 - 12 
Severe 11 - 13 8 - 9 13 - 16 
Extremely severe ≥ 14 ≥ 10 ≥ 17 
3.1.5 Data analyses 
3.1.5.1 Power calculation 
The sample size for this study was limited by feasibility, not dictated by the number 
needed to detect a particular effect. According to the time frame available for 
recruitment and data collection, as well as the average amount of surgeries 
performed in the bariatric clinics from where participants were recruited, a sample 
size of 30 participants was considered feasible. Although all measures of PA and SB 
were considered to be primary outcomes, due to limited information available on 
objectively-measured PA and SB among people undergoing bariatric surgery at the 
time this study was designed, the primary endpoints on which power calculations 
were undertaken were daily step count and time spent in SB. When daily step count 
was considered, the calculations were based on the pre-surgery daily step count 
reported by King et al. (20) (mean, 7569 steps/day; SD, 3159 steps/day) and by 
Langenberg et al. (27) (mean, 7140 steps/day; SD, 3422 steps/day). It was 
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anticipated that a feasible sample size of 30 participants would give a power of .96 
to detect a 30% change in daily step count at α=.05, assuming a conservative 
correlation between pre-surgery and follow-up measures of 0.5. When time spent in 
SB was considered, the calculations were based on the pre-surgery time spent in 
SB (reported as percentage of waking hours) reported by Bond et al. (22) (mean, 
81%; SD, 10%) and by Unick et al. (23) (mean, 80%; SD, 17%). It was anticipated 
that a feasible sample size of 30 participants would give a power of .89 to detect a 
7.5% change in time spent in SB at α=.05, assuming a conservative correlation 
between pre-surgery and follow-up measures of 0.5. 
3.1.5.2 Physical activity and sedentary behaviour data management 
3.1.5.2.1 Separating overnight sleep and non-wear time from total wear time 
Measurement of overnight sleep was excluded from the data collected with the SAB, 
since SB is defined as activities that involve low energy expenditure (i.e. < 1.5 
METs), and are performed during waking hours, in a sitting or reclining posture (45, 
387). Data from the SAB were exported to Excel™ and run through custom made 
software (LabVIEW 8.6.1; National Instruments, Austin, TX, USA) to exclude 
overnight sleep time. Using the custom made software, the beginning of the day was 
defined using postural data from the SAB, as the first time a participant accumulated 
≥ 20 consecutive minutes, after 5 am, in any posture other than supine (i.e. lying 
down in a completely horizontal posture). The end of the day was defined as the first 
time a participant laid down (supine) for ≥ 20 consecutive minutes after 8 pm. An 
average of all days that met these criteria was used for analysis. Although the 
criteria used to define the beginning and end of the day were arbitrary, they are 
consistent with earlier work which defined the start of the day as starting before 7 
am (20, 554) and would seem reasonable in the sample which was comprised by 
adults employed in day time jobs. 
3.1.5.2.2 Defining minimal requirements for inclusion in analyses 
There is considerable variability in the criteria used to define the minimum wear time 
needed for activity monitor data to be included in data analyses. Specifically, earlier 
research which has reported measures of PA and SB in people prior to and 
following bariatric surgery, have defined minimum acceptable monitor wear time as 
varying between 3 and 4 days, with at least 6 to 10 hours of data per day (6, 23, 34). 
Although earlier research does not consistently include data from a weekend day, 
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studies of overweight and obese populations have reported significant differences in 
PA and SB levels between weekend and week days (584, 585). Large 
epidemiological studies (n > 1,600) of adults living in the USA that have investigated 
time spent in PA and SB have suggested that a minimum of 4 days, each 
contributing ≥ 10 h of wear time, and the inclusion of at least 1 weekend day is 
needed to estimate habitual PA and SB (491, 586). 
For this programme of research, participants’ data obtained with the activity 
monitors were included in the analyses if they contributed a minimum of 4 valid days 
of data which included at least 1 weekend day. A valid day of data was defined as ≥ 
12 hours/day of monitor wear time. When comparing data from previous studies of 
bariatric surgery (22, 23, 536) to data from a population-based study (41), people 
who undergo bariatric surgery appear to spend more of their waking hours in SB 
than the general population (80% versus 56%). Therefore, the activity monitor wear 
time requirement of at least 12 hours/day was adopted to optimise the likelihood of 
capturing representative SB data in this sample. An average of all days that met 
these criteria was used for analysis. Although it is possible that different criteria may 
have yielded different estimates of PA and SB, a recent study in a large sample of 
adults who are overweight and obese with DM2 demonstrated that differences in 
minimum wear time criteria appear to have little effect on the estimate of PA (587).  
3.1.5.2.3 Exploring how physical activity and sedentary behaviour were 
accumulated 
To investigate how PA and SB were accumulated using data collected via the SAB, 
a custom made exposure variation analysis software was used (LabVIEW 8.6.1; 
National Instruments, Austin, TX, USA) (25, 588). The exposure variation analysis 
grouped the data in terms of intensity, using METs, corresponding to sedentary 
behaviour (< 1.5 METs), light intensity PA (1.5 to < 3 METs), and moderate to 
vigorous intensity PA (≥ 3 METs). Additionally, for each intensity, the duration of 
activity was grouped according to epochs of uninterrupted time equivalent to 0 to < 5 
minutes, 5 to < 10 minutes, 10 to < 30 minutes, 30 to < 60 minutes and ≥ 60 
minutes. Given the bariatric population has been shown to engage in little PA and 
spend most of their time in SB, data that reflects sub-optimal patterns of 
accumulation of SB and PA (i.e. short bouts of MVPA and prolonged bouts of SB) is 
reported. Previous research in the general adult population (44, 53, 391) has 
reported that prolonged periods of SB (i.e. ≥ 30 minutes) are associated with more 
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detrimental health effects, when compared to short periods of SB. Recent studies 
that have investigated the association between different durations of uninterrupted 
bouts of objectively-measured SB and cardiometabolic risk factors, in the general 
and obese populations, have suggested that the accumulation of SB in 
uninterrupted bouts ≥ 10 minutes is a more conservative threshold to identify 
prolonged periods of SB and should be considered when using objective measures 
of SB (392, 393). Based on these earlier studies, the accumulation of SB in 
uninterrupted bouts of both ≥ 10 minutes and ≥ 30 minutes was explored. Regarding 
the accumulation of MVPA, it is possible that accumulating time in MVPA in very 
short bouts (i.e. < 10 minutes) may be less beneficial than accumulating time in 
MVPA in longer bouts (i.e. ≥ 10 minutes) (50). Therefore, the sub-optimal pattern of 
accumulation of time in MVPA in uninterrupted bouts < 10 minutes was explored. 
Finally, data on patterns of accumulation of SB and MVPA that appear to be more 
optimal for health were also investigated. That is, the amount of time participants 
engaged in short bouts (< 10 minutes) of SB and uninterrupted bouts ≥ 10 minutes 
of MVPA was also reported. 
3.1.5.3 Statistical analyses 
Statistical analyses were performed using Stata Statistical Software 13.1 for 
Windows (StataCorp LP, College Station, TX, USA). The distribution of data was 
assessed by graphical (frequency histograms) and statistical methods (testing and 
comparing skewness and kurtosis of a ladder of power transformations of each 
variable). Change in normally distributed variables measured pre-surgery, and 3, 6, 
9, and 12 months post-surgery was analysed using multilevel, mixed-effects linear 
regression models. Multilevel regression models have advantages over traditionally 
used repeated measures analysis of variance in these circumstances as they (i) 
allow the correlation of the within-subject repeated measures to be explicitly 
accounted for, (ii) allow flexible modelling of time, and (iii) allow use of all cases 
including those with missing data at one or more time points, which allows for 
unbiased estimates for time-points with missing data providing data is at least 
missing at random (589). For these multilevel models, a variety of correlation 
structures were estimated and compared using maximum likelihood-based model-
selection statistics, namely Akaike and Bayesian information criteria. The selection 
procedure indicated that a model with a random intercept and level-one 
autoregressive error correlation structure was the most optimal. Due to nonlinearity 
observed for the effect of time over the five repeated assessments for numerous 
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outcomes, time was modelled as a categorical variable, allowing separate estimates 
of change between all assessment time points. A priori contrasts of interest for time 
were change from the preceding time-point, and total change from pre-surgery to 12 
months post-surgery. To compare measures of PA and SB and measures related to 
weight between surgery type, models included a dummy variable for surgical type 
and an interaction term between time and surgery type. This allowed comparison of 
estimates of change over time between the two surgical procedures. Tables and 
Figures presented for each multilevel model include the estimate for each 
assessment time point using all available information, that is, using only those cases 
observed at that time point (observed mean) and also using the full sample, i.e. 
including cases missing at that time point (predicted mean). Regarding the exposure 
variation analysis data, only descriptive statistics were presented in this thesis. 
Inferential statistics for temporal changes in exposure variation analysis data require 
complex statistical methods involving compositional analysis which are beyond the 
scope of this thesis and are methods currently under development by the 
supervisory team. 
The distribution of the DASS-21 score and the count variable apnoea-hypopnoea 
index (collected pre-surgery, and 3, 6, 9, and 12 months post-surgery) were right-
skewed and change in these measures was analysed using a negative-binomial 
model utilising generalised estimating equations with a level-one autoregressive 
error correlation structure. Generalised estimating equations are an alternative 
method to multilevel regression models to account for the non-independence in the 
data (i.e. the repeated measures of each individual), which also result in unbiased 
estimates providing the correlation structure is correctly modelled (589). For both 
linear multilevel and negative binomial models, plots of change over time for each 
individual were examined to identify potential outliers and cases having potential 
undue influence over model estimates. The comparison of continuous, normally 
distributed data for variables measured only pre-surgery and 12 months post-
surgery was done using paired sample t-tests. The comparison of categorical data 
for variables measured pre-surgery and 12 months post-surgery was done using 
McNemar’s exact test. 
The association between percentage of weight loss and pre- to 12 months post-
surgery change in measures of PA and SB was analysed using linear regression 
analysis. The degree of change in each measure of PA and SB associated with a 
10% increment of percentage weight loss was estimated. This association was 
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analysed with and without adjustment for type of surgery. A p value ≤ 0.05 was 
considered statistically significant for all analyses. All data were expressed as mean 
(standard deviation) or median (interquartile range), unless otherwise stated. 
Change between assessment time points was reported as mean change in units of 
measurement for linear models, and as incidence rate ratios (i.e. proportional 
change) for negative binomial models, with 95% confidence intervals. The exposure 
variation analysis data were expressed in bouts of time (minutes) and as 
percentages of total average daily monitor wear time (i.e. waking hours). 
3.2 Study 2 
3.2.1 Study design 
3.2.1.1 Overview 
The study was longitudinal and qualitative in design. Data collection was undertaken 
between January 2013 and August 2014. Adults scheduled to undergo restrictive 
bariatric surgery were recruited from two private bariatric surgery clinics in Perth, 
Western Australia. Semi-structured interviews were conducted pre-surgery and 12 
months post-surgery. The results from the pre-surgery interview are presented and 
discussed in Chapter 5 (Study 2(A) - Results and discussion). The results from the 
follow-up interview at 12 months post-surgery are presented and discussed in 
Chapter 6 (Study 2(B) - Results and discussion).  
3.2.1.2 Approval from human research ethics committee 
The study was approved by the Human Research Ethics Committee at Curtin 
University (approval number PT225/2012).  
3.2.1.3 Participants 
3.2.1.3.1 Inclusion criteria  
Individuals were eligible to participate in the study if they were aged over 18 years, 
with BMI > 30 kg/m2 and scheduled to undergo primary LAGB or LSG. 
3.2.1.3.2 Exclusion criteria  
Exclusion criteria comprised; (i) pregnancy or planning pregnancy within 12 months, 
(ii) presence of a permanent health condition such as a neurological, cardiovascular 
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or orthopaedic disease that could compromise the performance of daily PA, and (iii) 
cognitive impairments or language barriers which could interfere with participation in 
the interviews. 
3.2.2 Recruitment 
Participants were recruited between January 2013 and July 2013 from two private 
bariatric surgery clinics in Perth. The recruitment process was as described in 
section 3.1.2 (Recruitment).  
3.2.3 Assessment protocol 
Data collection comprised semi-structured, one-on-one interviews pre-surgery, and 
12 months post-surgery. Data collection took place between January and July of 
2013 for the pre-surgery interview, and between February and August of 2014 for 
the post-surgery interview. The interviews were conducted by Juliana Zabatiero 
(JZ), at the bariatric surgery clinic rooms, a research room at Curtin University or 
over the phone, according to participants’ preference, and audio-recorded with a 
digital recorder (IC Recorder, ICD-PX312; Sony Corporation, Tokyo, Japan).  
3.2.3.1 Interview schedules 
The interview schedule for the pre-surgery interview (see Appendix 1) was based on 
findings from previous research that had explored barriers and facilitators to PA 
among obese adults (215, 219), as well as in consultation with bariatric surgeons, 
physiotherapists and health psychology academics. Open-ended questions focused 
on the participants’ beliefs about PA (i.e. health benefits of PA, what qualifies 
someone as physically active), as well as their perceived barriers and facilitators to 
PA. During the interview, clarification (e.g. What do you mean when you say…?) 
and elaboration probes (e.g. Can you give me an example of…?), as well as 
paraphrasing were used to prompt participants and optimise clarity and depth of 
data. 
The interview schedule for the follow-up interview at 12 months post-surgery (see 
Appendix 2) also used open-ended questions that focused on the potential changes 
in participants’ engagement in PA, perceived ability to engage in PA, perceived 
barriers and facilitators, as well as their perceived motivators to PA. Opening 
questions explored participants’ perceptions of any changes in their participation in 
PA and were followed by more direct questions, which were informed by findings 
Chapter 3: Methods 
90 
 
from the pre-surgery interview. Similarly to the pre-surgery interview, clarification 
probes, elaboration probes, and paraphrasing were used to prompt participants and 
optimise clarity and depth of data. 
3.2.4 Data analysis 
The interview audio-recordings, for both pre- and post-surgery interviews, were 
transcribed verbatim and entered into NVivo10 (QSR International Pty Ltd, version 
10, 2012) to facilitate data organisation, coding, and management. Data analysis 
was performed concurrently with data collection to monitor the emergence of new 
themes. Recruitment ceased when data saturation was achieved (i.e. no new 
themes emerged).  
Thematic analysis is a widely used and flexible method to identify, describe, analyse 
and report patterns (themes) within qualitative data (590). A theme is a pattern 
found in the data that can initially describe and organise observations, and further 
provide interpretations of a phenomenon (591). Since thematic analysis provides a 
rich and detailed account of qualitative data, and can be performed independently of 
any theoretical framework (590), it was deemed the most appropriate approach to 
analyse data from the interviews collected in this study.  
There are two primary ways to identify patterns within the data when using thematic 
analysis (590). An inductive approach means that the analysis is data-driven, that is, 
the identified themes are linked to the data themselves, whereas a deductive 
approach seeks to provide a description and interpretation of themes, often relating 
to findings from previous studies or existing theories, in order to identify patterns 
related to a specific research question (590). In this study, an integrated approach of 
inductive and deductive thematic analysis was employed in order to identify codes 
and themes from the participants’ discourse (i.e. inductively) that reflected broader 
deductive categories (e.g. perceived barriers to PA). The process of data analysis 
followed steps proposed by Braun and Clarke (590), and is described in more detail 
bellow. 
3.2.4.1 Familiarity and closeness to the data 
Familiarity and closeness to the data were certified through the collection of data, 
transcription of interviews, and reading and re-reading of transcripts with an active 
approach (i.e. searching for meanings and patterns within the data). The 
transcription of interviews was done partly by the interviewer (around 20% of the 
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data collected), with the remaining performed by a professional transcribing service. 
Around half of the professional service’s transcriptions were checked against the 
audio-recordings to ensure the original meaning was retained. During this process of 
familiarisation, notes were taken regarding potential codes present in the data.  
3.2.4.2 Coding 
After becoming familiar with the data, the next step was to generate initial codes. 
Codes can be described as labels that capture a meaningful aspect of the data 
(591). Coding was conducted line-by-line in order to compare and contrast 
similarities and differences in the data, and individual extracts were coded for as 
many potential themes as deemed appropriate. Data extracts were considered 
meaningful when they were related to any of the deductive categories. Labels were 
then allocated to the data extracts to assist in the process of grouping related 
concepts within the participants’ discourse. 
3.2.4.3 Identification of themes 
The process of grouping similar codes into themes was finalised after all transcripts 
were coded. The codes generated were sorted and initially combined under one or 
more potential themes within each of the broad deductive categories, and further 
arranged to better illustrate the overarching themes. 
3.2.4.4 Revision of themes 
The initial themes identified from the data were reviewed and refined in order to 
assure that they presented a coherent pattern of data. For instance, regarding the 
pre-surgery interview data, under the category of beliefs about PA, initial themes 
such as ‘PA maintains your muscle strength’ and ‘PA maintains fitness’ were 
combined into the theme of ‘physical health benefits of PA’. Central to this process 
was exploring how codes were similar to but different from others (e.g. the theme 
‘PA maintains your muscles toned’ is related to physical appearance, while the 
theme ‘PA maintains fitness’ is related to people’s capacity to engage in PA; 
however, both were included into a broader theme of physical benefits of PA). After 
the review and refinement of individual themes, a thematic map was generated and 
the themes were reviewed and considered against the entire data set to ensure they 
accurately reflected the meanings evident in the data as a whole. 
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To enhance the trustworthiness of the analysis process, the interpretation of the 
themes during the ‘identification of themes’ step were checked against the raw data 
to ensure that it reflected the discourse of participants. The final thematic map 
generated at the end of the ‘revision of themes’ step was also checked against the 
raw data to ensure the credibility of the analysis. A second analyst, experienced with 
thematic analysis, independently analysed randomly selected transcripts from 30% 
of the sample to ascertain the credibility of the primary analyst’s (JZ) interpretation 
of the raw data. When comparing the independent analyses, inter-rater reliability 
was approximately 90% for codes and themes identified; discrepancies were 
clarified through discussions regarding possible interpretations of each code. Final 
themes and interpretations were discussed with supervisors, who served as a 
sounding board for the data analysis and exploration of alternative explanations and 
interpretations of the participants’ discourse. 
.
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CHAPTER 4 STUDY 1 - RESULTS AND DISCUSSION 
Overview 
This chapter presents the results and discussion of the outcomes related to Study 1. 
The methods relating to this study, including the description of study design, 
inclusion and exclusion criteria, recruitment process, assessment protocol, and data 
analyses have been described in Chapter 3 (section 3.1 Study 1). Section 4.1 
describes the study participants and presents data pertaining to changes, over the 
first year following restrictive bariatric surgery, in the primary and secondary 
outcome measures. For section 4.1 data are first presented pertaining to change in 
the primary outcome measures of physical activity (PA) and sedentary behaviour 
(SB). Thereafter, data are presented pertaining to change in the secondary 
outcomes relevant to PA, including measures of cardiovascular fitness, self-efficacy 
to exercise, sleep quality, daytime sleepiness, body composition and bone mineral 
density (BMD). Finally, data are presented pertaining to change in the secondary 
outcomes used to confirm the efficacy of bariatric surgery, including measures of 
weight, obesity-related comorbid conditions, health-related quality of life (HRQoL), 
obesity-related quality of life and weight-related symptoms, and symptoms of mental 
health disorders. Section 4.2 discusses the results presented for this study.  
The specific research questions answered in this chapter are:  
(i) Compared with measures collected pre-surgery, what is the magnitude of change 
in measures of PA and SB collected over the first 12 months following restrictive 
bariatric surgery? 
(ii) Compared with measures collected pre-surgery, what is the magnitude of change 
in measures of cardiovascular fitness, self-efficacy to exercise, sleep quality, 
daytime sleepiness, and body composition and BMD, collected over the first 12 
months following restrictive bariatric surgery? 
(iii) Compared with measures collected pre-surgery, what is the magnitude of 
change in measures of weight, obesity-related comorbid conditions, HRQoL, 
obesity-related quality of life and weight-related symptoms, and symptoms of 
depression, anxiety and stress; and (iv) does the magnitude of change in measures 
of weight differ between laparoscopic sleeve gastrectomy (LSG) in comparison to 
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laparoscopic adjustable gastric banding (LAGB) over the first 12 months following 
restrictive bariatric surgery? 
4.1 Results 
4.1.1 Participants 
Between April 2013 and June 2014, a total of 279 people who were obese were 
screened to participate, of whom 180 (65%) were considered eligible. Thirty-six of 
the 180 eligible people agreed to participate. Six (17%) of them withdrew before the 
pre-surgery assessment, and 30 (83%) provided written informed consent and were 
included in the study. A study flowchart is provided in Figure 4.1. The characteristics 
of participants at the pre-surgery assessment time point are presented in Table 4.1. 
The average length of hospital stay was 2.1 days (standard deviation [SD], 0.3) and 
there were no peri-operative or early post-operative complications. One participant 
underwent a hip replacement 5 months post-surgery, and another participant 
underwent a prostatectomy 9 months post-surgery. One participant who underwent 
LSG withdrew from this study before completing the 6-month assessment. All 
assessments were done, on average, within a 2-week range from the assessment 
time points, with the exception of nine participants that were assessed around one 
month prior to surgery for the pre-surgery assessment, and one participant 
assessed 5 weeks after their 9-month assessment date. 
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Figure 4.1. Study 1 flowchart. 
 
Potential participants screened  
n = 279 
Did not consent to be contacted: 
n = 144 
• Not interested  
            n = 98 
• Not decided about surgery  
            n = 46 
Not eligible: 
n = 99 
• Had previous bariatric surgery 
n = 66 
• Body weight > 160 kg  
            n = 14  
• Body mass index < 30 kg/m
2
  
            n = 4 
• Physical activity affected by 
permanent comorbid conditions  
            n = 15 
• Withdrawn before pre-surgery 
assessment  
            n = 5 
• Did not undergo surgery  
            n = 1 
Consented to participate 
n = 36 
Completed assessments 
n = 29 
Withdrawn (no reason) 
n = 1 
Included in the study 
n = 30 
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Table 4.1. Characteristics of participants at the pre-surgery assessment 
Characteristic 
 
Combined group  
(n = 30) 
LSG 
(n = 22) 
LAGB 
(n = 8) 
 Mean (range) 
Age (yr) 44.1 (22.0 – 65.0) 43.3 (22 – 65) 46.3 (32.0 – 54.0) 
Height (m) 1.7 (1.5 – 1.9) 1.7 (1.5 – 1.9) 1.7 (1.5 – 1.8) 
Weight (kg) 
114.6 (84.1 – 
154.3) 
111.0 (84.1 – 
133.5) 
124.7 (93.9 – 
154.3) 
Body mass index 
(kg/m2) 39.6 (30.9 – 50.9) 38.4 (30.9 – 47.7) 42.8 (33.8 – 51.0) 
 n (%) 
Gender (Male/Female) 10 (33)/20 (67) 6 (20)/16 (54) 4 (13)/4 (13) 
Smokers 2 (7) 2 (7) 0 (0) 
Class I obesity 8 (27) 7 (23) 1 (3) 
Class II obesity 8 (27) 6 (20) 2 (7) 
Class III obesity 14 (46) 9 (30) 5 (17) 
Medication use n (%) 
Diabetes mellitus type 2 3 (10) 1 (3) 2 (7) 
Hypertension 6 (20) 3 (10) 3 (10) 
Dyslipidaemia 2 (7) 2 (7) 0 (0) 
Abbreviations: LAGB: laparoscopic adjustable gastric banding; LSG: laparoscopic sleeve 
gastrectomy; SD: standard deviation.  
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4.1.2 Physical activity and sedentary behaviour 
This section provides data pertaining to change in the primary outcome measures of 
PA and SB, collected pre-surgery, and 3, 6, 9 and 12 months post-surgery in order 
to answer research question (i). Participants wore the SenseWear Armband (SAB) 
for an average of 5.7 days (SD, 1.1) pre-surgery, 6.0 days (SD, 1.0) at 3 months, 5.6 
days (SD, 0.8) at 6 months, 6.1 days (SD, 1.1) at 9 months, and 6.0 days (SD, 1.0) 
at 12 months post-surgery. The average daily wear time for the SAB was 16.3 
hours/day (SD, 2.4) pre-surgery, 15.2 hours/day (SD, 1.5) at 3 months, 15.0 
hours/day (SD, 1.5) at 6 months, 15.0 hours/day (SD, 1.0) at 9 months, and 15.1 
hours/day (SD, 1.1) at 12 months post-surgery. Participants wore the StepWatch 3 
Activity Monitor (SAM) for an average of 6.6 days (SD, 0.9) pre-surgery, 6.6 days 
(SD, 0.6) at 3 months, 6.5 days (SD, 0.9) at 6 months, 6.5 days (SD, 0.8) at 9 
months, and 6.5 days (SD, 1.0) at 12 months post-surgery. 
Total time spent in sedentary behaviour, light intensity physical activity and 
moderate to vigorous intensity physical activity 
Table 4.2 presents data pertaining to change in the percentage of waking hours 
spent in SB, light intensity PA, and moderate to vigorous intensity PA (MVPA). 
Figures 4.2 to 4.4 present data collected at each assessment time point for the 
percentage of waking hours spent in SB, light intensity PA, and MVPA, respectively, 
with the addition of plots for individual participants to depict individual variability. 
Compared to pre-surgery measures, 12 months post-surgery, there was no change 
in the percentage of waking hours spent in SB (mean change, -2%; 95% confidence 
interval [CI], -6 to 3), light intensity PA (mean change, 1% ; 95% CI, -3 to 5), or 
MVPA (mean change, 1%; 95% CI, -1 to 3). Figure 4.5 presents the data collected 
for each participant, at each assessment time point, for the percentage of waking 
hours spent in SB, light intensity PA, and MVPA, and shows the variability within the 
individual participant data. For instance, participant 10 presented no change in the 
percentage of waking hours spent in SB, light intensity PA and MVPA over the five 
assessment time points, while participant 3 presented a reduction in the percentage 
of waking hours spent in SB and an increase in the percentage of waking hours 
spent in light intensity PA between the pre-surgery and the 6-month post-surgery 
assessments, which were not maintained up to 12 months post-surgery. Similar 
results were found when total time spent in SB, light intensity PA and MVPA were 
reported as minutes/day (Appendix 3). 
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When participants were grouped according to surgery type, no difference was found 
in the change in time spent in SB, light intensity PA and MVPA, reported as both 
percentage of waking hours and minutes/day, between those who underwent LSG 
and LAGB (Appendix 4). 
Associations between pre- to 12 months post-surgery measures of PA and SB and 
the percentage of weight loss were analysed using linear regression analysis 
(Appendix 5). When the association of change in each measure of PA and SB (i.e. 
daily step count, min/day spent in light intensity PA, min/day spent in MVPA and 
min/day spent in SB) with a 10% increment of percentage weight loss was 
estimated, both unadjusted and adjusted by type of surgery, the only significant 
association identified was an association of less steps/day with more weight loss (-
1993 steps/day; 95% CI, -3188 to -798; p = 0.002), which was unaffected by 
adjustment for type of surgery (-2309 steps/day; 95% CI, -3738 to -880; p = 0.003).  
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Table 4.2. Change in the total time (percentage of waking hours) spent in sedentary 
behaviour, light intensity physical activity, and moderate to vigorous intensity 
physical activity 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change 
from preceding 
time point 
(95%CI) 
p-value 
Sedentary behaviour (% of waking hours) 
Pre-surgery 30 74 (11) 74 --- --- 
3 months 27 72 (11) 71 -2 (-5 to 0) 0.06 
6 months 28 71 (13) 70 -1 (-4 to 2) 0.42 
9 months 24 72 (9) 70 0 (-3 to 3) 0.96 
12 months 20 73 (9) 72 2 (-1 to 5) 0.29 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -2 (-6 to 3) 0.44 
Light intensity physical activity (% of waking hours) 
Pre-surgery 30 21 (9) 21 --- --- 
3 months 27 23 (10) 23 2 (0 to 4) 0.08 
6 months 28 22 (10) 23 0 (-2 to 2) 0.94 
9 months 24 21 (7) 22 -1 (-3 to 2) 0.64 
12 months 20 21 (7) 22 0 (-3 to 2) 0.79 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 1 (-3 to 5) 0.56 
Moderate to vigorous intensity physical activity (% of waking hours) 
Pre-surgery 30 5 (3) 5 --- --- 
3 months 27 6 (4) 6 0 (-1 to 2) 0.43 
6 months 28 7 (6) 7 1 (0 to 2) 0.11 
9 months 24 7 (5) 7 0 (-1 to 2) 0.52 
12 months 20 6 (4) 6 -1 (-3 to 0) 0.08 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 1 (-1 to 3) 0.56 
Abbreviations: CI: confidence interval; SD: standard deviation. All comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available information (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]) and only data from participants who met the minimal monitor 
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wear requirements were included in the analyses (see section 3.1.5.2.2 for definition of 
minimal monitor wear requirements).
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Figure 4.2. Data collected at each assessment time point for percentage of waking 
hours spent in sedentary behaviour (SB). The pre-surgery assessment time point is 
denoted by 0 months. 
 
Chapter 4: Study 1 - Results and discussion 
102 
 
 
Figure 4.3. Data collected at each assessment time point for percentage of waking 
hours spent in light intensity physical activity (LIPA). The pre-surgery assessment 
time point is denoted by 0 months. 
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Figure 4.4. Data collected at each assessment time point for percentage of waking 
hours spent in moderate to vigorous intensity physical activity (MVPA). The pre-
surgery assessment time point is denoted by 0 months. 
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Figure 4.5. Data collected for each participant, at each assessment time point, for 
percentage of waking hours spent in sedentary behaviour (SB), light intensity 
physical activity (LIPA), and moderate to vigorous intensity physical activity (MVPA). 
The pre-surgery assessment time point is denoted by 0 months. Gaps in the 
individual participant graphs denote the absence of valid data for the measure at the 
specific assessment time point. 
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Accumulation of sedentary behaviour and physical activity in bouts of 
uninterrupted time 
This sub-section provides descriptive data on how the percentage of waking hours 
spent in SB, light intensity PA and MVPA was accumulated. Table 4.3 presents data 
on the accumulation of SB, light intensity PA, and MVPA, for each assessment time 
point, in bouts of uninterrupted time ranging from 0 to < 5 minutes, 5 to < 10 
minutes, 10 to < 30 minutes, 30 to < 60 minutes, and ≥ 60 minutes, and Figure 4.6 
presents these data graphically to facilitate interpretation. Table 4.3 and Figure 4.6 
show that across all assessment time points, participants spent most of their waking 
hours in SB, which was accumulated mostly in uninterrupted bouts of ≥ 30 minutes, 
and little of their waking hours in light intensity PA and MVPA, accumulated mostly 
in short periods of < 10 minutes.  
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Table 4.3. Accumulation of sedentary behaviour, light intensity physical activity, and 
moderate to vigorous intensity physical activity in bouts of uninterrupted time 
Assessment 
time point 
 
0 to < 5 
minutes 
Mean (SD) 
5 to < 10 
minutes 
Mean (SD) 
10 to < 30 
minutes 
Mean (SD) 
30 to < 60 
minutes 
Mean (SD) 
≥ 60 
minutes 
Mean (SD) 
Sedentary behaviour (% of waking hours) 
Pre-surgery 7 (3) 6 (3) 17 (5) 18 (7) 25 (16) 
3 months 8 (3) 6 (2) 17 (6) 17 (6) 24 (16) 
6 months 8 (3) 6 (3) 18 (6) 17 (7) 22 (18) 
9 months 8 (3) 7 (2) 19 (6) 18 (6) 21 (14) 
12 months 7 (3) 6 (3) 19 (5) 18 (5) 23 (17) 
Light intensity physical activity (% of waking hours) 
Pre-surgery 12 (4) 6 (3) 3 (3) 0 (0) 0 (0) 
3 months 12 (4) 6 (3) 4 (4) 0 (1) 0 (0) 
6 months 12 (4) 6 (3) 4 (5) 1 (2) 0 (0) 
9 months 12 (4) 5 (2) 4 (3) 0 (1) 0 (0) 
12 months 12 (4) 6 (2) 4 (2) 0 (0) 0 (0) 
Moderate to vigorous physical activity (% of waking hours) 
Pre-surgery 4 (2) 1 (1) 1 (1) 0 (0) 0 (1) 
3 months 4 (2) 1 (1) 1 (1) 0 (0) 0 (0) 
6 months 4 (3) 1 (2) 1 (1) 0 (1) 0 (1) 
9 months 3 (2) 1 (1) 1 (2) 0 (1) 0 (0) 
12 months 4 (2) 1 (1) 1 (1) 0 (0) 0 (0) 
Abbreviations: SD: standard deviation. At each assessment time point, only data from 
participants who met the minimal monitor wear requirements were included in the analyses 
(see section 3.1.5.2.2 for definition of minimal monitor wear requirements).  
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Figure 4.6. Percentage of waking hours spent in sedentary behaviour (SB), light 
intensity physical activity (LIPA), and moderate to vigorous intensity physical activity 
(MVPA), for each assessment time point, accumulated in bouts of uninterrupted 
time.
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Table 4.4 presents data on the accumulation of SB in uninterrupted bouts ≥ 10 
minutes and ≥ 30 minutes as a percentage of total time spent in SB and of MVPA in 
bouts < 10 minutes as a percentage of total time spent in MVPA. Figures 4.7 and 
4.8 present these data collected at each assessment time point for the accumulation 
of SB and MVPA, respectively, with the addition of plots for individual participants to 
depict individual variability. Table 4.4 and Figure 4.7 show that at all assessment 
time points, most of the time spent in SB (i.e. ≥ 78%) was accumulated in 
uninterrupted bouts of ≥ 10 minutes and more than half of the time spent in SB (i.e. 
≥ 51%) was accumulated in uninterrupted bouts of ≥ 30 minutes. Table 4.4 and 
Figure 4.8 show that at all assessment time points, the majority of the time spent in 
MVPA (i.e. ≥ 82%) was accumulated in short bouts of < 10 minutes. Data on the 
accumulation of SB in uninterrupted bouts of < 10 minutes and MVPA in 
uninterrupted bouts of ≥ 10 minutes is presented in Appendix 6. 
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Table 4.4. Accumulation of sedentary behaviour in uninterrupted bouts ≥ 10 minutes 
and ≥ 30 minutes and of moderate to vigorous physical activity in bouts < 10 
minutes 
Assessment 
time point 
 
n 
SB 
(% of total SB  
in bouts ≥ 10 
minutes) 
Mean (SD) 
SB 
(% of total SB  
in bouts ≥ 30 
minutes) 
Mean (SD) 
MVPA 
(% of total MVPA  
in bouts <10 
minutes) 
Mean (SD) 
Pre-surgery 30 80 (11) 56 (17) 88 (14) 
3 months 27 80 (10) 55 (19) 88 (15) 
6 months 28 78 (11) 52 (19) 86 (14) 
9 months 24 79 (9) 51 (17) 82 (15) 
12 months 20 80 (10) 53 (18) 86 (14) 
Abbreviations: MVPA: moderate to vigorous physical activity; SB: sedentary behaviour.  At 
each assessment time point, only data from participants who met the minimal monitor wear 
requirements were included in the analyses (see section 3.1.5.2.2 for definition of minimal 
monitor wear requirements).  
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Figure 4.7. Data collected at each assessment time point for percentage of total 
time spent in sedentary behaviour (SB) accumulated in bouts (A) ≥ 10 minutes and 
(B) ≥ 30 minutes. The pre-surgery assessment time point is denoted by 0 months. 
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Figure 4.8. Data collected at each assessment time point for percentage of total 
time spent in moderate to vigorous physical activity (MVPA) accumulated in bouts < 
10 minutes. The pre-surgery assessment time point is denoted by 0 months. 
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Daily step count 
Table 4.5 presents data pertaining to change in the daily step count. Figure 4.9 
presents data collected at each assessment time point for the daily step count, with 
the addition of plots for individual participants to depict individual variability. 
Compared to pre-surgery measures, 12 months post-surgery, there was no change 
in the daily step count (mean change, 775 steps/day; 95% CI, -741 to 2291). When 
participants were grouped according to surgery type, no difference was found in the 
change in daily step count between those who underwent LSG and LAGB (Appendix 
7).
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Table 4.5. Change in daily step count 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time point 
(95%CI) 
p-value 
Daily step count (steps/day) 
Pre-surgery 29 8122 (3543) 8042 --- --- 
3 months 27 8578 (3195) 8575 533 (-406 to 1471) 0.26 
6 months 26 9280 (3594) 9038 463 (-494 to 1420) 0.34 
9 months 26 8713 (2677) 9164 126 (-848 to 1099) 0.80 
12 months 22 8871 (2842) 8817 -347 (-1397 to 702) 0.51 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 775 (-741 to 2291) 0.31 
Abbreviations: CI: confidence interval; SD: standard deviation. All comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available information (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]) and only data from participants who met the minimal monitor 
wear requirements were included in the analyses (see section 3.1.5.2.2 for definition of 
minimal monitor wear requirements).  
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Figure 4.9. Data collected at each assessment time point for daily step count. The 
pre-surgery assessment time point is denoted by 0 months. 
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The following sections provide data pertaining to change in secondary outcome 
measures. A summary of descriptive data on changes in secondary outcome 
measures with participants grouped according to surgery type is presented in 
Appendix 8. 
4.1.3 Cardiovascular fitness 
This section provides data pertaining to change in measures of cardiovascular 
fitness collected pre-surgery and 12 months post-surgery in order to answer 
research question (ii). Table 4.6 presents data pertaining to change in 
cardiovascular fitness measured using the Physical Working Capacity 170 test 
(PWC-170). Compared to pre-surgery measures, 12 months post-surgery, there was 
no change in the mean estimated load required to achieve a heart rate of 170 beats 
per minute in the test. 
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Table 4.6. Change in cardiovascular fitness 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Mean change 
(95%CI) 
p-value 
Cardiovascular fitness (PWC-170 [Watts]) 
Pre-surgery 16 194 (64) --- --- 
12 months 16 210 (52) 16 (-7 to 39) 0.14 
Abbreviations: CI: confidence interval; SD: standard deviation. Comparison done using 
paired samples t-test. 
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4.1.4 Self-efficacy to exercise  
This section provides data pertaining to change in measures of self-efficacy to 
exercise collected pre-surgery, and 3, 6, 9 and 12 months post-surgery in order to 
answer research question (ii). Table 4.7 presents data pertaining to change in self-
efficacy to exercise measured using the Exercise Self-Efficacy Scale (ESES). Figure 
4.10 presents data collected at each assessment time point for self-efficacy to 
exercise, expressed by the ESES score, with the addition of plots for individual 
participants to depict individual variability. Compared to pre-surgery measures, 12 
months post-surgery, there was an increase in the self-efficacy to exercise (mean 
change, 18.9; 95% CI, 11.3 to 26.5). Table 4.7 and Figure 4.10 show that the 
majority of change in self-efficacy to exercise occurred in the first 3 months, and was 
maintained up to 12 months post-surgery. 
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Table 4.7. Change in self-efficacy to exercise 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time 
point 
(95%CI) 
p-value 
Self-efficacy to exercise (Exercise Self-Efficacy Scale score) 
Pre-surgery 30 53.4 (17.2) 53.4 --- --- 
3 months 30 67.2 (19.1) 67.2 13.8 (9.1 to 18.6) < 0.001 
6 months 29 71.4 (15.3) 71.4 4.2 (-0.6 to 9.0) 0.08 
9 months 29 70.9 (14.8) 71.0 -0.4 (-5.3 to 4.4) 0.85 
12 months 28 72.3 (18.3) 72.3 1.3 (-3.6 to 6.2) 0.60 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 18.9 (11.3 to 26.5) < 0.001 
Abbreviations: CI: confidence interval; SD: standard deviation. All comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available information (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]). 
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Figure 4.10. Data collected at each assessment time point for self-efficacy to 
exercise, expressed by the score of the Exercise Self-Efficacy Scale (ESES). The 
pre-surgery assessment time point is denoted by 0 months. 
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4.1.5 Sleep quality 
This section provides data pertaining to change in measures of sleep quality 
collected pre-surgery, and 3, 6, 9 and 12 months post-surgery in order to answer 
research question (ii). Table 4.8 presents data pertaining to change in sleep quality 
measured using the Pittsburgh Sleep Quality Index (PSQI). Figure 4.11 presents 
data collected at each assessment time point for sleep quality, expressed by the 
PSQI score, with the addition of plots for individual participants to depict individual 
variability. Compared to pre-surgery measures, 12 months post-surgery, there was 
an improvement in sleep quality (mean change, -3.1; 95% CI, -4.6 to -1.6). Table 4.8 
and Figure 4.11 show that the majority of change in sleep quality occurred in the first 
3 months, and was maintained up to 12 months post-surgery. 
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Table 4.8. Change in sleep quality 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time point 
(95%CI) 
p-value 
Sleep quality (Pittsburgh Sleep Quality Index score) 
Pre-surgery 30 8.7 (2.9) 8.7 --- --- 
3 months 30 6.3 (3.6) 6.3 -2.5 (-3.4 to -1.5) < 0.001 
6 months 29 5.5 (4.0) 5.5 -0.8 (-1.7 to 0.2) 0.11 
9 months 29 4.8 (3.2) 4.8 -0.8 (-1.7 to 0.2) 0.11 
12 months 28 5.7 (3.5) 5.7 0.9 (-0.1 to 1.9) 0.06 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -3.1 (-4.6 to -1.6) < 0.001 
Abbreviations: CI: confidence interval; SD: standard deviation. All comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available information (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]).
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Figure 4.11. Data collected at each assessment time point for sleep quality, 
expressed by the score of the Pittsburgh Sleep Quality Index (PSQI). The pre-
surgery assessment time point is denoted by 0 months. 
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4.1.6 Daytime sleepiness 
This section provides data pertaining to change in measures of daytime sleepiness 
collected pre-surgery, and 3, 6, 9 and 12 months post-surgery in order to answer 
research question (ii). Table 4.9 presents data pertaining to change in daytime 
sleepiness measured using the Epworth Sleepiness Scale (ESS). Figure 4.12 
presents data collected at each assessment time point for daytime sleepiness, 
expressed by the ESS score, with the addition of plots for individual participants to 
depict individual variability. Compared to pre-surgery measures, 12 months post-
surgery, there was a reduction in daytime sleepiness (mean change, -3.0; 95% CI, -
1.3 to -4.7). Table 4.9 and Figure 4.12 show that the majority of change in daytime 
sleepiness occurred in the first 3 months, and was maintained up to 12 months post-
surgery. 
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Table 4.9. Change in daytime sleepiness 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time point 
(95%CI) 
p-value 
Daytime sleepiness (Epworth Sleepiness Scale score) 
Pre-surgery 30 8.5 (4.6) 8.5 --- --- 
3 months 30 5.8 (4.4) 5.8 -2.7 (-3.7 to -1.7) < 0.001 
6 months 29 4.9 (4.0) 5.1 -0.7 (-1.8 to 0.3) 0.15 
9 months 29 5.3 (4.6) 5.4 0.3 (-0.7 to 1.4) 0.51 
12 months 28 5.4 (3.7) 5.5 0.1 (-0.9 to 1.1) 0.86 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -3.0 (-4.7 to -1.3) 0.001 
Abbreviations: CI: confidence interval; SD: standard deviation. All comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available information (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]). 
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Figure 4.12. Data collected at each assessment time point for daytime sleepiness, 
expressed by the score of the Epworth Sleepiness Scale (ESS). The pre-surgery 
assessment time point is denoted by 0 months.
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4.1.7 Body composition and bone mineral density 
This section provides data pertaining to change in measures of body composition 
and BMD collected pre-surgery and 12 months post-surgery in order to answer 
research question (ii). Table 4.10 presents data pertaining to change in body 
composition and BMD, measured using whole-body dual energy x-ray 
absorptiometry scanning (DXA). Compared to pre-surgery measures, 12 months 
post-surgery, there were significant reductions in absolute and percentage fat mass 
(FM) and in absolute fat-free mass (FFM). Both pre-surgery and 12 months post-
surgery, no participant presented with total body T-scores indicative of osteopenia 
(i.e. between -1 and -2.5 SD) or osteoporosis (i.e. below -2.5 SD) (592). Compared 
to pre-surgery measures, 12 months post-surgery, there were significant reductions 
in the regional BMD measures of the spine and pelvis.
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Table 4.10. Change in body composition and bone mineral density 
Measure 
 
n 
Pre-surgery 
Mean (SD) 
12-month  
post-surgery 
Mean (SD) 
Mean change 
(95% CI) 
p-value 
Body composition 
FM (kg) 26 55.7 (10.6) 33.8 (12.5) -21.9 (-26.9 to -17.0) < 0.001 
FM (%) 26 49 (6) 39 (8) -10 (-13 to -8) < 0.001 
FFM (kg) 26 59.4 (10.1) 54.2 (9.5) -5.1 (-6.5 to -3.7) < 0.001 
FFM (%) 26 52 (6) 63 (8) 11 (8 to 14) < 0.001 
Bone mineral density 
Total body (g/cm2) 26 1.26 (0.12) 1.26 (0.13) 0.00 (-0.02 to 0.02) > 0.99 
Total body T-score 26 1.45 (1.06) 1.39 (1.19) -0.06 (-0.19 to 0.07) 0.36 
Spine (g/cm2) 26 1.33 (0.15) 1.24 (0.03) -0.08 (-0.12 to -0.04) < 0.001 
Pelvis (g/cm2) 26 1.13 (0.17) 1.08 (0.15) -0.05 (-0.07 to -0.03) < 0.001 
Abbreviations: CI: confidence interval; FFM: fat-free mass; FM: fat mass; SD: standard 
deviation. All comparisons done using paired samples t-test. 
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4.1.8 Weight-related measures 
This section provides data pertaining to change in weight-related measures 
collected pre-surgery, and 3, 6, 9 and 12 months post-surgery in order to answer 
research question (iii). Table 4.11 presents data pertaining to change in weight-
related measures. Figures 4.13 and 4.14 present data collected at each assessment 
time point for body weight and body mass index (BMI), and weight expressed as the 
percentage of pre-surgery weight loss and as the percentage of excess weight loss 
(%EWL), respectively, with the addition of plots for individual participants to depict 
individual variability. Compared to pre-surgery measures, 12 months post-surgery, 
there was a mean weight reduction of 27.9 kg (95% CI, 24.5 to 31.4), a mean BMI 
reduction of 9.7 kg/m2 (95%, 8.5 to 10.9), a mean loss of 24% (95% CI, 21 to 28) of 
pre-surgery weight, and a mean %EWL of 72% (95% CI, 61 to 83). Table 4.11 and 
Figures 4.13 and 4.14 show that the majority of change in weight-related measures 
occurred in the first 3 months, with smaller changes up to 9 months, which were 
maintained up to 12 months post-surgery. Pre-surgery, eight (27%) participants 
were classified into class I obesity (i.e. BMI: 30 to 34.9 kg/m2), eight (27%) into class 
II obesity (i.e. BMI: 35 to 39.9 kg/m2), and 14 (47%) into class III obesity (i.e. BMI > 
40 kg/m2). At 12 months post-surgery, four (14%) participants reached the normal-
weight range (i.e. BMI: 18.5 to 24.9 kg/m2), 13 (45%) were classified as overweight 
(BMI: 25 to 29.9 kg/m2), seven (24%) were classified into class I obesity, three 
(10%) into class II obesity, and two (7%) into class III obesity. 
Compared to pre-surgery measures, 12 months post-surgery, participants had a 
mean waist circumference reduction of 22.7 cm (95% CI, 18.2 to 27.2). Pre-surgery, 
all participants presented waist circumference measures greater than the risk values 
determined by the World Health Organisation (i.e. > 88 cm for women and > 102 cm 
for men). At 12 months post-surgery, three (30%) of the 10 men and seven (35%) of 
the 20 women had waist circumference measures below the risk values.  
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Table 4.11. Change in weight-related measures 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time 
point 
(95%CI) 
p-value 
Weight (kg)* 
Pre-surgery 30 114.6 (17.2) 114.6 --- --- 
3 months 30 95.9 (16.5) 96.0 -18.7 (-20.4 to -16.9) < 0.001 
6 months 30 89.7 (17.3) 89.7 -6.3 (-8.0 to -4.5) < 0.001 
9 months 29 87.4 (17.8) 86.8 -2.9 (-4.7 to -1.1) 0.001 
12 months 28 88.2 (18.9) 86.7 -0.1 (-1.9 to 1.8) 0.95 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -27.9 (-31.4 to -24.5) <0.001 
Body mass index (kg/m2)* 
Pre-surgery 30 39.6 (5.5) 39.6 --- --- 
3 months 30 33.1 (5.5) 33.1 -6.4 (-7.0 to -5.8) < 0.001 
6 months 30 30.9 (5.7) 30.9 -2.2 (-2.8 to -1.6) < 0.001 
9 months 29 30.2 (5.9) 29.9 -1.0 (-1.6 to -0.4) 0.001 
12 months 28 30.4 (6.3) 29.9 -0.0 (-0.7 to 0.6) 0.91 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -9.7 (-10.9 to -8.5) < 0.001 
% of pre-surgery weight loss*  
3 months 30 -16 (5) -16 -16 (-20 to -13) < 0.001 
6 months 30 -22 (9) -22 -5 (-7 to -4) < 0.001 
9 months 29 -24 (10) -24 -3 (-4 to -1) < 0.001 
12 months 28 -24 (12) -24 -0 (-1 to 1) 0.99 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -24 (-28 to -21) < 0.001 
 continues next page 
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Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time 
point 
(95%CI) 
p-value 
% of excess weight loss* 
3 months 30 -49 (22) -49 -49 (-60 to -38) < 0.001 
6 months 30 -65 (30) -65 -16 (-19 to -12) < 0.001 
9 months 29 -71 (33) -72 -7 (-10 to -4) < 0.001 
12 months 28 -69 (37) -72 0 (-3 to 4) 0.89 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -72 (-83 to -61) < 0.001 
Waist circumference (cm)† 
Pre-surgery 30 124.8 (13.1) --- --- --- 
12 months 28 102.9 (17.2) --- -22.7 (-27.2 to -18.2) < 0.001 
Abbreviations: CI: confidence interval; SD: standard deviation. *Comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available information (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]). †: Comparison done using paired samples t-test. 
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Figure 4.13. Data collected at each assessment time point for measures of (A) 
weight and (B) body mass index (BMI). The pre-surgery assessment time point is 
denoted by 0 months. 
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Figure 4.14. Data collected at each assessment time point for measures of (A) % of 
pre-surgery weight loss and (B) % of excess weight loss. 
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4.1.8.1 Weight-related measures according to surgery type 
Table 4.12 presents data pertaining to differences, between those who underwent 
LSG and LAGB, in change in weight-related measures. Figures 4.15 and 4.16 
present data collected at each assessment time point for weight and BMI, and 
weight loss expressed as the percentage of pre-surgery weight and the percentage 
of excess weight, respectively, with participants grouped according to surgery type. 
There was a greater change in all weight-related measures for those who underwent 
LSG when compared to those who underwent LAGB. Compared to pre-surgery 
measures, 12 months post-surgery, there was a mean weight reduction of 31.9 kg 
(95% CI, 28.2 to 35.6) following LSG and 17.3 kg (95% CI, 11.2 to 23.3) following 
LAGB, a mean BMI reduction of 11.1 kg/m2 (95% CI, 9.9 to 12.4) following LSG and 
5.8 kg/m2 (95% CI, 3.7 to 7.9) following LAGB, a mean loss of 29% (95% CI, 26 to 
32) of their pre-surgery weight following LSG and 13% (95% CI, 8 to 18) following 
LAGB, and a mean %EWL of 87% (95% CI, 77 to 97) following LSG and 33% (95% 
CI, 17 to 50) following LAGB. Table 4.12 and Figures 4.15 and 4.16 show that the 
majority of change in weight-related measures occurred in the first 3 months for both 
surgery types, followed by smaller changes up to 12 months post-surgery. There 
was a greater weight loss in those who underwent LSG, when compared to those 
who underwent LAGB, during the first 6 months post-surgery, and similar weight 
loss occurred for both surgery types between 6 and 12 months post-surgery. 
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Table 4.12. Change in weight-related measures according to surgery type 
Assessment 
time point 
n 
Predicted 
Mean 
Mean change 
from preceding 
time point 
Difference in 
mean change 
between 
LSG and LAGB 
(95%CI) 
p-value 
  LSG LAGB LSG LAGB   
Weight (kg) 
Pre-surgery 30 111.0 124.7 --- --- --- --- 
3 months 30 90.6 110.6 -20.4 -14.0 -6.4 (-10.0 to -2.7) 0.001 
6 months 30 83.0 107.9 -7.6 -2.8 -4.8 (-8.5 to -1.1) 0.010 
9 months 29 79.6 106.2 -3.4 -1.6 -1.8 (-5.5 to 1.9) 0.34 
12 months 28 79.1 107.4 -0.6 1.2 -1.7 (-5.4 to 2.0) 0.36 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months -31.9 -17.3 -14.6 (-21.8 to -7.5) < 0.001 
Body mass index (kg/m2) 
Pre-surgery 30 38.4 42.9 --- --- --- --- 
3 months 30 31.3 38.1 -7.1 -4.8 -2.3 (-3.6 to -1.1) < 0.001 
6 months 30 28.7 37.2 -2.7 -0.9 -1.7 (-2.9 to -0.5) 0.007 
9 months 29 27.5 36.6 -1.2 -0.5 -0.7 (-1.9 to 0.6) 0.29 
12 months 28 27.3 37.1 -0.2 0.4 -0.6 (-1.9 to 0.6) 0.31 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months -11.1 -5.8 -5.3 (-7.7 to -2.9) < 0.001 
% of baseline weight loss 
3 months 30 -18 -11 -18 -11 -7 (-13 to -2) 0.013 
6 months 30 -25 -13 -7 -2 -5 (-7 to -2) <0.001 
9 months 29 -28 -14 -3 -1 -2 (-4 to 1) 0.15 
12 months 28 -29 -13 -1 1 -2 (-4 to 0) 0.22 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months -29 -13 -15 (-21 to -10) < 0.001 
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Assessment 
time point 
n 
Predicted 
Mean 
Mean change 
from preceding 
time point 
Difference in 
mean change 
between 
LSG and LAGB 
(95%CI) 
p-value 
% of excess weight loss 
3 months 30 -57 -28 -57 -28 -28 (-48 to -9) 0.003 
6 months 30 -77 -33 -20 -5 -15 (-22 to -8) < 0.001 
9 months 29 -86 -36 -9 -3 -6 (-13 to 2) 0.12 
12 months 28 -87 -33 -1 3 -4 (-11 to 3) 0.27 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months -87 -33 -53 (-72 to -34) < 0.001 
Abbreviations: CI: confidence interval. All comparisons done using multilevel mixed-effects 
linear regression model. At each assessment time point, data were presented as the 
estimate for each time point including cases missing in that time point [predicted mean]). 
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Figure 4.15. Data collected at each assessment time point for measures of (A) 
weight and (B) body mass index (BMI), with participants grouped according to 
surgery type (predicted means with 95% confidence intervals). The pre-surgery 
assessment time point is denoted by 0 months. 
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Figure 4.16. Data collected at each assessment time point for measures of (A) % of 
pre-surgery weight loss and (B) % of excess weight loss, with participants grouped 
according to surgery type (predicted means with 95% confidence intervals).  
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4.1.9 Obesity-related comorbid conditions 
This section provides data pertaining to change in measures of obesity-related 
comorbid conditions collected pre-surgery and 12 months post-surgery, as well as in 
measures of sleep disordered breathing collected pre-surgery, and 3, 6, 9 and 12 
months post-surgery in order to answer research question (iii). Table 4.13 presents 
data pertaining to resolution in obesity-related comorbid conditions. Both pre-
surgery and 12 months post-surgery, 8 (27%) participants presented with at least 
one medically diagnosed obesity-related comorbid condition.  
Improvement in obesity-related comorbid conditions was seen in two (25%) of the 
eight participants who had dyslipidaemia and three (38%) of the eight participants 
who had hypertension. Three (43%) of the six participants who presented with 
medically diagnosed obstructive sleep apnoea (OSA) made use of a continuous 
positive airway pressure device pre-surgery, which was discontinued by two at 12 
months post-surgery. Table 4.13 shows that two (40%) of five participants presented 
resolution of diabetes mellitus type 2, and three (38%) of eight presented resolution 
of hypertension.  
Table 4.14 presents data pertaining to change in sleep disordered breathing 
measured using the ApneaLinkTM. Figure 4.17 presents data collected at each 
assessment time point for sleep disordered breathing, expressed by the apnoea-
hypopnoea index (AHI). As these data were analysed using a negative binomial 
model due to the right skewed distribution, change estimates are reported as 
incidence rate ratios (IRR), which represent the proportional rather than absolute 
change between assessment time points. Compared to pre-surgery measures, 12 
months post-surgery, there was no change in the AHI (IRR, 0.45; 95% CI, 0.14 to 
1.41). 
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Table 4.13. Resolution in obesity-related comorbid conditions 
Obesity-related comorbid condition 
 
p-value 
Diabetes mellitus type 2 
 12 months post-surgery  
Pre-surgery Present Absent  
Present 3 2  
Absent 0 24 0.50 
Dyslipidaemia 
 12 months post-surgery  
Pre-surgery Present Absent  
Present 8 0  
Absent 0 21 > 0.99 
Hypertension 
 12 months post-surgery  
Pre-surgery Present Absent  
Present 5 3  
Absent 0 21 0.25 
Obstructive sleep apnoea 
 12 months post-surgery  
Pre-surgery Present Absent  
Present 6 0  
Absent 0 23 > 0.99 
All comparisons done using McNemar’s exact test.  
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Table 4.14. Change in sleep disordered breathing 
Assessment 
time point 
 
n 
Observed 
Median (IQR) 
Predicted 
Mean 
IRR 
(95%CI) 
p-value 
Sleep disordered breathing (apnoea-hypopnoea index [events/hour]) 
Pre-surgery 20 4.5 (2.5 - 9.0) 8 --- --- 
3 months 17 5.0 (2.0 - 6.0) 6 0.80 (0.54 to 1.18) 0.27 
6 months 11 4.0 (1.0 - 13.0) 7 1.15 (0.75 to 1.77) 0.50 
9 months 12 2.5 (1.0 - 4.5) 6 0.82 (0.50 to 1.36) 0.45 
12 months 10 4.0 (2.0 - 9.0) 3 0.58 (0.24 to 1.38) 0.22 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 0.45 (0.14 to 1.41) 0.17 
Abbreviations: CI: confidence interval; IQR: interquartile range. The model estimates mean 
and proportional change in the mean (expressed by the incidence rate ratio [IRR]) relative to 
the preceding assessment time point. All comparisons done using negative binomial model.  
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Figure 4.17. Data collected at each assessment time point for sleep disordered 
breathing, expressed by the apnoea-hypopnoea index (AHI). The pre-surgery 
assessment time point is denoted by 0 months. 
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4.1.10 Health-related quality of life, obesity-related quality of life and weight-
related symptoms 
This section provides data pertaining to change in measures of HRQoL and obesity-
related quality of life and weight-related symptoms collected pre-surgery, and 3, 6, 9 
and 12 months post-surgery in order to answer research question (iii). 
4.1.10.1 Health-related quality of life 
Table 4.15 presents data pertaining to change in physical and mental HRQoL 
measured using the component summaries of the Medical Outcomes Study Short 
Form 12 General Health Survey version 2 (SF-12v2). Figure 4.18 presents data 
collected at each assessment time point for physical and mental HRQoL, expressed 
by the scores of the component summaries of the SF-12v2, with the addition of plots 
for individual participants to depict individual variability. Compared to pre-surgery 
measures, 12 months post-surgery, there was an increase in physical HRQoL, 
measured using the physical component summary (PCS) of the SF-12v2 (mean 
change, 12.2; 95% CI, 8.5 to 15.9). Table 4.15 and Figure 4.18(A) show that the 
majority of change in physical HRQoL occurred in the first 3 months, and was 
maintained up to 12 months post-surgery. Compared to pre-surgery measures, 12 
months post-surgery, there was no change in mental HRQoL measured using the 
mental component summary (MCS) of the SF-12v2 (mean change, 3.4; 95% CI, -0.9 
to 7.6). Table 4.15 and Figure 4.18(B) show that there was a significant increase in 
mental HRQoL between the pre-surgery assessment and the 3-month post-surgery 
assessment (mean change, 5.1; 95% CI, 2.4 to 7.8), which was not maintained up to 
12 months post-surgery. Of note, at 12 months, the change in both PCS and MCS 
scores exceeded the minimal clinically important difference reported for these 
measures of 3 to 5 points (568, 569). 
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Table 4.15. Change in physical and mental health-related quality of life 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time 
point 
(95%CI) 
p-value 
Physical health-related quality of life (PCS score of the SF-12v2) 
Pre-surgery 30 43.2 (7.9) 43.2 --- --- 
3 months 30 52.5 (7.0) 52.5 9.3 (6.5 to 12.1) < 0.001 
6 months 29 51.7 (9.8) 51.7 -0.8 (-3.6 to 2.1) 0.59 
9 months 29 54.3 (5.9) 54.3 2.6 (-0.3 to 5.4) 0.07 
12 months 28 55.2 (6.4) 55.4 1.1 (-1.8 to 4.0) 0.47 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 12.2 (8.5 to 15.9) < 0.001 
Mental health-related quality of life (MCS score of the SF-12v2) 
Pre-surgery 30 47.1 (9.9) 47.1 --- --- 
3 months 30 52.2 (8.2) 52.2 5.1 (2.4 to 7.8) < 0.001 
6 months 29 51.1 (9.4) 51.1 -1.1 (-3.8 to 1.6) 0.42 
9 months 29 50.4 (10.0) 50.4 -0.7 (-3.4 to 2.0) 0.63 
12 months 28 50.8 (9.5) 50.5 0.0 (-2.7 to 2.8) 0.98 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 3.4 (-1 to 7.6) 0.11 
Abbreviations: CI: confidence interval; MCS: mental component summary; PCS: physical 
component summery; SD: standard deviation; SF-12v2: Medical Outcomes Study Short 
Form 12 General Health Survey version 2. All comparisons done using multilevel mixed-
effects linear regression model. At each assessment time point, data were presented as the 
estimate for each time point using all available information (i.e. using only those cases 
observed at that time point [observed mean] and including cases missing in that time point 
[predicted mean]). 
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Figure 4.18. Data collected at each assessment time point for (A) physical health-
related quality of life (HRQoL), measured using the physical component summary 
(PCS) of the Medical Outcomes Study Short Form 12 General Health Survey 
version 2 (SF-12v2) and (B) mental HRQoL, measured using the mental component 
summary (MCS) of the SF-12v2. The pre-surgery assessment time point is denoted 
by 0 months. 
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4.1.10.2 Obesity-related quality of life and weight-related symptoms 
Obesity-related quality of life was measured with two instruments: the Impact of 
Weight on Quality of Life Questionnaire (IWQOL-Lite) and the Obesity and Weight-
loss Quality-of-life Instrument (OWLQOL), while weight-related symptoms were 
measured using the Weight-related Symptoms Measure (WRSM). Table 4.16 
presents data pertaining to change in obesity-related quality of life, measured using 
the IWQOL-Lite. Figure 4.19 presents data collected at each assessment time point 
for obesity-related quality of life, expressed by the total score of the IWQOL-Lite, 
with the addition of plots for individual participants to depict individual variability. 
Compared to pre-surgery measures, 12 months post-surgery, there was an 
improvement in obesity-related quality of life measured using the total and domains’ 
scores of the IWQOL-Lite (total: mean change, 34.1; 95% CI, 28.1 to 40.0; physical 
function domain: mean change, 37.1; 95% CI, 30.3 to 44.0; self-esteem domain: 
mean change, 42.8; 95% CI, 33.0 to 52.6; sexual life domain: mean change, 27.6; 
95% CI, 17.2 to 38.1; public distress domain: mean change, 29.1; 95% CI, 21.1 to 
37.1; work domain: mean change, 22.7; 95% CI, 17.0 to 28.5). Table 4.16 and 
Figure 4.19 show that the majority of change in obesity-related quality of life 
occurred in the first 3 months, with the total score demonstrating smaller changes at 
6 and 9 months, which were maintained up to 12 months post-surgery. Of note, at 
12 months, the change in the total score of the IWQOL-Lite exceeded the minimal 
clinically important difference reported for this measure of 12 points (574). 
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Table 4.16. Change in obesity-related quality of life 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time point 
(95%CI) 
p-value 
Total score of the IWQOL_Lite 
Pre-surgery 30 56.3 (15.7) 56.3 --- --- 
3 months 30 79.5 (19.8) 79.5 23.3 (19.9 to 26.7) < 0.001 
6 months 29 84.4 (17.7) 84.5 5.0 (1.5 to 8.4) 0.005 
9 months 29 89.1 (13.0) 89.2 4.7 (1.2 to 8.2) 0.008 
12 months 28 90.1 (12.8) 90.3 1.1 (-2.4 to 4.6) 0.54 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 34.1 (28.1 to 40.0) < 0.001 
Physical function domain score of the IWQOL_Lite 
Pre-surgery 30 54.5 (19.4) 54.5 --- --- 
3 months 30 84.1 (21.3) 84.1 29.5 (25.5 to 33.6) < 0.001 
6 months 29 87.5 (14.6) 87.9 3.8 (-0.4 to 7.9) 0.07 
9 months 29 90.6 (12.2) 91.0 3.0 (-1.1 to 7.2) 0.15 
12 months 28 91.2 (12.5) 91.7 0.8 (-3.4 to 5.0) 0.72 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 37.1 (30.3 to 44.0) < 0.001 
Self-esteem domain score of the IWQOL_Lite 
Pre-surgery 30 41.7 (23.8) 41.7 --- --- 
3 months 30 68.2 (23.9) 68.2 26.5 (20.3 to 32.8) < 0.001 
6 months 29 76.5 (24.4) 76.6 8.4 (2.0 to 14.8) 0.010 
9 months 29 84.5 (17.2) 84.6 8.0 (1.6 to 14.3) 0.015 
12 months 28 84.4 (16.9) 84.4 -0.1 (-6.6 to 6.4) 0.96 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 42.8 (33.0 to 52.6) < 0.001 
 continues next page 
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Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time point 
(95%CI) 
p-value 
Sexual life domain score of the IWQOL_Lite 
Pre-surgery 30 61.5 (27.5) 61.5 --- --- 
3 months 30 74.4 (26.8) 74.4 12.9 (6.6 to 19.3) < 0.001 
6 months 29 80.4 (25.5) 79.8 5.4 (-1.0 to 11.8) 0.09 
9 months 29 86.9 (23.3) 86.4 6.6 (0.2 to 13.1) 0.043 
12 months 28 89.1 (18.2) 89.1 2.7 (-3.9 to 9.2) 0.42 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 27.6 (17.2 to 38.1) < 0.001 
Public distress domain score of the IWQOL_Lite 
Pre-surgery 30 65.0 (21.3) 65.0 --- --- 
3 months 30 83.3 (20.9) 83.3 18.3 (13.5 to 23.2) < 0.001 
6 months 29 87.8 (23.5) 88.0 4.7 (-0.2 to 9.7) 0.06 
9 months 29 90.9 (15.9) 91.1 3.0 (-1.9 to 8.0) 0.23 
12 months 28 93.8 (11.1) 94.1 3.1 (-2.0 to 8.1) 0.23 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 29.1 (21.1 to 37.1) < 0.001 
Work domain score of the IWQOL_Lite 
Pre-surgery 30 70.4 (20.7) 70.4 --- --- 
3 months 30 87.3 (20.1) 87.3 16.9 (13.8 to 19.9) < 0.001 
6 months 29 89.4 (20.1) 89.3 2.0 (-1.2 to 5.1) 0.21 
9 months 29 93.3 (15.0) 93.2 3.9 (0.8 to 7.0) 0.014 
12 months 28 93.1 (15.4) 93.1 -0.0 (-3.2 to 3.2) 0.99 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 22.7 (17.0 to 28.5) < 0.001 
Abbreviations: CI: confidence interval; IWQOL-Lite: short version of the Impact of Weight on 
Quality of Life Questionnaire; SD: standard deviation. All comparisons done using multilevel 
mixed-effects linear regression model. At each assessment time point, data were presented 
as the estimate for each time point using all available information (i.e. using only those cases 
observed at that time point [observed mean] and including cases missing in that time point 
[predicted mean]). 
Chapter 4: Study 1 - Results and discussion 
148 
 
 
Figure 4.19. Data collected at each assessment time point for obesity-related 
quality of life (QoL), expressed by the total score of the short version of the Impact 
of Weight on Quality of Life Questionnaire (IWQOL-Lite). The pre-surgery 
assessment time point is denoted by 0 months. 
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Table 4.17 presents data pertaining to change in obesity-related quality of life and 
weight-related symptoms, measured using the OWLQOL and WRSM, respectively. 
Figure 4.20 presents data collected at each assessment time point for obesity-
related quality of life, expressed by the OWLQOL score, and weight-related 
symptoms, expressed by the WRSM score, with the addition of plots for individual 
participants to depict individual variability. Compared to pre-surgery measures, 12 
months post-surgery, there was an improvement in obesity-related quality of life 
(mean change, 42.8; 95% CI, 34.0 to 51.5) and a reduction in weight-related 
symptoms (mean change, -23.7; 95% CI, -29.6 to -17.8). Table 4.17 and Figure 4.20 
show that the majority of change in obesity-related quality of life and in weight-
related symptoms occurred in the first 3 months, with smaller changes up to 6 
months, which were maintained up to 12 months post-surgery.  
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Table 4.17. Change in obesity-related quality of life and weight-related symptoms 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time point 
(95%CI) 
p-value 
Obesity-related quality of life (OWLQOL score) 
Pre-surgery 30 38.5 (17.0) 38.5 --- --- 
3 months 30 68.8 (23.8) 68.8 30.3 (24.8 to 35.8) < 0.001 
6 months 29 76.4 (21.0) 76.6 7.8 (2.2 to 13.4) 0.006 
9 months 29 80.9 (17.7) 81.0 4.5 (-1.1 to 10.1) 0.11 
12 months 28 81.3 (19.0) 81.2 0.2 (-5.5 to 5.9) 0.95 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 42.8 (34.0 to 51.5) < 0.001 
Weight-related symptoms (WRSM score) 
Pre-surgery 30 33.4 (16.8) 33.4 --- --- 
3 months 30 16.0 (15.0) 16.0 -17.4 (-21.0 to -13.7) < 0.001 
6 months 29 11.4 (11.2) 11.8 -4.2 (-7.9 to -0.5) 0.026 
9 months 29 11.6 (12.4) 11.8 -0.0 (-3.7 to 3.7) 0.99 
12 months 28 9.6 (10.1) 9.7 -2.1 (-5.9 to 1.6) 0.26 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -23.7 (-29.6 to -17.8) < 0.001 
Abbreviations: CI: confidence interval; OWLQOL: Obesity and Weight-loss Quality-of-life 
Instrument; SD: standard deviation; WRSM: Weight-related Symptoms Measure. All 
comparisons done using multilevel mixed-effects linear regression model. At each 
assessment time point, data were presented as the estimate for each time point using all 
available information (i.e. using only those cases observed at that time point [observed 
mean] and including cases missing in that time point [predicted mean]).  
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Figure 4.20. Data collected at each assessment time point for (A) obesity-related 
quality of life (QoL), expressed by the score of the OWLQOL, and (B) weight-related 
symptoms, expressed by the score of the WRSM. The pre-surgery assessment time 
point is denoted by 0 months. 
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4.1.11 Mental health 
This section provides data pertaining to change in measures of symptoms of 
depression, anxiety and stress collected pre-surgery, and 3, 6, 9 and 12 months 
post-surgery in order to answer research question (iii). Symptoms of depression 
were measured using the Beck Depression Inventory (BDI), and symptoms of 
depression, anxiety and stress were measured using the Depression Anxiety Stress 
Scales (DASS-21). Table 4.18 presents data pertaining to change in symptoms of 
depression measured using the BDI. Figure 4.21 presents data collected at each 
assessment time point for symptoms of depression, expressed by the BDI score, 
with the addition of plots for individual participants to depict individual variability. 
Compared to pre-surgery measures, 12 months post-surgery, there was a reduction 
in symptoms of depression (mean change, -7.7; 95% CI, -10.4 to -5.1). Table 4.18 
and Figure 4.21 show that the majority of change in symptoms of depression 
occurred in the first 3 months, and was maintained up to 12 months post-surgery. Of 
note, at 12 months, the change in the BDI score exceeded the minimal clinically 
important difference reported for this measure (i.e. change > 17.5% of the pre-
surgery BDI score) (593). 
Table 4.19 presents data pertaining to change in symptoms of depression, anxiety 
and stress, measured using the subscales of the DASS-21. Figures 4.22 to 4.24 
present data collected at each assessment time point for symptoms of depression, 
anxiety, and stress, measured using the subscales of the DASS-21, with the 
addition of plots for individual participants to depict individual variability. As these 
data were analysed using a negative binomial model due to the right skewed 
distribution, change estimates are reported as IRRs. Compared to pre-surgery 
measures, 12 months post-surgery, there was a 44% reduction in symptoms of 
depression, 54% reduction in symptoms of anxiety, and 39% reduction in symptoms 
of stress. Table 4.19 and Figures 4.22 to 4.24 show that the majority of change in 
symptoms of depression, anxiety and stress occurred in the first 3 months, and was 
maintained up to 12 months post-surgery.  
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Table 4.18. Change in symptoms of depression 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change from 
preceding time point 
(95%CI) 
p-value 
Symptoms of depression (Beck Depression Inventory score) 
Pre-surgery 30 12.4 (7.5) 12.4 --- --- 
3 months 30 6.6 (5.9) 6.6 -5.8 (-7.3 to -4.2) < 0.001 
6 months 29 6.2 (6.7) 6.2 -0.4 (-2.0 to 1.2) 0.64 
9 months 29 5.0 (6.0) 5.0 -1.3 (-2.9 to 0.3) 0.11 
12 months 28 4.6 (5.4) 4.6 -0.3 (-1.9 to 1.3) 0.69 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -7.7 (-10.4 to -5.1) < 0.001 
Abbreviations: CI: confidence interval; SD: standard deviation. All comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available informat ion (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]). 
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Figure 4.21. Data collected at each assessment time point for symptoms of 
depression, expressed by the score of the Beck Depression Inventory (BDI). The 
pre-surgery assessment time point is denoted by 0 months. 
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Table 4.19. Change in symptoms of depression, anxiety and stress 
Assessment 
time point 
 
n 
Observed 
Median (IQR) 
Predicted 
Mean 
IRR 
(95%CI) 
p-value 
Symptoms of depression (depression subscale of the DASS-21) 
Pre-surgery 30 3.0 (0 - 7.0) 4.9 --- --- 
3 months 30 1.0 (0 - 3.0) 2.3 0.47 (0.33 to 0.68) < 0.001 
6 months 29 2.0 (0 - 4.0) 3.2 1.38 (0.96 to 1.97) 0.07 
9 months 29 1.0 (0 - 4.0) 2.9 0.90 (0.64 to 1.25) 0.53 
12 months 28 1.0 (0 - 4.0) 2.8 0.95 (0.67 to 1.35) 0.79 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 0.56 (0.32 to 0.97) 0.040 
Symptoms of anxiety (anxiety subscale of the DASS-21) 
Pre-surgery 30 3.0 (1.0 - 6.0) 3.6 --- --- 
3 months 30 1.0 (0 - 2.0) 1.7 0.45 (0.32 to 0.65) < 0.001 
6 months 29 1.0 (0 - 2.0) 1.8 1.05 (0.72 to 1.54) 0.78 
9 months 29 1.0 (0 - 2.0) 1.7 0.95 (0.65 to 1.47) 0.81 
12 months 28 1.0 (0 - 2.0) 1.7 0.99 (0.67 to 1.47) 0.99 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 0.46 (0.26 to 0.79) 0.006 
Symptoms of stress (stress subscale of the DASS-21) 
Pre-surgery 30 6.0 (3.0 - 11.0) 6.8 --- --- 
3 months 30 5.0 (1.0 - 7.0 4.6 0.67 (0.52 to 0.85) 0.001 
6 months 29 4.0 (1.0 - 6.0) 4.6 1.0 (0.77 to 1.30) 0.97 
9 months 29 2.0 (1.0 - 6.0) 4.3 0.94 (0.71 to 1.23) 0.65 
12 months 28 4.0 (1.0 - 6.5) 4.2 0.96 (0.73 to 1.27) 0.81 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 0.61 (0.41 to 0.91) 0.017 
Abbreviations: CI: confidence interval; DASS-21: Depression Anxiety Stress Scales; IQR: 
interquartile range. The model estimates mean and proportional change in the mean 
(expressed by the incidence rate ratio [IRR]) relative to the preceding assessment time point. 
All comparisons done using negative binomial model.  
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Figure 4.22. Data collected at each assessment time point for symptoms of 
depression, expressed by the score of the depression subscale of the Depression 
Anxiety Stress Scales (DASS-21_D). The pre-surgery assessment time point is 
denoted by 0 months. 
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Figure 4.23. Data collected at each assessment time point for symptoms of anxiety, 
expressed by the score of the anxiety subscale of the Depression Anxiety Stress 
Scales (DASS-21_A). The pre-surgery assessment time point is denoted by 0 
months. 
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Figure 4.24. Data collected at each assessment time point for symptoms of stress, 
expressed by the score of the stress subscale of the Depression Anxiety Stress 
Scales (DASS-21_S). The pre-surgery assessment time point is denoted by 0 
months. 
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4.2 Discussion 
This study is the first to collect detailed measures of PA and SB both pre-surgery 
and every 3 months up to 12 months post-surgery in a group of adults who 
underwent restrictive bariatric surgery. These data demonstrated that, when 
compared to pre-surgery measures, there were no changes in measures of PA and 
SB in the first 12 months post-surgery. This occurred despite the fact that 
participants demonstrated large and significant reductions in weight-related 
measures that were consistent with the weight loss expected and previously 
described following LAGB and LSG (131-135). At all assessment time points, 
participants spent over 70% of their waking hours in SB, which was mostly 
accumulated in prolonged uninterrupted bouts ≥ 30 minutes, and only 5% of their 
waking hours in MVPA, which was mostly accumulated in very short bouts < 10 
minutes. Additionally, the data showed that the little time participants spent in PA 
was mostly accumulated in short bouts of light intensity PA. Consistent with these 
findings was the lack of change in cardiovascular fitness. The lack of change in 
measures of PA, SB and cardiovascular fitness also occurred despite a significant 
improvement in participants’ self-efficacy to exercise. Further, this study collected 
data pertaining to changes in body composition, measured using DXA. These data 
showed that the substantial weight loss achieved post-surgery was accompanied by 
an expected and desirable reduction in FM, as well as by an undesirable reduction 
in FFM. For those outcomes in which surgery produced a significant effect, the 
majority of change was observed in the first 3 months, with less, if any change 
between 6 and 12 months post-surgery.  
Data collected in this study revealed no change in measures of PA and SB collected 
over the first 12 months post-surgery. Specifically, pre-surgery and at all 
assessment time points post-surgery, participants spent most (> 70% or > 638 
minutes/day) of their waking hours in SB, little (around 20% or 209 minutes/day) of 
their waking hours in light intensity PA and almost none (around 5% or 54 
minutes/day) of their waking hours in MVPA. There was also no change in 
participants’ daily step count. The persistent minimal participation in MVPA is 
consistent with the lack of change in cardiovascular fitness following surgery shown 
in this study, and by others (83, 84). That is, following surgery, in order for 
participants to demonstrate a reduction in heart rate at a given work rate, and 
improve their performance on the PWC-170, the contribution stroke volume makes 
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to cardiac output at similar work rates would need to increase. For such changes to 
occur following bariatric surgery, participants would need to have increased their 
participation in purposeful exercise, which would, in turn, have been captured as an 
increased participation in MVPA and/or daily step count (594). The lack of change in 
measures of PA and SB is generally consistent with earlier research of people at 6 
and 9 months following gastric bypass (5, 8, 9). The present study has extended the 
current knowledge by providing robust data, collected using two state-of-the-art 
devices, over multiple time points during the first 12 months following restrictive 
bariatric surgery, which demonstrates that despite substantial weight loss, and low 
prevalence of obesity-related comorbid conditions, restrictive bariatric surgery did 
not change participation in PA and SB. There is, however, previous work arising 
from a large multicentre study of people who underwent different types of bariatric 
surgery (mostly gastric bypass) which reported small but significant favourable 
changes in time spent in SB and MVPA at 12 months post-surgery, measured using 
the SAM (6, 7). The contrasting findings between this earlier work and the present 
study could be explained by possible differences regarding advice to increase 
participation in PA between the different centres, which was not recorded or 
controlled for in these studies.  
Findings from a previous study of people who underwent bariatric surgery (RYGB = 
214, LAGB = 67, other = 29) have shown that, at 12 months post-surgery, a 10% 
greater weight loss was independently associated with a significantly higher 
increase in min/week during which high cadence walking was recorded, but not 
number of steps/day or active min/day, adjusted for surgery type (21 min/week; p = 
0.01; no CIs provided) (6). The only statistically significant association found in the 
present study was between less steps/day with more weight loss. This finding, and 
the lack of association of any other measure of PA and SB with weight loss or type 
of surgery may be a result of the small sample size available for analysis and the 
small and nonsignificant change in measures of PA and SB, therefore definitive 
conclusions of association between weight loss and measures of PA and SB cannot 
be drawn from these results. 
This study is the first to demonstrate that, when compared to pre-surgery measures, 
the way SB and MVPA were accumulated was similar at all post-surgery 
assessment time points. At all assessment time points, most of the time participants 
spent in SB (≥ 78%) was accumulated in uninterrupted bouts of ≥ 10 minutes and 
over 50% of the time participants spent in SB was accumulated in uninterrupted 
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bouts ≥ 30 minutes. This finding is of importance, as SB, especially that which is 
accumulated in prolonged uninterrupted periods, has been associated with poorer 
metabolic health (53, 439, 488). This association may be explained by the skeletal 
muscle’s impaired ability to metabolise triglycerides and glucose caused by a 
reduction in skeletal muscle lipoprotein lipase activity that occurs in response to 
prolonged periods of SB (70, 595, 596). This reduction in skeletal muscle lipoprotein 
lipase activity contributes to increased cardiovascular risk by increasing plasma 
triglycerides and glucose levels, and inducing oxidative stress and systemic 
inflammation. The findings from the present study also showed that, at all 
assessment time points, the little time participants spent in MVPA was mostly (> 
80%) accumulated in short bouts of < 10 minutes. This finding is important since the 
reduction in cardiometabolic risk associated with MVPA is likely to be dependent on 
prolonged exposure to MVPA, which results in improvements in flow-mediated 
endothelial function (50). Although there are no data to show the minimum bout 
duration of MVPA needed to condition the endothelium, current international 
guidelines pertaining to the amount of MVPA needed to produce health benefits 
states that MVPA should be accumulated in bouts of at least 10 minutes (50). These 
data supports findings from previous studies that reported the majority of people, 
both pre- and post-bariatric surgery, do not engage in sufficient bout-related MVPA 
in order to meet international guidelines for the development and maintenance of 
health (5-9).  
When compared to pre-surgery measures, there was a significant improvement in 
self-efficacy to exercise measured at 12 months post-surgery. The lack of change in 
measures of PA and SB was somewhat surprising given this significant 
improvement in self-efficacy to exercise, which has been recognised as an important 
determinant of change in PA behaviour (74). This suggests that post-surgery factors 
other than participation in PA, such as greater ease of movement due to a reduction 
in physical limitations, led to participants perceiving they were more able to engage 
in PA or exercise. The fact that the improvement in self-efficacy to exercise found in 
the present study did not translate into actual change in PA behaviour supports the 
concept of PA behaviour being determined by multiple factors (74, 597), and 
suggests that there might be other factors relevant to PA behaviour that were not 
changed post-surgery and need to be addressed in order to optimise post-surgery 
participation in PA.  
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Regarding changes in measures of sleep quality and daytime sleepiness, the 
current study demonstrated that when compared to pre-surgery measures, there 
were significant improvements over the first 12 months post-surgery. These 
improvements appeared to follow the same pattern of change seen for weight-
related measures, and at 12 months post-surgery, participants presented good 
sleep quality (PSQI score < 5) and no symptoms of excessive daytime sleepiness 
(ESS score < 10). Although the magnitude of change in measures of sleep quality 
and daytime sleepiness found in this study is in accordance to previous reports (93, 
95, 96, 368), findings from the present study indicated that improved sleep quality 
and daytime sleepiness do not seem to result in enhanced participation in PA and 
SB. 
Regarding changes in body composition and BMD, this study demonstrated that 
when compared to pre-surgery measures, there were significant reductions in FM 
and FFM, as well as in regional measures of BMD collected at 12 months post-
surgery. These data are important and novel as to date, research that has explored 
measures of body composition following restrictive bariatric surgery have mostly 
used measurement methods known to have considerable error (i.e. bioelectrical 
impedance analysis) and those which have used DXA have focused exclusively on 
people who underwent LAGB and were limited to samples comprised only of women 
(99-104). Although the magnitude of reduction in FM, FFM and BMD seen in this 
study is consistent with earlier studies that have used DXA, the present study 
findings were derived from a sample that included LAGB and LSG with 
representation from both genders, and are therefore likely to be of greater relevance 
to most bariatric practices. While the reduction in FM is an expected and desirable 
outcome of bariatric surgery, the concomitant reduction in FFM is an undesirable 
consequence of the surgery. This is because decreased muscle mass, which is a 
component of FFM, has been associated with limitations in mobility and increased 
risk of falls, particularly among older adults (114, 115). These findings suggest that 
PA or exercise interventions, particularly resistance training, might be needed in 
order to preserve FFM during the period of rapid weight loss that occurs over the 
first few months post-surgery (119). Although there were small reductions in regional 
measures of BMD, they do not appear to be of great importance, since no changes 
were found in measures of total body BMD and total body T-scores post-surgery. 
However, clinicians should be aware of changes in regional measures of BMD, 
particularly among people who are at risk of, or diagnosed with, osteoporosis (e.g. 
post-menopausal women). 
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Pre-surgery, participants presented impaired physical and mental HRQoL, 
confirmed by a range of validated generic and obesity-related quality of life 
instruments (566, 574). Findings from the present study support previous reports of 
significant and clinically important improvements in HRQoL following restrictive 
bariatric surgery, mainly in physical domains and obesity-related measures, (95, 
129, 154, 155, 160, 162, 163, 165-167, 170, 174, 175). At 12 months post-surgery, 
participants’ generic and obesity-related quality of life was comparable to the 
general population (566, 574). Similar to measures of HRQoL, our findings showed 
that when compared to pre-surgery measures, there was a significant reduction in 
weight-related symptoms. This study is the first to demonstrate that the 
improvement in measures of generic and obesity-related quality of life and weight-
related symptoms appears to follow the same pattern of change as measures 
related to weight, and suggest improved HRQoL does not seem to result in 
enhanced participation in PA and SB. 
Regarding symptoms of mental health disorders, pre-surgery, participants had mild 
symptoms of depression, anxiety and stress, recorded using two validated 
measures. The mean scores for the sample pre-surgery for each of these measures 
were greater than general population normative values (598). The present study 
also supports previous reports of significant and clinically important improvements in 
symptoms of depression, anxiety and stress following restrictive bariatric surgery 
(94, 154, 156, 162, 167, 168, 181, 185, 186, 188). The improvement over the first 12 
months post-surgery resulted in participants presenting with similar or lower 
symptoms of depression and anxiety when compared to the general population at 
the time of the final assessment (598). Further, our findings showed that the 
improvement in symptoms of mental health disorders appears to follow the same 
pattern of change of measures related to weight, and suggest the reduced 
symptoms of depression, anxiety and stress do not seem to aid with optimising PA 
and SB. 
Clinical messages 
This study has demonstrated that, when compared to pre-surgery measures, there 
was no change in the amount of time participants engaged in PA and SB in the first 
12 months following restrictive bariatric surgery. Additionally, estimates of the way in 
which PA and SB were accumulated were similar at all assessment time points. Of 
note, 12 months post-surgery, when compared to objective measures collected in 
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the general adult population, the average daily step count was somewhat lower 
(8,871 versus 9,676 steps/day), and the amount of time spent in SB was greater 
(73% versus 56% of waking hours) (41, 599). Although caution is needed when 
comparing estimates of PA and SB as these studies used different activity monitors 
and applied different criteria to include monitor data in their analyses, these 
comparisons with data available in the general population suggest that people who 
undergo restrictive bariatric surgery are at a higher risk of the detrimental health 
effects associated with little PA and increased time in SB. Addressing PA following 
bariatric surgery is also likely to be important as participation in low levels of PA has 
been reported as an important contributing factor to weight regain post-surgery 
(600-603). 
This study highlights the potential importance of the involvement of a multi-
disciplinary team in this clinical population to increase PA and reduce SB. 
Specifically, the data suggest that substantial weight loss, large improvements in 
self-efficacy to exercise and HRQoL, as well as large reductions in symptoms of 
mental health disorders and weight-related symptoms were not sufficient to induce a 
health behaviour change of increased participation in PA and reduced SB. It is likely 
that in order to change PA, a behavioural intervention which targets motivation, self-
efficacy, problem solving, goal setting and commitment to behaviour change is 
required (75, 604, 605). Such an approach has been shown to produce greater 
short-term improvements in objective measures of MVPA pre-surgery, when 
compared to standard care (34). In order to develop such an intervention, further 
investigation is needed of specific factors related to PA (e.g. perceived barriers, 
facilitators and motivators to PA) among people who undergo restrictive bariatric 
surgery. 
Regarding goal setting, the present study demonstrated that most of participants’ PA 
was performed at a light intensity rather than moderate to vigorous intensity. 
Therefore, it is likely that targeting an increase in light intensity PA, as an initial step, 
may assist with both reducing SB and also serve as a gateway to increased 
participation in MVPA. Earlier research in overweight Australian adults has shown 
that there is an almost perfect inverse relationship between light intensity PA and SB 
(46). Therefore, aiming to increase participation in light intensity PA, rather than 
MVPA, is most likely to reduce time spent in SB. This is particularly relevant given 
the recent data which demonstrated the beneficial associations of light intensity PA 
with cardiometabolic risk factors and the health benefits of interrupting SB with short 
Chapter 4: Study 1 - Results and discussion 
165 
 
bouts of light intensity PA (46, 48, 70). For instance, a recent study of adults in the 
general population has shown that replacing time spent in SB with time in light 
intensity PA produced significant favourable effects on measures of insulin, insulin 
resistance and triglycerides (48). Further, targeting to replace SB with light intensity 
PA in this population could influence the amount of time people engage in MVPA, as 
demonstrated by previous studies of women and older adults who are obese, with 
significant reductions in time spent in SB and improvements in time spent in light 
intensity PA and MVPA following interventions aimed at reducing SB (606, 607). 
Behavioural interventions are more likely to produce greater effects when they 
initially target feasible changes in PA (75, 608-610). This is because promoting 
feasible changes and achievable goals are more likely to increase people’s self-
efficacy to progress to more challenging activities.  
This study is the first to investigate the pattern of change in several outcomes 
following restrictive bariatric surgery. For those outcomes which improved 
significantly after surgery, the majority of change occurred in the first 3 months, with 
less or no change between 6 and 12 months following surgery. This provides 
information for patients, which is helpful in the formation of realistic expectations for 
the post-surgical period. Further, this information can inform optimal post-surgical 
management and timing for interventions aimed at promoting change in PA 
behaviour. For example, the optimal time to introduce a post-surgery intervention 
aimed at increasing participation in PA appears to be after the first 3 to 6 months 
post-surgery, when the majority of weight loss and improvement in outcomes that 
may be related to engagement in PA, such as self-efficacy to exercise, sleep quality 
and daytime sleepiness, has occurred.  
Strengths and limitations 
The main strength of this study pertains to the assessment of objective measures of 
PA and SB at multiple time points over the first 12 months following restrictive 
bariatric surgery using two state-of-the-art, highly sensitive monitors that provided 
robust complementary data. Further, the use of a complex and comprehensive 
analysis plan, with strict criteria for inclusion of monitor data and the use of exposure 
variation analysis strengthened the PA and SB findings. Other strengths of the 
current study include the investigation of changes in outcomes which have not yet 
been extensively investigated and which are likely to influence changes in measures 
of PA and SB (e.g. self-efficacy to exercise, cardiovascular fitness, sleep quality and 
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daytime sleepiness). This study is also the first to investigate a large range of 
important outcomes at multiple time points post-surgery and to demonstrate that, for 
all outcomes in which restrictive bariatric surgery promoted a significant effect, the 
changes followed a similar pattern to weight loss. Finally, for most outcome 
measures collected in this study there was minimal loss to follow up, and the use of 
multiple time points combined with multilevel mixed effects model limited bias of 
estimates at assessment time points with missing data.  
Limitations of the present study include the fact that the sample was comprised of 
people who attended a private practice, which may limit the generalisability of the 
findings to people who undergo bariatric surgery through the public health system or 
who have low socio-economic status. Additionally, there was a large number of 
eligible participants who were not willing to participate in the study, which may also 
affect the generalisability of the findings, given these people might have different PA 
and SB levels when compared to those who participated in the study. Since people 
who presented with any permanent health condition that could compromise the 
performance of daily PA were excluded from the study, the findings from this study 
do not extend to this specific group of people. The interpretation of data pertaining to 
change in measures of obesity-related comorbid conditions was influenced by a low 
prevalence of such conditions in this sample. However, the findings of this study 
with regard to weight-related measures are consistent with previous reports (121-
130). This confirms the efficacy of restrictive surgery for weight loss was as 
expected, and thus the effect (or lack thereof) of this surgery on other outcomes 
occurred in the context of the large degree of weight loss which results from 
restrictive bariatric procedures. This, combined with similar characteristics in terms 
of age, gender and BMI when compared to samples from other studies, increases 
the external validity of the findings of the present study. The fact that the majority of 
change in those outcomes which improved significantly post-surgery followed a 
similar pattern of change to measures related to weight supports the association 
between change in these measures with magnitude of weight loss, as previously 
reported (93, 104, 113, 138, 160, 167, 381).  
Although the comparison of changes in the primary outcome measures with 
participants grouped according to the type of surgery was not one of the aims of this 
study, further analysis showed no evidence of differences in the change in 
measures of PA and SB between those participants who underwent LSG and LAGB. 
These results should be interpreted with caution due to the small sample size of this 
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study, and future studies with larger samples should aim to investigate differences in 
the change in objective measures of PA and SB between people who undergo LSG 
and LAGB. This study, however, had enough statistical power to compare changes 
in weight-related measures with participants grouped according to type of surgery, 
which again confirmed that the weight loss following each restrictive procedure 
occurred similarly to previous reports (121-130). The comparison of changes in 
secondary outcomes other than weight-related measures (e.g. cardiovascular 
fitness, self-efficacy to exercise, sleep quality, daytime sleepiness, HRQoL and 
symptoms of mental health disorders) between groups according to the type of 
surgery was limited by the small number of participants who underwent LAGB (n = 
8), when compared to those who underwent LSG (n = 22).  
In conclusion, this study demonstrated no change in objective measures of PA and 
SB following restrictive bariatric surgery, despite substantial and significant weight 
loss, as well as significant improvements in several outcomes that could influence 
PA behaviour. These findings highlight the need for further investigation of specific 
factors related to PA behaviour among people who undergo restrictive bariatric 
surgery, as it appears restrictive bariatric surgery itself is not sufficient to effect 
change in measures of PA and SB.  
 
Chapter 5: Study 2(A) – Results and discussion 
168 
 
CHAPTER 5 STUDY 2(A) – RESULTS AND DISCUSSION 
Overview 
This chapter presents data pertaining to Study 2. The methods relating to this study, 
including the description of study design, inclusion and exclusion criteria, 
recruitment process, interview schedule, and data analyses have been described in 
Chapter 3 (section 3.2 Study 2). Section 5.1 describes the study participants and 
present data pertaining to the pre-surgery qualitative exploration. Section 5.2 
discusses the results presented for the pre-surgery qualitative exploration. The data 
presented in this chapter has been published in the Obesity Surgery Journal in 2015 
(611).  
The specific research question answered in this chapter is: prior to restrictive 
bariatric surgery, what are participants’ beliefs about PA, and perceived barriers and 
facilitators to physical activity (PA)? 
5.1 Results 
5.1.1 Participants 
Between January 2013 to July 2013, a total of 108 people who were obese and 
scheduled to undergo restrictive bariatric surgery were screened to participate in this 
study, of whom 70 (65%) were considered eligible. Twenty-three of the 70 eligible 
people agreed to participate, four of them withdrew before the pre-surgery interview, 
and 19 (27%) provided written informed consent and were included in the study. A 
study flowchart is provided in Figure 5.1.  
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Figure 5.1. Study 2 flowchart. 
 
Potential participants screened  
n = 108 
Did not consent to be contacted: 
• Not interested  
            n = 40 
• Undecided about surgery  
            n = 7 
Not eligible: 
• Had previous bariatric surgery  
            n = 28 
• Cognitive impairment  
            n = 2 
• Language barrier  
            n = 1 
• Physical activity affected by 
comorbid conditions  
            n = 7 
Included in the study and completed  
pre-surgery interview 
n = 19 
Withdrew before pre-surgery interview 
n = 4 
Consented to participate 
n = 23 
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The characteristics of participants at the pre-surgery interview are presented in 
Table 5.1. Pre-surgery, the mean age of participants was 41.6 years (range, 19 - 
66), weight was 119.2 kg (range, 92.8 - 182.2) and body mass index was 41.6 kg/m2 
(range, 30.0 - 54.2). Participants were interviewed, on average, within one month 
prior to their surgery. Interviews lasted for an average of 30.6 minutes (standard 
deviation, 12.5). According to participant preference, five (26%) interviews were 
conducted in a research room at Curtin University and 14 (74%) at the bariatric 
surgery practice rooms.
Chapter 5: Study 2(A) – Results and discussion 
171 
 
Table 5.1. Characteristics of participants at the pre-surgery interview 
Code Sex 
Age  
(years) 
Weight  
(kg) 
BMI  
(kg/m2) 
Marital 
Status 
Occupation 
P1 M 63 115.5 34.5 Married Manager 
P2 M 38 130.0 39.2 Married Draftsman 
P3 F 47 114.0 36.8 Married Business Manager 
P4 F 36 106.0 38.5 Married Nanny 
P5 F 39 92.8 30.3 Married Office Manager 
P6 F 37 100.8 38.4 Married Function Planner 
P7 F 43 93.7 34.8 Married House worker 
P8 F 19 123.8 38.6 Single Student 
P9 F 41 144.0 54.2 Married House worker 
P10 M 66 128.0 42.3 Separated Entrepreneur 
P11 F 32 116.6 42.3 Single Cost Manager 
P12 F 47 125.0 51.4 Single Research Assistant 
P13 F 24 124.4 44.6 Single Post Office Agent 
P14 F 39 106.3 40.5 Single Nurse 
P15 F 50 102.9 37.8 Married Caterer 
P16 F 35 104.4 37.0 Married Student 
P17 F 29 127.6 46.9 Single 
Anaesthetic 
Technician 
P18 F 50 125.9 48.6 Married House worker 
P19 M 55 182.2 53.8 Married Office Manager 
Abbreviations: BMI: body mass index; F: female; M: male. 
 
Chapter 5: Study 2(A) – Results and discussion 
172 
 
5.1.2 Categories and emergent themes 
Data collection and analysis continued until data saturation was achieved, that is, 
the inclusion of further participants would not alter the main emergent themes (i.e. 
repetition in key content of themes). Three broader categories were explored in the 
pre-surgery interviews: beliefs about PA, perceived barriers to PA, and perceived 
facilitators to PA. The term perceived was used to convey the factors participants 
believe they experienced or could experience, regardless of whether or not 
participants truly experienced them.  
The emergent themes reflecting the broader categories explored in the pre-surgery 
interviews are presented in Figure 5.2. The description of the emergent themes and 
supporting quotes are presented in the following sections. Additional supporting 
quotes are presented in Appendix 9. 
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Figure 5.2. Categories and emergent themes from the pre-surgery interview. 
 
Chapter 5: Study 2(A) – Results and discussion 
174 
 
5.1.2.1 Beliefs about physical activity 
Participants were asked to report their beliefs regarding what it means to be 
physically active and the health benefits of participation in regular PA.  
Comprehensive benefits. All participants reported that they believed participating in 
regular PA resulted in health benefits, which were largely related to the maintenance 
of physical health and wellbeing. These beliefs included the influence of PA on 
mobility, strength and flexibility (P2, P12). 
‘I would say you know, core strength as well as also flexibility…that is 
something I’ve noticed I’ve really gone downhill with, is my flexibility. 
Umm…yeah, everything from heart, lungs, VO2max through to blood 
pressure…vitamin deficiencies, just being inside, indoors instead of 
outdoors.’ (P2) 
‘Oh, the fact that it keeps all your joints moving. It keeps you all limbered 
up. Your joints all going in the right direction.’ (P12) 
Participants also reported the beneficial influence of PA on fitness and weight 
management (P5, P8, P17). 
 ‘You drop your weight.’ (P5) 
‘Like losing weight or even just toning up.’ (P8)  
‘Healthy heart and just cardiovascular fitness, obviously maintaining a 
healthy weight.’ (P17) 
Most participants believed participation in PA was related to increased vitality, as 
well as better mood and appearance (P4, P11, P16). 
‘Not feeling sluggish or tired or …more energy, absolutely more energy.’  
(P4) 
‘You feel more energetic, I think you have a slightly better mood as well, 
sort of, yeah. I mean that's just in terms of mood and all that - but, you 
know, if you're exercising regularly you don't feel as breathless and 
things like that when you're doing what should be fairly mundane 
activities.’ (P11) 
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‘Oh, things like, you look and feel better and your mood is better and 
you’ve got more energy.’ (P16) 
They also related PA to non-physical benefits, such as improved mental health 
(P11, P18, P19). 
‘It helps better with your mental health … maybe it helps to lessen those 
symptoms sort of thing of depression or even that you're gonna get them 
in the first place.’ (P11) 
‘It’s good for your mind, definitely is good for your - if you have 
depression and things like that.’ (P18) 
‘Well, I think you get depressed if you are not active, like it’s a natural 
sort of transition to an unhappy state…it’s not too many inactive people 
that are happy.’ (P19) 
In addition, participants described the role of PA in the prevention of health 
conditions such as cardiovascular and metabolic diseases (P13, P14). 
‘I guess by pretty much taking care of your heart …bone density…you 
know I suppose you’ve got a less chance maybe, unless it’s genetic, of 
getting diabetes and things like that.’ (P13) 
‘Increase your metabolism, lower your risk of cardiovascular disease you 
know, and stroke and blood pressure, you know, reduces blood 
pressure, umm it could reduce your waist circumference, and also risk 
of heart disease, diabetes, everything really.’ (P14) 
Physical appearance. Participants often described a physically active person in 
terms of positive attributes related to physical appearance, such as complexion (P3, 
P11, P16), muscularity (P1, P16), fitness (P11, P16) and slimness (P8, P9, P16). 
‘Healthy…toned, glowing I suppose…you know, healthy complexion and 
everything.’ (P3) 
‘They generally look fit, they seem healthy, you know, they've got a nice 
colour…you know, they don't look pale like me.’ (P11) 
‘Someone who is fitter and healthy and they wear clothes that look nice 
on them and…they enjoy exercise and…they eat well and you know, 
Chapter 5: Study 2(A) – Results and discussion 
176 
 
they look healthier and brighter in the face and, and in terms of size I 
probably would put someone between a 10 and a 12. Size 10 and 12.’ 
(P16) 
‘I guess they are trimmed and suppled and muscly and all sort of things. 
I guess yeah...it looks as if they enjoy themselves.’ (P1) 
‘They’ll be like a healthy weight. Yeah, they’re slim.’ (P8) 
‘Probably not too much fat on them, not overweight.’ (P9) 
 What qualifies a person as ‘physically active’. When questioned about what they 
believe PA meant, most participants believed that a physically active person would 
be involved in organised sports (P1, P17) or regular exercise undertaken at a 
moderate to vigorous intensity, such as going to the gym, walking and running (P11, 
P13, P15). 
‘They play, they participate, play a lot of sports.’ (P1) 
‘Someone who exercises regularly… in any form, whether is a team 
sport or going to the gym.’ (P17) 
‘My idea of it is someone who's getting some cardiovascular sort of 
exercise. I know you've got Pilates and all of that sort of stuff which is 
good, you know, for your muscles and your posture and all that — but, 
when I think physically active, I'm thinking someone who, yeah, gets a 
bit of cardiovascular stuff.’ (P11) 
‘Going out and actually exercising, going to the gym. Cardio, walking, 
bike riding.’ (P13) 
‘I would think, you know, any form of, of exercise – sort of walking, 
running, Pilates. At least four times a week.’ (P15) 
In contrast, some participants described their perception of being physically active 
as being able to undertake activities of daily living without barriers (P2, P12, P18). 
‘Not being afraid to sort of get up and do stuff. Being physically active to 
me is someone who at the moment’s notice will get up and do stuff as 
oppose to think of excuses as to why not to or think of putting it off or 
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procrastinating and so forth, so being physically active is someone who 
is constantly on the go.’ (P2) 
‘Well, most people would say, physical activity is getting out there and 
jumping up and down the street or whatever. For me, it is to be able to 
get on my knees, to be able to do things like if you’re with your girlfriends’ 
kids, or whatever, you can actually be sitting on the ground. You can put 
your knees down so you can actually get back up…It’s also the ability to 
be able to get out and do the gardening and stuff. I mean, you know, I 
run around with a lawnmower and that. But by the time I’m finished, trust 
me, I’m ready for the cardiac ward. But to be able to do just your normal 
everyday activities without having the hassles that I go through as it is.’ 
(P12) 
‘To be able to do anything you want to do, that is what I think being 
physically active is, if you decide to climb a hill or mountain, just to do it. 
If you decide to do a job, just do it.’ (P18) 
5.1.2.2 Perceived barriers to physical activity 
Participants were asked to discuss their perceived barriers to PA. Perceived barriers 
to PA were defined as factors that prevented or made it difficult to engage in PA 
according to participants’ perceptions. The barriers to PA that emerged from 
participants reports were both obesity and non-obesity related.  
5.1.2.2.1 Obesity-related perceived barriers to physical activity 
Physical barriers. Common to the report of all participants was bodily pain as a 
physical barrier to PA. This pain was mostly described as lower limb and back pain 
(P9, P15) and was often perceived to be due to the increased load on the joints 
resulting from the excess weight (P17, P19). 
‘I get a sore back after a while, yeah … I have to stop there and then 
'cause it really hurts sometimes, yeah.’ (P9) 
‘I mean, at the moment, probably my greatest barrier is sore feet and 
knees.’ (P15) 
‘I get lots of joint pain because of my weight.’ (P17) 
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‘My skeletal system has finally succumbed to the excess weight that I’m 
carrying for a long period of time so…my ankles hurt, my legs swells up, 
my knees ache, my back, I’ve got a couple of fractured facet joints in 
there, so that hurts umm…so it’s a lot of pain to do any physical activity.’ 
(P19) 
Extra physical work, in terms of ‘strain’, ‘stress’ and ‘effort’ (P1, P3) or feeling less 
agile (P2, P9), as a consequence of their excess weight, was also described a 
barrier to PA. 
‘Umm...yeah, well I think weight is the big thing, I mean, it’s...the more 
weight more stress on your knees and legs and the less enthused you 
are and wanting to go out and play a game of golf or have a walk around, 
that sort of things.’ (P1) 
‘I think just physically carrying around an extra 40 kilos in weight, you 
know, it is harder, you know, to even to get out of the car…and stuff like 
that, it’s physically harder…and you know, like I’ve said, walking down 
hills and stuff…yeah, it’s a big strain, that kind of thing.’ (P3) 
‘Just my bulkiness, I feel a lot less agile, a lot less…even…everything 
just takes that much more effort to do.’ (P2) 
‘I have to have like a three-wheeler one 'cause like on a two-one 
(bicycle), because my legs are so big, I can't pedal properly and trying 
to get on to a bike is very hard 'cause I lose my balance. I lose … being 
this big, you lose all your coordination.’ (P9) 
However, being overweight itself was also described as limiting participation in PA, 
irrespective of whether the excess weight resulted in weight-related pain or bodily 
strain (P3, P11, P19). 
‘It’s the weight. Yeah, the main thing that’s preventing it (doing PA) is 
the weight.’ (P3) 
‘I'm hoping exercise will come easier because - and correct me if I'm 
wrong - I sort of feel that when you're a bigger person, it feels that much 
harder, or it's a lot more work.’ (P11)  
‘So there is…being big creates its own limitations.’ (P19) 
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Self-presentational concerns. Most participants described concerns about their 
physical appearance in terms of size and engaging in PA in public (P16, P17). 
‘I know I look horrible in the uniform and, you know, I'm scared of people 
watching me 'cause I look fat.’ (P16) 
‘There is nothing preventing me physically but because of the way I feel 
about my physical appearance I don’t want to be in a bathing suit and 
go into the pool…’ (P17) 
This concern was mostly related to being watched (P4, P12), and the perception of 
being judged by people due to being overweight (P19). 
‘There have been times when I first joined the gym five years ago, it was 
very emotional to go, because I… a big girl and everyone else there is 
skinny and you know…definitely felt like people were looking. So, 
emotionally, it was hard to go.’ (P4) 
‘Okay, when it comes to walking around the block or that, I’d rather go 
walk down the coast where the neighbours can’t see me, that’s for sure. 
Umm, same as swimming, I’d rather go swim somewhere where nobody 
knows me.’ (P12) 
‘To get on my kayak and don’t have people look at you and, you know, 
look at that fat bastard sort of handling that kayak and…you know, that 
is…when you are my size that is what people…I’m used to people 
looking.’ (P19) 
Feeling helpless and/or hopeless. Feelings of helplessness were frequently 
described towards weight loss. These feelings were often related to several failed 
attempts to lose weight through a combination of dieting and increased PA or 
exercise (P3, P12, P17). 
‘I don’t know…because I’ve been overweight all my life and I’ve been on 
yo-yo diets and you know…and you sort of…unless you see…it’s quite 
disheartening when you go on a diet, and they are usually ridiculous, 
bad strict diets…but you go on a diet and it’s ridiculous for a week or so, 
you know, it’s really hard and after a week there is no physical sign that 
you’ve lost weight, you know.’ (P3) 
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‘Yeah, 1996 and it sort of… it goes up and down from there (body 
weight), backwards and forwards.  But really by the time I hit, oh, about 
37 years old, I thought I’d stuffed this I’m over it. Accept your body for 
what your body is.’ (P12)  
‘I think it was a combination of things, I don’t think I saw the success that 
I wanted to see (with PA)…I’ve always really struggled to lose weight 
even when I’ve dieted and exercised and I think having worked so hard 
I’ve just thought oh, well, what’s the point?’ (P17) 
Further, they reported feeling hopeless about future weight management, also 
related to using PA as a method of weight control (P16, P19). 
‘I think that also is tied up in the fact that I have got so much weight to 
lose that it seems such an insurmountable task, almost, so and it's … 
there's a massive fear of failure in that as well. Like I feel like, why do I 
bother (to engage in PA) 'cause I'm probably just gonna fail anyway?’ 
(P16) 
‘It sounds like you putting a lot of emphasis on the surgery but I am 
because without it I haven’t got the strength to do it myself so this is a 
tool to help me have that strength.’ (P19) 
5.1.2.2.2 Non-obesity related perceived barriers to physical activity 
Lack of motivation. Although many participants reported a feeling of wellbeing 
resulting from participation in PA, there were frequent reports of a lack of motivation 
(P15, P16), particularly to initiate PA (P4, P5, P9). 
‘No, not physical (barrier) but motivation. I’m not always … I’m not 
always highly motivated.’ (P15) 
‘It's weird, 'cause I feel better when I do it but I still can't get up the 
motivation to do it every day’ (P16) 
‘Yeah, and I like the way I feel afterwards, but sometimes getting there 
is hard work.’ (P4) 
‘Just getting up at the treadmill that’s already difficult.’ (P5) 
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‘Oh no, yeah, I feel good, I enjoy it. Umm, there's just getting … it's 
starting it, it's umm … like, 'Oh nah, I don't wanna go for a walk'… Umm, 
it's just the motivation of getting into it, yeah.’ (P9) 
Many participants believed that the lack of motivation was closely related to their 
perception of ‘being lazy’ (P3, P4, P14). 
‘I’m just lazy, I’ll put it off pretty much.’ (P3) 
‘Because I’m too lazy, I can’t be bothered.’ (P4) 
‘Because I’m lazy, that’s the simple answer.’ (P14) 
Lack of time. A common barrier among participants was not having enough time to 
engage in PA due to the nature of their occupation (e.g. full-time sedentary jobs) 
(P2, P5, P17) and family responsibilities (P6, P14). 
‘I mean it’s a very sedentary style…umm…occupation, involves sitting 
in front a computer screen for 9, 10 hours a day.’ (P2) 
‘I think it’s difficult being a shift worker because I can’t really commit with 
a certain day of the week and time of day.’ (P5) 
‘But obviously during the week you get home really late so there’s no 
time to actually do that (PA).’ (P17) 
‘I could … you know, for me, right now, probably my biggest barrier is 
my time.  I don’t have the time to do three times a week or four times a 
week.  So, even, even to walk an extra day just doesn’t seem to happen 
because I’m running after the kids, you know, with sports and stuff.  So, 
probably my time is my biggest barrier.’ (P6) 
‘I mean there are some, you know like before, my work is a barrier 
because umm, if I wanted to take my daughter to the Child Care, it’s only 
open 9:00 until 12:00. Well I work 7:00 until 3:00 so, so there is no one 
to look after my daughter while I go to the gym.’ (P14) 
Lifestyle. Sedentary activities, such as watching TV or sleeping were frequently 
reported as leisure time activities (P3, P4). 
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‘I just would rather sit on the couch and watch TV than get outside and 
do something.’ (P3) 
‘I quilt, sew and craft, do lots of different crafts, I read and I watch TV 
and I’d be with my family.’ (P4) 
When questioned about how they spent their leisure time, most participants 
indicated a preference for engaging in activities other than planned and structured 
PA (i.e. exercise) during leisure time (P4, P5, P6). 
‘No, no, why? (laughs) Why would I do that? (PA on leisure time). I just 
think there are other things I’d rather do than that.’ (P4) 
‘So I catch—like on my days off I catch a coffee with a girlfriend or go to 
the movies with a friend or shopping or what have you.’ (P5) 
‘You’d rather be going out with friends more than going to a gym or 
somewhere.’ (P6) 
Environment and resources. A small number of participants reported difficulties with 
coping with hot or cold weather (P1, P5, P9). 
‘I wouldn’t have any drama with any except for the weather…if it rains 
you see…well, I’m not a wet weather type.’ (P1) 
‘Through winter where you sort of feel, you know, you can’t go outside, 
it’s raining, what have you, can’t be bothered.’ (P5) 
‘Hot season … I feel sick, yeah.  Umm, very … I just get very sweaty 
and very uncomfortable, very uncomfortable.’ (P9) 
Some reported a lack of appropriate environment or equipment that would suit a 
larger person for specific modalities of PA (P2, P16, P19). 
‘The bike riding side of things, I would love to get back on a bike but 
unfortunately, most bikes aren’t really built to take 130kg person pushing 
it too hard.’ (P2) 
‘We don't have opportunities to go and hit a gym or anything down here 
unless we have to drive 45 minutes away and not many of us do that!’ 
(P16) 
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‘I can go back to my kayak, I had to buy a particular type of kayak to 
carry my weight. Because the one that I wanted umm…would carry a 
person up to 150Kg and I couldn’t buy that so I had to compromise and 
you know, buy something that could actually probably fit three people 
on.’ (P19) 
For some, the lack of financial resources was also identified as a barrier to 
participating in PA (P12, P14). 
‘I mean, you know, people say, “Why don’t you go to the gym?” Hello? 
Who’s got the money to waste going to a gym every day?’ (P12) 
‘Hmm, finance; money. You know, I used have a high disposable 
income. I used to be able to throw money at the trainers you know, and 
make me thin. (laughs). I don’t have that anymore you know. Umm, just 
yeah some money, gyms are expensive, membership and stuff. I just 
can’t afford that.’ (P14) 
Social support issues. Some participants considered the lack of company (from 
family, friends or a professional) to engage in PA or to motivate them as a barrier 
(P11, P13, P14). 
‘If you’re talking about someone who's gonna hold me accountable to 
exercise and all that, the only person that's gonna do that is me.’ (P11) 
‘More probably … no support of doing it (PA).’ (P13) 
‘Mm yeah, that’s hard because I have to be responsible.  You know, 
there’s no one there going, “Woo-hoo, go and do it, go and do it.’ (P14) 
5.1.2.3 Perceived facilitators to physical activity 
Participants were asked to consider perceived facilitators to PA. Perceived 
facilitators to PA were defined as factors that that helped or made it easier to 
engage in PA according to participants’ perceptions. The facilitators to PA that 
emerged from participants reports were both obesity and non-obesity related.  
5.1.2.3.1 Obesity-related perceived facilitator to physical activity 
Weight loss. Losing weight was reported to be the main factor that would make 
engaging in PA easier (P1, P4). 
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‘Oh…just taking the weight off…for me that’s all. You know, once this 
weight starts coming off, it should be a lot easier to do (PA).’ (P1)  
‘I think losing weight will make exercise maybe not as challenging as in 
… I’ll have less weight to carry around with my body.’ (P4) 
This belief was mostly related to the expectation that weight loss would reduce the 
obesity-related physical barriers described earlier (P17, P19). 
‘Umm…feeling more physically able I guess…some days I feel like an 
old lady because I find it hard to move being my size so…I think if I felt 
more mobile and more umm…I think that that would help, yeah.’ (P17) 
‘Get my weight off, because with that will come less pain.’ (P19) 
5.1.2.3.2 Non-obesity related perceived facilitators to physical activity 
Social factors. Many participants reported that social interaction or support while 
engaging in PA would increase their motivation and make the activity more 
enjoyable (P9, P13, P17). 
‘I feel like if you're with someone when you're walking, you don't feel 
more, 'Uh, how long is it gonna be?'  'Where are we?' Umm, how many 
hours I've been out or … you don't think about that when you're with 
someone. Well just having that person with me to encourage, to carry- 
get me along. (P9) 
‘Yeah, if I’ve got company, I’m motivated to do it, yeah. But if it’s just me, 
then it’s just boring.’ (P13) 
‘It makes it more enjoyable if you exercise with friends and it makes it 
not just about weight loss, it makes it about doing something social too.’ 
(P17) 
In addition, some participants described help from professionals (e.g. personal 
trainer) and friends as a facilitator to PA (P5, P17). 
‘Yeah, if someone comes, because a couple of years ago I actually had 
a personal trainer and she came three times a week. And so she 
motivated me.’ (P5) 
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‘I think the support that I’ll have with the bariatric clinic and with my 
friends and stuff will make things easier for me.’ (P17) 
Time management. Some participants expressed that allocating specific time for PA 
could facilitate participation in PA (P11, P16, P17). 
‘In terms of physical activity, that all comes back down to me, sorting 
that time issue. I need to be more selfish with my time so umm, I've 
already had a discussion with my boss around that I can't do everything.’ 
(P11) 
‘Probably not committing myself to so many things in the community and 
so often.’ (P16) 
‘Yes, I think it’s getting into a routine and making it a regular thing rather 
than you know, one day and not for another four days because if you 
develop a routine and a habit you are more likely to follow through.’ (P17) 
Financial resources. A small number of participants reported that having more 
money would facilitate engagement in PA, as this would allow access to a 
gymnasium (P12, P14). 
‘Right. Give me a million bucks and I’ll work it out from there (laughs).’ 
(P12)  
‘Free membership to the gym…Or money to pay the gym trainer umm, 
yeah umm, yeah. A free year's membership at the gym.’ (P14) 
5.2 Discussion 
The present study is the first to provide an in-depth exploration of beliefs about PA, 
perceived barriers and facilitators to PA among candidates for restrictive bariatric 
surgery. Based on 19 interviews of candidates for bariatric surgery, the findings 
revealed that most participants believed regular PA conferred important health 
benefits, and that the majority reported they did not engage in sufficient PA to confer 
these benefits. Most participants also believed that engagement in planned and 
structured PA (i.e. exercise) or sport is required to be considered physically active. 
The perceived barriers to PA were both obesity-related (e.g. pain and physical 
strain, self-presentational concerns) and non-obesity related (e.g. lack of motivation, 
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lack of time). Weight loss was identified as the primary facilitator to PA, and other 
facilitators not related to obesity were also reported (e.g. social support and better 
time management).  
The most prevalent obesity-related barriers reported by participants were bodily 
pain, physical strain, and self-presentational issues. These findings are consistent 
with those from a questionnaire study involving people prior to bariatric surgery in 
which more than 90% of participants reported physical barriers (e.g. physical 
limitations, tiredness and pain) and self-presentational barriers to PA (e.g. concern 
about appearance and clothes) (548). Also, a qualitative study that explored PA 
experiences of people awaiting to undergo gastric bypass found that excess weight 
was considered an obstacle to PA, primarily due to joint pain and difficulty due to a 
bigger body size, in addition to self-consciousness (223). In studies that compared 
obese adults to their non-obese counterparts, physical barriers such as pain and 
tiredness, and feeling self-conscious were more frequently reported by people who 
are obese (217, 224, 543). Napolitano et al (217) investigated self-reported barriers 
to PA with a questionnaire, as well as their influence on participation in PA in 280 
inactive women involved in a 12-week PA promotion trial, and found that reports of 
feeling too overweight, feeling self-conscious, minor aches and pains, and lack of 
self-discipline were more frequent in obese participants when compared to those 
with normal-weight and overweight. Leone et al (224) used an online survey to 
investigate the reasons why obese women engage in less PA when compared to 
those in the normal-weight range. Their findings showed that, when compared to 
non-obese women, those who were obese were less likely to report enjoyment 
towards exercise (odds ratio, 0.4; 95% confidence interval [CI], 0.2 to 0.8), and more 
likely to both agree that their weight makes exercise difficult (odds ratio, 10.6; 95% 
CI, 4.2 to 27.1) and report that they only exercise when trying to lose weight (odds 
ratio, 3.8; 95% CI, 1.6 to 8.9). Thus, converging evidence from multiple studies, 
which involved varied designs, suggests that physical issues and self-presentational 
concerns are particularly important considerations for PA among people who are 
obese. 
The present findings suggest participants have salient barriers regarding feelings of 
helplessness (i.e. perceptions of lack of control over the environment resulting in 
negative emotions) and hopelessness (i.e. negative attributions about oneself 
resulting in disbelief that investments in the future will pay off) towards weight loss 
and weight maintenance, particularly related to previous weight loss attempts 
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involving diet and exercise. These findings are congruent with a study that explored 
people’s journey to laparoscopic adjustable gastric banding (221). Pfeil et al (221) 
found that feelings of lack of control over their body weight, and the perception that 
bariatric surgery is the only viable option after a history of unsuccessful conservative 
attempts at losing weight were predominant among participants (221). It appears 
that attributional style (i.e. a tendency to explain events in certain ways) (612) may 
be an important consideration for PA behaviour of candidates for bariatric surgery. 
Attributional style is characterised by explanations that are internal or external to the 
person (locus of causality), and the degree to which the cause is within the person’s 
control (controllability) or permanent versus temporary (stability) (612). The present 
findings suggest that candidates for bariatric surgery explain their PA experiences 
as being external, uncontrollable, and permanent primarily as a result of repeated 
unsuccessful attempts at weight loss with increased PA and diet. 
The findings also highlight non-obesity related perceived barriers, such as lack of 
motivation, self-described ‘laziness’, and lack of time as key barriers to PA for 
participants. Perceived lack of time and motivation are reported as the most frequent 
non-weight related barriers in questionnaire studies of candidates for bariatric 
surgery (548) and obese women (219, 541), and are among the most commonly 
reported barriers by non-obese adults in the general population (204, 207). For 
instance, middle-aged Australian men who participated in focus groups sessions 
described lack of time to be physically active, due to work and family responsibilities, 
and lack of motivation to engage in PA as key themes that reflected their perceived 
barriers to PA (207). The lack of motivation reported by participants can be 
characterised by a lack of intentionality, which can result from feelings of 
incompetence, or a belief that the activity will not result in the desired outcome 
(613). Lack of intentionality, and feelings of incompetence or devaluation of the 
activity are important aspects of psychological theories of motivation and are related 
to desistence and avoidance of PA (17, 614, 615). Given studies in the general 
population have reported similar findings regarding a lack of motivation to engage in 
PA, it is important to consider that in addition to low motivation, participants in the 
present study have reported feelings of helplessness and hopelessness about 
engaging in PA as part of their previous weight loss attempts. Congruent findings 
among obese populations and candidates for bariatric surgery highlight the potential 
clinical importance for both the recognition and understanding of the psychological 
processes (e.g. attributional style and lack of intentionality) that may impact on PA 
behaviour of people undergoing bariatric surgery, regardless of obesity itself.  
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This study is the first to investigate perceived facilitators to PA in candidates for 
restrictive bariatric surgery. Weight loss, the only obesity-related facilitator to PA 
reported by participants, has been reported as a facilitator to PA in a previous 
questionnaire study of overweight women (219); however, this study is the first in 
which weight loss was reported as the main perceived facilitator to PA in candidates 
for restrictive bariatric surgery. The non-obesity related perceived facilitators to PA 
described by participants (i.e. better time management, social support, and financial 
resources) seem to involve factors related to self-regulatory skills, as well as 
environmental and social contexts, and were similar to those in samples of non-
obese adults in the general population (208, 209) and people with chronic health 
conditions, such as diabetes mellitus type 2 (616) and musculoskeletal disorders 
(617).  
Although post-surgery weight loss may facilitate PA, through reduction of some 
obesity-related barriers (e.g. extra physical work), it is unlikely to change non-
obesity related barriers or influence a person’s social support, time availability, or 
financial status. Obesity-related perceived barriers such as joint pain might still 
remain, and new self-presentational concerns may result from weight loss (e.g. 
excess skin). In accordance with this, motivational and physical barriers were the 
most frequent factors reported by people who underwent bariatric surgery on an 
online survey assessing post-surgery barriers to exercise (222). A recent qualitative 
study used semi-structured interviews to explore how participants experienced PA 
12 months following bariatric surgery, and found that physical issues, low motivation 
and self-presentational issues continue to be reported as barriers to PA post-surgery 
(225). 
Clinical messages 
Optimising PA in people who undergo bariatric surgery may improve fitness and 
body composition, reduce surgical complications, enhance recovery, and result in 
greater weight loss and maintenance (50, 69). The impact of bariatric surgery on 
participation in PA appears to be, at best, trivial (5, 6) and therefore, this population 
is still at risk of health conditions related to inactivity (e.g. increased risk of 
cardiovascular diseases and mortality), irrespective of the weight loss and the 
improvement achieved in obesity-related comorbid conditions. Achieving change in 
PA is challenging (192), and some of the perceived barriers to PA identified in this 
study may be difficult to modify (e.g. financial resources). However, as identification 
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and management of barriers to PA and optimisation of facilitators to PA has been 
shown to be an integral component of developing behavioural interventions which 
are effective at producing short-term improvements in objective measures of PA 
prior to bariatric surgery (34), the findings of the present study provide a framework 
for clinicians to discuss and address several of the beliefs, barriers and facilitators to 
PA in people who are obese prior to bariatric surgery. For instance, it would seem 
important for the staff of bariatric surgery practices to routinely provide educational 
counselling to this population that PA is not restricted to participation in exercise or 
sports by informing them of the health benefits associated with reducing sedentary 
behaviour and increasing participation in light-intensity PA. The educational 
counselling could involve strategies to decrease sedentary behaviour by interrupting 
prolonged periods of sitting time with standing and slow walking (43).  
In addition to educational counselling regarding the different types of PA, people 
who undergo bariatric surgery may also benefit from advice on strategies to 
overcome the non-obesity related perceived barriers to PA that are not likely to 
change as a result of the surgery alone, such as time management strategies to 
assist with participation in PA. As candidates for bariatric surgery appear to  have 
low motivation and experience several barriers to PA, it would seem important to 
promote the use of goal setting strategies that incorporate realistic goals, such as 
targeting achievable and small changes in PA initially, in combination with regular 
progression to activities of higher intensity that can be maintained. Additionally, 
given the frequent reports of feelings of helplessness and hopelessness regarding 
their lack of previous success in losing weight with increased PA, candidates for 
bariatric surgery may have low self-efficacy to engage in PA, as well as difficulties to 
understand the value of PA. Therefore, a focus on educating people who undergo 
bariatric surgery on the health benefits of PA that have been demonstrated in people 
who are obese in the absence of weight loss, such as reduction in abdominal 
obesity and cardiometabolic risk factors (618), could be of benefit to increase their 
motivation. Earlier research in this population reports that participants believed 
ongoing support from health professionals, as well as from family and friends, was 
beneficial to increase participation in PA and this should be considered when 
designing interventions that aim to optimise participation in PA (225). 
Strengths and limitations 
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The main strength of this study is the in-depth qualitative exploration of beliefs about 
PA, perceived barriers and facilitators to PA, which provided detailed information 
regarding important factors related to participation in PA among candidates for 
bariatric surgery. Nevertheless, the findings of the present study should be 
considered within the context of its limitations. First, the sample was comprised of 
people attending a private bariatric clinic, which may limit the transferability of the 
results to those receiving treatment in the public health system or with a lower socio-
economic status. Future studies should consider the investigation of beliefs, 
perceived barriers and facilitators to PA in these populations, in order to explore the 
potential differences that might be related to the health services provided and socio-
economic status (e.g. limited access to health professionals or higher need for social 
support). Future research should also consider the way in which factors relevant to 
PA may change in the context of undergoing bariatric surgery. For example, as 
bariatric surgery results in substantial and significant weight loss and improvement 
and/or resolution of obesity-related comorbid conditions, obesity-related barriers and 
facilitators to PA may change concomitantly. In conclusion, this study provides in-
depth information regarding beliefs about PA, in addition to perceived barriers and 
facilitators to PA in candidates for restrictive bariatric surgery. These data provide a 
framework for clinicians to develop strategies which target these factors, in an 
attempt to increase participation in PA in this population. 
.
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CHAPTER 6 STUDY 2(B) – RESULTS AND DISCUSSION 
Overview 
This chapter presents data pertaining to Study 2. The methods relating to this study, 
including the description of study design, inclusion and exclusion criteria, 
recruitment process, interview schedule, and data analyses have been described in 
Chapter 3 (section 3.2 Study 2). Characteristics of the participants and results of the 
pre-surgery qualitative exploration have been described in Chapter 5 (Study 2(A) 
Results and discussion). Section 6.1 describes the study participants and presents 
data pertaining to the 12-month follow-up post-surgery qualitative exploration. 
Section 6.2 discusses the results presented for the 12-month follow-up post-surgery 
qualitative exploration. 
The specific research questions answered in this chapter are: Twelve months 
following restrictive bariatric surgery, (a) what are the perceptions of participants 
regarding their ability to participate in physical activity (PA) as well as barriers and 
facilitators to PA? (b) How do these perceptions differ from participants’ perceptions 
pre-surgery? and (c) What are the perceived motivators to PA at 12 months 
following restrictive bariatric surgery? 
6.1 Results 
6.1.1 Participants 
Follow-up interviews were conducted with 14 (74%) of the 19 participants who 
participated in the pre-surgery interview. Four participants were lost to follow-up due 
to non-response to the interviewer’s (JZ) contact attempts and one did not undergo 
the surgery. The themes identified in the pre-surgery interviews of the five 
participants lost to follow-up did not differ from those who participated in the post-
surgery interviews. The characteristics of participants who participated in both pre- 
and post-surgery interviews are presented in Table 6.1. At the follow-up interview, 
participants presented with a mean weight of 90.3 kg (range, 60.0 - 152.0 kg), and 
body mass index (BMI) of 31.7 kg/m2 (range, 22.3 - 48.2 kg/m2). The average weight 
loss was 24% (range, 1 - 40) of pre-surgery weight or 66% (range, 2 - 127) of 
excess weight (i.e. difference between a person’s weight and his/her ideal weight, 
which is the weight for a BMI of 25 kg/m2). Participants were interviewed, on 
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average, within 12.7 (standard deviation [SD], 1.1) months post-surgery. Interviews 
lasted for an average of 32.2 minutes (SD, 11.2). According to participant 
preference, five (36%) interviews were conducted in a research room at Curtin 
University and nine (64%) were conducted over the phone. There was no difference 
between the content of interviews conducted in person or over the phone.
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Table 6.1. Characteristics of participants at the post-surgery interview 
Code 
Type of 
surgery 
Weight 
(kg) 
BMI 
(kg/m2) 
Weight loss 
(% of pre-surgery 
weight) 
Weight loss 
(% of excess 
weight loss) 
P2 LSG 85.0 25.7 35 95 
P3 LAGB 94.0 30.3 18 55 
P5 LAGB 82.0 26.8 12 67 
P6 LSG 68.5 26.1 32 92 
P7 LSG 60.0 22.3 36 127 
P9 LSG 108.0 40.6 25 46 
P11 LAGB 96.0 34.8 18 43 
P13 LSG 74.5 26.7 40 91 
P14 LSG 69.0 26.3 35 92 
P15 LSG 70.5 25.9 31 93 
P16 LAGB 100.0 35.4 4 13 
P17 LSG 80.0 29.4 37 80 
P18 LAGB 125.0 48.2 1 1 
P19 LAGB 152.0 44.9 17 31 
Abbreviations: BMI: body mass index; LAGB: laparoscopic adjustable gastric 
banding; LSG: laparoscopic sleeve gastrectomy. 
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6.1.2 Categories and emergent themes 
Six broader categories were explored in the post-surgery interviews: changes in 
reported participation in PA, changes in perceived ability to participate in PA, 
changes in perceived barriers to PA, residual perceived barriers to PA, residual 
perceived facilitators to PA, and perceived motivators to PA. The term perceived 
was used to convey the factors participants believe they experienced or could 
experience, regardless of whether or not participants truly experienced them. 
Residual perceived barriers and facilitators to PA are those reported at both pre- 
and post-surgery interviews. 
The emergent themes reflecting the broader categories explored in the post-surgery 
interviews are presented in Figure 6.1. The description of the emergent themes and 
supporting quotes are presented in the following sections. Additional supporting 
quotes are presented in Appendix 10. 
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Figure 6.1. Categories and emergent themes from the post-surgery interview. 
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6.1.2.1 Changes in reported participation in physical activity  
Participants were asked to report their participation in PA over the 12 months post-
surgery and how this differed from their pre-surgery perceptions.  
No participation in physical activity in the first months following surgery. Most 
participants reported they did not need or want to participate in PA within the first 3 
to 6 months following restrictive bariatric surgery (P2, P17), regardless of their pre-
surgery participation in PA. Participants explained that as the weight loss was 
occurring rapidly even in the absence of PA, due to the drastic dietary changes, they 
believed PA was unnecessary.  
‘So it's only really the last six months that I've made more efforts towards 
activities. The first six months really was pretty much just not doing much 
at all.’ (P2) 
‘I guess because some days, particularly early on when you're not in the 
habit of exercising, and you don't necessarily want to because the weight 
is coming off so easily, you don't really have to exercise. It sounds 
terrible. Because it always used to feel like a punishment and then all of 
a sudden you're losing the weight and you don't have to do the physical 
activity so you know, “Oh well, just you know, I'm doing fine without it.” 
You feel lazy thinking that way, but that's the way it is in the beginning.’ 
(P17) 
Increased participation in physical activity. Compared to their pre-surgery 
perceptions of participation in PA, many participants reported being more active 
post-surgery. The weight loss of those participants who reported increased 
participation in PA ranged from 31% to 127% of their excess weight. The reported 
increase in PA was primarily related to daily life or leisure-time PA (P3, P7), such as 
playing with their children and walking their dog.  
‘I take the dog for a walk now. I make sure if I come home sometimes 
from work, and I’ve had a day where I’ve been in the office all day, sitting 
around all day at meetings, I’ll come home and go for a walk around the 
block. Yeah, I just generally am more active.’ (P3)  
‘I think that I’m doing more housework. Yeah, doing more housework 
and not sitting on my ass because I was so heavy. Yeah, we just get out 
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more. We do more, go to places. So I'm actually, in this last month or six 
weeks I've been like walking to the park instead of driving to the park, 
and walking to the park, walking back, taking my little son. You see, my 
number one son, we just used to sit around the house, the poor little 
bugger. And now it's just so different with this little fellow, with number 
two. We walk into town or we walk, we get on the bikes a bit more. We 
do a bit more family stuff. You know what I mean?’ (P7) 
When compared to their pre-surgery perceptions of participation in PA, some 
participants reported that the increase in participation in PA comprised an increase 
in both quantity and intensity of planned and structured PA (P6, P17).  
‘I’m still doing my personal training twice a week with the group training. 
I also jog now. So I jog or walk probably three or four times a week. It 
just depends how busy I am with work. Between 30 minutes and one 
hour.’ (P6) 
‘I go to yoga regularly now to help with my muscle flexibility and strength. 
I really enjoy that and I find that it relaxes me as well. It was quite 
amazing for me doing some of the poses I knew that I would have never 
been able to achieve in a million years that I can do now because my 
body has changed, so that's good. Yeah, and I go walking and that, but 
in the last month or so, I've tried to introduce exercise that gets my heart 
rate up a bit more. So I'm doing a running training program where you 
do interval training. You walk for a few minutes, run for a few minutes 
and build up your fitness until you can just run.’ (P17) 
No change or decreased participation in physical activity. Compared to their pre-
surgery perceptions of participation in PA, several participants reported no change 
in their participation in PA (P5, P16), or a decrease in the amount of PA they engage 
with (P14).  
‘Yeah, I’ve been going walking three times a week. I still just do my 
walking with friends, and then if they can’t come I’ll just go on the 
treadmill. But I haven’t joined the gym or anything like that. Yeah, I think 
it is exactly the same. Well, I haven’t pushed myself any further, do you 
know what I mean? I haven’t pushed myself to a higher level.’ (P5) 
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‘Nothing, really, to be honest. I am not more physically active now. I’ve 
played netball for six months (as before the surgery), and I love netball. 
I love team sports, and that’s what I did six months, and I love that. When 
netball tends to finish, I kind of just fall into a bit of a heap.’ (P16)  
 ‘None. Not really. I’ve got less activity. I did more before. Carrying her 
(daughter). That's about it. None, none. No. I walk to the park, but it's 
like walking from here to the car park. It’s not getting my heart rate up, 
you know? Before, I’d be getting my heart rate up.’ (P14) 
Some participants indicated that although the quantity of pre-surgery PA was 
maintained, they believed there was an improvement in the intensity of the PA 
performed post-surgery (P9, P18), such as engagement in more challenging 
exercises and an increase in the intensity of walking.  
‘Because we’ve got a dog, I take her walking probably three times a 
week, twice a day, for about half an hour. It was a light walk. But now, 
it’s like a brisk walk now, when I walk.’ (P9)  
‘Yeah, twice a week it's been (Pilates class, same as before surgery) but 
the type of exercises are more … the harder exercises. I've just 
improved in that way.’ (P18) 
Of note, the lack of change or decreased participation in PA was reported both by 
participants who lost small amounts of weight (e.g. P16 lost 13% of her excess 
weight and P18 lost 1%) and those who lost between 46% and 92% of their excess 
weight. 
6.1.2.2 Changes in perceived ability to participate in physical activity 
Participants were asked to describe their perceived ability to participate in PA over 
the 12 months post-surgery and how this differed from their pre-surgery perceptions.  
Physical activity was easier. Several participants reported that engaging in PA was 
easier (P6, P15), and attributed this change to factors related to the weight loss they 
experienced, such as reduction in obesity-related physical issues that acted as 
barriers to PA pre-surgery. 
‘Well, I’ve always done personal training. So I still do that. But it’s a lot 
easier now, and yeah, I can do a lot more and can be pushed a lot 
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further. Definitely it’s a lot easier. I look back and I think, “Gosh, I could 
only do that! Now I’m probably doubling or tripling what I used to do”. 
Like before I’d go, “Are you kidding me? I don’t want to do that kind of 
thing”, but now I just do whatever has to be done.’ (P6) 
‘Physical activity is a lot easier than it was. I'm still not doing enough of 
it but it's a lot easier than it was.’ (P15) 
Improvement in perceived ability to engage in physical activity. Participants 
perceived a greater ability or confidence to engage in PA (P13, P17).  
‘I feel good. Because I’m able to do it as I wasn’t able to do it before. 
Now I can do it, yeah. Physically, I feel like I could do anything and get 
away with it. Before, I couldn’t.’ (P13). 
‘Yeah. Well, before, it was sort of the first thing that would pop into my 
head, was, “Oh no, I can't do that.” Now I think, “Oh yeah, I think I could 
do that. I'd like to try and see. That’s something that is within my power 
to change now (PA levels), whereas before I didn't feel like it was within 
reach.’ (P17) 
This perception was confirmed by experiences of performing activities that they did 
not believe were possible pre-surgery (P9, P14). 
‘We went up North, up Northwest. We walked, and walked, and walked. 
And I thought, “I couldn’t have done this before!” Then, a couple of 
months later, we went down South. We went whale-watching, and we 
did a five-kilometre walk. I thought, “I couldn’t have done that before, 
because I wouldn’t have had the energy.” I would have to my husband, 
“Nah, I can’t, turn around. Let’s stop and go back.” But I continued. I just 
walked, and walked, and walked.’ (P9) 
‘We’ve got this big hill where I work. It’s massive. It’s on a really big 
gradient.  And I used to get sore knees and be puffing when I used to 
get to the top of the hill to work. And probably embarrassing if anyone 
was behind me. Now, not even puffing at all. I could run down again, 
back up again. So that was nice.’ (P14)  
One participant indicated that the greater ease to engage in PA resulted in a 
renewed perception of what constitutes exercise (P3).  
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‘Where I used to think I was exercising and it was a chore, now that’s 
just normal, active life. I think what I see as exercise now, I didn’t before. 
Before, I used to see everything as exercise - moving almost as 
exercise, if you know what I mean. The most basic thing was exercise. 
To me, exercise was hard work and it made you sweat and feel gross, 
and my face would go red. But now those things don’t make me feel like 
that, so I just do those things normally.’ (P3) 
6.1.2.3 Changes in perceived barriers to physical activity 
Participants were asked to discuss their perceived barriers to PA over the 12 
months post-surgery and how they differed from their pre-surgery perceptions. 
Consistent with the pre-surgery interview, perceived barriers to PA were defined as 
factors that prevented or made it difficult to engage in PA according to participants’ 
perceptions. 
Physical barriers. Most participants who identified bodily pain as a barrier to PA in 
the pre-surgery interview reported reductions in pain, particularly of the lower limb 
and back (P7, P15).  
‘Just being able to walk down the beach and in the sand dunes and be 
able to carry my boy. Far out, it was just … yeah, I can't tell you how 
bloody unreal it was. My knees, my legs weren't sore, and I was back 
and forth.’ (P7) 
‘I think the main thing is the easing of the physical pain in the feet and 
knees particularly. I had to have orthotics. Yes, to go for a walk I would 
have to change into joggers with orthotics. Now, I can walk a couple of 
kilometres in just whatever shoes I happen to be wearing. When we went 
to Sydney I didn't have to wear special shoes. Actually, I really noticed 
it when we went to America, because we did a lot of walking. By the end 
of the day I'd have had foot pain and knee pain. And it was great. I loved 
that I could … where you could just walk all day and I was fine.’ (P15) 
All participants who experienced pain pre-surgery reported a reduction in pain, 
which was often attributed to the decreased load on the joints that accompanied the 
weight loss (P6, P13). 
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‘I have had nothing. It’s just amazing that my feet … I haven’t had any 
injuries or anything. So now all good – I don’t have any pain on the heel. 
Obviously the weight’s come off and the feet don’t take as much … don’t 
have to hold as much weight I suppose.’ (P6) 
‘I don’t have pain. I don’t suffer from my knee problem anymore, no back 
problems, as before that would stop me because of the excess weight, 
and now I just feel good.’ (P13) 
When compared to their pre-surgery perceptions, participants also reported a 
significant reduction in the extra physical work they experienced when participating 
in PA, often referred to as ‘strain’, ‘stress’ or feeling unfit (P5, P11, P17). 
‘I huffed and puffed, because it was harder for me to get uphill because 
I was bringing more … you’re obviously carrying more weight. Whereas 
now I sort of cruise up the hill, so I get up quite quickly. Yeah, I’ve got 
more energy, I’ve got more oomph to go.’ (P5) 
‘Physically it doesn’t feel like there’s so much of a toll either on the legs. 
I mean, I don’t feel like I’m dragging myself around now, yeah.’ (P11) 
‘Well, before I used to get short of breath really easily. I climbed to the 
top, and I actually got to the top before a few of my friends who I thought 
were slimmer and fitter than me. For me, it was a really special 
achievement, because I know that I would have never been able to do 
that, or I would have never even considered it because I would have 
gone, “No, I can't do that. I'll be in pain.” Or you know, “I'm  not fit 
enough.”’ (P17) 
Some participants reported a change in the fear of the physical consequences of 
obesity they experienced pre-surgery (P3, P13) 
‘I don’t feel like I’m going to have a heart attack, and I can get in and out 
of cars without straining.’ (P3) 
‘I don’t think I’ve ever like done so much effort in 45 minutes (in a 
personal training session) to be honest. Like luckily, I’m a smaller person 
now because I don’t think my heart would have taken it if I was bigger. I 
would probably die of a heart attack if I was to do it.’ (P13) 
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Self-presentational concerns. Pre-surgery, participants reported feeling self-
conscious and worried about people’s judgement when engaging in PA in public. 
Following surgery, most participants reported not being as concerned about 
people’s thoughts, nor feeling ‘judged’ because of their size as they did pre-surgery 
(P3, P17, P19). 
‘That’s very different (feeling self-conscious when engaging in PA). I 
don’t feel so out of it now. I feel more normal. And yeah, I do feel like, in 
my own mind feeling better. Even though nobody has actually changed 
towards me, it’s the way I feel, it has made a difference in my perception 
of what people think of me.’ (P3) 
‘Well, before when I went out walking or whatever, even though it wasn't 
necessarily a rational thought, I always felt like everyone was staring at 
me. Particularly if I was in a place like a gym, I felt like a fish out of water, 
because I was this morbidly obese person in the gym with people who 
looked fit and healthy and slim. Now, I don't feel like I stick out like a sore 
thumb. I can go out and do my running or I can go to yoga. I can go to 
those places though and just feel normal. I just feel like I blend in, which 
is great.’ (P17) 
‘I don’t walk into a room feeling that people are looking at me, thinking, 
"Oh, Jesus Christ, he's huge," and things like that. I'm a bit more 
comfortable with myself so I'm able to socialise more and be very 
comfortable, more active.’ (P19) 
Improvement in wellbeing and vitality. Compared to their pre-surgery perceptions, 
several participants reported improvements in their perceived wellbeing and vitality 
(P5, P9). Participants explained that the pre-surgery perceptions of low energy and 
health impairment influenced their participation in PA.  
‘So yeah, I feel healthier. I’ve got more energy. I have lots more energy, 
some days I wouldn’t want to get out of bed, you feel really lethargic 
because of that extra weight holding you down. Whereas now, I’m up 
early, and out and about doing things, and I feel good, I feel really good. 
I don’t know, just a lot more energy.’ (P5) 
‘I just had no energy at all. I just felt lifeless. Just my outlook on life, I just 
see my life differently now … a lot happier. I’m a lot happier. My diabetes. 
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That’s under control now. My cholesterol, my blood pressure – that’s all 
under control...’ (P9) 
6.1.2.4 Residual perceived barriers to physical activity 
Despite the aforementioned reports of improvements in obesity-related barriers to 
PA, several participants reported that some of the obesity-related physical and 
psychological barriers to PA reported in the pre-surgery interview remained at 12 
months post-surgery. Many of the non-obesity related barriers to PA identified in the 
pre-surgery interview remained post-surgery. 
6.1.2.4.1 Residual obesity-related perceived barriers to physical activity 
Physical barriers. Despite the theme of positive changes in pain as a result of the 
surgery, some participants reported that pain was not completely resolved, and that 
it consequently remained a barrier to PA. The persistence of pain as a physical 
barrier to PA was mostly reported for those participants who experienced chronic 
issues such as chronic low back pain (P5) and osteoarthritis (P19).  
‘And I’ve always suffered … the reason why I had the operation was 
because I suffered from a lot of back pain, and I still do but not as much.’ 
(P5) 
‘Pain, still the fear of ... both my ankles, I've had ligament surgery and 
bits and pieces and the bone fragments so very, very unstable. So 
walking for me is a concentrated effort rather than ... I can't walk on 
uneven surfaces with any confidence. My left knee is just starting to flare 
up again at the moment.’ (P19) 
The fear of pain also appeared to act as a barrier to PA for P19, who despite a 
substantial loss of 31% of his excess weight was still obese at 12 months post-
surgery.  
‘Look, the main things are obviously getting out in the cold air has 
certainly been a major barrier and the other is, yeah, just I suppose the 
pain, the fear of or the lack of confidence, I suppose, in my limbs, my 
lower limbs.’ (P19) 
Self-presentational concerns. When compared to their pre-surgery perceptions, 
some participants reported residual self-consciousness regarding their physical 
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appearance or size when engaging in PA, particularly for exercise in a group setting 
(P11, P19). 
‘Yeah, I think if I was exercising in a group environment like doing boot 
camp or things like that, I’d still be self-conscious about it, yeah.’ (P11) 
‘If I was feeling accepted, I would ... if I went into a gym, I would feel like 
the odd one out, I suppose, so I avoid those circumstances. So getting 
out and doing exercise in a public beach with my kayak still isolates me 
from the rest of the world but going to a gym means you're in a confined 
space with people who are generally, they're pretty hot. They're pretty 
muscley. You are really, really the odd one out. No matter what you're 
there for, you are.’ (P19) 
For other participants, there was a shift in focus regarding their self-presentational 
concerns, which was related to excess skin resulting from weight loss, rather than 
the pre-surgery concern about the excess weight (P15, P17). 
‘Oh, certainly with swimming … I mean, I've got a bit of loose skin. You're 
sort of aware of that. But then I'm 51. But a bit more loose skin than you 
would have’ (P15) 
‘I think while I do feel a lot better about how I look and how I feel about 
myself, I think it's going take time for me to feel really happy with my 
body, because now I've got loose skin. In some ways, I feel like I still 
have self-image issues, but they're just slightly different. Rather than it 
being about my thighs, it's about how my body has changed, and I have 
loose skin and stuff.’ (P17) 
6.1.2.4.2 Residual non-obesity-related perceived barriers to physical activity 
Lack of motivation. Several participants reported that lack of motivation remained a 
barrier to PA (P5), which for some was linked to a perceived lack of discipline or 
laziness (P14, P15).  
‘I just need to push myself. I mean, that’s the thing – I’ve got get my head 
set around like, if I do want to join a gym and go, and do that sort of thing 
again like I used to years ago.’ (P5) 
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‘Just put lazy. I guess now I’m at maintenance, nearly at maintenance, 
so I need to be looking at toning up. I know when I need to tone up, so 
I’ve got some free weights at home. But I could’ve been doing that 
already and have nice arms, but I haven’t, because I’m lazy. I’m like, 
“Oh, I’ll do that next week, next month”.’ (P14) 
‘Lack of motivation it would appear. And lack of organization. But I will 
have to think about what motivates me, because clearly I'm not a highly 
motivated person. Apparently self-discipline has to come in, or 
organisation has to come in. I think it's not a nice realization to come to, 
but I think I'm a naturally … in some ways I'm a naturally lazy person’ 
(P15) 
Specifically, many participants reported lack of motivation to engage in PA in the 
first few months post-surgery. Participants explained that they were not motivated to 
engage in PA during this period since considerable weight loss was happening as a 
result of the drastic dietary changes (P2, P14, P17). The lack of motivation to 
engage in PA in the first few months post-surgery was mostly reported by those 
participants who lost over 80% of their excess weight in the first 12 months post-
surgery. 
‘One of the interesting things that I found about having gone through the 
operation is in that first probably two- to three-month period, because 
you're on very restricted calorie and volume amounts, I was losing quite 
a lot of weight without really doing anything. So there is a certain level 
of apathy that sets in, where you just think, “Well, it doesn't matter what 
I do. So long as I just stick to that amount of volume of food and that 
type of food, I'm going to keep losing weight anyway.” So, I guess the 
drive to back that up with doing something physical, activity-wise, wasn't 
really there. Because I was getting good loss of weight without doing 
anything.’ (P2) 
‘Don't need to exercise because I’m losing weight. Now I’m losing 
weight, so the motivation to do that is gone. I have all of them (benefits 
of PA) without doing the exercise [laughs]. Do you know what I mean? 
And I’ve always been lazy, but I did that before (PA), because I knew I 
had to at least make an effort and try and lose weight. But now I don't 
need to make an effort because it's just happening by itself.’ (P14) 
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‘Definitely in the beginning when your weight loss is coming off so 
rapidly, you think, “Oh, well, I don't really need to. [laughs]. I'd go for a 
walk every now and then, but it was just … in some ways, it's scary how 
fast it comes off (the weight), and you sort of like you go, “Oh gosh, I 
don't want it to come off too fast”.’ (P17) 
Lack of time. Several participants reported that a lack of time to engage in PA due to 
work and family responsibilities remained a barrier to PA (P2, P5). 
‘It's all that I can do at the moment, with the kids and with work. I don’t 
have time for anything. I like doing it. It's not something I get to do a lot 
of, because I've got a pretty sedentary sort of job and so forth, and the 
kids keep the rest of the time active. But when I do get to go for a ride or 
catch up with friends and go do other stuff, it's good. I enjoy it. And I feel 
pretty good doing it.’ (P2) 
‘But then I look at my … the main days that I do my exercise are the 
days that I have off, but when I work, we leave home at seven o’clock in 
the morning, we come home at 6.30 at night, so it’s really difficult. You 
come home and you’re tired, it’s been a long day, and then you got to 
cook. So that’s why those sort of days you don’t really do any exercise. 
So it’s mainly the weekends and the couple of days that I have off during 
the week. If I was home all day, you’d have plenty of time to do exercise. 
[laughs]’ (P5) 
Although participants did not report it as a perceived barrier, the following quotes 
suggest that participants did not believe PA was of sufficient importance to be 
prioritised against other aspects of daily life (P3, P7, P11). 
‘I’ve just started doing Pilates videos, so I’m going to try and do that three 
times a week. Yeah, that’s sort of just now, start training a bit more, 
training my body up a little bit more. Other than that it’s mostly just 
walking, playing with my daughter and sometimes bike riding.’ (P3) 
‘No, just been touching on a bit of Pilates to strengthen up my pelvic 
floor area and my lower back. And that's probably what I'll continue to 
do and I'll do more sessions of that. I've been doing one a fortnight which 
is way better than anything yet and then I'll slowly move into that. We've 
got a busy couple of months coming up and then I'll lock in.’ (P7)  
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‘I did enrol for boot camp, and then they cancelled it, but I did see 
another sign for boot camp across the road from my work, so I did say 
that I was going to do that when I get back to Melbourne next week, go 
and enquire. Fingers crossed. [laughs]’ (P11) 
Social support issues. Some participants reported that the lack of company to 
engage in PA and lack of support with family responsibilities such as child care 
remained a barrier to PA (P5, P14, P16). 
‘I mean I’d always like to do more. If I had … see, that’s the thing – not 
that I need motivation, but I like to go walking with somebody. I don’t like 
to go by myself. So when I’ve got a walking partner, I’d go every day. 
But unfortunately, I haven’t gotten a walking partner three days, so that’s 
why I’m limited to that 3-4 times a week.’ (P5) 
‘She (daughter) won’t go in the pram anymore, and she won’t walk very 
far. So that’s my walk out. If I want to go for a walk, I have to go by 
myself, and that’s very difficult to do, because she’s always with me. So 
that’s a barrier.’ (P14) 
‘I try to get out and go for a walk or a run or something, and just because 
it’s me, on my own, doing it myself, I’m not accountable to anyone, I just 
don’t do it, because I’ve got assignments to do and everything like that. 
It’s all busy, so I think, “I’ll just do this, and I’ll exercise later,” and it never 
happens.’ (P16)  
6.1.2.5 Residual perceived facilitators to physical activity 
Participants were asked to discuss their perceived facilitators to PA over the 12 
months post-surgery and how they differed from their pre-surgery perceptions. 
Consistent with the pre-surgery interview, perceived facilitators to PA were defined 
as factors that participants perceived to help or make it easier to engage in PA.  
6.1.2.5.1 Residual obesity-related perceived facilitator to physical activity 
Weight loss. Weight loss remained the main perceived facilitator to PA. Participants 
who reported an increase in PA post-surgery explained that the effect of weight loss 
on their physical barriers and perceived ability to engage in PA was the main 
facilitator for the change in PA (P2, P9, P13).  
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‘Because I was lighter. There was less stress on my knees and ankles 
and so forth. So walking and even simple things like going upstairs and 
so forth, you were no longer out of breath doing so.’ (P2) 
‘Just knowing that I’ve lost all this weight, and just knowing that I can do 
it. I can do the walking, and I know I can do the exercises now.’ (P9) 
‘Being lighter. I was able to get out there and do it, yeah.’ (P13) 
6.1.2.5.2  Residual non-obesity related perceived facilitators to physical activity 
Social factors. Some participants reported that having company to engage in PA 
remained a facilitator to PA. The increase in perceived ability to participate in PA 
reported by participants appeared to enable them to engage in PA with friends or 
family members (P17).  
‘I have lots of friends and family members who like things like say, 
cycling or running, and before I never felt like I could join them in those 
activities. So now I feel like I can, so I definitely think it's a maintainable 
thing.’ (P17)  
One participant, who reported an increase in participation in specific types of PA that 
he found enjoyable following surgery (e.g. kayaking), indicated that having company 
would facilitate engagement in activities he would not normally do. 
‘My son is fairly active now and we’ll catch up with him. He's moved back 
closer to Perth so I sort of see him once a month and we'll go walking 
and things like that.’ (P19) 
Another participant, who reported a decrease in participation in PA post-surgery 
mostly due to lack of motivation and family commitments, reported that participation 
in PA would be easier if she would have someone to help with child care and to 
engage in PA with her. 
‘Somebody looking after (child’s name), and then another friend saying, 
“Come on, let’s go out for a walk together”.’ (P14) 
Time management. For some participants, better time management in order to 
prioritise time for PA was found to facilitate their participation in PA (P11, P17).  
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‘Then you come to the exercise that I’m actually in a bit of a routine now 
because I’ve got the work hours under control.’ (P11) 
‘Sometimes, I might have a week where I just don't have the time to do 
as much (PA) as I normally do, but then the next week when I've got 
more time I get back into it. Do you know what I mean?’ (P17) 
6.1.2.6 Perceived motivators to physical activity  
Given lack of motivation was a frequently reported barrier to PA in the pre-surgery 
interview, at the post-surgery interview, participants were asked to report on their 
motivators to PA. Perceived motivators to PA were defined as factors that 
participants perceived to make them want to engage in PA.  
Body weight and appearance. The main perceived motivators to participate in PA for 
most participants were additional weight loss and/or maintenance of the weight loss 
achieved post-surgery, as well as to improve their physical appearance. These 
motivators were described by both those participants who reported no change or 
decreased participation in PA (P5, P14, P16) and those who reported increased 
participation in PA (P13, P17). 
‘To lose more weight. Or to look good, and to fit into clothes, [laughs] 
some old clothes that … nice clothes that I haven’t fit into for many years. 
Oh – to maintain, because basically, I’ve known all my life, if I don’t do 
exercise, I gain weight. So regardless of what I eat, it’s … obviously, I’ve 
got a sluggish metabolism that I need to do exercise, some form of 
exercise. I guess sometimes when you still look in the mirror you see … 
I mean you know you’ve done well and you’ve lost weight, but I try and 
still push myself to lose some more, because I really think that I should 
be able to move those extra five kilos if I work harder.’ (P5) 
‘I know I need to tone up my arms, so I need to start doing my weights. 
I haven’t started that yet. I’m in the pre-contemplation phase. Yeah, 
yeah. So summer’s coming, so I know that a lot of the dresses that I’ve 
got are sleeveless, so yeah. That will be a motivation to … yeah, tone 
up my arms. You don't tone up your arms by walking.’ (P14)  
‘I want to say to lose weight. Sometimes when I get a really, really strong 
willpower, I know there’s nothing that will deviate me from doing exercise 
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every day, and I feel guilty if I miss a day. Yeah, so I guess the number 
one motivator for me is to lose weight, and that comes back to 
associating it with loss of weight.’ (P16) 
‘Well, I knew there would have to be a time that I would have excessive 
skin, so I just thought I’d get onto that before me having that problem of 
having another surgery just to get rid of the excess skin but yeah, me 
getting onto that has made it a bit better.’ (P13)  
‘Like I said before the last … it will feel so ... like I was told I would only 
get down to 90 kilos, and it felt amazing when I went further than that. I 
just think it will feel amazing if I get to say 68 kilos, which is what I'm 
meant to be and to be a normal BMI. I think that will be an amazing 
feeling and a feeling of achievement and accomplishment, and I never 
ever imagined that I would ever be able to get to 68 kilos. Whereas now 
I can imagine it and I can see that it's possible, so that has a huge part 
in motivating me to exercise. Over the last few months, I have made an 
effort to be more active. Not that I didn't do any exercise before, but now, 
because I would like to lose those last 15 kilos, I'm thinking more about 
what I can do physically, in terms of physical exercise to help that.’ (P17) 
Additionally, some participants reported that wanting to improve their fitness levels 
also motivated them to increase their participation in PA (P9, P17). 
‘Just wanting to get fit, just wanting to lose a bit more weight and just be 
a bit more healthy.’ (P9) 
‘I think definitely when my weight loss slowed down, right down -- I lose 
about a kilo a month now -- that's when I started thinking more about 
aerobic exercise that it would increase my fitness.’ (P17) 
Social interaction. Some participants reported that they were motivated by the social 
aspect of engaging in PA with someone else or with a pet (P9, P11, P13).  
‘My husband sometimes comes with me when I go walking. That’s good, 
because you can talk. He motivates me to keep going, and I motivate 
him to keep going, so we both motivate each other.’ (P9) 
‘A little bit of guilt that the dogs have been home all day. They live in a 
small yard now, so they need that stimulation to go out. That’s a 
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motivator to be a responsible pet owner, [laughs] to get them the 
exercise. I know it makes them happy, so it makes me happy. That’s my 
main motivator, my little babies.’ (P11) 
‘Just for that motivation to keep going, that nothing in life can stop me 
now. And just to maybe like even go out there and meet new people with 
my PT or whatever. I think because we live like right near Asheville 
Reserve, so there is like always something happening there, and 
especially the motivation to have a look at hot Italian guys playing 
soccer. That’s a great motivator. Good motivator.’ (P13) 
Enjoyment of activity. A small number of participants reported that choosing to 
engage in types of PA they find enjoyable was a motivator to participating in PA (P2, 
P6). 
‘It's something I did when I was a kid, and the enjoyment of it has not 
diminished, which is great. You enjoy it for what it is rather than feeling 
… so like I can do things and enjoy the activity, rather than thinking about 
how I'm feeling in the activity. So you're enjoying the scenery or the 
company or the conversation. Whereas in the past, it was more about 
how do you feel in that situation.’ (P2) 
‘Hmm, what motivates me? I do love it. I just love doing it. So it’s not 
something I think, “Oh gosh, I’ve got personal training tonight.” You know 
what I mean? I just love going, and it is a social aspect as well, but I do 
like …I think now, I just realized that the diet … you have to have a good 
diet and you have to push yourself to maintain what you’ve lost, 
basically. And I think that’s in the back of my head as well. You’ve got to 
keep doing this. You know? But I think I just love it more than anything. 
I think always my head’s loved the sport and loved that kind of thing, but 
the weight definitely put me off unfortunately. No, I love it. I love it. I still 
always liked it, but I absolutely love going and I definitely push myself 
now to my limits, especially on those personal training sessions.’ (P6) 
6.2 Discussion 
This study is the first to provide a longitudinal, in-depth exploration of people’s 
perceived ability to engage in PA, and perceived barriers and facilitators to PA 
Chapter 6: Study 2(B) – Results and discussion 
212 
 
following restrictive bariatric surgery, including how these factors changed over the 
first 12 months following restrictive bariatric surgery. Additionally, this study is also 
the first to explore factors people perceived to be motivators to PA over the first 12 
months following restrictive bariatric surgery. Findings from 14 participants who 
were interviewed pre-surgery and 12 months post-surgery revealed that most 
participants reported not engaging in PA during the first 3 to 6 months post-surgery. 
Participants reported an increase in perceived ability to engage in PA, mostly 
described as a result of the reduction in obesity-related perceived physical barriers 
to PA achieved with weight loss. Regarding perceived barriers to PA, although there 
were reports of improvements in some obesity-related barriers to PA (e.g. bodily 
pain and self-presentational concerns), many participants indicated that there were 
residual obesity-related perceived barriers to PA and for some there was a shift in 
focus regarding self-presentational concerns (i.e. from excess weight to excess skin) 
from pre-surgery to 12 months post-surgery. Most participants reported that pre-
surgery non-obesity related perceived barriers to PA (e.g. lack of motivation and 
lack of time) were still present at 12 months post-surgery. Perceived facilitators to 
PA were consistent between pre- and post-surgery interviews being weight loss, 
social factors and time management. Regarding motivators to PA, at 12 months 
post-surgery, weight loss and improvement in physical appearance were most 
commonly reported, and some participants also reported social interaction and 
enjoyment of PA. 
Although some participants reported an increase in their participation in PA after the 
first few months post-surgery, many reported no change or decreased participation. 
Regardless of whether their reported participation in PA had changed, most 
participants indicated that they did not engage in PA during the first 3 to 6 months 
post-surgery. Participants often explained that they did not find the need or will to 
participate in PA during the first few months post-surgery due to the substantial 
weight loss achieved as a result of the drastic dietary changes. These findings 
suggest that the optimal time to promote changes in PA may be approximately 6 
months post-surgery, when a substantial amount of weight had been lost, weight 
loss had started to slow down, and people appeared to be more receptive to 
engaging in PA. 
The participants who reported an increase in participation in PA indicated that the 
increase was primarily related to daily life and leisure-time PA, rather than planned 
and structured PA (i.e. exercise). The increased participation in daily life and leisure-
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time PA, rather than planned and structured PA, might be explained by the fact that 
participants reported feeling more able to engage in everyday tasks that had 
previously been difficult or impossible (e.g. walk to the shops or run around with 
their children). As most participants did not engage in planned and structured PA 
pre-surgery, this study reveals that surgery did not change the way in which people 
participate in PA (i.e. daily life and leisure time PA versus exercise). This finding 
supports earlier research demonstrating that participation in PA is determined by 
multiple factors (74), and is consistent with a recent qualitative exploration that 
interviewed two women at four different times over the first year following gastric 
bypass (619). These women reported they believed to be more active following 
surgery, due to increased daily life PA, but did not increase their participation in 
planned and structured PA that had been recommended by health professionals. 
Participants reported that PA was easier post-surgery, and attributed this greater 
ease to the substantial weight loss achieved and consequent reduction in the pre-
surgery obesity-related perceived barriers to PA, such as bodily pain. When 
compared to pre-surgery perceptions, participants reported an increase in their 
ability or confidence to engage in PA that was reflected by participant reports of 
performing activities they did not believe were possible pre-surgery. Previous cross-
sectional qualitative studies have reported that participants believed themselves to 
be more able to engage in PA between 6 to 12 months following gastric bypass, and 
attributed this increased ability to a reduction in obesity-related physical barriers to 
PA (225, 619, 620). Self-efficacy, defined as the belief that one has the ability to 
successfully engage in a specific behaviour, has been recognised as a main 
determinant of change in PA (74, 75). According to Bandura’s theory of self-efficacy, 
different factors may influence people’s perceived self-efficacy to PA, including their 
interpretation of physical and emotional reactions when engaging in PA (e.g. anxiety 
due to increased heart rate when engaging in PA), personal mastery of PA tasks 
(e.g. accomplishments related to PA), verbal persuasion (e.g. encouragement 
and/or feedback delivered by important others), and modelling experiences (e.g. 
observing someone similar to oneself succeeding in PA-related tasks) (73). At 12 
months post-surgery, participants reported positive physical and emotional reactions 
to PA as a result of a greater ease to engage in PA, as well as the experience of 
mastering activities they previously believed they were not able to perform, which 
likely enhanced their perceived self-efficacy to engage in PA. 
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The present findings show that although participants reported improvements in 
some of the obesity-related perceived barriers to PA (e.g. bodily pain and self-
presentational concerns) when compared to their pre-surgery perception, many 
reported that these barriers were still present post-surgery. These findings are 
consistent with previous research on barriers to PA and experiences of PA following 
bariatric surgery (222, 225, 620, 621). For instance, a recent study using an online 
survey in 366 people who underwent bariatric surgery showed that bodily pain and 
presence of chronic obesity-related comorbid conditions were frequent physical 
barriers (222). The present findings highlight not only that pain might still act as a 
barrier to PA post-surgery, but that for those people who experience chronic obesity-
related comorbid conditions (e.g. osteoarthritis) or who are still overweight, fear of 
pain and/or injury might also act as a barrier to PA. In a study that investigated 
changes in self-reported PA and exercise cognitions following restrictive bariatric 
surgery, fear of injury was also found to be a barrier to PA at 1 year, and a predictor 
of reduced participation in PA at 2 years post-surgery (621). 
Regarding self-presentational concerns, the presence of excess skin resulting from 
substantial weight loss was described as a new barrier to PA. Similarly, a cross-
sectional qualitative study that explored people’s experiences, on average 28 
months following gastric bypass, found that excess skin was commonly reported as 
an undesired consequence of weight loss (620). Their findings showed that some 
participants reported to be more self-conscious about the excess skin than they had 
been about being obese. 
The present findings also highlighted that several non-obesity related perceived 
barriers to PA identified pre-surgery, including lack of motivation, lack of time, and 
social support issues persisted at 12 months post-surgery. Specifically, participants 
reported low motivation to engage in PA during the first months post-surgery due to 
substantial weight loss. Findings from the pre-surgery exploration of participants’ 
perceived barriers to PA showed the presence of feelings of helplessness and 
hopelessness towards weight loss and weight maintenance (611). As a result of 
unsuccessful attempts at weight loss using diet and increased PA, participants 
appeared to believe that their PA behaviour was permanently outside of their 
control. Although participants believed that regular participation in PA results in 
extensive health benefits, their previous experiences of participation in PA were 
primarily concerned with weight loss. Given participants generally experienced 
weight loss post-surgery without increasing their participation in PA, they perceived 
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PA to be unnecessary post-surgery. A lack of intentionality (i.e. people may not want 
to engage in PA) and devaluation of the activity (i.e. people may not value the 
outcomes of PA enough to engage in regular PA), as well as a lack of willingness to 
invest the necessary effort to overcome the residual perceived barriers to PA (e.g. 
learn and apply time management strategies to overcome lack of time as a barrier to 
PA) seem to contribute to the lack of motivation to engage in PA that was reported 
by participants in the post-surgery interview. These factors are consistent with the 
concept of amotivation (i.e. lack of intention to act) and are associated with 
avoidance and desistance of participation in PA (16, 17, 613, 622). 
Perceived lack of time has also been frequently reported as a perceived barrier to 
PA in previous studies involving people who underwent bariatric surgery, people 
who are obese, and the general adult population (207, 219, 222, 548). Although 
participants did not report it as a barrier, the present findings suggested they did not 
believe PA to be important enough to be a priority. Most people have multiple 
concomitant goals in everyday life (e.g. succeed at work, spend time with family and 
friends, maintain a healthy lifestyle) that may conflict when they compete for the 
same resources (e.g. time, money) (623, 624). Goal commitment (i.e. the 
determination to reach a goal) is usually based on the belief that a goal is both 
desirable, which is determined by the expected value or attractiveness of the 
activity, and feasible, which is determined by one’s belief they can achieve the 
expected outcome by their own effort (625). Participants appeared to experience 
conflicting goals regarding participation in PA and other activities, such as family 
and/or work responsibilities, which was likely influenced by the devaluation of PA, 
resulting in lack of prioritisation of PA (626). Similarly, the results of an online survey 
highlighted that lack of motivation was a commonly reported barrier to exercise 
among people who underwent bariatric surgery, which was related to difficulties with 
participating in regular PA and making PA a priority (222). Social support issues, 
such as lack of support with family responsibilities and lack of company to engage in 
PA, have also been previously reported as a barrier to PA by people following 
bariatric surgery (222, 225). Social support issues are also likely to influence 
people’s belief regarding the feasibility of regular participation in PA, and therefore 
negatively influence their commitment to participate in PA. A recent qualitative study 
found that the need of support from family, friends and health professionals in order 
to be physically active was a salient theme at 12 months following gastric bypass 
(225). Although previous investigations were cross-sectional in nature, converging 
evidence from different studies suggests that the substantial weight loss achieved 
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following bariatric surgery does not remove all perceived barriers to PA, particularly 
those non-obesity related (e.g. lack of motivation, time and social support). 
This study is the first to explore the perceived facilitators to PA following restrictive 
bariatric surgery and how they differed from participants’ pre-surgery perceptions. 
Weight loss was reported as the most important and only obesity-related perceived 
facilitator to PA at the post-surgery interview, which was consistent with pre-surgery 
perceptions. Weight appears to be related to both perceived barriers and facilitators 
to PA, since at the post-surgery interview participants believed weight loss was a 
facilitator to PA and excess weight was no longer a barrier to PA. Non-obesity 
related perceived facilitators identified in the pre-surgery interview were confirmed 
post-surgery, including social factors (e.g. company to engage in PA) and better 
time management. A systematic review and meta-analysis found that time 
management and social support/social change were the most effective behaviour 
change techniques in changing self-efficacy to engage in PA in people who are 
obese, and that social support was also effective in changing  PA behaviour of 
people who are obese (75). Since social support and better time management were 
reported as perceived facilitators to PA both pre- and post-surgery, it is reasonable 
to expect that strategies aimed at enhancing these factors would facilitate 
participation in PA. 
This study is the first to explore factors perceived as motivators to PA over the first 
12 months following restrictive bariatric surgery. Different types of motivations 
emerged from participants’ reports, which can be understood within the context of 
Self-determination Theory (16, 613). Most participants, regardless of the reported 
participation in PA, indicated that the main motivators to PA at the post-surgery 
interview were additional weight loss or maintenance of weight loss, as well as 
improvement in physical appearance. Specifically, participants explained that 
additional weight loss or maintenance of weight loss acted as motivators to PA 
around the 6 months post-surgery, when their weight loss slowed down or 
plateaued, and the presence of excess skin started to be a concern. These 
motivators appear to be based on esteem-related factors, which are considered an 
extrinsic or controlled type of motivation (i.e. dependent on external reward, avoiding 
a punishment, or attaining approval), and have been shown to have little association 
with maintenance of PA behaviour (16, 17). Few participants reported that 
enjoyment of activity was a motivator to PA, which is considered a more intrinsic or 
autonomous type of motivation (i.e. dependent on the inherent pleasures and 
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satisfactions provided by the activity), and positively associated with maintenance of 
PA behaviour (16, 17). 
Clinical messages 
In addition to the comprehensive health benefits of regular participation in PA, there 
is evidence to suggest that the optimisation of PA, both pre- and post-bariatric 
surgery, results in better post-surgery outcomes, such as less surgical 
complications, greater weight loss and maintenance, and favourable changes in 
body composition and cardiometabolic risk factors (66, 69, 419). However, several 
studies have reported little or no change in participation in PA post-surgery, with 
most people failing to achieve international recommendations for the amount of PA 
required to improve and/or maintain health (4-8). The lack of significant changes in 
PA might be partially explained by the residual perceived barriers to PA reported in 
the post-surgery interview, as well as by a lack of appropriate interventions and/or 
services aimed at helping people who undergo bariatric surgery to engage in PA 
(222). The knowledge of factors related to PA (i.e. perceived barriers, facilitators, 
and motivators to PA) is relevant to inform health professionals on the development 
of successful strategies that target the specific needs of people who undergo 
bariatric surgery. 
The findings of the present study offer a framework for clinicians to discuss and 
address several of the barriers, facilitators, and motivators to PA in order to optimise 
PA in people who undergo restrictive bariatric surgery. The first months following 
bariatric surgery are a period of recovery from the surgical procedure and adaptation 
to drastic changes in eating habits and body weight (225, 619). According to 
participants’ reports, it appears that they were more receptive and motivated to 
change their PA around 6 months post-surgery, once the post-surgery adaptation 
period is over and they felt more able or confident to engage in PA. Given most 
participants reported an increase in their perceived ability or confidence to engage in 
PA, strategies aimed at promoting further improvements in people’s self-efficacy to 
engage in PA might have a positive influence on their motivation to PA. 
Interventions aimed at promoting PA following bariatric surgery could build on the 
positive changes reported by participants (i.e. positive physical and emotional 
reactions to PA and mastery of activities) in order to further improve their perceived 
self-efficacy. For instance, clinicians could provide meaningful positive feedback 
related to competence or mastery of PA to help people understand their own 
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abilities and skills. Clinicians could also provide opportunities for people who 
undergo bariatric surgery to engage in modelling experiences, such as observing 
significant others who have similar physical abilities perform PA. Planning has been 
reported as an useful strategy to manage goal conflict and improve maintenance of 
PA behaviour (627). Interventions that aim to optimise action planning (i.e. planning 
when, where, and how goals will be pursued) and coping planning (i.e. anticipating 
obstacles and devising coping strategies) may also be beneficial to optimise PA 
among people who undergo bariatric surgery (623). 
Barrier identification and problem solving have been found to be associated with 
more effective PA behaviour change interventions among people who are obese 
and the general population (75). It would seem important for clinicians working with 
people who undergo bariatric surgery to routinely provide information regarding the 
expected changes (or lack thereof) in perceived barriers to PA. Also, patients could 
benefit from a multidisciplinary approach that provides strategies to minimise the 
residual perceived barriers to PA and the new barriers to PA that appear post-
surgery. For instance, those people who perceive chronic pain and/or fear of pain as 
barriers to PA would benefit from optimal pain management and development of 
coping strategies to deal with PA-related pain and/or fear of pain. Similarly, those 
people who experience barriers to PA related to excess skin would benefit from 
advice on preventive strategies for potential skin rashes or infections related to 
participation in PA. In addition to managing barriers, the identification of perceived 
facilitators to PA can inform clinicians about people’s specific needs in order to 
provide tailored interventions. Increasing motivation to engage in PA among people 
who undergo bariatric surgery is needed, given that lack of motivation has been 
frequently reported as a perceived barrier to PA, both pre- and post-surgery. 
Specifically, interventions aimed at optimising PA in this population could benefit 
from focusing on reducing amotivation and promoting more autonomous or intrinsic 
types of motivation rather than controlled or extrinsic types of motivation (16, 622). 
Meta-analytic data have supported the positive effects of intrinsic motivation (i.e. 
when the activity is inherently enjoyable; beneficial for personal goals, values or 
aspirations) on PA and weight loss (628). Motivational interviewing has been found 
to reduce resistance and increase motivation to behaviour change, particularly 
among people who are amotivated (622, 629). A recent meta-analysis has reported 
that the addition of motivational interviewing to usual care results in increased PA 
among people with chronic health conditions (630). This approach is often directed 
at building motivation for a specific behaviour (e.g. PA) by highlighting the benefits 
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and costs of changing versus not changing thereby aiming to resolve the 
ambivalence between desired and actual behaviour (622). 
Strengths and limitations 
The present study highlighted the complexity of perceived barriers and facilitators, 
as well as motivators to PA among people who underwent restrictive bariatric 
surgery, which included physical, psychological and social factors that were both 
specific to this population (e.g. concerns about excess skin) and common to the 
general population (e.g. lack of motivation). The main strength of this study is the 
longitudinal in-depth exploration (pre- and post-surgery interviews) that provided 
insight into temporal characteristics of some of the important factors related to 
participation in PA. Additionally, the focus on people who underwent restrictive 
bariatric surgery is also a strength, given the lack of in-depth explorations of factors 
related to PA in this population despite the large increase in the amount of restrictive 
procedures performed in preference to malabsorptive or mixed procedures. 
Limitations of this study include a sample of people who attended a private bariatric 
clinic, which may limit the transferability of the results to people undergoing bariatric 
surgery in the public health system or of a lower socio-economic status. Also, 
previous studies have shown that people who are obese, including those who 
underwent bariatric surgery, often overestimate participation in PA when assessed 
by subjective methods (e.g. self-report), therefore, it is not clear if the increased 
participation in PA reported by some participants was real or if the increase in 
participants’ perceived ability to participate in PA was mistakenly understood as an 
increase in actual participation in PA (5, 401). Future studies should consider the 
combination of objective methods (e.g. accelerometers) to investigate changes in 
PA with qualitative exploration of factors related to PA following bariatric surgery. In 
conclusion, this study provides in-depth information regarding changes in perceived 
ability to engage in PA, barriers and facilitators to PA, as well as motivators to PA 
over the first 12 months following restrictive bariatric surgery. These data are 
relevant to inform the development of tailored interventions to optimise participation 
in PA in this population. 
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CHAPTER 7 SUMMARY AND CONCLUSIONS 
Overview 
This programme of research comprised two studies. Study 1 was quantitative, 
longitudinal and observational in design, and investigated changes in measures of 
physical activity (PA), sedentary behaviour (SB), and other health outcomes over 
the first 12 months following restrictive bariatric surgery. Study 2 was qualitative and 
longitudinal in design, and explored participants’ perceptions of factors related to 
their participation in PA pre- and post-surgery and how these changed 12 months 
post-surgery. Although a combined (i.e. mixed-methods) analysis was not possible 
due to the fact the studies were performed in separate samples, the findings of the 
two separate studies have provided novel data regarding the effect of restrictive 
bariatric surgery on objective measures of PA and on factors that are relevant to 
participation in PA in this population. The findings of both studies, when taken 
together, can provide clinicians with relevant information to be used in the 
development of interventions aimed at optimising PA in people who undergo 
bariatric surgery. This chapter summarises the important and novel findings 
presented in this thesis and discusses the implications of these findings for clinical 
practice and future research. 
7.1 Restrictive bariatric surgery produces large and significant 
improvements in several health outcomes, but does not change 
participation in physical activity or time spent in sedentary 
behaviour  
Findings from Study 1 demonstrated that, when compared with pre-surgery 
measures, there were no changes in total time spent in PA and SB or in the way PA 
and SB were accumulated over the first 12 months following restrictive bariatric 
surgery. Similarly, there was no change in cardiovascular fitness. This lack of 
change in measures of PA, SB and cardiovascular fitness occurred despite large 
and significant weight loss, as well as significant improvements in outcomes relevant 
to participation in PA, such as self-efficacy to exercise, sleep quality and daytime 
sleepiness. Of note, findings indicated that the significant improvements in 
measures of HRQoL, obesity-related quality of life, and symptoms of mental health 
disorders, which had normalised at 12 months post-surgery, did not result in 
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enhanced participation in PA and SB. Both pre-surgery and at multiple time points 
over the first 12 months post-surgery, participants spent more than 70% of their 
waking hours in SB, which was mostly accumulated in prolonged uninterrupted 
bouts ≥ 30 minutes, around 20% of their waking hours in light intensity PA and only 
5% of their waking hours in moderate to vigorous (MVPA), which was mostly 
accumulated in very short bouts < 10 minutes. Further, at 12 months post-surgery, 
when compared to previous reports for the general population, participants 
presented lower average daily step count, and greater amount of time spent in SB. 
This is of importance, as when compared to the general population, people who 
undergo restrictive bariatric surgery are at a higher risk of the detrimental health 
effects associated with participation in little PA and increased time in SB. Given 
restrictive bariatric surgery appears to be insufficient to produce changes in PA. 
7.2 Considerations for increasing physical activity prior to 
bariatric surgery 
In accordance with data from Study 1 showing little participation in PA pre-surgery, 
findings from the sample included in Study 2(A) showed that although most 
participants believed regular PA was associated with important health benefits, the 
majority reported they did not engage in sufficient PA to confer such benefits. Most 
participants also believed that engagement in planned and structured PA (i.e. 
exercise) or sport was required to be considered physically active and described 
several barriers to PA, which were both obesity and non-obesity related. Weight loss 
was identified as the primary facilitator to PA, with other facilitators not related to 
obesity being reported less commonly (e.g. social support and better time 
management). Increasing participation in PA in people who are scheduled to 
undergo bariatric surgery may improve cardiovascular fitness and body composition, 
reduce surgical complications, enhance post-surgery recovery, and promote greater 
weight loss and maintenance (50, 69). Understanding barriers and facilitators to PA 
has been shown to be an integral component of developing behavioural 
interventions which are effective at producing short-term improvements in objective 
measures of PA prior to bariatric surgery (34).  
In this regard, the findings from Study 2(A) provide a framework for clinicians to 
discuss and address several of the beliefs, barriers and facilitators to PA in people 
prior to bariatric surgery. For instance, it would seem important for clinicians working 
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with people who are scheduled to undergo bariatric surgery to challenge their beliefs 
regarding what PA is and provide educational counselling to this population that PA 
is not restricted to participation in exercise or sports. This can be achieved by 
informing them of the health benefits associated with reducing time spent in SB and 
increasing participation in light intensity PA. The educational counselling could 
involve strategies to decrease SB by interrupting prolonged periods of sitting time 
with standing and slow walking. In addition to educational counselling regarding the 
different types of PA, people who undergo bariatric surgery may also benefit from 
advice on strategies to overcome the non-obesity related barriers to PA that are not 
likely to change as a result of the surgery alone, such as time management 
strategies to assist with participation in PA. As people who are scheduled to 
undergo bariatric surgery appear to have several perceived barriers to PA and low 
motivation, it would seem important to promote the use of goal setting strategies that 
incorporate realistic goals, such as initially targeting achievable increases in time 
spent in light intensity PA, in combination with regular progression to more 
challenging activities that can be sustained. Further, participants frequently reported 
feelings of helplessness and hopelessness regarding their lack of previous success 
in losing weight with increased participation in PA. Given the potential negative 
impact of these feelings on people’s self-efficacy and perceived value of engaging in 
PA, a focus on educating people who undergo bariatric surgery on the health 
benefits related to PA that have been demonstrated in people who are obese in the 
absence of weight loss, such as reduction in abdominal obesity and cardiometabolic 
risk factors (618), could be of benefit to increase their motivation. Additionally, 
providing access to support, from clinicians or friends and family members may 
contribute to people’s participation in PA.  
7.3 Considerations for increasing physical activity following 
bariatric surgery 
Study 2(B) demonstrated that, at 12 months following restrictive bariatric surgery, 
participants reported an increase in their ability to engage in PA. This seems to 
relate to a greater ease to engage in PA as a result of post-surgery weight loss and 
consequent reduction in obesity-related perceived barriers to PA. This finding 
reported in Study 2(B) concurs with data reported in Study 1 showing significant 
improvements in self-efficacy to exercise, physical and obesity-related quality of life 
measures, as well as large reductions in weight and weight-related symptoms over 
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the first 12 months post-surgery. However, these favourable changes did not appear 
to be sufficient to induce a behaviour change of increased participation in PA. The 
qualitative study revealed that most participants reported not engaging in PA during 
the first 3 to 6 months post-surgery, and many reported no change or decreased 
participation in PA over the first 12 months post-surgery. This is consistent with the 
lack of change in objective measures of PA found in the sample of Study 1, and 
might explain the association found between decreased number of steps/day and 
increased weight loss found in this sample. Furthermore, many participants in Study 
2(B) reported that there were residual obesity-related barriers to PA, and most 
participants reported that pre-surgery non-obesity related barriers to PA (e.g. lack of 
motivation and lack of time) were still present at 12 months post-surgery. Of note, at 
12 months post-surgery, most participants reported extrinsic types of motivation, 
such as additional weight loss and improvement in physical appearance, and few 
participants reported to be intrinsically motivated by enjoyment of PA. The 
persistence of barriers to PA and predominance of extrinsic or controlled types of 
motivation to PA could partially explain the lack of change in PA seen over the first 
12 months following restrictive bariatric surgery.  
Findings from this programme of research, in combination to current research on 
health behaviour change models, suggest that behavioural interventions with a 
multidisciplinary approach are likely required in order to increase participation in PA 
in this population (540, 604, 610). Furthermore, the combined findings from the 
studies reported in this thesis indicate that in order to change PA post-surgery, a 
behavioural intervention which targets goal setting, problem solving, self-efficacy, 
and motivation to behaviour change is likely to be required (75, 604, 605). Of 
particular interest to clinicians is the finding that people who undergo restrictive 
bariatric surgery are more likely to participate in light intensity PA rather than MVPA. 
Behavioural interventions targeting goal setting may be more successful at 
promoting PA if there is a focus on initially increasing light intensity PA in place of 
SB. This may, in turn, promote increased participation in MVPA. This is because 
encouraging feasible changes and achievable goals is more likely to increase 
people’s self-efficacy to progress to more challenging activities (75, 608-610). 
People who undergo restrictive bariatric surgery could also benefit from participation 
in resistance exercise, in order to prevent the significant loss of fat-free mass found 
post-surgery. Additionally, since surgery may also result in reductions in measures 
of bone mineral density, those people who are at risk of or are diagnosed with 
osteoporosis could benefit from weight-bearing activities. Further, given the lack of 
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change in cardiovascular fitness, people who present with impaired cardiovascular 
fitness pre-surgery could benefit from participating in a supervised exercise program 
that could offer improvements in aerobic reserve. 
Participants reported that many of the barriers to PA identified pre-surgery, such as 
pain, self-presentational concerns, lack of motivation, lack of time and social support 
issues were still present 12 months post-surgery. Therefore, this population could 
benefit from a multidisciplinary approach that provides information regarding the 
expected changes (or lack thereof) in perceived barriers to PA and strategies to 
minimise the residual barriers to PA and the new barriers to PA that may appear 
post-surgery. For example, optimal pain management and development of coping 
strategies to deal with PA-related pain and/or fear of pain could be beneficial to 
those people who perceive chronic pain and/or fear of pain as barriers to PA. 
Likewise, those people who experience problems related to excess skin would 
benefit from advice on preventive strategies for potential skin rashes or infections 
related to participation in PA. The identification of perceived facilitators to PA, such 
as social support and better time management could also inform interventions that 
target people’s specific needs. For example, having company to engage in PA (e.g. 
friend, family member or professional) could be beneficial to people who perceived 
social support as a facilitator to PA. Of note, lack of motivation to PA was frequently 
reported as a barrier to PA, both pre- and post-surgery. Thus, there is a clear need 
for the use of strategies to increase motivation to PA in this population. Specifically, 
most motivators to PA reported by participants were based on esteem-related 
factors, which are considered extrinsic types of motivation, and have little 
association with maintenance of PA (16, 17). Few participants reported intrinsic 
types of motivation, which are more associated with maintenance of PA. Therefore, 
it appears that interventions aimed at increasing participation in PA in this population 
should include strategies to reduce amotivation and promote more intrinsic or 
autonomous types of motivation rather than extrinsic or controlled types of 
motivation. For example, motivational interviewing, in addition to usual care, has 
been found to increase participation in PA among people with chronic health 
conditions (630). People who undergo bariatric surgery and have low motivation to 
PA could benefit from a motivational interviewing approach, since this focuses on 
building motivation for PA by helping people identify the benefits and costs of 
changing versus not changing, and therefore aiming to resolve the ambivalence 
between desired and actual behaviour (622). 
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This programme of research also provided novel information regarding the pattern of 
change in several outcomes following restrictive bariatric surgery. Study 1 
demonstrated that for those outcomes in which surgery produced a significant effect, 
the majority of change was observed in the first 3 to 6 months, with less, if any 
change between 6 and 12 months post-surgery. Of note, the pattern of change for 
those outcomes followed the same pattern of weight loss. Additionally, most 
participants from Study 2(B) reported they did not find participation in PA needed or 
desirable during the first 3 to 6 months post-surgery, given the substantial weight 
loss achieved as a result of the drastic dietary changes. These findings suggest that 
the best time to introduce interventions aimed at optimising PA may be after the first 
3 to 6 months post-surgery, when the majority of weight loss has occurred and 
participants appeared to be more receptive to engaging in PA.  
7.4 Future research directions  
This programme of research provided novel and relevant data to inform clinicians of 
factors relevant to participation in PA prior to and following restrictive bariatric 
surgery. Future research is needed to draw definite conclusions on differences in 
the changes in objective measures of PA and SB between those who undergo LSG 
and LAGB, as well as on associations between weight loss and change in objective 
measures of PA and SB. Future research is also needed to investigate if a 
multidisciplinary behavioural intervention aimed at optimising participation in PA in 
people who underwent bariatric surgery can provide significant and sustained 
changes in PA. The findings of this thesis suggest such an intervention should 
include goal setting strategies that target feasible goals for increasing participation in 
PA, such as an initial increase in light intensity PA, which is likely to enhance 
people’s self-efficacy to progress to an increase in participation in MVPA, as well as 
promote a reduction in time spent in SB. Additionally, such an intervention should 
incorporate problem solving and planning strategies to manage the several 
perceived barriers to PA identified both pre- and post-surgery. Further, the use of 
strategies that aim to reduce amotivation and promote more intrinsic or autonomous 
types of motivation appears to be a promising way to enhance participation in PA 
among people who undergo bariatric surgery. Of note, the investigation of the short 
and long-term effects of such intervention on other relevant outcomes, such as 
reduced cardiometabolic risk and weight maintenance is warranted.  
Chapter 7: Summary and conclusions 
226 
 
Although this programme of research comprised both quantitative and qualitative 
studies, a combined, mixed-methods approach was not possible as the studies were 
conducted in different samples. Therefore, our conclusions may be limited by having 
different samples. For example, although the report of most participants in Study 
2(B) indicated a lack of change in PA post-surgery, this could not be confirmed by 
objective measures of PA. The use of mixed-methods research is recommended, as 
this would allow for a detailed qualitative exploration of factors underlying 
differences between people in the degree of change in quantitative measures of PA 
pre- and post-surgery. This detailed account could provide further understanding to 
enhance and better target interventions aimed at optimising PA in this population. 
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Appendix 1 
Pre-surgery interview schedule 
 
What does it mean to be physically active?  
(How would you describe a physically active person? What would they need to do to 
be considered physically active?) 
What do you believe are the benefits of engaging in regular physical activity? What 
amount of physical activity is needed for health benefits?  
Is there anything that prevents you or makes it difficult for you to engage in physical 
activity?  
(Are there any physical difficulties that prevent you from engaging in physical 
activity? Do you experience any emotional reason that prevents you of engaging in 
physical activity? Do you experience any social difficulty that prevents you of 
engaging in physical activity? Do you think there is any environmental factor that 
prevents you of engaging in physical activity?) 
What do you believe would make it easier for you to engage in physical activity? 
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Post-surgery interview schedule 
Have there been any changes in your life after the surgery? (Is there anything you 
feel hasn’t changed? What seem to be the most significant changes?) 
Over the last 12 months, did things happen the way you expected? 
Can you remind me of what being physically active means to you? 
Over the last 12 months, have there been any changes in your physical activity? 
(What type/frequency/duration of physical activity do you currently do? What where 
the barriers/challenges/obstacles to change? What facilitated the changes?) 
Is there anything that prevents you or makes it difficult for you to engage in physical 
activity? (How does this compare to before surgery?) 
What do you believe would make it easier for you to engage in physical activity? 
(How does this compare to before surgery?) 
Over the last 12 months, how do you feel when doing physical activity? (Is it the 
same or different from before the surgery?) 
How do you feel about yourself when doing physical activity? (Is it the same or 
different from before the surgery?) 
Why have you changed (or not) your physical activity? (what motivated you to 
change?) 
What makes you want to do (or not) physical activity? 
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Change in total time (minutes/day) spent in sedentary behaviour, light 
intensity physical activity, and moderate to vigorous intensity physical activity 
Assessment 
time point 
 
n 
Observed 
Mean (SD) 
Predicted 
Mean 
Mean change 
from preceding 
time point 
(95%CI) 
p-value 
Sedentary behaviour (minutes/day) 
Pre-surgery 30 732 (121) 705 --- --- 
3 months 27 655 (124) 665 -40 (-67 to -14) 0.003 
6 months 28 638 (137) 647 -18 (-43 to 8) 0.17 
9 months 24 656 (101) 648 1 (-25 to 27) 0.94 
12 months 20 661 (99) 664 16 (-14 to 47) 0.29 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months -41 (-86 to 4) 0.07 
Light intensity physical activity (minutes/day) 
Pre-surgery 30 209 (97) 195 --- --- 
3 months 27 208 (90) 211 15 (-7 to 38) 0.17 
6 months 28 200 (82) 208 -3 (-24 to 19) 0.80 
9 months 24 188 (60) 204 -4 (-26 to 18) 0.74 
12 months 20 192 (62) 202 -3 (-28 to 23) 0.83 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 6 (-31 to 44) 0.73 
Moderate to vigorous intensity physical activity (minutes/day) 
Pre-surgery 30 54 (33) 51 --- --- 
3 months 27 51 (35) 53 2 (-10 to 14) 0.71 
6 months 28 63 (54) 64 10 (-1 to 22) 0.08 
9 months 24 59 (48) 66 3 (-9 to 15) 0.65 
12 months 20 54 (24) 55 -11 (-25 to 2) 0.09 
 
Mean change 
(95%CI) 
p-value 
Pre-surgery to 12 months 4 (-16 to 23) 0.71 
Abbreviations: CI: confidence interval; SD: standard deviation. All comparisons done using 
multilevel mixed-effects linear regression model. At each assessment time point, data were 
presented as the estimate for each time point using all available information (i.e. using only 
those cases observed at that time point [observed mean] and including cases missing in that 
time point [predicted mean]) and only data from participants who met the minimal monitor 
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wear requirements were included in the analyses (see section 3.1.5.2.2 for definition of 
minimal monitor wear requirements).
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Change in total time (percentage of waking hours) spent in sedentary 
behaviour, light intensity physical activity, and moderate to vigorous intensity 
physical activity according to surgery type 
Assessment 
time point 
n 
Predicted 
Mean 
Mean change 
from preceding 
time point 
Difference in 
mean change 
between 
LSG and LAGB 
(95%CI) 
p-value 
  LSG LAGB LSG LAGB   
Sedentary behaviour (% of waking hours) 
Pre-surgery 30 72 78 --- --- --- --- 
3 months 27 69 78 -3 0 -3 (-9 to 3) 0.27 
6 months 28 68 76 -1 -2 1 (-4 to 7) 0.66 
9 months 24 69 76 0 0 0 (-6 to 6) 0.91 
12 months 20 71 76 2 1 1 (-6 to 8) 0.73 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months -2 -2 0 (-10 to 10) 0.94 
Light intensity physical activity (% of waking hours) 
Pre-surgery 30 22 17 --- --- --- --- 
3 months 27 25 18 3 0 3 (-2 to 8) 0.29 
6 months 28 24 19 -1 1 -2 (-7 to 3) 0.48 
9 months 24 24 18 -1 -1 0 (-5 to 5) 1.00 
12 months 20 23 18 0 0 0 (-6 to 6) 0.92 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months 1 1 1 (-8 to 8) 0.89 
Moderate to vigorous physical activity (% of waking hours) 
Pre-surgery 30 6 5 --- --- --- --- 
3 months 27 6 5 1 0 1 (-2 to 3) 0.69 
6 months 28 7 5 1 1 1 (-2 to 3) 0.71 
9 months 24 8 6 0 1 0 (-3 to 3) 0.89 
12 months 20 6 8 -2 -1 -1 (-4 to 3) 0.68 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months 1 0 0 (-4 to 5) 0.93 
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Abbreviations: CI: confidence interval. All comparisons done using multilevel mixed-effects 
linear regression model. At each assessment time point, data were presented as the 
estimate for each time point including cases missing in that time point [predicted mean]) and 
only data from participants who met the minimal monitor wear requirements were included in 
the analyses (see section 3.1.5.2.2 for definition of minimal monitor wear requirements).  
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Change in total time (minutes/day) spent in sedentary behaviour, light 
intensity physical activity, and moderate to vigorous intensity physical activity 
according to surgery type 
Assessment 
time point 
n 
Predicted 
Mean 
Mean change 
from preceding 
time point 
Difference in 
mean change 
between 
LSG and LAGB 
(95%CI) 
p-value 
  LSG LAGB LSG LAGB   
Sedentary behaviour (minutes/day) 
Pre-surgery 30 696 731 --- --- --- --- 
3 months 27 645 715 -50 -16 -34 (-89 to 21) 0.22 
6 months 28 628 697 -17 -18 1 (-54 to 56) 0.97 
9 months 24 630 695 2 -1 4 (-56 to 64) 0.90 
12 months 20 648 707 18 12 6 (-60 to 72) 0.86 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months -48 -25 -23 (-120 to 74) 0.63 
Light intensity physical activity (minutes/day) 
Pre-surgery 30 209 158 --- --- --- --- 
3 months 27 229 164 20 6 14 (-33 to 61) 0.55 
6 months 28 221 174 -8 10 -18 (-65 to 29) 0.45 
9 months 24 217 168 -4 -5 2 (-49 to 52) 0.94 
12 months 20 215 167 -2 -2 -1 (-57 to 55) 0.98 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months 6 9 -3 (-82 to 77) 0.94 
Moderate to vigorous physical activity (minutes/day) 
Pre-surgery 30 53 45 --- --- --- --- 
3 months 27 56 45 3 0 3 (-22 to 29) 0.79 
6 months 28 69 50 13 5 7 (-18 to 33) 0.58 
9 months 24 70 56 1 6 -5 (-32 to 23) 0.73 
12 months 20 57 48 -13 -8 -5 (-35 to 25) 0.74 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months 4 3 1 (-41 to 43) 0.97 
Abbreviations: CI: confidence interval. All comparisons done using multilevel mixed-effects 
linear regression model. At each assessment time point, data were presented as the 
estimate for each time point including cases missing in that time point [predicted mean]) and 
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only data from participants who met the minimal monitor wear requirements were included in 
the analyses (see section 3.1.5.2.2 for definition of minimal monitor wear requirements).  
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Estimated pre- to 12 months post-surgery change in measures of physical 
activity and sedentary behaviour with a 10% increase in percentage weight 
loss 
 
n Estimate 95% CI p-value 
Daily step count (steps/day) 
Unadjusted 21 -1993 -3188 to -798 0.002 
Adjusted for type 
of surgery 
21 -2309 -3738 to -880 0.003 
Light intensity physical activity (min/day) 
Unadjusted 20 -2 -32 to 28 0.89 
Adjusted for type 
of surgery 
20 10 -35 to 54 0.65 
Moderate to vigorous intensity physical activity (min/day) 
Unadjusted 20 1 -7 to 10 0.73 
Adjusted for type 
of surgery 
20 1 -11 to 14 0.81 
Sedentary behaviour (min/day) 
Unadjusted 20 -29 -77 to 20 0.22 
Adjusted for type 
of surgery 
20 -5 -76 to 66 0.88 
Abbreviation: CI: confidence interval. 
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Accumulation of sedentary behaviour in uninterrupted bouts < 10 minutes and 
of moderate to vigorous physical activity in bouts ≥ 10 minutes 
Assessment 
time point 
 
n 
SB 
(% of total SB  
in bouts < 10 minutes) 
Mean (SD) 
MVPA 
(% of total MVPA  
in bouts ≥10 minutes) 
Mean (SD) 
Pre-surgery 30 20 (11) 12 (14) 
3 months 27 20 (10) 12 (15) 
6 months 28 22 (11) 14 (14) 
9 months 24 21 (9) 18 (15) 
12 months 20 20 (10) 14 (14) 
Abbreviations: MVPA: moderate to vigorous physical activity; SB: sedentary behaviour. At 
each assessment time point, only data from participants who met the minimal monitor wear 
requirements were included in the analyses (see section 3.1.5.2.2 for definition of minimal 
monitor wear requirements).  
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Change in daily step count according to surgery type 
Assessment 
time point 
n 
Predicted 
Mean 
Mean change 
from preceding 
time point 
Difference in mean 
change between 
LSG and LAGB 
(95%CI) 
p-value 
  LSG LAGB LSG LAGB   
Daily step count (steps/day) 
Pre-surgery 29 8455 6952 --- --- --- --- 
3 months 27 8641 8400 186 1448 -1262 (-3347 to 823) 0.23 
6 months 26 9154 8754 513 354 159 (-1942 to 2260) 0.88 
9 months 26 9071 9397 -83 643 -726 (-2842 to 1390) 0.50 
12 months 22 8788 8880 -283 -517 234 (-2028 to 2495) 0.84 
 Mean change 
Difference in mean 
change (95% CI) 
p-value 
Pre-surgery to 12 months 333 1929 -1596 (-4900 to 1708) 0.34 
Abbreviation: CI: confidence interval. 
 
Appendix 8 
287 
 
Appendix 8 
 
Summary of descriptive statistics for secondary outcomes according to 
surgery type 
 
Cardiovascular fitness (Physical Working Capacity 170 test [Watts]) 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Pre-surgery 24 191 (64) 198 (74) 
12 months 16 205 (54) 223 (48) 
 
Self-efficacy to exercise (Exercise Self-Efficacy Scale score) 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Pre-surgery 30 55.7 (16.4) 46.8 (18.8) 
3 months 30 67.8 (19.8) 65.5 (18.1) 
6 months 29 71.5 (16.5) 70.9 (12.1) 
9 months 29 70.2 (15.7) 72.6 (12.9) 
12 months 28 73.4 (17.1) 69.3 (21.8) 
 
Sleep quality (Pittsburgh Sleep Quality Index score) 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Pre-surgery 30 8.5 (2.9) 9.1 (2.7) 
3 months 30 6.2 (3.8) 6.2 (2.7) 
6 months 29 5.3 (3.9) 5.8 (4.1) 
9 months 29 4.9 (3.5) 4.3 (2.5) 
12 months 28 5.4 (3.8) 6.2 (2.6) 
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Daytime sleepiness (Epworth Sleepiness Scale score) 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Pre-surgery 30 8.2 (4.1) 9.2 (6.0) 
3 months 30 5.4(3.8) 6.8 (5.7) 
6 months 29 4.6 (3.9) 5.7 (3.4) 
9 months 29 4.7 (4.6) 6.7 (4.4) 
12 months 28 4.7 (3.2) 6.8 (4.5) 
 
Body composition (DXA) 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Fat mass (kg) 
Pre-surgery 28 53.8 (9.8) 61.0 (10.3) 
12 months 26 28.5 (7.0) 48.1 (13.1) 
Fat mass (%) 
Pre-surgery 28 49 (5) 52 (6) 
12 months 26 36 (6) 46 (9) 
Fat-free mass (kg) 
Pre-surgery 28 58.0 (9.3) 60.2 (12.6) 
12 months 26 52.7(8.5) 58.2 (11.3) 
Fat-free mass (%) 
Pre-surgery 28 52 (5) 49 (5) 
12 months 26 65 (6) 54 (9) 
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Bone mineral density (DXA) 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Total body (g/cm2) 
Pre-surgery 28 1.26 (0.12) 1.23 (0.11) 
12 months 26 1.27 (0.13) 1.22 (0.09) 
Total body T-score 
Pre-surgery 28 1.54 (1.10) 1.11 (0.79) 
12 months 26 1.52 (1.26) 1.00 (0.95) 
Spine (g/cm2) 
Pre-surgery 28 1.32 (0.14) 1.31 (0.13) 
12 months 26 1.24 (0.18) 1.26 (0.17) 
Pelvis (g/cm2) 
Pre-surgery 28 1.14 (0.17) 1.06 (0.13) 
12 months 26 1.09 (0.15) 1.04 (0.14) 
 
Health-related quality of life (SF-12v2) 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Physical health-related quality of life (PCS score of the SF-12v2) 
Pre-surgery 30 43.3 (7.8) 42.8 (8.7) 
3 months 30 53.9 (5.6) 48.6 (9.2) 
6 months 29 53.6 (9.6) 46.6 (8.8) 
9 months 29 54.7 (5.3) 52.9 (7.3) 
12 months 28 56.5 (6.1) 51.9 (6.2) 
Mental health-related quality of life (MCS score of the SF-12v2) 
Pre-surgery 30 47.3 (10.5) 46.3 (8.3) 
3 months 30 52.1 (8.6) 52.4 (7.0) 
6 months 29 50.8 (10.1) 51.7 (7.3) 
9 months 29 50.3 (9.6) 50.6 (11.4) 
12 months 28 51.0 (10.2) 50.1 (7.7) 
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Obesity-related quality of life and weight-related symptoms 
Assessment 
time point 
n 
Observed Mean  
(Standard deviation) 
  LSG LAGB 
Total score of the IWQOL_Lite 
Pre-surgery 30 56.2 (17.3) 56.2 (10.4) 
3 months 30 82.0 (20.9) 72.7 (15.1) 
6 months 29 86.9 (18.3) 77.5 (14.6) 
9 months 29 91.7 (13.2) 82.1 (9.7) 
12 months 28 91.8 (13.8) 85.5 (9.9) 
Obesity-related quality of life (OWLQOL score) 
Pre-surgery 30 38.0 (18.0) 39.7 (14.8) 
3 months 30 71.6 (24.0) 60.9 (22.9) 
6 months 29 81.8 (19.2) 62.0 (19.6) 
9 months 29 86.1 (15.6) 67.0 (15.8) 
12 months 28 85.2 (18.8) 71.4 (16.3) 
Weight-related symptoms (WRSM score) 
Pre-surgery 30 32.1 (17.4) 36.6 (15.2) 
3 months 30 13.8 (12.4) 22.7 (20.0) 
6 months 29 9.4 (9.2) 16.6 (14.7) 
9 months 29 9.0 (7.8) 18.1 (19.3) 
12 months 28 8.2 (8.6) 13.1 (13.1) 
Abbreviations: IWQOL-Lite: short version of the Impact of Weight on Quality of Life 
Questionnaire; OWLQOL: Obesity and Weight-loss Quality-of-life Instrument; WRSM: 
Weight-related Symptoms Measure. 
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Mental Health (Beck Depression Inventory score) 
Assessment 
time point 
n 
Observed 
Mean (SD) 
  LSG LAGB 
Symptoms of depression  
Pre-surgery 30 13.4 (8.2) 9.5 (4.4) 
3 months 30 6.8 (6.8) 6.0 (2.0) 
6 months 29 6.5 (7.5) 5.5 (4.0) 
9 months 29 5.3 (6.7) 4.0 (3.4) 
12 months 28 5.1 (6.1) 3.5 (2.9) 
 
Mental Health (Depression, Anxiety and Stress Scales) 
Assessment 
time point 
n 
Observed Median 
[Interquartile range] 
  LSG LAGB 
Symptoms of depression (depression subscale of the DASS-21) 
Pre-surgery 30 2.0 [0 – 10] 4.0 [2.5 – 6.5] 
3 months 30 1.0 [0 – 3.0] 1.0 [1.0 – 2.0] 
6 months 29 1.0 [0 – 4.0] 2.5 [1.5 – 3.5] 
9 months 29 1.0 [0 – 5.0] 5.0 [0 – 2.5] 
12 months 28 0 [0 – 4.0] 1.5 [0.5 – 4.5] 
Symptoms of anxiety (anxiety subscale of the DASS-21) 
Pre-surgery 30 2.0 [1.0 – 6.0] 3.5 [2.0 – 6.0] 
3 months 30 1.0 [0 – 2.0] 1.0 [1.0 – 2.5] 
6 months 29 1.0 [0 – 2.0] 1.0 [1.0 – 2.0] 
9 months 29 1.0 [0 – 2.0] 1.0 [0.5 – 2.0] 
12 months 28 0 [0 – 2.0] 1.5 [0.5 – 3.5] 
Symptoms of stress (stress subscale of the DASS-21) 
Pre-surgery 30 6.0 [3.0 – 10.0] 5.5 [3.5 – 10.0] 
3 months 30 4.5 [1.0 – 7.0] 6.0 [2.0 – 7.0] 
6 months 29 3.0 [0 – 5.0] 5.5 [1.5 – 8.5] 
9 months 29 2.0 [0 – 6.0] 2.5 [1.0 – 6.5] 
12 months 28 4.0 [0.5 – 6.0] 5.0 [2.0 – 7.0] 
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Abbreviation: DASS-21: Depression, Anxiety and Stress Scales. 
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Appendix 9 
Additional supporting quotes for emergent themes in the pre-surgery 
interview 
Beliefs about physical activity 
Comprehensive 
benefits 
‘I would assume as a physical active person, you know … 
your muscle tone is better.’ (P15) 
 
‘Well you’re fitter, and you can do more.’ (P15) 
 
‘It makes you healthier, because then you don’t have excess 
weight on you.’ (P13) 
 
‘You know, give your body the best chance not to get 
diseases down the track.’ (P3) 
 
‘Yeah, I think it can prevent, sort of things like depression and 
that sort of thing and also helps the heart and lungs, and all 
your bodily functions are a lot better off with regular physical 
activity, I believe.’ (P16) 
Perceived barriers to physical activity 
Obesity-related perceived barriers to physical activity 
Physical barriers ‘I do suffer from a lot, a lot of back pain. And then I obviously I 
have neck issues as well.’ (P5) 
Self-
presentational 
concerns 
‘I don’t like to see myself do that so why would anyone else?’ 
(P14) 
 
‘Ah no…yeah, self-consciousness, self-consciousness, there 
is no way I’d set foot into a gym, a public gym umm…not at 
my size that I am now, I wouldn’t do it umm…I suppose you 
are embarrassed, I suppose…you know…I suppose so…and 
most people in the gym are fairly fit and active you know, I 
can’t run.’ (P19) 
Non-obesity-related residual perceived barriers to physical activity 
Lack of 
motivation 
‘Maybe it is a motivation thing, because if I was truly, truly 
motivated, I would find the time in there (to do PA).’ (P11) 
 
‘Oh can’t be bothered going for a walk, I'll do it later, or 
tomorrow, or never.’ (P16) 
Lack of time ‘But I have no desire at the moment to get up at five in the 
morning because of all the other things that are happening. 
So, for me, it is, the main issue at the moment is that I'm 
working too much.’ (P11) 
 
‘Three kids! three kids…take them through about 8, 8:30 in 
the evening and then you have to clean the house, that takes 
you through about 9, 9:30 and then is finally some time with 
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my wife and actually having some you know, us time…so 
down time it’s just not much…umm…very little.’ (P2) 
Lifestyle ‘Not a lot, catch up on sleep, (laughs) that’s about it. I don’t, I 
don’t do a lot.’ (P13) 
 
‘There is no doubt I can get up and walk and that, is just I 
don’t prioritise’ (P18) 
Perceived facilitators to physical activity 
Obesity-related perceived facilitator to physical activity 
Weight loss ‘Losing weight would help me motivate myself.’ (P13) 
 
‘Losing weight, losing weight is number one. Because, umm, I 
know I can … I will be healthier and more energetic and 
probably with that a bit more … you know, with that feeling of 
having more energy, I will be more motivated to go out and do 
some exercise.’ (P16) 
Non-obesity related perceived facilitators to physical activity 
Social factors ‘I have my best success when I had a friend of mine help me 
stay motivated in the gym, he would turn up in the morning, 
half past five and beep his horn until I get out of bed and join 
him, he would drive me around to the gym and so forth so, I 
had someone who was forcing me to do stuff and who I was 
letting down if I didn’t do stuff and that had a massive impact 
in terms of sticking with stuff, especially in that first two 
months window, you know where is pretty easy to sort of go 
oh, I’m not going there today, I’m a bit sore, not gonna do it. 
So having someone going come on, get in the car, let’s go, it 
was definitely a benefit.’ (P2) 
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Appendix 10 
Additional supporting quotes for emergent themes in the post-surgery 
interview 
Changes in reported participation in physical activity 
No participation in 
physical activity in 
the first months 
following surgery 
‘So basically, for I would say three months, I did no 
personal training. I did nothing. And then probably about 
two and a half months in, I did start just short walks and 
stuff. And then I did go back to personal training and I did 
light stuff, just to get myself there.’ (P6) 
 
‘I just still didn’t feel that I needed to (engage in PA in the 
first few months after surgery), you know what I mean?’ 
(P13) 
Increased 
participation in 
physical activity 
 
‘I consciously, when the opportunity arises, try and walk a 
bit further and during the day at work now I find I get up 
and I go for a walk around the yard and things like that, 
and interact with people a bit more, whereas before I was 
quite comfortable to sit in my office for a period of time. I 
tend to now park further away from the shopping centre 
front door to make myself walk. So I consciously don’t look 
for the closest car park anymore. I look for the farthest.’ 
(P19) 
 
‘Yeah, it's just leisure time rather than actually planned 
activity. As far as also with the kids, and getting out on a 
weekend, instead of just sitting around the house and 
doing nothing. It's easier to get out and take them out 
places and go to the park or do an activity with them.’ (P2) 
 
‘Well, it’s certainly not perfect, but I’m doing more. I’m 
getting out. I’m feeling better about it. The dogs are 
benefitting from it. They’ve lost weight too. [laughs] I 
actually have a post office box in the city. I don’t get my 
mail delivered to my home address because I want to go 
for that 15, 20 minute walk during the day to get out of the 
office, to get some fresh air.’ (P11) 
No change or 
decreased 
participation in 
physical activity 
‘I’d like to be more active. Before, I did lots of … I was at 
the gym and I’d go rock climbing and lots of sports and 
swimming and walking. And I’ve always been lazy, but I did 
that before, because I knew I had to at least make an effort 
and try and lose weight.’ (P14) 
 
‘The walk I'm walking faster. The physical activity on the 
walk, it's better. The number of times I'm doing it, not so 
much. The fact that it’s easier isn't meaning that I'm doing it 
more, which I thought it probably would. I'm still doing the 
once-a-week Pilates physio, which is good.’ (P15) 
Changes in perceived ability to participate in physical activity 
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Physical activity was 
easier 
‘It’s different. Normal physical activity is easy now, easy for 
me, like physically, so that’s not a problem’ (P3) 
Improvement in 
perceived ability to 
engage in physical 
activity 
‘I feel like I can do a lot more, and I feel lighter. I feel like 
before, as I said, I felt like an old lady, so I felt like there 
were a lot of things I couldn't do, certain exercises and 
what not.’ (P17) 
 
‘Now, I feel younger and healthier in that I still have 
moments where I'm like, “Wow, I can't believe I can do that 
now, I can't believe my body is capable of those things.” 
Like I said, walking to the top of that temple, or doing a 
certain pose in yoga, I'm like, “Wow, I can do this stuff”.’ 
(P17) 
 
‘I mean, I think the physical component is a huge factor 
that my attitude about what I'm capable of and what I can 
do has changed so much that if someone said … my friend 
has always wanted me to do City to Surf or one of the fun 
runs they have during the year, and I've always thought, 
“There's no way I want to go on a run with a bunch of 
healthy people and be the last person across the line and 
struggle and be in pain.”  Whereas now I go, “Yes, I can do 
that,” and that's because my mental outlook, I guess, has 
changed.’ (P17) 
 
‘Also, I do Pilates physio once a week. The improvement – 
as I lost the weight, I could feel physical strength. The 
squats were able to be deeper. Stretches were easier. 
Yeah. And more range, a lot more range. I've been doing 
that for three years, and in the last 12 months the 
improvement feels like it's three times – it’s probably not, 
but it feels like it is three times. I can step up onto a 
platform that's the equivalent of three regular steps, which I 
couldn't do before. I didn't have the lift in my knees.’ (P15) 
 
‘Particularly in America we travelled with a couple who's a 
bit older than us but they're active. But it surprised me that 
they were tired. And they are older, but I’d considered them 
quite fit, but I had more energy than they did. That kind of 
felt good, not that I felt like I was better than them, but it felt 
good for me because I don't think that would've been the 
case before the surgery. I think I’d have been the one who 
got tired first.’ (P15) 
 
‘As I said before, like climbing up and down rocks with 
confidence, walking a lot further than I used to. My wife 
used to lead the way. Now it's me leading the way and her 
saying, "Can you wait for me?".’ (P19) 
 
‘It's not a hassle anymore. It's not a hassle. It’s not a 
hassle. [laughs] I just didn’t feel like it (doing PA) … yeah, 
now for me it's just not a hassle to get up and just go out, 
walk to a friend's house instead of getting in the car.’ (P7) 
Appendix 10 
297 
 
Changes in perceived barriers to physical activity 
Physical barriers ‘Yeah, well before, I was basically taking pain medication 
every day when I got home from work, because I'd have a 
really sore lower back. I used to get like a sort of sciatic 
type pain down the back of my legs. I'd often be like 
limping around at work, and that basically never happens 
anymore.’ (P17) 
 
‘Because at work, I’ve got to walk upstairs to get to the 
staff room. Before that, my knee used to click, but it doesn’t 
anymore. Prior to my surgery, yeah. There’s no pain in my 
legs anymore. Before the surgery, there was pain in my 
back. But now there’s no pain as such, because of the 
weight.’ (P9)  
 
I just think that because my body’s changed so much, and 
it is so much easier – I don’t have sore feet, I don’t have a 
sore knee. Do you know what I mean? It’s just easier. I just 
think it’s easier when you don’t have the excess weight on.’ 
(P6) 
 
‘It’s obviously with my knee reconstruction, the damage I 
had to my left knee, that's been fantastic as well because 
losing the weight has taken the pressure off my joints so I 
don’t have that constant pain. I don’t have to live with that 
so I’m really very comfortable with how all that's turned 
out.’ (P19) 
 
‘Part of it's also just when you're big and unhealthy you 
don't want to move. You don't want to run around and 
place strain and stress on your knees and shoulders and 
so forth. So having lost the weight, those sort of barriers 
are definitely a lot less, and I'm more inclined to do stuff. 
Whereas before I was more inclined to not do stuff. Now, 
it's actually a conscious sort of thing. In the past I would 
think “Oh, I don't know that I could do that,” because I was 
worried about being unfit and not being able to last very 
long, playing with the kids and so forth. Whereas that's no 
longer a conscious decision – it's just whether I want to do 
it or not.’ (P2) 
 
‘I mean getting out on the bike and so forth; it's a lot less of 
a struggle. It's a lot better feeling of doing something rather 
than … I don't know how to put it in words. In the past 
when I was riding the bike before the surgery, you felt 
lethargic. You felt sort of heavy. Mentally you just feel 
heavy.’ (P2)  
 
‘Yeah, just having the energy to do it. Before I just couldn’t 
do it. Just being so big, and I would just go walking for 10 
minutes and be breathless. Now, I can just do it without 
even thinking of it, and thinking, “Oh, my God. I’m going to 
be breathless.” But now, I just do it.’ (P9) 
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‘Just before, I just didn’t want to walk because I would get 
so breathless very quickly. But, now, I know I can do it and 
just keep going. I feel really good about it.’ (P9)  
 
‘We’ve got this big hill where I work. It’s massive. It’s on a 
really big gradient.  And I used to get sore knees and be 
puffing when I used to get to the top of the hill to work. And 
probably embarrassing if anyone was behind me. Now, not 
even puffing at all. I could run down again, back up again. 
So that was nice.’ (P14)  
 
‘Yeah. It used to, like getting in and out of cars and things, 
it used to be hard, strained. My health, my heart doesn’t 
feel like it’s palpitating and things like that. I generally feel 
healthier.’ (P3) 
 
‘So you know, even if it's something as simple as just going 
for a walk and so forth, instead of worrying about is your 
heart rate going too much, are you out of breath, and so 
forth, you can walk and just enjoy the walk. Whereas in the 
past, it was more about how do you feel in that situation.’ 
(P2) 
Self-presentational 
concerns 
‘Now, I go to a yoga class that’s run by a yoga instructor, 
not a physiotherapist. It's a big class, and I don't feel self-
conscious about being in the class or anything, and I really 
enjoy it.’ (P17) 
 
‘I can get clothes on. It's no bloody hassle to get out the 
front door. I just put on a pair of pants and a T-shirt and off 
I go whereas before it was like, "What am I going to wear? 
What fits me?" The confidence to … being scared to walk 
on the street and people look at you because you just look 
revolting or I felt revolting, and now you just feel unreal.’ 
(P7)  
 
‘I don’t get stared at anymore [chuckles] when you go 
walking or in shops. Because when you’re obese, you 
know people are looking at you. You know what they’re 
thinking. But that doesn’t happen anymore, so it’s really 
good.’ (P9) 
 
‘I had very low self-esteem. I always knew that whenever 
someone looked at me, I would be judged because of my 
body image, but now it doesn’t have that effect on me 
anymore. In myself, I always thought that I wasn’t good 
enough for people. I always put myself in a lower level. I 
think it’s definitely a confidence barrier again. That I’m not 
scared of being the way I am now as before I was, and 
then the insecurities and stuff like that. Now, I just don’t 
care what people think of me.’ (P13) 
 
‘Maybe my confidence … I’ve always been confident, but 
it's gone up a little bit, I would say. Yeah, yeah. I was 
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always confident before, but I always mindful that people 
might be looking at me because I’m a bigger person. Now I 
don't feel like they're looking at me, I’m just … yeah. It’s 
more about perception.’ (P14) 
Improvement in 
wellbeing and 
vitality 
‘I feel happier, I’ve got more energy, and obviously I’ve 
seen results, so you feel better in yourself once you’ve lost 
weight and you’re fitting into clothes that you haven’t fitted 
into for quite some time. So it’s obviously the band is 
helping me a lot with my eating, so I eat smaller portions, 
I’m eating the right foods, and yeah, I feel healthy, I feel 
good.’ (P5) 
 
‘Well, I’ve lost 20 kilos, and I feel 100% better than I did 
before, and I … yeah, just in everything, in my health and 
just in my wellbeing as well. I feel healthier.’ (P3) 
 
‘Obviously the physical changes, and I’m much more 
healthier than I was. What makes me feel healthier? Just 
the amount of exercise, I suppose, that I can do now. I 
never would ever think that I would go jogging, but I go 
jogging now, and stuff like that.’ (P6) 
Residual perceived barriers to physical activity 
Residual obesity-related perceived barriers to physical activity 
Physical barriers ‘I still do, but not as severe, because before the surgery, 
because of the extra weight, I used to have severe 
migraines, but I haven’t had too many. I’ve been pretty 
good since I’ve lost the weight. I mean I’ve got scoliosis 
and my back is bad, so I have those days every now and 
then, that it’s sore, but nowhere near as bad as it used to 
be when I had the extra weight on.’ (P5) 
 
‘I'm going through a lot of pain and stuff in my back and 
kidneys and all those sorts of things so I'm getting 
acupuncture which is probably the best thing that I've ever 
… I'm bouncing off the walls with that. It's just fantastic and 
it's also training my pelvic floor which was really weak 
because I was so big. If you know what I mean, I was really 
weak there and my lower back was really sore and stuff. 
And it's like the surgeon said, you know, he said, “You 
thought that was all going to go.” And I was like, “Yeah.” 
But it's not, because you've been working, you've been 
walking around in a certain way for so many years but now 
that you're lighter, the pain is still there.’ (P7) 
Self-presentational 
concerns 
‘And then, the pool’s opening soon. So I’m looking forward 
to that opening, but still I think, “No, I need to lose weight 
before I go to the pool. I’m embarrassed the way I look. I 
look like I do going to the pool, blah, blah, blah”.’ (P16) 
 
‘Having lost the weight, and even now, I'm a lot less self-
conscious and a lot more willing to put myself in situations 
where I'll be doing something or go to do something, 
because I just look and feel better. So mentally, I don't put 
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that roadblock between myself and think, “Oh, what if 
someone looks at me funny,” or whatever it is. But there's 
times, mental-wise, everyone still has those days when it 
doesn't quite … the planets don't quite align and you think 
the worst of yourself.’ (P2) 
‘Before, the way I felt about my body was overwhelming. 
It's all I thought about, whereas now it's something that 
only really bothers me when I really think about it.  Do you 
know what I mean? Yeah, so I mean, that hasn't changed. 
I still need to work on my body image, but it's not as bad as 
it used to be.’ (P17) 
Residual non-obesity related perceived barriers to physical activity 
Lack of motivation ‘Yeah. I'm not hugely self-motivated. I have to make a 
concentrated effort to do that and that's been me, like 
through life. Even when I was involved in sport ... if I do 
something I do it at 100% but I don’t always do it for a long 
period of time. When I played football, my lack of 
dedication, I suppose, and commitment for a long period of 
time limited my career, I suppose. That's just me.’ (P19)  
Lack of time ‘Only really like … I work full time and I'm a shift-worker, 
and I also am a University student as well, part time. The 
only barriers I have now, is that sometimes I feel a bit time 
poor, like during exam week for example. I think that's a 
pretty normal or a pretty common barrier with a lot of 
people regardless of their weight or their fitness level’ 
(P17) 
 
‘Oh, I’ve done a few of the aqua-aerobics kind of classes 
and stuff, but for that you have to drive a fair distance. For 
me, we don’t have a pool that’s five minutes away. I just 
found that by the time that you leave the house and you 
get back to the house is a two-hour period. And two hours 
is a lot … it’s just too much, really, when I’m trying to fit in 
work and the kids. I have done a few bits and pieces of 
that, but it’s just time, for me, for that.’ (P6) 
 
‘Oh, time. Actually, making time.’ (P11) 
Social support 
issues 
‘If I had someone coming in every day, cooking my meals 
and telling me to get off the couch and go exercising, and 
keeping me accountable, I think I’d be a lot better. I would 
love that. If I didn’t have to cook meals, and if I had 
someone that was making me go out and exercise, that 
would be really good. I’d love that. But of course, who has 
that? Other than a celebrity …[laughter]…and I could not 
afford that ever, but even someone that could do that for 
three weeks, and get me started, and I’d see the results.’ 
(P16) 
Residual perceived facilitators to physical activity 
Residual obesity-related facilitator to physical activity 
Weight loss ‘Being lighter. Being lighter, for God’s sake. [laughs] Yeah, 
absolutely, just being lighter and just feeling great, and 
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people telling you, you look great. Far out, that is unreal.’ 
(P7) 
 
‘I guess if you have more energy (after losing weight) … if 
you get up and you feel good you feel more that you want 
to go and do exercise.’ (P5) 
 
‘I just think that because my body’s changed so much, and 
it is so much easier – I don’t have sore feet, I don’t have a 
sore knee. Do you know what I mean? It’s just easier.’ (P6) 
Perceived motivators to physical activity 
Body weight and 
appearance 
‘And I felt better and was losing weight, so it probably just 
clicked into my mind that it’s not eating much plus exercise 
equals skinnier and healthier. So something clicked, I 
suppose.’ (P3) 
 
‘Then when the weight loss slows down, and you reach a 
comfortable point, you think, “Okay, well where am I now, 
and where do I want to be?” You think, “I just want to be 
healthy, and get the best out of my body that I can.” That's 
when your attitude changes. I'm hoping that it'll help 
improve my body image, rather than seeing the loose skin 
and stuff. I think if I feel physically fit and healthy, or 
muscular, or whatever I think that it might help my body 
image as well.’ (P17) 
 
‘Fitness and that last 15 kilos. It is a little bit about weight 
loss, but it's mostly about fitness and health. Yeah, so 
fitness, to me, is being able to tolerate aerobic exercise 
where I'm getting my heart rate up.  I want to be someone 
that actually enjoys that, and I'm getting that way, yeah.’ 
(P17) 
Social interaction ‘So I guess it's the interest in … and walking the dog – the 
dog likes it, so you feel that's a nice experience for you 
both, because you've made the dog happy, and also as a 
dog owner you have a responsibility to put the dog to get 
some exercise.’ (P15) 
Enjoyment of 
activity 
‘I think it’s just a nice feeling to get out there, especially 
when the air is crisp and you feel that on your face. I like 
that feeling. It is a little bit of a stress reliever as well. You 
actually do unwind a bit more, yeah.’ (P11) 
 
‘Getting out in the fresh air. Getting out of the house, and 
getting fresh air and just wanting to get active.’ (P9) 
 
‘I don’t consciously think about it. I do what I do and I do it 
because I enjoy it. I think the main thing is I'm not 
frightened to have a go at something whereas before I 
would avoid it. I would avoid going to the beach and 
swimming and things like that, whereas now I actually … if 
I want to do that, I'll go and do it and that comes about 
through that confidence, I suppose. I’m less introverted and 
wanting to be out and about. I actually want to get out and 
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do things but I want to get out and do things at a leisurely 
pace. I'm not into sort of power walking and things like that, 
but if we had to go to a waterfall or something out in the 
bush or whatever, I'm quite happy to walk at my pace and 
go and do those things.’ (P19) 
 
